@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#a-x3k6oj30-v51yt7tbNvA>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#vKDH1NRgjUG0c_tOdVCBPw>;
                                                                        nicebnf:hasTitle """<title>Abelcet<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "abelcet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#PHP83542> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#PHP83554> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#a-x3k6oj30-v51yt7tbNvA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "test dose 1 mg, to be given over 15 minutes, then 5 mg/kg once daily for at least 14 days."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Test dose 1 mg, to be given over 15 minutes, then 5 mg/kg once daily for at least 14 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Test dose 1 mg, to be given over 15 minutes, then 5 mg/kg once daily for at least 14 days.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severeInvasiveCandidiasis>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#severeSystemicFungalInfectionsInPatientsNotRespondingToConventionalAmphotericinOrToOtherAntifungalDrugsOrWhereToxicityOrRenalImpairmentPrecludesConventionalAmphotericinIncludingInvasiveAspergillosisCryptococcalMeningitisAndDisseminatedCryptococcosisInHivPatients>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#PHP83542>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#vKDH1NRgjUG0c_tOdVCBPw> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <b>Amphotericin (lipid complex)</b>
  </p>
  <p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Glucose 5%. Allow suspension to reach room temperature, shake gently to ensure no yellow settlement, withdraw requisite dose (using 17-19 gauge needle) into one or more 20-mL syringes; replace needle on syringe with a 5-micron filter needle provided (fresh needle for each syringe) and dilute to a concentration of 1 mg/mL (2 mg/mL can be used in fluid restriction and in children); preferably give <i>via</i> an infusion pump at a rate of 2.5 mg/kg/hour (initial test dose of 1 mg over 15 minutes); an in-line filter (pore size no less than 15 micron) may be used; do not use sodium chloride or other electrolyte solutions, flush existing intravenous line with glucose 5% or use separate line.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/abelcet#PHP83554>;
                                                                                               nicebnf:hasTextContent """Amphotericin (lipid complex)

For intravenous infusion, give intermittently in Glucose 5%. Allow suspension to reach room temperature, shake gently to ensure no yellow settlement, withdraw requisite dose (using 17-19 gauge needle) into one or more 20-mL syringes; replace needle on syringe with a 5-micron filter needle provided (fresh needle for each syringe) and dilute to a concentration of 1 mg/mL (2 mg/mL can be used in fluid restriction and in children); preferably give via an infusion pump at a rate of 2.5 mg/kg/hour (initial test dose of 1 mg over 15 minutes); an in-line filter (pore size no less than 15 micron) may be used; do not use sodium chloride or other electrolyte solutions, flush existing intravenous line with glucose 5% or use separate line.

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#severeInvasiveCandidiasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe invasive candidiasis</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Severe invasive candidiasis

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "severe invasive candidiasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeSystemicFungalInfectionsInPatientsNotRespondingToConventionalAmphotericinOrToOtherAntifungalDrugsOrWhereToxicityOrRenalImpairmentPrecludesConventionalAmphotericinIncludingInvasiveAspergillosisCryptococcalMeningitisAndDisseminatedCryptococcosisInHivPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe systemic fungal infections in patients not responding to conventional amphotericin or to other antifungal drugs or where toxicity or renal impairment precludes conventional amphotericin, including invasive aspergillosis, cryptococcal meningitis and disseminated cryptococcosis in HIV patients</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                                                                                 nicebnf:hasTextContent """Severe systemic fungal infections in patients not responding to conventional amphotericin or to other antifungal drugs or where toxicity or renal impairment precludes conventional amphotericin, including invasive aspergillosis, cryptococcal meningitis and disseminated cryptococcosis in HIV patients

"""^^xsd:string;
                                                                                                                                                                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                                                                                 rdfs:label "severe systemic fungal infections in patients not responding to conventional amphotericin or to other antifungal drugs or where toxicity or renal impairment precludes conventional amphotericin, including invasive aspergillosis, cryptococcal meningitis and disseminated cryptococcosis in hiv patients"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#H6_gZ0RmTEqIJUhBfqgJtQ>;
                                                                        nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#H7NRi3KqeUuAXnquUnU10g>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#521n6Wapa0CaY6XpbbMb2g>;
                                                                        nicebnf:hasTitle """<title>Abstral<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "abstral"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#521n6Wapa0CaY6XpbbMb2g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients should be advised not to eat or drink until the tablet is completely dissolved.</p>
  <p>In patients with a dry mouth, the buccal mucosa may be moistened with water before administration of tablet.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98136>;
                                                                                               nicebnf:hasTextContent """Patients should be advised not to eat or drink until the tablet is completely dissolved.

In patients with a dry mouth, the buccal mucosa may be moistened with water before administration of tablet.

"""^^xsd:string;
                                                                                               a nicebnf:GeneralPatientAdvice,
                                                                                                 nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#H6_gZ0RmTEqIJUhBfqgJtQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (January 2009) that <i>Abstral</i><tm tmtype=\"reg\" /> sublingual tablets should be restricted for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short acting opioids are unsuitable.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98153>;
                                                                                               nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (January 2009) that Abstral sublingual tablets should be restricted for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short acting opioids are unsuitable.

"""^^xsd:string;
                                                                                               a nicebnf:FundingDecision,
                                                                                                 nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#H7NRi3KqeUuAXnquUnU10g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 100 micrograms, then 100 micrograms after 15–30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units 15–30 minutes apart, for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 2 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 100 micrograms, then 100 micrograms after 15–30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units 15–30 minutes apart, for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 2 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 100 micrograms, then 100 micrograms after 15–30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units 15–30 minutes apart, for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 2 hours between treatment of episodes of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingSublingualTablets>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98060>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98060> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98136> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/abstral#PHP98153> a nicebnf:NationalFunding.
<http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Breakthrough pain in patients receiving opioid therapy for chronic cancer pain

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "breakthrough pain in patients receiving opioid therapy for chronic cancer pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingSublingualTablets> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                         rdfs:label "by mouth using sublingual tablets"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/acea> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/acea#LahMK4gzcEauQ0EbhUI4jw>;
                                                                     nicebnf:hasTitle """<title>Acea<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                     rdfs:label "acea"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/acea#LahMK4gzcEauQ0EbhUI4jw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "apply twice daily for 8 weeks, to be applied thinly."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>Apply twice daily for 8 weeks, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """Apply twice daily for 8 weeks, to be applied thinly.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/acea#PHP83351>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/acea#PHP83351> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute inflammatory exacerbation of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Acute inflammatory exacerbation of rosacea

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "acute inflammatory exacerbation of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#Zlwg-spBZkSOMbqWAPLaCQ>;
                                                                        nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#GyXxr_YyT0W-Ll2NvqHHYw>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#iOvUNihtlkqDTXARG8CK9A>;
                                                                        nicebnf:hasTitle """<title>Aclasta<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "aclasta"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#GyXxr_YyT0W-Ll2NvqHHYw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "5 mg 1 times yearly, to be administered over at least 15 minutes, in patients with a recent low-trauma hip fracture, the dose should be given 2 or more weeks following hip fracture repair; before first infusion give 50000–125000 units of vitamin d."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5 mg 1 times yearly, to be administered over at least 15 minutes, in patients with a recent low-trauma hip fracture, the dose should be given 2 or more weeks following hip fracture repair; before first infusion give 50000–125000 units of vitamin D.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5 mg 1 times yearly, to be administered over at least 15 minutes, in patients with a recent low-trauma hip fracture, the dose should be given 2 or more weeks following hip fracture repair; before first infusion give 50000–125000 units of vitamin D.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPostmenopausalOsteoporosisAndOsteoporosisInMenIncludingCorticosteroidInducedOsteoporosis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#PHP82220>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#PHP82220> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#PHP82262> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#Zlwg-spBZkSOMbqWAPLaCQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (February 2008) that in postmenopausal women <i>Aclasta</i><tm tmtype=\"reg\" /> is accepted for restricted use within the NHS Scotland for the treatment of osteoporosis in those for whom oral treatment options for osteoporosis are inappropriate and when initiated by a specialist.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#PHP82262>;
                                                                                               nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (February 2008) that in postmenopausal women Aclasta is accepted for restricted use within the NHS Scotland for the treatment of osteoporosis in those for whom oral treatment options for osteoporosis are inappropriate and when initiated by a specialist.

"""^^xsd:string;
                                                                                               a nicebnf:FundingDecision,
                                                                                                 nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#iOvUNihtlkqDTXARG8CK9A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "5 mg 1 times yearly, to be administered over at least 15 minutes, at least 500 mg elemental calcium twice daily (with vitamin d) for at least 10 days is recommended following infusion."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5 mg 1 times yearly, to be administered over at least 15 minutes, at least 500 mg elemental calcium twice daily (with vitamin D) for at least 10 days is recommended following infusion.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5 mg 1 times yearly, to be administered over at least 15 minutes, at least 500 mg elemental calcium twice daily (with vitamin D) for at least 10 days is recommended following infusion.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPagetSDiseaseOfBone>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aclasta#PHP82220>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPagetSDiseaseOfBone> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of Paget's disease of bone</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment of Paget's disease of bone

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment of paget's disease of bone"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPostmenopausalOsteoporosisAndOsteoporosisInMenIncludingCorticosteroidInducedOsteoporosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of postmenopausal osteoporosis and osteoporosis in men (including corticosteroid-induced osteoporosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                              nicebnf:hasTextContent """Treatment of postmenopausal osteoporosis and osteoporosis in men (including corticosteroid-induced osteoporosis)

"""^^xsd:string;
                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                              rdfs:label "treatment of postmenopausal osteoporosis and osteoporosis in men (including corticosteroid-induced osteoporosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/actilyse-cathflo> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/actilyse-cathflo#cgBmrqlqpEmVYhwUH5zzRw>;
                                                                                 nicebnf:hasTitle """<title>Actilyse Cathflo<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "actilyse cathflo"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/actilyse-cathflo#PHP63398> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/actilyse-cathflo#cgBmrqlqpEmVYhwUH5zzRw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#thrombolyticTreatmentOfOccludedCentralVenousAccessDevices>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/actilyse-cathflo#PHP63398>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#thrombolyticTreatmentOfOccludedCentralVenousAccessDevices> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Thrombolytic treatment of occluded central venous access devices</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Thrombolytic treatment of occluded central venous access devices

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "thrombolytic treatment of occluded central venous access devices"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#VlW10ogwhEmqrjv92VMLQQ>;
                                                                          nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#BHbHrbBxcUaqXyOQvBw3Ew>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#SvqiwPAJVE2cizD5Hxvh_w>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#EH_yoFNxzEeLRGyKqSiOpg>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#Kbz-XiRe0kW41idLYIR4UA>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#ORgr6SMGXEyGa0GR3GJ8kA>;
                                                                          nicebnf:hasTitle """<title>Adalat<tm tmtype=\"reg\" /> LA</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "adalat la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#BHbHrbBxcUaqXyOQvBw3Ew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "30 mg once daily, increased if necessary up to 90 mg once daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>30 mg once daily, increased if necessary up to 90 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """30 mg once daily, increased if necessary up to 90 mg once daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60912>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#EH_yoFNxzEeLRGyKqSiOpg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60909>;
                                                                                                 nicebnf:hasTextContent """Dose form not appropriate.

"""^^xsd:string;
                                                                                                 a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#Kbz-XiRe0kW41idLYIR4UA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablet membrane may pass through gastro-intestinal tract unchanged, but being porous has no effect on efficacy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60876>;
                                                                                                 nicebnf:hasTextContent """Tablet membrane may pass through gastro-intestinal tract unchanged, but being porous has no effect on efficacy.

"""^^xsd:string;
                                                                                                 a nicebnf:GeneralPatientAdvice,
                                                                                                   nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#ORgr6SMGXEyGa0GR3GJ8kA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate for use where there is a history of oesophageal or gastro-intestinal obstruction, decreased lumen diameter of the gastro-intestinal tract, or inflammatory bowel disease (including Crohn's disease).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60938>;
                                                                                                 nicebnf:hasTextContent """Dose form not appropriate for use where there is a history of oesophageal or gastro-intestinal obstruction, decreased lumen diameter of the gastro-intestinal tract, or inflammatory bowel disease (including Crohn's disease).

"""^^xsd:string;
                                                                                                 a nicebnf:ImportantAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60876> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60909> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60912> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60938> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#SvqiwPAJVE2cizD5Hxvh_w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "20–30 mg once daily, increased if necessary up to 90 mg once daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20–30 mg once daily, increased if necessary up to 90 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20–30 mg once daily, increased if necessary up to 90 mg once daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60912>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#VlW10ogwhEmqrjv92VMLQQ> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#crohnSDisease>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Caution#decreasedLumenDiameterOfTheGastroIntestinalTract>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Caution#historyOfGastroIntestinalObstruction>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Caution#historyOfOesophagealObstruction>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Caution#inflammatoryBowelDisease>;
                                                                                                 nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Crohn's disease</ph>; <ph outputclass=\"caution\">decreased lumen diameter of the gastro-intestinal tract</ph>; <ph outputclass=\"caution\">history of gastro-intestinal obstruction</ph>; <ph outputclass=\"caution\">history of oesophageal obstruction</ph>; <ph outputclass=\"caution\">inflammatory bowel disease</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-la#PHP60938>;
                                                                                                 nicebnf:hasTextContent """Crohn's disease; decreased lumen diameter of the gastro-intestinal tract; history of gastro-intestinal obstruction; history of oesophageal obstruction; inflammatory bowel disease

"""^^xsd:string;
                                                                                                 a nicebnf:CautionsGroup,
                                                                                                   nicebnf:GeneralCautions.
<http://ld.nice.org.uk/ns/bnf/Caution#crohnSDisease> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Crohn's disease</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "Crohn's disease"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                     rdfs:label "crohn's disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#decreasedLumenDiameterOfTheGastroIntestinalTract> nicebnf:hasDitaContent """<ph outputclass=\"caution\">decreased lumen diameter of the gastro-intestinal tract</ph>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent "decreased lumen diameter of the gastro-intestinal tract"^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                        rdfs:label "decreased lumen diameter of the gastro-intestinal tract"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#historyOfGastroIntestinalObstruction> nicebnf:hasDitaContent """<ph outputclass=\"caution\">history of gastro-intestinal obstruction</ph>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent "history of gastro-intestinal obstruction"^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                            rdfs:label "history of gastro-intestinal obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#historyOfOesophagealObstruction> nicebnf:hasDitaContent """<ph outputclass=\"caution\">history of oesophageal obstruction</ph>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent "history of oesophageal obstruction"^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                       rdfs:label "history of oesophageal obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#inflammatoryBowelDisease> nicebnf:hasDitaContent """<ph outputclass=\"caution\">inflammatory bowel disease</ph>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent "inflammatory bowel disease"^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                rdfs:label "inflammatory bowel disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-retard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-retard#1LJ4zuo0Rkml19sZ1OHRhg>;
                                                                              nicebnf:hasTitle """<title>Adalat Retard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "adalat retard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-retard#1LJ4zuo0Rkml19sZ1OHRhg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "10 mg twice daily, adjusted according to response to 40 mg twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>10 mg twice daily, adjusted according to response to 40 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """10 mg twice daily, adjusted according to response to 40 mg twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-retard#PHP63826>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat-retard#PHP63826> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#QxSiXnbEm0iPpGl_BTRdhw>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#u9j1qgXbCESzZRZnUH75EA>;
                                                                       nicebnf:hasTitle """<title>Adalat<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "adalat"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#PHP80956> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#QxSiXnbEm0iPpGl_BTRdhw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 5 mg 3 times a day, then adjusted according to response to 20 mg 3 times a day."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 5 mg 3 times a day, then adjusted according to response to 20 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 5 mg 3 times a day, then adjusted according to response to 20 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingImmediateReleaseMedicines>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxisNotRecommended>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#raynaudSPhenomenon>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#PHP80956>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#u9j1qgXbCESzZRZnUH75EA> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>Adalat liquid gel capsules contain 5 mg nifedipine in 0.17 mL and 10 mg nifedipine in 0.34 mL.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adalat#PHP80956>;
                                                                                              nicebnf:hasTextContent """Dose equivalence and conversionAdalat liquid gel capsules contain 5 mg nifedipine in 0.17 mL and 10 mg nifedipine in 0.34 mL.

"""^^xsd:string;
                                                                                              a nicebnf:DoseEquivalence,
                                                                                                nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxisNotRecommended> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis (not recommended)</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """Angina prophylaxis (not recommended)

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "angina prophylaxis (not recommended)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#raynaudSPhenomenon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Raynaud's phenomenon</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Raynaud's phenomenon

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "raynaud's phenomenon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingImmediateReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                 rdfs:label "by mouth using immediate-release medicines"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adcortyl-intra-articularintradermal> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adcortyl-intra-articularintradermal#KC_A9CIEok233N6MM6-GKw>;
                                                                                                    nicebnf:hasTitle """<title>Adcortyl<tm tmtype=\"reg\" /> intra-articular/intradermal</title>"""^^<rdf:XMLLiteral>;
                                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                    rdfs:label "adcortyl intra-articular/intradermal"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adcortyl-intra-articularintradermal#KC_A9CIEok233N6MM6-GKw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                              rdfs:label "2.5–15 mg, adjusted according to size (for larger doses use kenalog). where appropriate dose may be repeated when relapse occurs, for details consult product literature."^^xsd:string ; 
                                                                                                                                              nicebnf:hasDitaContent """<p>2.5–15 mg, adjusted according to size (for larger doses use <i>Kenalog</i><tm tmtype=\"reg\" />). Where appropriate dose may be repeated when relapse occurs, for details consult product literature.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                                              nicebnf:hasTextContent """2.5–15 mg, adjusted according to size (for larger doses use Kenalog). Where appropriate dose may be repeated when relapse occurs, for details consult product literature.

"""^^xsd:string ; 
                                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection>],
                                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                              rdfs:label "2–3 mg, max. 5 mg at any one site (total max. 30 mg). where appropriate may be repeated at intervals of 1–2 weeks, for details consult product literature."^^xsd:string ; 
                                                                                                                                              nicebnf:hasDitaContent "<p>2–3 mg, max. 5 mg at any one site (total max. 30 mg). Where appropriate may be repeated at intervals of 1–2 weeks, for details consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                              nicebnf:hasTextContent """2–3 mg, max. 5 mg at any one site (total max. 30 mg). Where appropriate may be repeated at intervals of 1–2 weeks, for details consult product literature.

"""^^xsd:string ; 
                                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntradermalInjection>];
                                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues>;
                                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adcortyl-intra-articularintradermal#PHP83939>;
                                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adcortyl-intra-articularintradermal#PHP83939> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Local inflammation of joints and soft tissues</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Local inflammation of joints and soft tissues

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "local inflammation of joints and soft tissues"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                     rdfs:label "by intra-articular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntradermalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intradermal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#O3JdJhFTuEWA-DXDWI5fvA>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#WjUUh4sfEk6toBixSYTy8w>;
                                                                               nicebnf:hasTitle """<title>Addiphos<tm tmtype=\"reg\" /> vials</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "addiphos vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#O3JdJhFTuEWA-DXDWI5fvA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Addiphos</i>
    <tm tmtype=\"reg\" /> sterile solution contains phosphate 40 mmol, K<sup>+</sup> 30 mmol, Na<sup>+</sup> 30 mmol/20 mL.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#PHP107547>;
                                                                                                      nicebnf:hasTextContent """Addiphos sterile solution contains phosphate 40 mmol, K+ 30 mmol, Na+ 30 mmol/20 mL.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#PHP107533> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#PHP107547> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#WjUUh4sfEk6toBixSYTy8w> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to <i>Vamin</i><tm tmtype=\"reg\" /> solutions and glucose intravenous infusions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/addiphos-vials#PHP107533>;
                                                                                                      nicebnf:hasTextContent """For addition to Vamin solutions and glucose intravenous infusions.

"""^^xsd:string;
                                                                                                      a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#3x0Exhke_kGMZmkl1vBhDg>,
                                                                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#DJ_1VNPrG0G1gvACEl3UCQ>,
                                                                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#kmKVhiwRT0a4WImYu4ilgg>;
                                                                                                              nicebnf:hasTitle "<title>Additrace solution for infusion 10ml ampoules</title>"^^<rdf:XMLLiteral>;
                                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                              rdfs:label "additrace solution for infusion 10ml ampoules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#3x0Exhke_kGMZmkl1vBhDg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For patients over 40 kg.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#PHP107340>;
                                                                                                                                     nicebnf:hasTextContent """For patients over 40 kg.

"""^^xsd:string;
                                                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#DJ_1VNPrG0G1gvACEl3UCQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Additrace</i>
    <tm tmtype=\"reg\" /> solution contains traces of Fe<sup>3+</sup>, Zn<sup>2+</sup>, Mn<sup>2+</sup>, Cu<sup>2+</sup>, Cr<sup>3+</sup>, Se<sup>4+</sup>, Mo<sup>6+</sup>, F<sup>-</sup>, I<sup>-</sup>. </p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#PHP107340>;
                                                                                                                                     nicebnf:hasTextContent """Additrace solution contains traces of Fe3+, Zn2+, Mn2+, Cu2+, Cr3+, Se4+, Mo6+, F-, I-. 

"""^^xsd:string;
                                                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#PHP107300> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#PHP107340> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#kmKVhiwRT0a4WImYu4ilgg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For adddition to <i>Vamin</i><tm tmtype=\"reg\" /> solutions and glucose intravenous infusions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/additrace-solution-for-infusion-10ml-ampoules#PHP107300>;
                                                                                                                                     nicebnf:hasTextContent """For adddition to Vamin solutions and glucose intravenous infusions.

"""^^xsd:string;
                                                                                                                                     a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-mr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-mr#m1-7iEAheEu6zRt6Vo1DOA>;
                                                                           nicebnf:hasTitle """<title>Adipine<tm tmtype=\"reg\" /> MR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "adipine mr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-mr#PHP63480> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-mr#m1-7iEAheEu6zRt6Vo1DOA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "10 mg twice daily, adjusted according to response to 40 mg twice daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>10 mg twice daily, adjusted according to response to 40 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """10 mg twice daily, adjusted according to response to 40 mg twice daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-mr#PHP63480>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-xl#cNt6ZgRx6EOLbE10pYFm9g>;
                                                                           nicebnf:hasTitle """<title>Adipine<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "adipine xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-xl#PHP62932> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-xl#cNt6ZgRx6EOLbE10pYFm9g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "30 mg daily, increased if necessary up to 90 mg daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>30 mg daily, increased if necessary up to 90 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """30 mg daily, increased if necessary up to 90 mg daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adipine-xl#PHP62932>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#Hh3VvQF3M0-WVKikVmYvPw>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#j6Fqi6wVx0eXXMsO4p2dyQ>;
                                                                                   nicebnf:hasTitle """<title>Adizem-SR<tm tmtype=\"reg\" /> Capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "adizem-sr capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#Hh3VvQF3M0-WVKikVmYvPw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "120 mg twice daily, dose form not appropriate for initial dose titration."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>120 mg twice daily, dose form not appropriate for initial dose titration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """120 mg twice daily, dose form not appropriate for initial dose titration.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#PHP60617>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#PHP60617> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#j6Fqi6wVx0eXXMsO4p2dyQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-capsules#PHP60617>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#FonzyrLJtEG1MMNXqsI19g>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#YqzYqsL_nE6hTQIlnzQmpQ>;
                                                                                  nicebnf:hasTitle """<title>Adizem-SR<tm tmtype=\"reg\" /> Tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "adizem-sr tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#FonzyrLJtEG1MMNXqsI19g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "120 mg twice daily, dose form not appropriate for initial dose titration."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>120 mg twice daily, dose form not appropriate for initial dose titration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """120 mg twice daily, dose form not appropriate for initial dose titration.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#PHP60392>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#PHP60392> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#YqzYqsL_nE6hTQIlnzQmpQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Initially 90 mg twice daily; increased if necessary to 180 mg twice daily, dose form not appropriate for initial dose titration in the elderly.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-sr-tablets#PHP60392>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#1YyE8c8GUkClKWBAzXTLyg>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#DhWWDl5REEWJNmugmXHtEA>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#bOogFLj9K0SYuyuRo_5smw>;
                                                                          nicebnf:hasTitle """<title>Adizem-XL<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "adizem-xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#1YyE8c8GUkClKWBAzXTLyg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 240 mg daily, increased if necessary to 300 mg daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 240 mg daily, increased if necessary to 300 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 240 mg daily, increased if necessary to 300 mg daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "initially 120 mg daily, increased if necessary up to 300 mg daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 120 mg daily, increased if necessary up to 300 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 120 mg daily, increased if necessary up to 300 mg daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60214>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#DhWWDl5REEWJNmugmXHtEA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60204>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60204> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60209> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60214> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#bOogFLj9K0SYuyuRo_5smw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adizem-xl#PHP60209>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#EoYQJRHtNEaY3CpvEyeZQQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#G-IkzZ6940Wcvq6X8I59mg>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#IARSksY6A0y7BM5_C-eD_w>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#aO8j_Nv7b0m8UMfmRE3rhA>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#fgY7-2hKTkG2WK8nCYhjIQ>;
                                                                        nicebnf:hasTitle """<title>Adoport<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "adoport"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#EoYQJRHtNEaY3CpvEyeZQQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#G-IkzZ6940Wcvq6X8I59mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#IARSksY6A0y7BM5_C-eD_w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#aO8j_Nv7b0m8UMfmRE3rhA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#fgY7-2hKTkG2WK8nCYhjIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/adoport#PHP80219>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#MGAfKgyFsUaQ9OANJ5gzUg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#R0Jm3ST0-0SEnw-fotBN5g>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#h8FLN0Ma2U-1DgPBGGT-wQ>;
                                                                         nicebnf:hasTitle """<title>Advagraf<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "advagraf"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#MGAfKgyFsUaQ9OANJ5gzUg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "200–300 micrograms/kg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>200–300 micrograms/kg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """200–300 micrograms/kg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#PHP80200>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#PHP80200> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#R0Jm3ST0-0SEnw-fotBN5g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "100–200 micrograms/kg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>100–200 micrograms/kg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """100–200 micrograms/kg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting1218HoursAfterTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#PHP80200>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#h8FLN0Ma2U-1DgPBGGT-wQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/advagraf#PHP80200>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting1218HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12–18 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                        nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12–18 hours after transplantation

"""^^xsd:string;
                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                        rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12–18 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#iaQna96jrka7H8Ss828C2g>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#2osA4M-eQ0WB86q4eEz1mw>;
                                                                         nicebnf:hasTitle """<title>Afinitor<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "afinitor"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#2osA4M-eQ0WB86q4eEz1mw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "10 mg once daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>10 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """10 mg once daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAdvancedRenalCellCarcinomaWhenTheDiseaseHasProgressedDespiteTreatmentWithVascularEndothelialGrowthFactorTargetedTherapy>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHormoneReceptorPositiveHumanEpidermalGrowthFactor2Her2NegativeAdvancedBreastCancerInCombinationWithExemestaneInPostmenopausalWomenWithoutSymptomaticVisceralDiseaseAfterRecurrenceOrProgressionFollowingANonSteroidalAromataseInhibitor>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfUnresectableOrMetastaticWellOrModeratelyDifferentiatedNeuroendocrineTumoursOfPancreaticOrigin>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#PHP79863>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#PHP79863> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#PHP79921> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#iaQna96jrka7H8Ss828C2g> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (April 2012) that everolimus (<i>Afinitor</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland for the treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumours of pancreatic origin (pNET) in adults with progressive disease.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/afinitor#PHP79921>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (April 2012) that everolimus (Afinitor) is accepted for restricted use within NHS Scotland for the treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumours of pancreatic origin (pNET) in adults with progressive disease.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAdvancedRenalCellCarcinomaWhenTheDiseaseHasProgressedDespiteTreatmentWithVascularEndothelialGrowthFactorTargetedTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of advanced renal cell carcinoma when the disease has progressed despite treatment with vascular endothelial growth factor-targeted therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                             nicebnf:hasTextContent """Treatment of advanced renal cell carcinoma when the disease has progressed despite treatment with vascular endothelial growth factor-targeted therapy

"""^^xsd:string;
                                                                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                             rdfs:label "treatment of advanced renal cell carcinoma when the disease has progressed despite treatment with vascular endothelial growth factor-targeted therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHormoneReceptorPositiveHumanEpidermalGrowthFactor2Her2NegativeAdvancedBreastCancerInCombinationWithExemestaneInPostmenopausalWomenWithoutSymptomaticVisceralDiseaseAfterRecurrenceOrProgressionFollowingANonSteroidalAromataseInhibitor> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of hormone-receptor-positive, human epidermal growth factor-2 (HER-2) negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                                                             nicebnf:hasTextContent """Treatment of hormone-receptor-positive, human epidermal growth factor-2 (HER-2) negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor

"""^^xsd:string;
                                                                                                                                                                                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                                                             rdfs:label "treatment of hormone-receptor-positive, human epidermal growth factor-2 (her-2) negative advanced breast cancer, in combination with exemestane, in postmenopausal women without symptomatic visceral disease after recurrence or progression following a non-steroidal aromatase inhibitor"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfUnresectableOrMetastaticWellOrModeratelyDifferentiatedNeuroendocrineTumoursOfPancreaticOrigin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumours of pancreatic origin</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                   nicebnf:hasTextContent """Treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumours of pancreatic origin

"""^^xsd:string;
                                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                   rdfs:label "treatment of unresectable or metastatic, well- or moderately-differentiated neuroendocrine tumours of pancreatic origin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/alateris> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/alateris#TLuYXUqV4Eyv5OD6nZd4NA>;
                                                                         nicebnf:hasTitle """<title>Alateris<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "alateris"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/alateris#PHP83971> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/alateris#TLuYXUqV4Eyv5OD6nZd4NA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "2 tablets once daily, review treatment if no benefit after 2–3 months."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>2 tablets once daily, review treatment if no benefit after 2–3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """2 tablets once daily, review treatment if no benefit after 2–3 months.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/alateris#PHP83971>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic relief of mild to moderate osteoarthritis of the knee</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Symptomatic relief of mild to moderate osteoarthritis of the knee

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "symptomatic relief of mild to moderate osteoarthritis of the knee"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#FH05sDMmoEWzsbmU8vLGHQ>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#bKLA8--hHkSoCs_zmAmo4Q>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#hmGtmdpGvUe7xZw-WimsnQ>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#fttvmtP5x0K63Syk2iqCrQ>;
                                                                       nicebnf:hasTitle """<title>Aldara<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "aldara"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#FH05sDMmoEWzsbmU8vLGHQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 3 times a week for 4 weeks, to be applied to lesion at night, assess response after a 4 week treatment-free interval; repeat 4-week course if lesions persist, maximum 2 courses."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 3 times a week for 4 weeks, to be applied to lesion at night, assess response after a 4 week treatment-free interval; repeat 4-week course if lesions persist, maximum 2 courses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 3 times a week for 4 weeks, to be applied to lesion at night, assess response after a 4 week treatment-free interval; repeat 4-week course if lesions persist, maximum 2 courses.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82476>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82476> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82506> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#bKLA8--hHkSoCs_zmAmo4Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 3 times a week until lesions resolve (maximum 16 weeks), to be applied thinly at night."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 3 times a week until lesions resolve (maximum 16 weeks), to be applied thinly at night.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 3 times a week until lesions resolve (maximum 16 weeks), to be applied thinly at night.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#wartsExternalGenitalAndPerianal>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82476>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#fttvmtP5x0K63Syk2iqCrQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Should be rubbed in and allowed to stay on the treated area for 6–10 hours for warts or for 8 hours for basal cell carcinoma and actinic keratosis, then washed off with mild soap and water (uncircumcised males treating warts under foreskin should wash the area daily). The cream should be washed off before sexual contact.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82506>;
                                                                                              nicebnf:hasTextContent """Should be rubbed in and allowed to stay on the treated area for 6–10 hours for warts or for 8 hours for basal cell carcinoma and actinic keratosis, then washed off with mild soap and water (uncircumcised males treating warts under foreskin should wash the area daily). The cream should be washed off before sexual contact.

"""^^xsd:string;
                                                                                              nicebnf:hasTitle "Important"^^xsd:string;
                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#hmGtmdpGvUe7xZw-WimsnQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply daily for 5 nights of each week for 6 weeks, to be applied to lesion and 1 cm beyond it, assess response 12 weeks after completing treatment."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply daily for 5 nights of each week for 6 weeks, to be applied to lesion and 1 cm beyond it, assess response 12 weeks after completing treatment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply daily for 5 nights of each week for 6 weeks, to be applied to lesion and 1 cm beyond it, assess response 12 weeks after completing treatment.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#superficialBasalCellCarcinoma>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aldara#PHP82476>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Actinic keratosis</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Actinic keratosis

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "actinic keratosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#superficialBasalCellCarcinoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Superficial basal cell carcinoma</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Superficial basal cell carcinoma

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "superficial basal cell carcinoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#wartsExternalGenitalAndPerianal> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Warts (external genital and perianal)</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """Warts (external genital and perianal)

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "warts (external genital and perianal)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#0JSNQzpHi0ydRxuHM4C1Ng>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#JKnMpQQYWU6VLllnRvloyA>;
                                                                                        nicebnf:hasTitle """<title>Alphosyl 2 in 1<tm tmtype=\"reg\" /> shampoo</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "alphosyl 2 in 1 shampoo"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#0JSNQzpHi0ydRxuHM4C1Ng> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "apply 1–2 times a week as required."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Apply 1–2 times a week as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Apply 1–2 times a week as required.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dandruff>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#PHP107136>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#JKnMpQQYWU6VLllnRvloyA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "apply every 2–3 days."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Apply every 2–3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Apply every 2–3 days.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#itching>,
                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>,
                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#scaling>,
                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#seborrhoeicDermatitis>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#PHP107136>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/alphosyl-2-in-1-shampoo#PHP107136> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dandruff> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dandruff</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Dandruff

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "dandruff"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#itching> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Itching</p>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent """Itching

"""^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                  rdfs:label "itching"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#scaling> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Scaling</p>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent """Scaling

"""^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                  rdfs:label "scaling"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#seborrhoeicDermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Seborrhoeic dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Seborrhoeic dermatitis

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "seborrhoeic dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#Ri7z_MEcWk-FnOEZ9cHahA>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#KiCS1yVW_0eCy9vIuPqRuA>;
                                                                        nicebnf:hasTitle """<title>Ambirix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "ambirix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#KiCS1yVW_0eCy9vIuPqRuA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Primary course should be completed with <i>Ambirix</i><tm tmtype=\"reg\" /> (single component vaccines given at appropriate intervals may be used for booster dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#PHP96235>;
                                                                                               nicebnf:hasTextContent """Primary course should be completed with Ambirix (single component vaccines given at appropriate intervals may be used for booster dose).

"""^^xsd:string;
                                                                                               a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#PHP96201> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#PHP96235> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#Ri7z_MEcWk-FnOEZ9cHahA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> ; 
                                                                                                                  rdfs:label "initially 1 ml for 1 dose, then 1 ml after 6–12 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 6–12 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 6–12 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambirix#PHP96201>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent """Immunisation against hepatitis A and hepatitis B infection

"""^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                              rdfs:label "immunisation against hepatitis a and hepatitis b infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–15 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#EDyZkQ4AxkeXY6syXMkA5g>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#oEI7be4u8EGzTRLLOnJcEQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#xyCHg_G3B0e7fOWC-qbCfw>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#RRNF_TRu4UqMJg9E5alH7w>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#VTMF0dV3QkGJy1Wvbe3Z_Q>;
                                                                         nicebnf:hasTitle """<title>AmBisome<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "ambisome"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#EDyZkQ4AxkeXY6syXMkA5g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severeSystemicOrDeepMycosesWhereToxicityParticularlyNephrotoxicityPrecludesUseOfConventionalAmphotericin>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#suspectedOrProvenInfectionInFebrileNeutropenicPatientsUnresponsiveToBroadSpectrumAntibacterials>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83590>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83590> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83597> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83598> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#RRNF_TRu4UqMJg9E5alH7w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Use at the maximum dose of 5 mg/kg once daily is an unlicensed dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83597>;
                                                                                                nicebnf:hasTextContent """Use at the maximum dose of 5 mg/kg once daily is an unlicensed dose.

"""^^xsd:string;
                                                                                                a nicebnf:UnlicencedUse.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#VTMF0dV3QkGJy1Wvbe3Z_Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <b>Amphotericin (liposomal)</b>
  </p>
  <p>For <i>intravenous infusion</i> (<i>AmBisome</i><tm tmtype=\"reg\" />), give intermittently <i>in</i> Glucose 5% or 10%. Reconstitute each vial with 12 mL water for injections and shake vigorously to produce a preparation containing 4 mg/mL; withdraw requisite dose from vial and introduce into infusion fluid through the 5 micron filter provided to produce a final concentration of 0.2–2 mg/mL; infuse over 30–60 minutes, or if non-anaphylactic infusion-related reactions occur infuse over 2 hours (initial test dose of 1 mg over 10 minutes); an in-line filter (pore size no less than 1 micron) may be used; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or 10%, or use separate line.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83598>;
                                                                                                nicebnf:hasTextContent """Amphotericin (liposomal)

For intravenous infusion (AmBisome), give intermittently in Glucose 5% or 10%. Reconstitute each vial with 12 mL water for injections and shake vigorously to produce a preparation containing 4 mg/mL; withdraw requisite dose from vial and introduce into infusion fluid through the 5 micron filter provided to produce a final concentration of 0.2–2 mg/mL; infuse over 30–60 minutes, or if non-anaphylactic infusion-related reactions occur infuse over 2 hours (initial test dose of 1 mg over 10 minutes); an in-line filter (pore size no less than 1 micron) may be used; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or 10%, or use separate line.

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#oEI7be4u8EGzTRLLOnJcEQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Test dose 1 mg, to be given over 10 minutes, then 3 mg/kg once daily; maximum 5 mg/kg per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aspergillosis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83590>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#xyCHg_G3B0e7fOWC-qbCfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1–3 mg/kg daily for 10–21 days to a cumulative dose of 21–30 mg/kg, alternatively 3 mg/kg for 5 consecutive days, followed by 3 mg/kg after 6 days for 1 dose."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1–3 mg/kg daily for 10–21 days to a cumulative dose of 21–30 mg/kg, alternatively 3 mg/kg for 5 consecutive days, followed by 3 mg/kg after 6 days for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1–3 mg/kg daily for 10–21 days to a cumulative dose of 21–30 mg/kg, alternatively 3 mg/kg for 5 consecutive days, followed by 3 mg/kg after 6 days for 1 dose.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#visceralLeishmaniasisUnresponsiveToTheAntimonialAlone>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ambisome#PHP83590>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#aspergillosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Aspergillosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Aspergillosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "aspergillosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeSystemicOrDeepMycosesWhereToxicityParticularlyNephrotoxicityPrecludesUseOfConventionalAmphotericin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe systemic or deep mycoses where toxicity (particularly nephrotoxicity) precludes use of conventional amphotericin</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                   nicebnf:hasTextContent """Severe systemic or deep mycoses where toxicity (particularly nephrotoxicity) precludes use of conventional amphotericin

"""^^xsd:string;
                                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                   rdfs:label "severe systemic or deep mycoses where toxicity (particularly nephrotoxicity) precludes use of conventional amphotericin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#suspectedOrProvenInfectionInFebrileNeutropenicPatientsUnresponsiveToBroadSpectrumAntibacterials> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Suspected or proven infection in febrile neutropenic patients unresponsive to broad-spectrum antibacterials</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Suspected or proven infection in febrile neutropenic patients unresponsive to broad-spectrum antibacterials

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "suspected or proven infection in febrile neutropenic patients unresponsive to broad-spectrum antibacterials"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#visceralLeishmaniasisUnresponsiveToTheAntimonialAlone> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Visceral leishmaniasis (unresponsive to the antimonial alone)</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Visceral leishmaniasis (unresponsive to the antimonial alone)

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "visceral leishmaniasis (unresponsive to the antimonial alone)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/anabact> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/anabact#qLjJ4WEoyUiyxKZ7vCwvlQ>;
                                                                        nicebnf:hasTitle """<title>Anabact<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "anabact"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/anabact#PHP84114> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/anabact#qLjJ4WEoyUiyxKZ7vCwvlQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#malodorousFungatingTumoursAndMalodorousGravitationalAndDecubitusUlcers>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/anabact#PHP84114>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#malodorousFungatingTumoursAndMalodorousGravitationalAndDecubitusUlcers> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Malodorous fungating tumours and malodorous gravitational and decubitus ulcers</p>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasTextContent """Malodorous fungating tumours and malodorous gravitational and decubitus ulcers

"""^^xsd:string;
                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                 rdfs:label "malodorous fungating tumours and malodorous gravitational and decubitus ulcers"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ancora-375-cu> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ancora-375-cu#dxxwK2bFLUCGOlfiWmo_qA>;
                                                                              nicebnf:hasTitle """<title>Ancora<tm tmtype=\"reg\" /> 375 Cu</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "ancora 375 cu"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ancora-375-cu#PHP105480> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ancora-375-cu#dxxwK2bFLUCGOlfiWmo_qA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length over 6.5 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ancora-375-cu#PHP105480>;
                                                                                                     nicebnf:hasTextContent """For uterine length over 6.5 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                     a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-sr#nVk_Dfo2dUKzf1w50n4--Q>;
                                                                           nicebnf:hasTitle """<title>Angitil<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "angitil sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-sr#PHP63831> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-sr#nVk_Dfo2dUKzf1w50n4--Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 90 mg twice daily; increased if necessary to 120–180 mg twice daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 90 mg twice daily; increased if necessary to 120–180 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 90 mg twice daily; increased if necessary to 120–180 mg twice daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-sr#PHP63831>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#iEyDE96uVkSWLScdwufXdg>;
                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#AvGkyEiALk-x0j56KR_yKg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#G2OtIcdVJkChyX3rTML-Xw>;
                                                                           nicebnf:hasTitle """<title>Angitil<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "angitil xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#AvGkyEiALk-x0j56KR_yKg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate for initial dose titration.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63338>;
                                                                                                  nicebnf:hasTextContent """Dose form not appropriate for initial dose titration.

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#G2OtIcdVJkChyX3rTML-Xw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate for initial dose titration.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63315>;
                                                                                                  nicebnf:hasTextContent """Dose form not appropriate for initial dose titration.

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63315> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63338> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63363> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#iEyDE96uVkSWLScdwufXdg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 240 mg daily; increased if necessary to 300 mg daily, dose form not appropriate for initial dose titration in the elderly."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 240 mg daily; increased if necessary to 300 mg daily, dose form not appropriate for initial dose titration in the elderly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 240 mg daily; increased if necessary to 300 mg daily, dose form not appropriate for initial dose titration in the elderly.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/angitil-xl#PHP63363>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#pgGqEywfbECNuD8CV4IkUQ>;
                                                                                               nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#QL-fMx2W80mdPkWq-EgQfQ>;
                                                                                               nicebnf:hasTitle """<title>Aprokam<tm tmtype=\"reg\" /> intracameral injection</title>"""^^<rdf:XMLLiteral>;
                                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                                               rdfs:label "aprokam intracameral injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#PHP106990> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#PHP107006> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#QL-fMx2W80mdPkWq-EgQfQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                         rdfs:label "1 mg, dose to be injected into the anterior chamber of the eye at the end of cataract surgery."^^xsd:string ; 
                                                                                                                                         nicebnf:hasDitaContent "<p>1 mg, dose to be injected into the anterior chamber of the eye at the end of cataract surgery.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                         nicebnf:hasTextContent """1 mg, dose to be injected into the anterior chamber of the eye at the end of cataract surgery.

"""^^xsd:string ; 
                                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracameralInjection>];
                                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfEndophthalmitisAfterCataractSurgery>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#PHP107006>;
                                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#pgGqEywfbECNuD8CV4IkUQ> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#combinedOperationsWithCataractSurgery>,
                                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Caution#complicatedCataracts>,
                                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Caution#reducedCornealEndothelialCellsLessThan2000>,
                                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Caution#severeRiskOfInfection>,
                                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Caution#severeThyroidDisease>;
                                                                                                                      nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Combined operations with cataract surgery</ph>; <ph outputclass=\"caution\">complicated cataracts</ph>; <ph outputclass=\"caution\">reduced corneal endothelial cells (less than 2000)</ph>; <ph outputclass=\"caution\">severe risk of infection</ph>; <ph outputclass=\"caution\">severe thyroid disease</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aprokam-intracameral-injection#PHP106990>;
                                                                                                                      nicebnf:hasTextContent """Combined operations with cataract surgery; complicated cataracts; reduced corneal endothelial cells (less than 2000); severe risk of infection; severe thyroid disease

"""^^xsd:string;
                                                                                                                      a nicebnf:CautionsGroup,
                                                                                                                        nicebnf:GeneralCautions.
<http://ld.nice.org.uk/ns/bnf/Caution#combinedOperationsWithCataractSurgery> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Combined operations with cataract surgery</ph>"""^^<rdf:XMLLiteral>;
                                                                             nicebnf:hasTextContent "Combined operations with cataract surgery"^^xsd:string;
                                                                             a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                             rdfs:label "combined operations with cataract surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#complicatedCataracts> nicebnf:hasDitaContent """<ph outputclass=\"caution\">complicated cataracts</ph>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent "complicated cataracts"^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                            rdfs:label "complicated cataracts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#reducedCornealEndothelialCellsLessThan2000> nicebnf:hasDitaContent """<ph outputclass=\"caution\">reduced corneal endothelial cells (less than 2000)</ph>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent "reduced corneal endothelial cells (less than 2000)"^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                  rdfs:label "reduced corneal endothelial cells (less than 2000)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#severeRiskOfInfection> nicebnf:hasDitaContent """<ph outputclass=\"caution\">severe risk of infection</ph>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent "severe risk of infection"^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                             rdfs:label "severe risk of infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#severeThyroidDisease> nicebnf:hasDitaContent """<ph outputclass=\"caution\">severe thyroid disease</ph>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent "severe thyroid disease"^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                            rdfs:label "severe thyroid disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfEndophthalmitisAfterCataractSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of endophthalmitis after cataract surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                           nicebnf:hasTextContent """Prophylaxis of endophthalmitis after cataract surgery

"""^^xsd:string;
                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                           rdfs:label "prophylaxis of endophthalmitis after cataract surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntracameralInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by intracameral injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquadrate> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/aquadrate#19tSjaTQn0uTN-XqYtgpUw>;
                                                                          nicebnf:hasTitle """<title>Aquadrate<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "aquadrate"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquadrate#19tSjaTQn0uTN-XqYtgpUw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                    rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aquadrate#PHP105757>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquadrate#PHP105757> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquamax-wash> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/aquamax-wash#3a8sCm0lM02M_Ydiub4BdA>;
                                                                             nicebnf:hasTitle """<title>Aquamax<tm tmtype=\"reg\" /> wash</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "aquamax wash"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquamax-wash#3a8sCm0lM02M_Ydiub4BdA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                       rdfs:label "to be applied to wet or dry skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>To be applied to wet or dry skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """To be applied to wet or dry skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "to be applied to wet or dry skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>To be applied to wet or dry skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """To be applied to wet or dry skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/aquamax-wash#PHP105758>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/aquamax-wash#PHP105758> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Dry skin conditions

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "dry skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/arimidex> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/arimidex#mXvzkWABpEmU_QvGQbJpGA>;
                                                                         nicebnf:hasTitle """<title>Arimidex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "arimidex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arimidex#PHP79818> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arimidex#mXvzkWABpEmU_QvGQbJpGA> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (August 2005 and October 2006) that anastrozole (<i>Arimidex</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland, within the licensed indications, for early breast cancer and early invasive breast cancer.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/arimidex#PHP79818>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (August 2005 and October 2006) that anastrozole (Arimidex) is accepted for restricted use within NHS Scotland, within the licensed indications, for early breast cancer and early invasive breast cancer.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-50200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-50200#CMhA71LqaU2UJ99v8XGQiQ>;
                                                                                nicebnf:hasTitle """<title>Arthrotec<tm tmtype=\"reg\" /> 50/200</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "arthrotec 50/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-50200#CMhA71LqaU2UJ99v8XGQiQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 tablet 2–3 times a day, take with food."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 tablet 2–3 times a day, take with food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 tablet 2–3 times a day, take with food.

"""^^xsd:string];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-50200#PHP95489>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-50200#PHP95489> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                    nicebnf:hasTextContent """Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis

"""^^xsd:string;
                                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                    rdfs:label "prophylaxis against nsaid-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-75200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-75200#WOT07uCwbUaDVUzRAaDlKg>;
                                                                                nicebnf:hasTitle """<title>Arthrotec<tm tmtype=\"reg\" /> 75/200</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "arthrotec 75/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-75200#PHP95522> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-75200#WOT07uCwbUaDVUzRAaDlKg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 tablet twice daily, take with food."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 tablet twice daily, take with food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 tablet twice daily, take with food.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/arthrotec-75200#PHP95522>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                    nicebnf:hasTextContent """Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis

"""^^xsd:string;
                                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                    rdfs:label "prophylaxis against nsaid-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#QJOvFNIqrUeRSIy0UE44Xg>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#Uni4Yhc4XUOXBDgWBkUGFw>;
                                                                                  nicebnf:hasTitle """<title>Asacol<tm tmtype=\"reg\" /> foam enema</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "asacol foam enema"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#PHP83130> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#QJOvFNIqrUeRSIy0UE44Xg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 g daily for 4–6 weeks, to be administered into the rectum."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 g daily for 4–6 weeks, to be administered into the rectum.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 g daily for 4–6 weeks, to be administered into the rectum.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectosigmoidRegion>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#PHP83130>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#Uni4Yhc4XUOXBDgWBkUGFw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "2 g once daily for 4–6 weeks, to be administered into the rectum."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>2 g once daily for 4–6 weeks, to be administered into the rectum.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """2 g once daily for 4–6 weeks, to be administered into the rectum.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheDescendingColon>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-foam-enema#PHP83130>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheDescendingColon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis, affecting the descending colon</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis, affecting the descending colon

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis, affecting the descending colon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectosigmoidRegion> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis, affecting the rectosigmoid region</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis, affecting the rectosigmoid region

"""^^xsd:string;
                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis, affecting the rectosigmoid region"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#Rvo1qqM-eEyZ15odlCcFvQ>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#YM8YGQ76W0G43M6uDMVb-w>;
                                                                                        nicebnf:hasTitle """<title>Asacol<tm tmtype=\"reg\" /> MR 400mg tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "asacol mr 400mg tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#PHP83194> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#Rvo1qqM-eEyZ15odlCcFvQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                  rdfs:label "800 mg 3 times a day."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>800 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """800 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#PHP83194>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#YM8YGQ76W0G43M6uDMVb-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                  rdfs:label "400–800 mg 2–3 times a day."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>400–800 mg 2–3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """400–800 mg 2–3 times a day.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "1.2–2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>1.2–2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """1.2–2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitisAndCrohnSIleoColitis>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-400mg-tablets#PHP83194>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitisAndCrohnSIleoColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis and Crohn's ileo-colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis and Crohn's ileo-colitis

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "maintenance of remission of ulcerative colitis and crohn's ileo-colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#Abiay-3xV0CHHGHOnPulZw>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#L1rlsOP7oUij5KkCsNFMmg>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#mMlwlURl2U63O3f9RQnr5Q>;
                                                                                        nicebnf:hasTitle """<title>Asacol<tm tmtype=\"reg\" /> MR 800mg tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "asacol mr 800mg tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#Abiay-3xV0CHHGHOnPulZw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "2.4–4.8 g daily in divided doses."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>2.4–4.8 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """2.4–4.8 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#PHP83223>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#L1rlsOP7oUij5KkCsNFMmg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "up to 2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Up to 2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Up to 2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfCrohnSIleoColitis>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#PHP83223>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#PHP83223> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#mMlwlURl2U63O3f9RQnr5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "up to 2.4 g once daily, alternatively up to 2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Up to 2.4 g once daily, alternatively up to 2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Up to 2.4 g once daily, alternatively up to 2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-mr-800mg-tablets#PHP83223>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfCrohnSIleoColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of Crohn's ileo-colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of Crohn's ileo-colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of crohn's ileo-colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-suppositories> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-suppositories#f65rJ0zg-ky-oZwe_JCeKA>;
                                                                                     nicebnf:hasTitle """<title>Asacol<tm tmtype=\"reg\" /> suppositories</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "asacol suppositories"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-suppositories#PHP83162> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-suppositories#f65rJ0zg-ky-oZwe_JCeKA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "0.75–1.5 g daily in divided doses, last dose to be administered at bedtime."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>0.75–1.5 g daily in divided doses, last dose to be administered at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """0.75–1.5 g daily in divided doses, last dose to be administered at bedtime.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAndMaintenanceOfRemission>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asacol-suppositories#PHP83162>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAndMaintenanceOfRemission> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis and maintenance of remission</p>"""^^<rdf:XMLLiteral>;
                                                                                                                           nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis and maintenance of remission

"""^^xsd:string;
                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                           rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis and maintenance of remission"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmabec-clickhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmabec-clickhaler#w-aOEp1cR02rZ4vkorULWg>;
                                                                                   nicebnf:hasTitle """<title>Asmabec Clickhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "asmabec clickhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmabec-clickhaler#PHP83018> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmabec-clickhaler#w-aOEp1cR02rZ4vkorULWg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                             rdfs:label "100–200 micrograms twice daily, dose to be adjusted as necessary."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>100–200 micrograms twice daily, dose to be adjusted as necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """100–200 micrograms twice daily, dose to be adjusted as necessary.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                             rdfs:label "100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """100–400 micrograms twice daily (max. per dose 1 mg twice daily), dose to be adjusted as necessary.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmabec-clickhaler#PHP83018>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#JJDg1MkQ6UyhXcLTdJXYAw>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#XLI-nPPMEUO3sH1Wd8u3XA>;
                                                                                   nicebnf:hasTitle """<title>Asmasal Clickhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "asmasal clickhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#JJDg1MkQ6UyhXcLTdJXYAw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1–2 puffs, up to 4 times daily for persistent symptoms."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1–2 puffs, up to 4 times daily for persistent symptoms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1–2 puffs, up to 4 times daily for persistent symptoms.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#PHP82493>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#PHP82493> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#XLI-nPPMEUO3sH1Wd8u3XA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1–2 puffs."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1–2 puffs.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1–2 puffs.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/asmasal-clickhaler#PHP82493>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Acute bronchospasm

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "acute bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Prophylaxis of allergen- or exercise-induced bronchospasm

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "prophylaxis of allergen- or exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#0aQpXQ-AoUey-fE02bfyKQ>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#KP7IBNmLA0W1JBjVjqdw6A>;
                                                                             nicebnf:hasTitle """<title>Avamys<tm tmtype=\"reg\" /> spray</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "avamys spray"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#0aQpXQ-AoUey-fE02bfyKQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "55 micrograms once daily, dose to be sprayed into each nostril, reduced to 27.5 micrograms once daily, to be sprayed into each nostril, dose to be reduced once control achieved; use minimum effective dose."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>55 micrograms once daily, dose to be sprayed into each nostril, reduced to 27.5 micrograms once daily, to be sprayed into each nostril, dose to be reduced once control achieved; use minimum effective dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """55 micrograms once daily, dose to be sprayed into each nostril, reduced to 27.5 micrograms once daily, to be sprayed into each nostril, dose to be reduced once control achieved; use minimum effective dose.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAndTreatmentOfAllergicRhinitis>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#PHP106723>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#KP7IBNmLA0W1JBjVjqdw6A> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 spray equivalent to 27.5 micrograms.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#PHP106723>;
                                                                                                    nicebnf:hasTextContent """Dose equivalence and conversion1 spray equivalent to 27.5 micrograms.

"""^^xsd:string;
                                                                                                    a nicebnf:DoseEquivalence,
                                                                                                      nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avamys-spray#PHP106723> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAndTreatmentOfAllergicRhinitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis and treatment of allergic rhinitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Prophylaxis and treatment of allergic rhinitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "prophylaxis and treatment of allergic rhinitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/avaxim> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/avaxim#YEEYiD-Mo0iSWg-GEvoHSg>;
                                                                       nicebnf:hasTitle """<title>Avaxim<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "avaxim"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avaxim#PHP81418> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avaxim#YEEYiD-Mo0iSWg-GEvoHSg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/avaxim#PHP81418>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis A infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis a infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-injection#xMiyv0AQNUCb6CIu3PydGw>;
                                                                                 nicebnf:hasTitle """<title>Avonex<tm tmtype=\"reg\" /> injection</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "avonex injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-injection#PHP79508> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-injection#xMiyv0AQNUCb6CIu3PydGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-injection#PHP79508>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-vial> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-vial#QheDRR7fikSgmuaaVbZRKQ>;
                                                                            nicebnf:hasTitle """<title>Avonex<tm tmtype=\"reg\" /> vial</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "avonex vial"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-vial#PHP79272> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-vial#QheDRR7fikSgmuaaVbZRKQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/avonex-vial#PHP79272>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#Vq8U9rPabkuwPALmia_ADw>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#Yz-apySt20msk6Iuq0Kqlw>;
                                                                       nicebnf:hasTitle """<title>Axsain<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "axsain"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#PHP84347> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#Vq8U9rPabkuwPALmia_ADw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 3–4 times a day for 8 weeks then review, dose to be applied sparingly, not more often than every 4 hours."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 3–4 times a day for 8 weeks then review, dose to be applied sparingly, not more often than every 4 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 3–4 times a day for 8 weeks then review, dose to be applied sparingly, not more often than every 4 hours.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#painfulDiabeticNeuropathyUnderExpertSupervision>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#PHP84347>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#Yz-apySt20msk6Iuq0Kqlw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 3–4 times a day, dose to be applied sparingly; important; after lesions have healed, not more often than every 4 hours."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 3–4 times a day, dose to be applied sparingly; <b>important; after</b> lesions have healed, not more often than every 4 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 3–4 times a day, dose to be applied sparingly; important; after lesions have healed, not more often than every 4 hours.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#postHerpeticNeuralgia>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/axsain#PHP84347>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#painfulDiabeticNeuropathyUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Painful diabetic neuropathy (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Painful diabetic neuropathy (under expert supervision)

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "painful diabetic neuropathy (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postHerpeticNeuralgia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Post-herpetic neuralgia</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Post-herpetic neuralgia

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "post-herpetic neuralgia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/bactroban-nasal> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/bactroban-nasal#dpKiSIhuIUiEVwG_xlTFDw>;
                                                                                nicebnf:hasTitle """<title>Bactroban Nasal<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "bactroban nasal"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/bactroban-nasal#PHP78903> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/bactroban-nasal#dpKiSIhuIUiEVwG_xlTFDw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                          rdfs:label "apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. Course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. Course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. Course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 2–3 times a day for 5 days; a sample should be taken 2 days after treatment to confirm eradication. Course may be repeated if sample positive (and throat not colonised), dose to be applied to the inner surface of each nostril.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forEradicationOfNasalCarriageOfStaphylococciIncludingMeticillinResistantStaphylococcusAureusMrsa>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/bactroban-nasal#PHP78903>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forEradicationOfNasalCarriageOfStaphylococciIncludingMeticillinResistantStaphylococcusAureusMrsa> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For eradication of nasal carriage of staphylococci, including meticillin-resistant <ph outputclass=\"organism\"><i>Staphylococcus aureus</i></ph> (MRSA)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                           nicebnf:hasTextContent """For eradication of nasal carriage of staphylococci, including meticillin-resistant Staphylococcus aureus (MRSA)

"""^^xsd:string;
                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                           rdfs:label "for eradication of nasal carriage of staphylococci, including meticillin-resistant staphylococcus aureus (mrsa)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/balance-activ-rx-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/balance-activ-rx-gel#jsEl0HV5qUCpD7uV2plFCQ>;
                                                                                     nicebnf:hasTitle """<title>Balance Activ Rx<tm tmtype=\"reg\" /> gel</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "balance activ rx gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balance-activ-rx-gel#PHP106722> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balance-activ-rx-gel#jsEl0HV5qUCpD7uV2plFCQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "5 ml 1–2 times a week, insert the content of 1 tube."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>5 mL 1–2 times a week, insert the content of 1 tube.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """5 mL 1–2 times a week, insert the content of 1 tube.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfBacterialVaginosis>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/balance-activ-rx-gel#PHP106722>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfBacterialVaginosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of bacterial vaginosis</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Prevention of bacterial vaginosis

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "prevention of bacterial vaginosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-bath-oil> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-bath-oil#TXjUbAzEv0W3YRRpTwdKuw>;
                                                                                 nicebnf:hasTitle """<title>Balneum<tm tmtype=\"reg\" /> bath oil</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "balneum bath oil"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-bath-oil#PHP105898> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-bath-oil#TXjUbAzEv0W3YRRpTwdKuw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> ; 
                                                                                                                           rdfs:label "5–15 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>5–15 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """5–15 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                           rdfs:label "20–60 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>20–60 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """20–60 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "20–60 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>20–60 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """20–60 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingThoseAssociatedWithDermatitisAndEczema>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-bath-oil#PHP105898>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingThoseAssociatedWithDermatitisAndEczema> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including those associated with dermatitis and eczema</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Dry skin conditions including those associated with dermatitis and eczema

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "dry skin conditions including those associated with dermatitis and eczema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 1–23 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-cream#rpUFvcLncUGPuyo-LXuYcg>;
                                                                              nicebnf:hasTitle """<title>Balneum<tm tmtype=\"reg\" /> cream</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "balneum cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-cream#PHP105935> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-cream#rpUFvcLncUGPuyo-LXuYcg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                        rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-cream#PHP105935>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Dry skin conditions

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "dry skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-bath-oil> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-bath-oil#bB7WvJmD90adevmw6md64Q>;
                                                                                      nicebnf:hasTitle """<title>Balneum<tm tmtype=\"reg\" /> plus bath oil</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "balneum plus bath oil"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-bath-oil#PHP105992> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-bath-oil#bB7WvJmD90adevmw6md64Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> ; 
                                                                                                                                rdfs:label "5 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>5 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """5 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                                rdfs:label "10–20 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>10–20 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """10–20 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "20 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>20 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """20 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingThoseAssociatedWithDermatitisAndEczemaWherePruritusAlsoExperienced>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-bath-oil#PHP105992>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingThoseAssociatedWithDermatitisAndEczemaWherePruritusAlsoExperienced> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including those associated with dermatitis and eczema where pruritus also experienced</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                       nicebnf:hasTextContent """Dry skin conditions including those associated with dermatitis and eczema where pruritus also experienced

"""^^xsd:string;
                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                       rdfs:label "dry skin conditions including those associated with dermatitis and eczema where pruritus also experienced"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 1–23 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-cream#CE7yLWztzkOdqIJVWR_grw>;
                                                                                   nicebnf:hasTitle """<title>Balneum<tm tmtype=\"reg\" /> plus cream</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "balneum plus cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-cream#CE7yLWztzkOdqIJVWR_grw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                             rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-cream#PHP106050>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/balneum-plus-cream#PHP106050> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/bedol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/bedol#b5umlu0hh0GlVISH3ervJA>;
                                                                      nicebnf:hasTitle """<title>Bedol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "bedol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/bedol#PHP97555> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/bedol#b5umlu0hh0GlVISH3ervJA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "2 mg daily, started on day 1–5 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>2 mg daily, started on day 1–5 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """2 mg daily, started on day 1–5 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/bedol#PHP97555>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#8JJgxUUifUqz_RjTAi6Qow>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#TJIDIRYE1Uakb_0oLmUa6w>;
                                                                         nicebnf:hasTitle """<title>Berinert<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "berinert"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#8JJgxUUifUqz_RjTAi6Qow> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1000 units for 1 dose, to be administered less than 6 hours before procedure."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1000 units for 1 dose, to be administered less than 6 hours before procedure.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1000 units for 1 dose, to be administered less than 6 hours before procedure.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjectionOrByIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#shortTermProphylaxisOfHereditaryAngioedemaBeforeDentalMedicalOrSurgicalProceduresUnderExpertSupervision>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#PHP83414>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#PHP83414> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#TJIDIRYE1Uakb_0oLmUa6w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "20 units/kg."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>20 units/kg.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """20 units/kg.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjectionOrByIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAttacksOfHereditaryAngioedemaUnderExpertSupervision>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/berinert#PHP83414>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAttacksOfHereditaryAngioedemaUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute attacks of hereditary angioedema (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Acute attacks of hereditary angioedema (under expert supervision)

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "acute attacks of hereditary angioedema (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#shortTermProphylaxisOfHereditaryAngioedemaBeforeDentalMedicalOrSurgicalProceduresUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                  nicebnf:hasTextContent """Short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)

"""^^xsd:string;
                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                  rdfs:label "short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjectionOrByIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                             rdfs:label "by slow intravenous injection, or by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/betadine-dry-powder-spray> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/betadine-dry-powder-spray#Fx99qWMbB0ya44_1jdCnXw>;
                                                                                          nicebnf:hasTitle """<title>Betadine<tm tmtype=\"reg\" /> dry powder spray</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "betadine dry powder spray"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betadine-dry-powder-spray#Fx99qWMbB0ya44_1jdCnXw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "not for use in serous cavities (consult product literature)."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Not for use in serous cavities (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Not for use in serous cavities (consult product literature).

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfectionParticularlyMinorWoundsAndInfections>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/betadine-dry-powder-spray#PHP85018>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betadine-dry-powder-spray#PHP85018> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfectionParticularlyMinorWoundsAndInfections> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Skin disinfection, particularly minor wounds and infections</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasTextContent """Skin disinfection, particularly minor wounds and infections

"""^^xsd:string;
                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                               rdfs:label "skin disinfection, particularly minor wounds and infections"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#xsV8cyIVXEKINWgA8gfIVA>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#imjf68fzFkaUAPch_GiDCA>;
                                                                                    nicebnf:hasTitle """<title>Betaferon<tm tmtype=\"reg\" /> injection</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "betaferon injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#PHP79356> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#PHP79384> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#imjf68fzFkaUAPch_GiDCA> nicebnf:hasDitaContent """<sectiondiv>
  <p>An auto-injector device (<i>Betaject</i><tm tmtype=\"reg\" /> Light) is available from Bayer Schering.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#PHP79384>;
                                                                                                           nicebnf:hasTextContent """An auto-injector device (Betaject Light) is available from Bayer Schering.

"""^^xsd:string;
                                                                                                           a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#xsV8cyIVXEKINWgA8gfIVA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#forSecondaryProgressiveMultipleSclerosisWithActiveDisease>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/betaferon-injection#PHP79356>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forSecondaryProgressiveMultipleSclerosisWithActiveDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For secondary progressive multiple sclerosis with active disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """For secondary progressive multiple sclerosis with active disease

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "for secondary progressive multiple sclerosis with active disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#-EsDNAO90kmQRZhfQpHDFA>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#hVMGg1l_bEq-MNhPQOlH_A>;
                                                                         nicebnf:hasTitle """<title>Betnesol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "betnesol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#-EsDNAO90kmQRZhfQpHDFA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 2–3 drops every 2–3 hours, reduce frequency when relief obtained."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 2–3 drops every 2–3 hours, reduce frequency when relief obtained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 2–3 drops every 2–3 hours, reduce frequency when relief obtained.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheEar>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#eczematousInflammationInOtitisExterna>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#PHP80373>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#PHP80373> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#hVMGg1l_bEq-MNhPQOlH_A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 2–3 drops 2–3 times a day, dose to be applied into each nostril."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 2–3 drops 2–3 times a day, dose to be applied into each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 2–3 drops 2–3 times a day, dose to be applied into each nostril.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#nonInfectedInflammatoryConditionsOfNose>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/betnesol#PHP80373>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#eczematousInflammationInOtitisExterna> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Eczematous inflammation in otitis externa</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Eczematous inflammation in otitis externa

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "eczematous inflammation in otitis externa"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#nonInfectedInflammatoryConditionsOfNose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Non-infected inflammatory conditions of nose</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Non-infected inflammatory conditions of nose

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "non-infected inflammatory conditions of nose"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheEar> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "to the ear"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#f17MCkVGBkST-Q7w91Bv8g>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#gGiaVtg5CU2DcY-tctajzA>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#gZ463MxzqkiDfVuglcvOFg>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#igPRoIgPqEq4KuGISDVEeQ>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#jjZ0bZ5TsUO5AxJ2dgWKxA>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#zOTbQ1_6UUKx29CjtHd8JQ>;
                                                                                             nicebnf:hasTitle """<title>Binocrit<tm tmtype=\"reg\" /> pre-filled syringes</title>"""^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "binocrit pre-filled syringes"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#f17MCkVGBkST-Q7w91Bv8g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toIncreaseYieldOfAutologousBloodToAvoidHomologousBloodInPredonationProgrammeInModerateAnaemiaEitherWhenLargeVolumeOfBloodRequiredOrWhenSufficientBloodCannotBeSavedForElectiveMajorSurgery>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#gGiaVtg5CU2DcY-tctajzA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 25–100 units/kg 3 times a week, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 25–100 units/kg 3 times a week, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 25–100 units/kg 3 times a week, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInPatientsOnHaemodialysis>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#gZ463MxzqkiDfVuglcvOFg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 ml per injection site."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 mL per injection site.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 mL per injection site.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateAnaemiaHaemoglobinConcentration1013G100MLBeforeElectiveOrthopaedicSurgeryInAdultsWithExpectedModerateBloodLossToReduceExposureToAllogeneicBloodTransfusionOrIfAutologousTransfusionUnavailable>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#igPRoIgPqEq4KuGISDVEeQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severeSymptomaticAnaemiaOfRenalOriginInAdultsWithRenalInsufficiencyNotYetOnDialysis>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#jjZ0bZ5TsUO5AxJ2dgWKxA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous injection to be given over 1–5 minutes, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInAdultsOnPeritonealDialysis>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#zOTbQ1_6UUKx29CjtHd8JQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 ml per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. discontinue approximately 4 weeks after ending chemotherapy."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 mL per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. Discontinue approximately 4 weeks after ending chemotherapy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 mL per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. Discontinue approximately 4 weeks after ending chemotherapy.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaInAdultsReceivingCancerChemotherapy>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/binocrit-pre-filled-syringes#PHP104438>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateAnaemiaHaemoglobinConcentration1013G100MLBeforeElectiveOrthopaedicSurgeryInAdultsWithExpectedModerateBloodLossToReduceExposureToAllogeneicBloodTransfusionOrIfAutologousTransfusionUnavailable> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate anaemia (haemoglobin concentration 10–13 g/100 mL) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                 nicebnf:hasTextContent """Moderate anaemia (haemoglobin concentration 10–13 g/100 mL) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable

"""^^xsd:string;
                                                                                                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                 rdfs:label "moderate anaemia (haemoglobin concentration 10–13 g/100 ml) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeSymptomaticAnaemiaOfRenalOriginInAdultsWithRenalInsufficiencyNotYetOnDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                              nicebnf:hasTextContent """Severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis

"""^^xsd:string;
                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                              rdfs:label "severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInAdultsOnPeritonealDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInPatientsOnHaemodialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia associated with chronic renal failure in patients on haemodialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                       nicebnf:hasTextContent """Symptomatic anaemia associated with chronic renal failure in patients on haemodialysis

"""^^xsd:string;
                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                       rdfs:label "symptomatic anaemia associated with chronic renal failure in patients on haemodialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaInAdultsReceivingCancerChemotherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia in adults receiving cancer chemotherapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Symptomatic anaemia in adults receiving cancer chemotherapy

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "symptomatic anaemia in adults receiving cancer chemotherapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#toIncreaseYieldOfAutologousBloodToAvoidHomologousBloodInPredonationProgrammeInModerateAnaemiaEitherWhenLargeVolumeOfBloodRequiredOrWhenSufficientBloodCannotBeSavedForElectiveMajorSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                     nicebnf:hasTextContent """To increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery

"""^^xsd:string;
                                                                                                                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                     rdfs:label "to increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#Bm1WGWBJIEC3dYZCGUSjrQ>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#vquazl2w5EW_lGM_XllvOg>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#hBTQN3jYTUKgP7XpQ7Ntdg>;
                                                                                  nicebnf:hasTitle """<title>Budelin Novolizer<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "budelin novolizer"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#Bm1WGWBJIEC3dYZCGUSjrQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#alternativeInMildToModerateAsthmaForPatientsPreviouslyStabilisedOnATwiceDailyDose>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#PHP83114>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#PHP83114> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#PHP83124> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#hBTQN3jYTUKgP7XpQ7Ntdg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on adminstration of <i>Budelin NovolizerA</i><tm tmtype=\"reg\" />.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#PHP83124>;
                                                                                                         nicebnf:hasTextContent """Patients or carers should be given advice on adminstration of Budelin NovolizerA.

"""^^xsd:string;
                                                                                                         a nicebnf:GeneralPatientAdvice,
                                                                                                           nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#vquazl2w5EW_lGM_XllvOg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "200–800 micrograms twice daily, dose is adjusted as necessary."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>200–800 micrograms twice daily, dose is adjusted as necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """200–800 micrograms twice daily, dose is adjusted as necessary.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budelin-novolizer#PHP83114>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#alternativeInMildToModerateAsthmaForPatientsPreviouslyStabilisedOnATwiceDailyDose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose</p>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasTextContent """Alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose

"""^^xsd:string;
                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                            rdfs:label "alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#Xogcj0NY-UuRgB-p8yRGRQ>;
                                                                                    nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#26SzdYSNzUGQe2m-ASKcUA>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#2FYi3sIgS0WY2nyL6XfcnQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#HM2UAf3jQ0KQwGG74u5vBQ>;
                                                                                    nicebnf:hasTitle """<title>Budenofalk<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "budenofalk capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#26SzdYSNzUGQe2m-ASKcUA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "3 mg twice daily."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>3 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """3 mg twice daily.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#autoimmuneHepatitisMaintenance>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83713>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#2FYi3sIgS0WY2nyL6XfcnQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "3 mg 3 times a day for up to 8 weeks, reduce dose for the last 2 weeks of treatment."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>3 mg 3 times a day for up to 8 weeks, reduce dose for the last 2 weeks of treatment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """3 mg 3 times a day for up to 8 weeks, reduce dose for the last 2 weeks of treatment.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicDiarrhoeaDueToCollagenousColitis>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83713>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#HM2UAf3jQ0KQwGG74u5vBQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "3 mg 3 times a day."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>3 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """3 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#autoimmuneHepatitisInductionOfRemission>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83713>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83713> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83737> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#Xogcj0NY-UuRgB-p8yRGRQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (April 2015) that <i>Budenofalk</i><tm tmtype=\"reg\" /> gastro-resistant capsules are accepted for restricted use within NHS Scotland for the treatment of autoimmune hepatitis in non-cirrhotic patients who are intolerant of conventional oral corticosteroids (prednisolone) with severe corticosteroid-related side effects (actual or anticipated) such as psychosis, poorly controlled diabetes or osteoporosis.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-capsules#PHP83737>;
                                                                                                           nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (April 2015) that Budenofalk gastro-resistant capsules are accepted for restricted use within NHS Scotland for the treatment of autoimmune hepatitis in non-cirrhotic patients who are intolerant of conventional oral corticosteroids (prednisolone) with severe corticosteroid-related side effects (actual or anticipated) such as psychosis, poorly controlled diabetes or osteoporosis.

"""^^xsd:string;
                                                                                                           a nicebnf:FundingDecision,
                                                                                                             nicebnf:SmcDecisions.
<http://ld.nice.org.uk/ns/bnf/Indication#autoimmuneHepatitisInductionOfRemission> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Autoimmune hepatitis, induction of remission</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Autoimmune hepatitis, induction of remission

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "autoimmune hepatitis, induction of remission"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#autoimmuneHepatitisMaintenance> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Autoimmune hepatitis, maintenance</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Autoimmune hepatitis, maintenance

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "autoimmune hepatitis, maintenance"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicDiarrhoeaDueToCollagenousColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic diarrhoea due to collagenous colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Chronic diarrhoea due to collagenous colitis

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "chronic diarrhoea due to collagenous colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate Crohn's disease affecting the ileum or ascending colon</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasTextContent """Mild to moderate Crohn's disease affecting the ileum or ascending colon

"""^^xsd:string;
                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                       rdfs:label "mild to moderate crohn's disease affecting the ileum or ascending colon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#WDRPqqVS0UWk9ZQjjIStfg>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#tdKf95G-CUyARQZXuFWm4A>;
                                                                                    nicebnf:hasTitle """<title>Budenofalk<tm tmtype=\"reg\" /> granules</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "budenofalk granules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#PHP83764> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#PHP83779> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#WDRPqqVS0UWk9ZQjjIStfg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "9 mg daily for up to 8 weeks, to be taken in the morning, dose to be reduced for the last two weeks of treatment."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>9 mg daily for up to 8 weeks, to be taken in the morning, dose to be reduced for the last two weeks of treatment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """9 mg daily for up to 8 weeks, to be taken in the morning, dose to be reduced for the last two weeks of treatment.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#collagenousColitis>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#PHP83764>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#tdKf95G-CUyARQZXuFWm4A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Granules should be placed on tongue and washed down with water without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-granules#PHP83779>;
                                                                                                           nicebnf:hasTextContent """Granules should be placed on tongue and washed down with water without chewing.

"""^^xsd:string;
                                                                                                           a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#collagenousColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Collagenous colitis</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Collagenous colitis

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "collagenous colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate Crohn's disease affecting the ileum or ascending colon</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasTextContent """Mild to moderate Crohn's disease affecting the ileum or ascending colon

"""^^xsd:string;
                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                       rdfs:label "mild to moderate crohn's disease affecting the ileum or ascending colon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#ZAy4cU7mskuklVkW-PaQFA>;
                                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#vNlFay4tr0eut5SB-5KiHw>;
                                                                                       nicebnf:hasTitle """<title>Budenofalk<tm tmtype=\"reg\" /> rectal foam</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "budenofalk rectal foam"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#PHP83814> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#ZAy4cU7mskuklVkW-PaQFA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 metered application once daily for up to 8 weeks."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 metered application once daily for up to 8 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 metered application once daily for up to 8 weeks.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ulcerativeColitisAffectingSigmoidColonAndRectum>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#PHP83814>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#vNlFay4tr0eut5SB-5KiHw> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 metered application is equivalent to budesonide 2 mg.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/budenofalk-rectal-foam#PHP83814>;
                                                                                                              nicebnf:hasTextContent """Dose equivalence and conversion1 metered application is equivalent to budesonide 2 mg.

"""^^xsd:string;
                                                                                                              a nicebnf:DoseEquivalence,
                                                                                                                nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#ulcerativeColitisAffectingSigmoidColonAndRectum> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ulcerative colitis affecting sigmoid colon and rectum</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Ulcerative colitis affecting sigmoid colon and rectum

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "ulcerative colitis affecting sigmoid colon and rectum"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#L3u485dRAkO5JB9gZQfffQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#4rQLdiHpIESFkEgonErd2w>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#Qj3EqAa1SEW3V4Sf3k-P7w>;
                                                                        nicebnf:hasTitle """<title>BuTrans<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "butrans"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#4rQLdiHpIESFkEgonErd2w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after 7 days and siting replacement patch on a different area (avoid same area for at least 3 weeks).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80079>;
                                                                                               nicebnf:hasTextContent """Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after 7 days and siting replacement patch on a different area (avoid same area for at least 3 weeks).

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#L3u485dRAkO5JB9gZQfffQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 5 micrograms/hour up to every 7 days, dose adjustments—when starting, analgesic effect should not be evaluated until the system has been worn for 72 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of at least 3 days using a patch of the next strength or a combination of 2 patches applied in different places (applied at same time to avoid confusion). maximum 2 patches can be used at any one time."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 5 micrograms/hour up to every 7 days, dose adjustments—when starting, analgesic effect should not be evaluated until the system has been worn for 72 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of at least 3 days using a patch of the next strength or a combination of 2 patches applied in different places (applied at <i>same time</i> to avoid confusion). Maximum 2 patches can be used at any one time.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 5 micrograms/hour up to every 7 days, dose adjustments—when starting, analgesic effect should not be evaluated until the system has been worn for 72 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of at least 3 days using a patch of the next strength or a combination of 2 patches applied in different places (applied at same time to avoid confusion). Maximum 2 patches can be used at any one time.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateNonMalignantPainUnresponsiveToNonOpioidAnalgesics>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80038>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80038> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80079> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80085> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#Qj3EqAa1SEW3V4Sf3k-P7w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer buprenorphine transdermal patches.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/butrans#PHP80085>;
                                                                                               nicebnf:hasTextContent """Patients or carers should be given advice on how to administer buprenorphine transdermal patches.

"""^^xsd:string;
                                                                                               a nicebnf:GeneralPatientAdvice,
                                                                                                 nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateNonMalignantPainUnresponsiveToNonOpioidAnalgesics> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate, non-malignant pain unresponsive to non-opioid analgesics</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Moderate, non-malignant pain unresponsive to non-opioid analgesics

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "moderate, non-malignant pain unresponsive to non-opioid analgesics"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by transdermal application using patches"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/caelyx> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/caelyx#9smQSf4N7Uu6sbkjWLWadA>;
                                                                       nicebnf:hasTitle """<title>Caelyx<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "caelyx"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caelyx#9smQSf4N7Uu6sbkjWLWadA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#advancedOvarianCancerWhenPlatinumBasedChemotherapyHasFailed>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#forAidsRelatedKaposiSSarcomaInPatientsWithLowCd4CountAndExtensiveMucocutaneousOrVisceralDisease>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForMetastaticBreastCancerInPatientsWithIncreasedCardiacRisk>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#progressiveMultipleMyelomaInCombinationWithBortezomibInPatientsWhoHaveReceivedAtLeastOnePriorTherapyAndWhoHaveUndergoneOrAreUnsuitableForBoneMarrowTransplantation>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caelyx#PHP79839>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caelyx#PHP79839> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#advancedOvarianCancerWhenPlatinumBasedChemotherapyHasFailed> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Advanced ovarian cancer when platinum-based chemotherapy has failed</p>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasTextContent """Advanced ovarian cancer when platinum-based chemotherapy has failed

"""^^xsd:string;
                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                      rdfs:label "advanced ovarian cancer when platinum-based chemotherapy has failed"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forAidsRelatedKaposiSSarcomaInPatientsWithLowCd4CountAndExtensiveMucocutaneousOrVisceralDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For AIDS-related Kaposi's sarcoma in patients with low CD4 count and extensive mucocutaneous or visceral disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """For AIDS-related Kaposi's sarcoma in patients with low CD4 count and extensive mucocutaneous or visceral disease

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "for aids-related kaposi's sarcoma in patients with low cd4 count and extensive mucocutaneous or visceral disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForMetastaticBreastCancerInPatientsWithIncreasedCardiacRisk> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Monotherapy for metastatic breast cancer in patients with increased cardiac risk</p>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasTextContent """Monotherapy for metastatic breast cancer in patients with increased cardiac risk

"""^^xsd:string;
                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                 rdfs:label "monotherapy for metastatic breast cancer in patients with increased cardiac risk"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#progressiveMultipleMyelomaInCombinationWithBortezomibInPatientsWhoHaveReceivedAtLeastOnePriorTherapyAndWhoHaveUndergoneOrAreUnsuitableForBoneMarrowTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Progressive multiple myeloma (in combination with bortezomib) in patients who have received at least one prior therapy and who have undergone or are unsuitable for bone-marrow transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                             nicebnf:hasTextContent """Progressive multiple myeloma (in combination with bortezomib) in patients who have received at least one prior therapy and who have undergone or are unsuitable for bone-marrow transplantation

"""^^xsd:string;
                                                                                                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                             rdfs:label "progressive multiple myeloma (in combination with bortezomib) in patients who have received at least one prior therapy and who have undergone or are unsuitable for bone-marrow transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/calmurid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/calmurid#T4o9sWqNokGNn2ZSGjIvYg>;
                                                                         nicebnf:hasTitle """<title>Calmurid<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "calmurid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/calmurid#PHP106107> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/calmurid#T4o9sWqNokGNn2ZSGjIvYg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                   rdfs:label "apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. can be diluted with aqueous cream (life of diluted cream is 14 days). half-strength cream can be used for 1 week if stinging occurs."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. Can be diluted with aqueous cream (life of diluted cream is 14 days). Half-strength cream can be used for 1 week if stinging occurs.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. Can be diluted with aqueous cream (life of diluted cream is 14 days). Half-strength cream can be used for 1 week if stinging occurs.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. can be diluted with aqueous cream (life of diluted cream is 14 days). half-strength cream can be used for 1 week if stinging occurs."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. Can be diluted with aqueous cream (life of diluted cream is 14 days). Half-strength cream can be used for 1 week if stinging occurs.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily, apply a thick layer for 3–5 minutes, massage into area, and remove excess. Can be diluted with aqueous cream (life of diluted cream is 14 days). Half-strength cream can be used for 1 week if stinging occurs.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/calmurid#PHP106107>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#7j7HT9-Fak-DZXUMGUj7yw>,
                                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#v5uBkJfvqkK_v0foQUl1rw>;
                                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#juIlIruS10GTvsOj0qaU7Q>;
                                                                                                  nicebnf:hasTitle """<title>Camcolit<tm tmtype=\"reg\" /> immediate-release tablet</title>"""^^<rdf:XMLLiteral>;
                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                  rdfs:label "camcolit immediate-release tablet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#7j7HT9-Fak-DZXUMGUj7yw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                            rdfs:label "initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>Initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """Initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                            rdfs:label "reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>Reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """Reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#PHP79304>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#PHP79304> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#juIlIruS10GTvsOj0qaU7Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#PHP79304>;
                                                                                                                         nicebnf:hasTextContent """Dose equivalence and conversionPreparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                                         a nicebnf:DoseEquivalence,
                                                                                                                           nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#v5uBkJfvqkK_v0foQUl1rw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                            rdfs:label "initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>Initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """Initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania>,
                                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-immediate-release-tablet#PHP79304>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Prophylaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "prophylaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Prophylaxis of mania

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Prophylaxis of recurrent depression

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Treatment of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "treatment of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Treatment of bipolar disorder

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "treatment of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mania</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Treatment of mania

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "treatment of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment of recurrent depression

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#5Esv8CzkT0uahH1HOH0Nkw>,
                                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#QyKScnGJGEiwDZ-1S4k2sg>;
                                                                                                 nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#Zc3g-1pBJUSE2TMWO0kMSA>;
                                                                                                 nicebnf:hasTitle """<title>Camcolit<tm tmtype=\"reg\" /> modified-release tablet</title>"""^^<rdf:XMLLiteral>;
                                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                 rdfs:label "camcolit modified-release tablet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#5Esv8CzkT0uahH1HOH0Nkw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                           rdfs:label "initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                           nicebnf:hasDitaContent "<p>Initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                           nicebnf:hasTextContent """Initially 300–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression>;
                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#PHP79134>;
                                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#PHP79134> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#QyKScnGJGEiwDZ-1S4k2sg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                           rdfs:label "initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                           nicebnf:hasDitaContent "<p>Initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                           nicebnf:hasTextContent """Initially 1–1.5 g daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                           rdfs:label "reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                                           nicebnf:hasDitaContent "<p>Reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                           nicebnf:hasTextContent """Reduce initial dose, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression>;
                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#PHP79134>;
                                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#Zc3g-1pBJUSE2TMWO0kMSA> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/camcolit-modified-release-tablet#PHP79134>;
                                                                                                                        nicebnf:hasTextContent """Dose equivalence and conversionPreparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                                        a nicebnf:DoseEquivalence,
                                                                                                                          nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Prophylaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "prophylaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Prophylaxis of mania

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Prophylaxis of recurrent depression

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Treatment of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "treatment of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Treatment of bipolar disorder

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "treatment of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mania</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Treatment of mania

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "treatment of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment of recurrent depression

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#5ODIn3BwSUazQFhre6wC4A>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#SvoiaDkwCUSa66DpGbVe8A>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#XHZ1rRmLiE6RNen4Km61ww>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#q7im1HaWO0WAMv9tWIb8Fg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#w2v6l68jyUuAZGMSGLX6mA>;
                                                                         nicebnf:hasTitle """<title>Capexion<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "capexion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#5ODIn3BwSUazQFhre6wC4A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#SvoiaDkwCUSa66DpGbVe8A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#XHZ1rRmLiE6RNen4Km61ww> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#q7im1HaWO0WAMv9tWIb8Fg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#w2v6l68jyUuAZGMSGLX6mA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/capexion#PHP80288>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#J050cDD1-0yEhr7kfcVORA>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#v-1V0R4qYUSQxuZXRNQ7CA>;
                                                                           nicebnf:hasTitle """<title>Caramet<tm tmtype=\"reg\" /> CR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "caramet cr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#J050cDD1-0yEhr7kfcVORA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "discontinue previous preparation at least 12 hours before first dose of carametcr; substitute carametcr to provide a similar amount of levodopa daily and extend dosing interval by 30–50%; dose then adjusted according to response at intervals of at least 2 days."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent """<p>Discontinue previous preparation at least 12 hours before first dose of <i>Caramet</i><tm tmtype=\"reg\" /><i>CR</i>; substitute <i>Caramet</i><tm tmtype=\"reg\" /><i>CR</i> to provide a similar amount of levodopa daily and extend dosing interval by 30–50%; dose then adjusted according to response at intervals of at least 2 days.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Discontinue previous preparation at least 12 hours before first dose of CarametCR; substitute CarametCR to provide a similar amount of levodopa daily and extend dosing interval by 30–50%; dose then adjusted according to response at intervals of at least 2 days.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsTransferringFromImmediateReleaseLevodopaDopaDecarboxylaseInhibitorPreparations>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#PHP81068>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#PHP81068> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#v-1V0R4qYUSQxuZXRNQ7CA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 100–200 mg twice daily, dose to be given at least 6 hours apart; dose adjusted according to response at intervals of at least 2 days."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 100–200 mg twice daily, dose to be given at least 6 hours apart; dose adjusted according to response at intervals of at least 2 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 100–200 mg twice daily, dose to be given at least 6 hours apart; dose adjusted according to response at intervals of at least 2 days.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsNotReceivingLevodopaDopaDecarboxylaseInhibitorPreparationsExpressedAsLevodopa>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caramet-cr#PHP81068>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsNotReceivingLevodopaDopaDecarboxylaseInhibitorPreparationsExpressedAsLevodopa> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor preparations, expressed as levodopa)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                 nicebnf:hasTextContent """Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor preparations, expressed as levodopa)

"""^^xsd:string;
                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                 rdfs:label "parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor preparations, expressed as levodopa)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsTransferringFromImmediateReleaseLevodopaDopaDecarboxylaseInhibitorPreparations> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)

"""^^xsd:string;
                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                  rdfs:label "parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                              rdfs:label "by mouth using modified-release tablets"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#03lQDtp5SUum-CyxfC4AKg>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#KP16Y6BaFkON0jZYnN_-hg>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#d5Nqr4Hmi0auDQuIwMMglw>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#zCPkwBLsq02Bb9hNIrD7zQ>;
                                                                            nicebnf:hasTitle """<title>Carbagen<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "carbagen sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#03lQDtp5SUum-CyxfC4AKg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> ; 
                                                                                                                      rdfs:label "initially 5 mg/kg daily in 1–2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 1–2 divided doses, increased if necessary up to 20 mg/kg daily in 1–2 divided doses."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 5 mg/kg daily in 1–2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 1–2 divided doses, increased if necessary up to 20 mg/kg daily in 1–2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 5 mg/kg daily in 1–2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 1–2 divided doses, increased if necessary up to 20 mg/kg daily in 1–2 divided doses.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                      rdfs:label "initially 100–400 mg daily in 1–2 divided doses, then increased to 400–1200 mg daily in 1–2 divided doses, increased if necessary up to 1.8 g daily in 1–2 divided doses, dose should be increased slowly."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 100–400 mg daily in 1–2 divided doses, then increased to 400–1200 mg daily in 1–2 divided doses, increased if necessary up to 1.8 g daily in 1–2 divided doses, dose should be increased slowly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 100–400 mg daily in 1–2 divided doses, then increased to 400–1200 mg daily in 1–2 divided doses, increased if necessary up to 1.8 g daily in 1–2 divided doses, dose should be increased slowly.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#focalAndGeneralisedTonicClonicSeizures>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#PHP80940>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#KP16Y6BaFkON0jZYnN_-hg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 100–400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 1–2 divided doses; increased if necessary up to 1.6–2 g daily in 1–2 divided doses."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 100–400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 1–2 divided doses; increased if necessary up to 1.6–2 g daily in 1–2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 100–400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 1–2 divided doses; increased if necessary up to 1.6–2 g daily in 1–2 divided doses.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                      rdfs:label "reduce initial dose."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Reduce initial dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Reduce initial dose.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#focalAndSecondaryGeneralisedTonicClonicSeizures>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#primaryGeneralisedTonicClonicSeizures>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#PHP80940>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#PHP80940> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#d5Nqr4Hmi0auDQuIwMMglw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 1–2 divided doses; maximum 1.6 g per day."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 1–2 divided doses; maximum 1.6 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 400 mg daily in 1–2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 1–2 divided doses; maximum 1.6 g per day.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorderUnresponsiveToLithium>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#PHP80940>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#zCPkwBLsq02Bb9hNIrD7zQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 100–200 mg daily in 1–2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 1–2 divided doses; increased if necessary up to 1.6 g daily in 1–2 divided doses."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 100–200 mg daily in 1–2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 1–2 divided doses; increased if necessary up to 1.6 g daily in 1–2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 100–200 mg daily in 1–2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 1–2 divided doses; increased if necessary up to 1.6 g daily in 1–2 divided doses.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#trigeminalNeuralgia>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/carbagen-sr#PHP80940>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#focalAndGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Focal and generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Focal and generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "focal and generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#focalAndSecondaryGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Focal and secondary generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Focal and secondary generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "focal and secondary generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#primaryGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Primary generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Primary generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "primary generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorderUnresponsiveToLithium> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder unresponsive to lithium</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Prophylaxis of bipolar disorder unresponsive to lithium

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "prophylaxis of bipolar disorder unresponsive to lithium"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#trigeminalNeuralgia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Trigeminal neuralgia</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Trigeminal neuralgia

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "trigeminal neuralgia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 5–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#95dMIO6Uo02sIfWb5MP8vQ>;
                                                                           nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#rU7PNJa6HU2aLQJCIrKtMQ>;
                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#-N_DdrRUE0WHhf3Gh0wnhg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#SFTGWu4lx0CPkCHy1tcr4g>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#VkIZuR2mMUWkZvZp5sA39g>;
                                                                           nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#VhTi4k21SE2LXqRWKtWKOA>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#psBwLpcurUWAF6LVuRBtKg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#tFPBmWpGoUuxyMnzUBBF3w>;
                                                                           nicebnf:hasTitle """<title>Cardioxane<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "cardioxane"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#-N_DdrRUE0WHhf3Gh0wnhg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Compound sodium lactate; reconstitute each vial with 25 mL water for injections and dilute each vial with 25–100 mL infusion fluid; give requisite dose over 15 minutes.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79782>;
                                                                                                  nicebnf:hasTextContent """For intravenous infusion, give intermittently in Compound sodium lactate; reconstitute each vial with 25 mL water for injections and dilute each vial with 25–100 mL infusion fluid; give requisite dose over 15 minutes.

"""^^xsd:string;
                                                                                                  a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#95dMIO6Uo02sIfWb5MP8vQ> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithHeartFailureNoInformationAvailable>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithMyocardialInfarctionInPrevious12MonthsNoInformationAvailable>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithSymptomaticValvularHeartDiseaseNoInformationAvailable>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithUncontrolledAnginaNoInformationAvailable>;
                                                                                                  nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Manufacturer advises caution in patients with heart failure—no information available</ph>; <ph outputclass=\"caution\">manufacturer advises caution in patients with myocardial infarction in previous 12 months—no information available</ph>; <ph outputclass=\"caution\">manufacturer advises caution in patients with symptomatic valvular heart disease—no information available</ph>; <ph outputclass=\"caution\">manufacturer advises caution in patients with uncontrolled angina—no information available</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79701>;
                                                                                                  nicebnf:hasTextContent """Manufacturer advises caution in patients with heart failure—no information available; manufacturer advises caution in patients with myocardial infarction in previous 12 months—no information available; manufacturer advises caution in patients with symptomatic valvular heart disease—no information available; manufacturer advises caution in patients with uncontrolled angina—no information available

"""^^xsd:string;
                                                                                                  a nicebnf:CautionsGroup,
                                                                                                    nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79701> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79722> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79726> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79733> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79763> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79782> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#SFTGWu4lx0CPkCHy1tcr4g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises that if anthracycline dose is reduced, reduce the <i>Cardioxane</i><tm tmtype=\"reg\" /> dose by a similar ratio.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79726>;
                                                                                                  nicebnf:hasTextContent """Manufacturer advises that if anthracycline dose is reduced, reduce the Cardioxane dose by a similar ratio.

"""^^xsd:string;
                                                                                                  a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#VhTi4k21SE2LXqRWKtWKOA> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">acute myeloid leukaemia</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">cough</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">lymphoedema</ph>; <ph outputclass=\"sideEffect\">nail disorder</ph>; <ph outputclass=\"sideEffect\">reduced ejection fraction</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">thromboembolism (when given with cytotoxic drugs)</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#uncommon>;
                                                                                                  nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#abdominalPain>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#acuteMyeloidLeukaemia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#constipation>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#cough>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#dyspepsia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#headache>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#lymphoedema>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#nailDisorder>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#reducedEjectionFraction>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#tachycardia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#thromboembolismWhenGivenWithCytotoxicDrugs>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79763>;
                                                                                                  nicebnf:hasTextContent """Abdominal pain; acute myeloid leukaemia; constipation; cough; dyspepsia; headache; lymphoedema; nail disorder; reduced ejection fraction; tachycardia; thromboembolism (when given with cytotoxic drugs)

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralSideEffects,
                                                                                                    nicebnf:SideEffectGroup,
                                                                                                    nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#VkIZuR2mMUWkZvZp5sA39g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises reduce dose by 50% if creatinine clearance less than 40 mL/minute.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79733>;
                                                                                                  nicebnf:hasTextContent """Manufacturer advises reduce dose by 50% if creatinine clearance less than 40 mL/minute.

"""^^xsd:string;
                                                                                                  a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#psBwLpcurUWAF6LVuRBtKg> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">anaemia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">phlebitis</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#notKnown>;
                                                                                                  nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#alopecia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#anaemia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#bloodDisorders>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#fatigue>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#injectionSiteReactions>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#leucopenia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#phlebitis>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#pruritus>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#pyrexia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#thrombocytopenia>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79763>;
                                                                                                  nicebnf:hasTextContent """Alopecia; anaemia; blood disorders; fatigue; injection-site reactions; leucopenia; phlebitis; pruritus; pyrexia; thrombocytopenia

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralSideEffects,
                                                                                                    nicebnf:SideEffectGroup,
                                                                                                    nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#rU7PNJa6HU2aLQJCIrKtMQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "administer 10 times the doxorubicin-equivalent dose or 10 times the epirubicin-equivalent dose, dose to be given 30 minutes before anthracycline administration."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Administer 10 times the doxorubicin-equivalent dose or 10 times the epirubicin-equivalent dose, dose to be given 30 minutes before anthracycline administration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Administer 10 times the doxorubicin-equivalent dose or 10 times the epirubicin-equivalent dose, dose to be given 30 minutes before anthracycline administration.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfChronicCumulativeCardiotoxicityCausedByDoxorubicinOrEpirubicinTreatmentInAdvancedOrMetastaticBreastCancerPatientsWhoHaveReceivedAPriorCumulativeDoseOf300MgMOfDoxorubicinOrAPriorCumulativeDoseOf540MgMOfEpirubicinWhenFurtherAnthracyclineTreatmentIsRequired>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79722>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#tFPBmWpGoUuxyMnzUBBF3w> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Anorexia</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">infection</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>; <ph outputclass=\"sideEffect\">syncope</ph>; <ph outputclass=\"sideEffect\">vomiting</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon>;
                                                                                                  nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#anorexia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#asthenia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#diarrhoea>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#dizziness>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#dryMouth>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#dyspnoea>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#erythema>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#infection>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#malaise>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#nausea>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#oedema>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#paraesthesia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#stomatitis>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#syncope>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/SideEffect#vomiting>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cardioxane#PHP79763>;
                                                                                                  nicebnf:hasTextContent """Anorexia; asthenia; diarrhoea; dizziness; dry mouth; dyspnoea; erythema; infection; malaise; nausea; oedema; paraesthesia; peripheral neuropathy; stomatitis; syncope; vomiting

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralSideEffects,
                                                                                                    nicebnf:SideEffectGroup,
                                                                                                    nicebnf:SideEffectsGroup.
<http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithHeartFailureNoInformationAvailable> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Manufacturer advises caution in patients with heart failure—no information available</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasTextContent "Manufacturer advises caution in patients with heart failure—no information available"^^xsd:string;
                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                  rdfs:label "manufacturer advises caution in patients with heart failure—no information available"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithMyocardialInfarctionInPrevious12MonthsNoInformationAvailable> nicebnf:hasDitaContent """<ph outputclass=\"caution\">manufacturer advises caution in patients with myocardial infarction in previous 12 months—no information available</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                            nicebnf:hasTextContent "manufacturer advises caution in patients with myocardial infarction in previous 12 months—no information available"^^xsd:string;
                                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                            rdfs:label "manufacturer advises caution in patients with myocardial infarction in previous 12 months—no information available"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithSymptomaticValvularHeartDiseaseNoInformationAvailable> nicebnf:hasDitaContent """<ph outputclass=\"caution\">manufacturer advises caution in patients with symptomatic valvular heart disease—no information available</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent "manufacturer advises caution in patients with symptomatic valvular heart disease—no information available"^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                     rdfs:label "manufacturer advises caution in patients with symptomatic valvular heart disease—no information available"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#manufacturerAdvisesCautionInPatientsWithUncontrolledAnginaNoInformationAvailable> nicebnf:hasDitaContent """<ph outputclass=\"caution\">manufacturer advises caution in patients with uncontrolled angina—no information available</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent "manufacturer advises caution in patients with uncontrolled angina—no information available"^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                        rdfs:label "manufacturer advises caution in patients with uncontrolled angina—no information available"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon> a nicebnf:Frequency;
                                                            rdfs:label "common or very common"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#notKnown> a nicebnf:Frequency;
                                                  rdfs:label "frequency not known"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#uncommon> a nicebnf:Frequency;
                                                  rdfs:label "uncommon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfChronicCumulativeCardiotoxicityCausedByDoxorubicinOrEpirubicinTreatmentInAdvancedOrMetastaticBreastCancerPatientsWhoHaveReceivedAPriorCumulativeDoseOf300MgMOfDoxorubicinOrAPriorCumulativeDoseOf540MgMOfEpirubicinWhenFurtherAnthracyclineTreatmentIsRequired> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin treatment in advanced or metastatic breast cancer patients who have received a prior cumulative dose of 300 mg/m² of doxorubicin or a prior cumulative dose of 540 mg/m² of epirubicin when further anthracycline treatment is required</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                                                                                     nicebnf:hasTextContent """Prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin treatment in advanced or metastatic breast cancer patients who have received a prior cumulative dose of 300 mg/m² of doxorubicin or a prior cumulative dose of 540 mg/m² of epirubicin when further anthracycline treatment is required

"""^^xsd:string;
                                                                                                                                                                                                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                                                                                     rdfs:label "prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin treatment in advanced or metastatic breast cancer patients who have received a prior cumulative dose of 300 mg/m² of doxorubicin or a prior cumulative dose of 540 mg/m² of epirubicin when further anthracycline treatment is required"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#abdominalPain> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Abdominal pain</ph>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent "Abdominal pain"^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                        rdfs:label "abdominal pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#acuteMyeloidLeukaemia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">acute myeloid leukaemia</ph>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent "acute myeloid leukaemia"^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                rdfs:label "acute myeloid leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#alopecia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Alopecia</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "Alopecia"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "alopecia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#anaemia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">anaemia</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "anaemia"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "anaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#anorexia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Anorexia</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "Anorexia"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "anorexia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#asthenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">asthenia</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "asthenia"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "asthenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#bloodDisorders> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">blood disorders</ph>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent "blood disorders"^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                         rdfs:label "blood disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#constipation> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">constipation</ph>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent "constipation"^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#cough> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">cough</ph>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent "cough"^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                rdfs:label "cough"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#diarrhoea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">diarrhoea</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "diarrhoea"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "diarrhoea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dizziness> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dizziness</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "dizziness"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "dizziness"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dryMouth> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dry mouth</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "dry mouth"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "dry mouth"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dyspepsia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dyspepsia</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "dyspepsia"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "dyspepsia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dyspnoea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dyspnoea</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "dyspnoea"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "dyspnoea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#erythema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">erythema</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "erythema"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "erythema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#fatigue> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">fatigue</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "fatigue"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "fatigue"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#headache> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">headache</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "headache"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "headache"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#infection> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">infection</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "infection"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#injectionSiteReactions> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">injection-site reactions</ph>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent "injection-site reactions"^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                 rdfs:label "injection-site reactions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#leucopenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">leucopenia</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "leucopenia"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "leucopenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#lymphoedema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">lymphoedema</ph>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent "lymphoedema"^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                      rdfs:label "lymphoedema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#malaise> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">malaise</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "malaise"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "malaise"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#nailDisorder> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">nail disorder</ph>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent "nail disorder"^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                       rdfs:label "nail disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#nausea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">nausea</ph>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent "nausea"^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                 rdfs:label "nausea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#oedema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">oedema</ph>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent "oedema"^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                 rdfs:label "oedema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#paraesthesia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">paraesthesia</ph>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent "paraesthesia"^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                       rdfs:label "paraesthesia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">peripheral neuropathy</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "peripheral neuropathy"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                               rdfs:label "peripheral neuropathy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#phlebitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">phlebitis</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "phlebitis"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "phlebitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#pruritus> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">pruritus</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "pruritus"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "pruritus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#pyrexia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">pyrexia</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "pyrexia"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "pyrexia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#reducedEjectionFraction> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">reduced ejection fraction</ph>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent "reduced ejection fraction"^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                  rdfs:label "reduced ejection fraction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#stomatitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">stomatitis</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "stomatitis"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "stomatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#syncope> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">syncope</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "syncope"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "syncope"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#tachycardia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">tachycardia</ph>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent "tachycardia"^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                      rdfs:label "tachycardia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#thrombocytopenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">thrombocytopenia</ph>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent "thrombocytopenia"^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                           rdfs:label "thrombocytopenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#thromboembolismWhenGivenWithCytotoxicDrugs> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">thromboembolism (when given with cytotoxic drugs)</ph>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent "thromboembolism (when given with cytotoxic drugs)"^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                                     rdfs:label "thromboembolism (when given with cytotoxic drugs)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#vomiting> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">vomiting</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "vomiting"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "vomiting"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#DVihC9zvSU6xVhJP_-pTiQ>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#J5TVkyTZy0-9_U92q0JcRw>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#SUqX9iBbCUezgQUlGHWrsA>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#rdobWrGf60eYu_ruzqbHmQ>;
                                                                                       nicebnf:hasTitle """<title>Caverject<tm tmtype=\"reg\" /> Dual Chamber</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "caverject dual chamber"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#DVihC9zvSU6xVhJP_-pTiQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "10–20 micrograms for 1 dose (consult product literature)."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>10–20 micrograms for 1 dose (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """10–20 micrograms for 1 dose (consult product literature).

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosis>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#PHP79327>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#J5TVkyTZy0-9_U92q0JcRw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>Initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """Initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunctionAssociatedWithNeurologicalDysfunction>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#PHP79327>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#PHP79327> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#SUqX9iBbCUezgQUlGHWrsA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature)."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>Initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """Initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature).

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosisWhereEvidenceOfNeurologicalDysfunction>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#PHP79327>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#rdobWrGf60eYu_ruzqbHmQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>Initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """Initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject-dual-chamber#PHP79327>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Aid to diagnosis</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Aid to diagnosis

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "aid to diagnosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosisWhereEvidenceOfNeurologicalDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Aid to diagnosis where evidence of neurological dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasTextContent """Aid to diagnosis where evidence of neurological dysfunction

"""^^xsd:string;
                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                               rdfs:label "aid to diagnosis where evidence of neurological dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Erectile dysfunction

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunctionAssociatedWithNeurologicalDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction associated with neurological dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Erectile dysfunction associated with neurological dysfunction

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "erectile dysfunction associated with neurological dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intracavernosal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#EXq12beX0UKdRuqKQGekew>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#b9NeVK48oUaCF9h0wMoruQ>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#e4xUAS0PFEyp-hgbltiXRA>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#tfW1YzwPakyCIUWWHFUl1A>;
                                                                          nicebnf:hasTitle """<title>Caverject<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "caverject"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#EXq12beX0UKdRuqKQGekew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosisWhereEvidenceOfNeurologicalDysfunction>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#PHP79240>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#PHP79240> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#b9NeVK48oUaCF9h0wMoruQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunctionAssociatedWithNeurologicalDysfunction>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#PHP79240>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#e4xUAS0PFEyp-hgbltiXRA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "10–20 micrograms for 1 dose (consult product literature)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>10–20 micrograms for 1 dose (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """10–20 micrograms for 1 dose (consult product literature).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#PHP79240>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#tfW1YzwPakyCIUWWHFUl1A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5–10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5–20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/caverject#PHP79240>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Aid to diagnosis</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Aid to diagnosis

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "aid to diagnosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#aidToDiagnosisWhereEvidenceOfNeurologicalDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Aid to diagnosis where evidence of neurological dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasTextContent """Aid to diagnosis where evidence of neurological dysfunction

"""^^xsd:string;
                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                               rdfs:label "aid to diagnosis where evidence of neurological dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Erectile dysfunction

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunctionAssociatedWithNeurologicalDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction associated with neurological dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Erectile dysfunction associated with neurological dysfunction

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "erectile dysfunction associated with neurological dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intracavernosal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-lotion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-lotion#QGNvCQYfnEWw8MINtYH_Cg>;
                                                                              nicebnf:hasTitle """<title>Cepton<tm tmtype=\"reg\" /> lotion</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "cepton lotion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-lotion#PHP99754> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-lotion#QGNvCQYfnEWw8MINtYH_Cg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                        rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfectionInAcne>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-lotion#PHP99754>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfectionInAcne> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For skin disinfection in acne</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """For skin disinfection in acne

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "for skin disinfection in acne"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-skin-wash> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-skin-wash#VE6ENQVp50OdmmO3wz1XxQ>;
                                                                                 nicebnf:hasTitle """<title>Cepton<tm tmtype=\"reg\" /> skin wash</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "cepton skin wash"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-skin-wash#PHP99924> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-skin-wash#VE6ENQVp50OdmmO3wz1XxQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forUseAsSkinWashInAcne>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cepton-skin-wash#PHP99924>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forUseAsSkinWashInAcne> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For use as skin wash in acne</p>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent """For use as skin wash in acne

"""^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                 rdfs:label "for use as skin wash in acne"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#hOmYstJmNE6FOQiG4bpGlA>,
                                                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#wcTofsJ6J0W5_TvBq2Dg_A>;
                                                                                                                  nicebnf:hasTitle "<title>Cernevit solution for injection vials and diluent</title>"^^<rdf:XMLLiteral>;
                                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                  rdfs:label "cernevit solution for injection vials and diluent"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#PHP107394> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#PHP107403> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#hOmYstJmNE6FOQiG4bpGlA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Cernevit</i>
    <tm tmtype=\"reg\" /> solution contains <i>dl</i>-alpha tocopherol 11.2 units, ascorbic acid 125 mg, biotin 69 micrograms, colecalciferol 220 units, cyanocobalamin 6 micrograms, folic acid 414 micrograms, glycine 250 mg, nicotinamide 46 mg, pantothenic acid (as dexpanthenol) 17.25 mg, pyridoxine hydrochloride 5.5 mg, retinol (as palmitate) 3500 units, riboflavin (as dihydrated sodium phosphate) 4.14 mg, thiamine (as cocarboxylase tetrahydrate) 3.51 mg.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#PHP107403>;
                                                                                                                                         nicebnf:hasTextContent """Cernevit solution contains dl-alpha tocopherol 11.2 units, ascorbic acid 125 mg, biotin 69 micrograms, colecalciferol 220 units, cyanocobalamin 6 micrograms, folic acid 414 micrograms, glycine 250 mg, nicotinamide 46 mg, pantothenic acid (as dexpanthenol) 17.25 mg, pyridoxine hydrochloride 5.5 mg, retinol (as palmitate) 3500 units, riboflavin (as dihydrated sodium phosphate) 4.14 mg, thiamine (as cocarboxylase tetrahydrate) 3.51 mg.

"""^^xsd:string;
                                                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#wcTofsJ6J0W5_TvBq2Dg_A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dissolve in 5 mL water for injections.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cernevit-solution-for-injection-vials-and-diluent#PHP107394>;
                                                                                                                                         nicebnf:hasTextContent """Dissolve in 5 mL water for injections.

"""^^xsd:string;
                                                                                                                                         a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#RvG8oRjzEUKHdlaEongzmw>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#R-mlywA4Ska4t0Z06V6cFg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#k5I9rC22k0eOEm9Kqg5MiA>;
                                                                         nicebnf:hasTitle """<title>Certican<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "certican"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#PHP108167> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#PHP108179> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#R-mlywA4Ska4t0Z06V6cFg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 750 micrograms twice daily, to be started as soon as possible after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 750 micrograms twice daily, to be started as soon as possible after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 750 micrograms twice daily, to be started as soon as possible after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#heartTransplantation>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#renalTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#PHP108167>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#RvG8oRjzEUKHdlaEongzmw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Everolimus (<i>Certican</i><tm tmtype=\"reg\" />) is <b>not</b> recommended within its marketing authorisation for preventing organ rejection in patients who have undergone a liver transplant. Patients currently receiving everolimus for this indication should have the option to continue treatment until they and their clinician consider it appropriate to stop.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasFundingIdentifier <http://www.nice.org.uk/TA348>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#PHP108179>;
                                                                                                nicebnf:hasTextContent """Everolimus (Certican) is not recommended within its marketing authorisation for preventing organ rejection in patients who have undergone a liver transplant. Patients currently receiving everolimus for this indication should have the option to continue treatment until they and their clinician consider it appropriate to stop.

"""^^xsd:string;
                                                                                                nicebnf:hasTitle "Everolimus for preventing organ rejection in liver transplantation (July 2015)"^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:NiceTechnologyAppraisals.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#k5I9rC22k0eOEm9Kqg5MiA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 1 mg twice daily, to be started approximately 4 weeks after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 1 mg twice daily, to be started approximately 4 weeks after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 1 mg twice daily, to be started approximately 4 weeks after transplantation; maintenance, dose adjusted according to response and whole blood everolimus concentration; dose adjustments can be made every 4–5 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#liverTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/certican#PHP108167>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#heartTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Heart transplantation</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Heart transplantation

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "heart transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#liverTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Liver transplantation</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Liver transplantation

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "liver transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#renalTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Renal transplantation</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Renal transplantation

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "renal transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.
<http://www.nice.org.uk/TA348> a <http://ld.nice.org.uk/ns/bnf/FundingIdentifier>;
                               rdfs:label "nice ta348"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cervarix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cervarix#kxZ_zdOvS0WwWisDE6Sxhg>;
                                                                         nicebnf:hasTitle """<title>Cervarix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "cervarix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cervarix#PHP81884> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cervarix#kxZ_zdOvS0WwWisDE6Sxhg> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalLesionsAndCervicalCancer>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cervarix#PHP81884>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalLesionsAndCervicalCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of premalignant genital lesions and cervical cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasTextContent """Prevention of premalignant genital lesions and cervical cancer

"""^^xsd:string;
                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                  rdfs:label "prevention of premalignant genital lesions and cervical cancer"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cetraben-bath> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cetraben-bath#RoeB2zhVy0uExScoP4S37A>;
                                                                              nicebnf:hasTitle """<title>Cetraben<tm tmtype=\"reg\" /> bath</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "cetraben bath"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cetraben-bath#PHP106150> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cetraben-bath#RoeB2zhVy0uExScoP4S37A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                        rdfs:label "0.5–1 capful/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>0.5–1 capful/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """0.5–1 capful/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                        rdfs:label "1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cetraben-bath#PHP106150>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions, including eczema</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Dry skin conditions, including eczema

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "dry skin conditions, including eczema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/chemydur-60xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/chemydur-60xl#vNK0-wdirEaQikfn8kVZMA>;
                                                                              nicebnf:hasTitle """<title>Chemydur<tm tmtype=\"reg\" /> 60XL</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "chemydur 60xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/chemydur-60xl#PHP62186> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/chemydur-60xl#vNK0-wdirEaQikfn8kVZMA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/chemydur-60xl#PHP62186>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/chloraprep> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/chloraprep#EA8_3Uk48ECvm4fsVA_heg>;
                                                                           nicebnf:hasTitle """<title>ChloraPrep<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "chloraprep"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/chloraprep#EA8_3Uk48ECvm4fsVA_heg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child2Months17Years> ; 
                                                                                                                     rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfectionBeforeInvasiveProcedures>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/chloraprep#PHP99964>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/chloraprep#PHP99964> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfectionBeforeInvasiveProcedures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For skin disinfection before invasive procedures</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """For skin disinfection before invasive procedures

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "for skin disinfection before invasive procedures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child2Months17Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                rdfs:label "child 2 months–17 years"^^xsd:string;
                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#E6-C-fAJf0SQFLYGz683Cw>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#SkawVcvCSUGScydcvU_H0Q>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#it7tsQHC7kK_lvtkSpw9Ew>;
                                                                        nicebnf:hasTitle """<title>Cinryze<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "cinryze"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#E6-C-fAJf0SQFLYGz683Cw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1000 units, repeated if necessary for 1 dose, dose may be repeated if necessary."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1000 units, repeated if necessary for 1 dose, dose may be repeated if necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1000 units, repeated if necessary for 1 dose, dose may be repeated if necessary.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAttacksOfHereditaryAngioedemaUnderExpertSupervision>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#PHP83446>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#PHP83446> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#SkawVcvCSUGScydcvU_H0Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1000 units every 3–4 days, interval between doses to be adjusted according to response."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1000 units every 3–4 days, interval between doses to be adjusted according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1000 units every 3–4 days, interval between doses to be adjusted according to response.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#longTermProphylaxisOfSevereRecurrentAttacksOfHereditaryAngioedemaWhereAcuteTreatmentIsInadequateOrWhenOralProphylaxisIsInadequateOrNotToleratedUnderExpertSupervision>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#PHP83446>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#it7tsQHC7kK_lvtkSpw9Ew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1000 units for 1 dose, to be administered up to 24 hours before procedure."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1000 units for 1 dose, to be administered up to 24 hours before procedure.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1000 units for 1 dose, to be administered up to 24 hours before procedure.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#shortTermProphylaxisOfHereditaryAngioedemaBeforeDentalMedicalOrSurgicalProceduresUnderExpertSupervision>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cinryze#PHP83446>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAttacksOfHereditaryAngioedemaUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute attacks of hereditary angioedema (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Acute attacks of hereditary angioedema (under expert supervision)

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "acute attacks of hereditary angioedema (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#longTermProphylaxisOfSevereRecurrentAttacksOfHereditaryAngioedemaWhereAcuteTreatmentIsInadequateOrWhenOralProphylaxisIsInadequateOrNotToleratedUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Long-term prophylaxis of severe, recurrent attacks of hereditary angioedema where acute treatment is inadequate, or when oral prophylaxis is inadequate or not tolerated (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                nicebnf:hasTextContent """Long-term prophylaxis of severe, recurrent attacks of hereditary angioedema where acute treatment is inadequate, or when oral prophylaxis is inadequate or not tolerated (under expert supervision)

"""^^xsd:string;
                                                                                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                rdfs:label "long-term prophylaxis of severe, recurrent attacks of hereditary angioedema where acute treatment is inadequate, or when oral prophylaxis is inadequate or not tolerated (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#shortTermProphylaxisOfHereditaryAngioedemaBeforeDentalMedicalOrSurgicalProceduresUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                  nicebnf:hasTextContent """Short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)

"""^^xsd:string;
                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                  rdfs:label "short-term prophylaxis of hereditary angioedema before dental, medical, or surgical procedures (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySlowIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by slow intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/citanest-1> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/citanest-1#Z9upbxVer0eHWsz7hCau7g>;
                                                                           nicebnf:hasTitle """<title>Citanest 1%<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "citanest 1%"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citanest-1#PHP82997> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citanest-1#Z9upbxVer0eHWsz7hCau7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "100–200 mg/minute, dose adjusted according to site of administration and response, increased if necessary up to 400 mg, dose may need to be adjusted in elderly or debilitated patients."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>100–200 mg/minute, dose adjusted according to site of administration and response, increased if necessary up to 400 mg, dose may need to be adjusted in elderly or debilitated patients.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """100–200 mg/minute, dose adjusted according to site of administration and response, increased if necessary up to 400 mg, dose may need to be adjusted in elderly or debilitated patients.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRegionalAdministration>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#infiltrationAnaesthesia>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#nerveBlock>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citanest-1#PHP82997>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#infiltrationAnaesthesia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Infiltration anaesthesia</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Infiltration anaesthesia

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "infiltration anaesthesia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#nerveBlock> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Nerve block</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Nerve block

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "nerve block"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRegionalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by regional administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#BVtiaMWook2fB9IiCYqoTw>;
                                                                                   nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#8VzgfolsfUKzCqjxWIFt7A>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#Lohxk-VfWkOrvO0sXlaVzA>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#kNh0aYcTSke9KrADSPV5SQ>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#wypiI_WDtUqa3FIekhp-yA>;
                                                                                   nicebnf:hasTitle """<title>CitraFleet<tm tmtype=\"reg\" /> sachets</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "citrafleet sachets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#8VzgfolsfUKzCqjxWIFt7A> nicebnf:hasDitaContent """<sectiondiv>
  <p>One sachet should be reconstituted with 150 mL (approx. half a glass) of cold water.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104649>;
                                                                                                          nicebnf:hasTextContent """One sachet should be reconstituted with 150 mL (approx. half a glass) of cold water.

"""^^xsd:string;
                                                                                                          a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#BVtiaMWook2fB9IiCYqoTw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationOnDayBeforeRadiologicalExaminationEndoscopyOrSurgery>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104633>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#Lohxk-VfWkOrvO0sXlaVzA> nicebnf:hasDitaContent """<section outputclass=\"pharmacokinetics\">
  <title>Pharmacokinetics</title>
  <p>Acts within 3 hours of first dose.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104633>;
                                                                                                          nicebnf:hasTextContent """PharmacokineticsActs within 3 hours of first dose.

"""^^xsd:string;
                                                                                                          a nicebnf:IndicationsAndDoseSection,
                                                                                                            nicebnf:Pharmacokinetics.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104633> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104649> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104653> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104658> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#kNh0aYcTSke9KrADSPV5SQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>One reconstituted sachet contains K<sup>+</sup> 5 mmol and Mg<sup>2+</sup> 86 mmol.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104658>;
                                                                                                          nicebnf:hasTextContent """One reconstituted sachet contains K+ 5 mmol and Mg2+ 86 mmol.

"""^^xsd:string;
                                                                                                          a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#wypiI_WDtUqa3FIekhp-yA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Low residue diet recommended on the day before procedure and copious intake of water or other clear fluids recommended during treatment.</p>
  <p>Patients and carers should be given advice on how to administer oral powder; they should be warned that heat is generated during reconstitution and that the solution should be allowed to cool before drinking.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/citrafleet-sachets#PHP104653>;
                                                                                                          nicebnf:hasTextContent """Low residue diet recommended on the day before procedure and copious intake of water or other clear fluids recommended during treatment.

Patients and carers should be given advice on how to administer oral powder; they should be warned that heat is generated during reconstitution and that the solution should be allowed to cool before drinking.

"""^^xsd:string;
                                                                                                          a nicebnf:GeneralPatientAdvice,
                                                                                                            nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationOnDayBeforeRadiologicalExaminationEndoscopyOrSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation on day before radiological examination, endoscopy, or surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasTextContent """Bowel evacuation on day before radiological examination, endoscopy, or surgery

"""^^xsd:string;
                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                              rdfs:label "bowel evacuation on day before radiological examination, endoscopy, or surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#GozzLvGc6ESEVUSwhL6Rwg>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#212Pdfevwke2GSFODnRz0Q>;
                                                                                nicebnf:hasTitle """<title>Clenil Modulite<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "clenil modulite"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#212Pdfevwke2GSFODnRz0Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Clenil Modulite</i>
    <tm tmtype=\"reg\" /> is not interchangeable with other CFC-free beclometasone dipropionate inhalers.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#PHP83069>;
                                                                                                       nicebnf:hasTextContent """Clenil Modulite is not interchangeable with other CFC-free beclometasone dipropionate inhalers.

"""^^xsd:string;
                                                                                                       a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#GozzLvGc6ESEVUSwhL6Rwg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child211Years> ; 
                                                                                                                          rdfs:label "100–200 micrograms twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>100–200 micrograms twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """100–200 micrograms twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                          rdfs:label "200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """200–400 micrograms twice daily, adjusted according to response; increased if necessary up to 1 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#PHP83050>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#PHP83050> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clenil-modulite#PHP83069> a nicebnf:PrescribingAndDispensingInformations.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child211Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-1-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-1-mg#ffjL1LAD7ECjj3Kkqu13eA>;
                                                                               nicebnf:hasTitle """<title>Climagest<tm tmtype=\"reg\" /> 1-mg</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "climagest 1-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-1-mg#PHP96131> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-1-mg#ffjL1LAD7ECjj3Kkqu13eA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "1 tablet daily for 16 days, grey tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, grey tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 tablet daily for 16 days, grey tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-1-mg#PHP96131>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-2-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-2-mg#4qJAI1u44kmtcCiHGWrWMQ>;
                                                                               nicebnf:hasTitle """<title>Climagest<tm tmtype=\"reg\" /> 2-mg</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "climagest 2-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-2-mg#4qJAI1u44kmtcCiHGWrWMQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "1 tablet daily for 16 days, blue tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, blue tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 tablet daily for 16 days, blue tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, white tablet to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsIfSymptomsNotControlledWithLowerStrength>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-2-mg#PHP96200>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climagest-2-mg#PHP96200> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsIfSymptomsNotControlledWithLowerStrength> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms (if symptoms not controlled with lower strength)</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Menopausal symptoms (if symptoms not controlled with lower strength)

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "menopausal symptoms (if symptoms not controlled with lower strength)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/climaval> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/climaval#aSJ6do2zMUCPns0qu-7M-w>;
                                                                         nicebnf:hasTitle """<title>Climaval<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "climaval"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climaval#PHP97434> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climaval#aSJ6do2zMUCPns0qu-7M-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1–2 mg daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1–2 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1–2 mg daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsIfPatientHasHadAHysterectomy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/climaval#PHP97434>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsIfPatientHasHadAHysterectomy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms (if patient has had a hysterectomy)</p>"""^^<rdf:XMLLiteral>;
                                                                                         nicebnf:hasTextContent """Menopausal symptoms (if patient has had a hysterectomy)

"""^^xsd:string;
                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                         rdfs:label "menopausal symptoms (if patient has had a hysterectomy)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/climesse> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/climesse#VUxjTOGIV0SWUv9gzjPRcw>;
                                                                         nicebnf:hasTitle """<title>Climesse<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "climesse"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climesse#PHP96116> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/climesse#VUxjTOGIV0SWUv9gzjPRcw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1 tablet daily continuously."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet daily continuously.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 tablet daily continuously.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/climesse#PHP96116>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/clinicalMedicinalProductInformation> nicebnf:hasTitle "<title>Clinical medicinal product information</title>"^^<rdf:XMLLiteral>;
                                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                    rdfs:label "clinical medicinal product information"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/clinorette> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/clinorette#rczGagmK-0SO4RqM__rM7g>;
                                                                           nicebnf:hasTitle """<title>Clinorette<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "clinorette"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clinorette#PHP96439> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/clinorette#rczGagmK-0SO4RqM__rM7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "1 tablet daily for 16 days, white tablets to be taken, starting on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, pink tablets to be taken, subsequent courses repeated without interval."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, white tablets to be taken, starting on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, pink tablets to be taken, subsequent courses repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """1 tablet daily for 16 days, white tablets to be taken, starting on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, pink tablets to be taken, subsequent courses repeated without interval.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/clinorette#PHP96439>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cocois-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cocois-ointment#E0HfrWGZc0CnYTygrnV43g>;
                                                                                nicebnf:hasTitle """<title>Cocois<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "cocois ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cocois-ointment#E0HfrWGZc0CnYTygrnV43g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                          rdfs:label "medical supervision required."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Medical supervision required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Medical supervision required.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                          rdfs:label "apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply once weekly as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#scalyScalpDisordersIncludingPsoriasisEczemaSeborrhoeicDermatitisAndDandruff>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cocois-ointment#PHP107373>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cocois-ointment#PHP107373> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#scalyScalpDisordersIncludingPsoriasisEczemaSeborrhoeicDermatitisAndDandruff> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff</p>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasTextContent """Scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff

"""^^xsd:string;
                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                      rdfs:label "scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "initially to the skin using scalp ointment"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#eB65geNz4EWe-E3k2vcAWw>;
                                                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#Gon23TZg1UCv-i2pkVqAZg>,
                                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#gVMIRfYMOEGGJ4K5uubppA>,
                                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#kKWOCRCeVkW82dU8vXW1PA>;
                                                                                                             nicebnf:hasTitle """<title>Colgate Duraphat<tm tmtype=\"reg\" /> 2800ppm fluoride toothpaste</title>"""^^<rdf:XMLLiteral>;
                                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                             rdfs:label "colgate duraphat 2800ppm fluoride toothpaste"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#Gon23TZg1UCv-i2pkVqAZg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Brush teeth for 1 minute before spitting out.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104724>;
                                                                                                                                    nicebnf:hasTextContent """Brush teeth for 1 minute before spitting out.

"""^^xsd:string;
                                                                                                                                    a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104708> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104724> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104728> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104735> a nicebnf:ProfessionSpecificInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#eB65geNz4EWe-E3k2vcAWw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1017Years> ; 
                                                                                                                                                       rdfs:label "apply 1 centimetre twice daily, to be applied using a toothbrush."^^xsd:string ; 
                                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 centimetre twice daily, to be applied using a toothbrush.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                       nicebnf:hasTextContent """Apply 1 centimetre twice daily, to be applied using a toothbrush.

"""^^xsd:string ; 
                                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste>],
                                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                       rdfs:label "apply 1 centimetre twice daily, to be applied using a toothbrush."^^xsd:string ; 
                                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 centimetre twice daily, to be applied using a toothbrush.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                       nicebnf:hasTextContent """Apply 1 centimetre twice daily, to be applied using a toothbrush.

"""^^xsd:string ; 
                                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste>];
                                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCaries>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104708>;
                                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#gVMIRfYMOEGGJ4K5uubppA> nicebnf:hasDitaContent """<sectiondiv>
  <p>May be prescribed as Sodium Fluoride Toothpaste 0.619%.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104735>;
                                                                                                                                    nicebnf:hasTextContent """May be prescribed as Sodium Fluoride Toothpaste 0.619%.

"""^^xsd:string;
                                                                                                                                    a nicebnf:DentalPractitionersFormularyInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#kKWOCRCeVkW82dU8vXW1PA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer sodium fluoride toothpaste.</p>
  <p>Avoid drinking or rinsing mouth for 30 minutes after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-2800ppm-fluoride-toothpaste#PHP104728>;
                                                                                                                                    nicebnf:hasTextContent """Patients or carers should be given advice on how to administer sodium fluoride toothpaste.

Avoid drinking or rinsing mouth for 30 minutes after use.

"""^^xsd:string;
                                                                                                                                    a nicebnf:GeneralPatientAdvice,
                                                                                                                                      nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCaries> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of dental caries</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Prophylaxis of dental caries

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "prophylaxis of dental caries"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1017Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 10–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                             rdfs:label "by mouth using paste"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#tL_YzovhAUiKqLTLXAiW7g>;
                                                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#6hHQZS0OsEW--Vp1iZ2IOg>,
                                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#QxusxG9Gm0yDbvqSgXha9Q>,
                                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#nh-LVq2UD0e4mZ61LWErrw>;
                                                                                                             nicebnf:hasTitle """<title>Colgate Duraphat<tm tmtype=\"reg\" /> 5000ppm fluoride toothpaste</title>"""^^<rdf:XMLLiteral>;
                                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                             rdfs:label "colgate duraphat 5000ppm fluoride toothpaste"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#6hHQZS0OsEW--Vp1iZ2IOg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Brush teeth for 3 minutes before spitting out.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104505>;
                                                                                                                                    nicebnf:hasTextContent """Brush teeth for 3 minutes before spitting out.

"""^^xsd:string;
                                                                                                                                    a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104443> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104505> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104523> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104551> a nicebnf:ProfessionSpecificInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#QxusxG9Gm0yDbvqSgXha9Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer Sodium fluoride toothpaste.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104523>;
                                                                                                                                    nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Sodium fluoride toothpaste.

"""^^xsd:string;
                                                                                                                                    a nicebnf:GeneralPatientAdvice,
                                                                                                                                      nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#nh-LVq2UD0e4mZ61LWErrw> nicebnf:hasDitaContent """<sectiondiv>
  <p>May be prescribed as Sodium Fluoride Toothpaste 1.1%.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104551>;
                                                                                                                                    nicebnf:hasTextContent """May be prescribed as Sodium Fluoride Toothpaste 1.1%.

"""^^xsd:string;
                                                                                                                                    a nicebnf:DentalPractitionersFormularyInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#tL_YzovhAUiKqLTLXAiW7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                                                       rdfs:label "apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush."^^xsd:string ; 
                                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                       nicebnf:hasTextContent """Apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush.

"""^^xsd:string ; 
                                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste>],
                                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                       rdfs:label "apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush."^^xsd:string ; 
                                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                       nicebnf:hasTextContent """Apply 2 centimetres 3 times a day, to be applied after meals using a toothbrush.

"""^^xsd:string ; 
                                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste>];
                                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCaries>;
                                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colgate-duraphat-5000ppm-fluoride-toothpaste#PHP104443>;
                                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCaries> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of dental caries</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Prophylaxis of dental caries

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "prophylaxis of dental caries"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingPaste> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                             rdfs:label "by mouth using paste"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/colomycin> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/colomycin#nVDiaSa_sUmPusobZYDSPA>;
                                                                          nicebnf:hasTitle """<title>Colomycin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "colomycin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colomycin#PHP98197> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colomycin#nVDiaSa_sUmPusobZYDSPA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Colomycin<tm tmtype=\"reg\" /> Injection may be used for nebulisation; administer required dose in 2–4 mL of sodium chloride 0.9%, (or water for injections) or a 1:1 mixture of sodium chloride 0.9% and water for injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colomycin#PHP98197>;
                                                                                                 nicebnf:hasTextContent """Colomycin Injection may be used for nebulisation; administer required dose in 2–4 mL of sodium chloride 0.9%, (or water for injections) or a 1:1 mixture of sodium chloride 0.9% and water for injection.

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/colpermin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/colpermin#ZFkkyMdumEiEGWXDZIPJ7Q>;
                                                                          nicebnf:hasTitle """<title>Colpermin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "colpermin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colpermin#PHP83062> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/colpermin#ZFkkyMdumEiEGWXDZIPJ7Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                    rdfs:label "1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1–2 capsules 3 times a day for up to 3 months if necessary, capsule to be swallowed whole with water.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfAbdominalColicAndDistensionParticularlyInIrritableBowelSyndrome>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/colpermin#PHP83062>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfAbdominalColicAndDistensionParticularlyInIrritableBowelSyndrome> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of abdominal colic and distension, particularly in irritable bowel syndrome</p>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasTextContent """Relief of abdominal colic and distension, particularly in irritable bowel syndrome

"""^^xsd:string;
                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                  rdfs:label "relief of abdominal colic and distension, particularly in irritable bowel syndrome"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/combivir-tablets> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/combivir-tablets#oDEhC6pbF0et2zczLnJ41A>;
                                                                                 nicebnf:hasTitle """<title>Combivir<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "combivir tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/combivir-tablets#PHP96442> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/combivir-tablets#oDEhC6pbF0et2zczLnJ41A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablets may be crushed and mixed with semi-solid food or liquid just before administration.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/combivir-tablets#PHP96442>;
                                                                                                        nicebnf:hasTextContent """Tablets may be crushed and mixed with semi-solid food or liquid just before administration.

"""^^xsd:string;
                                                                                                        a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#Bn4RepvtGEWzVV9RSSIHSw>;
                                                                            nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#bjCn5uHmjken9o2U3kttcg>;
                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#K2vo-3-omkawUOjnRD4MiA>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#M5Y_7Ma7wkC78jYA88Oj-Q>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#Xk8C0DYqA0WKazxxTvnCoQ>;
                                                                            nicebnf:hasTitle """<title>Concerta<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "concerta xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#Bn4RepvtGEWzVV9RSSIHSw> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#dysphagiaDoseFormNotAppropriate>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Caution#restrictedGastroIntestinalLumenDoseFormNotAppropriate>;
                                                                                                   nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Dysphagia (dose form not appropriate)</ph>; <ph outputclass=\"caution\">restricted gastro-intestinal lumen (dose form not appropriate)</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98041>;
                                                                                                   nicebnf:hasTextContent """Dysphagia (dose form not appropriate); restricted gastro-intestinal lumen (dose form not appropriate)

"""^^xsd:string;
                                                                                                   a nicebnf:CautionsGroup,
                                                                                                     nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#K2vo-3-omkawUOjnRD4MiA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Consists of an immediate-release component (22% of the dose) and a modified-release component (78% of the dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98163>;
                                                                                                   nicebnf:hasTextContent """Consists of an immediate-release component (22% of the dose) and a modified-release component (78% of the dose).

"""^^xsd:string;
                                                                                                   a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#M5Y_7Ma7wkC78jYA88Oj-Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>Total daily dose of 15 mg of standard-release formulation is considered equivalent to <i>Concerta</i><tm tmtype=\"reg\" /> XL 18 mg once daily.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98063>;
                                                                                                   nicebnf:hasTextContent """Dose equivalence and conversionTotal daily dose of 15 mg of standard-release formulation is considered equivalent to Concerta XL 18 mg once daily.

"""^^xsd:string;
                                                                                                   a nicebnf:DoseEquivalence,
                                                                                                     nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98041> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98063> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98142> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98163> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#Xk8C0DYqA0WKazxxTvnCoQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablet membrane may pass through gastro-intestinal tract unchanged.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98142>;
                                                                                                   nicebnf:hasTextContent """Tablet membrane may pass through gastro-intestinal tract unchanged.

"""^^xsd:string;
                                                                                                   a nicebnf:GeneralPatientAdvice,
                                                                                                     nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#bjCn5uHmjken9o2U3kttcg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 18 mg once daily, dose to be taken in the morning; adjusted at weekly intervals according to response; maximum 108 mg per day."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 18 mg once daily, dose to be taken in the morning; adjusted at weekly intervals according to response; maximum 108 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 18 mg once daily, dose to be taken in the morning; adjusted at weekly intervals according to response; maximum 108 mg per day.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/concerta-xl#PHP98063>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Caution#dysphagiaDoseFormNotAppropriate> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Dysphagia (dose form not appropriate)</ph>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent "Dysphagia (dose form not appropriate)"^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                       rdfs:label "dysphagia (dose form not appropriate)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#restrictedGastroIntestinalLumenDoseFormNotAppropriate> nicebnf:hasDitaContent """<ph outputclass=\"caution\">restricted gastro-intestinal lumen (dose form not appropriate)</ph>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent "restricted gastro-intestinal lumen (dose form not appropriate)"^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                             rdfs:label "restricted gastro-intestinal lumen (dose form not appropriate)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Attention deficit hyperactivity disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Attention deficit hyperactivity disorder

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "attention deficit hyperactivity disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/condyline> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/condyline#BOGy_ggvnEewWimylEDDvg>;
                                                                          nicebnf:hasTitle """<title>Condyline<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "condyline"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/condyline#BOGy_ggvnEewWimylEDDvg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of five 3-day treatment courses, direct medical supervision for lesions in the female and for lesions greater than 4 cm2 in the male, maximum 50 single applications (‘loops’) per session (consult product literature)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of five 3-day treatment courses, direct medical supervision for lesions in the female and for lesions greater than 4 cm<sup>2</sup> in the male, maximum 50 single applications (‘loops’) per session (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of five 3-day treatment courses, direct medical supervision for lesions in the female and for lesions greater than 4 cm2 in the male, maximum 50 single applications (‘loops’) per session (consult product literature).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/condyline#PHP82602>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/condyline#PHP82602> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Condylomata acuminata affecting the penis or the female external genitalia</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Condylomata acuminata affecting the penis or the female external genitalia

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "condylomata acuminata affecting the penis or the female external genitalia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#kDQqPfuO6k20KN1IH9JVEQ>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#P_BwFB6BjkSk48wDKOSA0Q>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#QS-n0YEXMEOzhBJRsIJyag>;
                                                                         nicebnf:hasTitle """<title>Convulex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "convulex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#PHP81005> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#PHP81031> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#P_BwFB6BjkSk48wDKOSA0Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <i>Convulex</i>
    <tm tmtype=\"reg\" /> has a 1:1 dose relationship with products containing sodium valproate, but nevertheless care is needed if switching or making changes.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#PHP81005>;
                                                                                                nicebnf:hasTextContent """Dose equivalence and conversionConvulex has a 1:1 dose relationship with products containing sodium valproate, but nevertheless care is needed if switching or making changes.

"""^^xsd:string;
                                                                                                a nicebnf:DoseEquivalence,
                                                                                                  nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#QS-n0YEXMEOzhBJRsIJyag> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients being treated for epilepsy may need to be maintained on a specific manufacturer's branded or generic oral valproic acid product.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#PHP81031>;
                                                                                                nicebnf:hasTextContent """Patients being treated for epilepsy may need to be maintained on a specific manufacturer's branded or generic oral valproic acid product.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#kDQqPfuO6k20KN1IH9JVEQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 600 mg daily in 2–4 divided doses, increased in steps of 150–300 mg every 3 days; usual maintenance 1–2 g daily in 2–4 divided doses, max. 2.5 g daily in 2–4 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 600 mg daily in 2–4 divided doses, increased in steps of 150–300 mg every 3 days; usual maintenance 1–2 g daily in 2–4 divided doses, max. 2.5 g daily in 2–4 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 600 mg daily in 2–4 divided doses, increased in steps of 150–300 mg every 3 days; usual maintenance 1–2 g daily in 2–4 divided doses, max. 2.5 g daily in 2–4 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#epilepsy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/convulex#PHP81005>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#epilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Epilepsy

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#AD-DIDtCq0ChOL32Og_drg>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#KcUcf_iT5kyriHulvjYRcw>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#TMp3tdPjHkKQJiv8cBzIbA>;
                                                                                nicebnf:hasTitle """<title>Copegus<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "copegus tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#AD-DIDtCq0ChOL32Og_drg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "usual dose 400 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Usual dose 400 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Usual dose 400 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCGenotype2Or3NotPreviouslyTreatedOrPatientsInfectedWithHivAndHepatitisCInCombinationWithPeginterferonAlfa>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#PHP83774>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#KcUcf_iT5kyriHulvjYRcw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo74Kg> ; 
                                                                                                                          rdfs:label "400 mg, dose to be taken in the morning and 600 mg, dose to be taken in the evening."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>400 mg, dose to be taken in the morning and 600 mg, dose to be taken in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """400 mg, dose to be taken in the morning and 600 mg, dose to be taken in the evening.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight75KgAndAbove> ; 
                                                                                                                          rdfs:label "600 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>600 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """600 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithDirectActingAntiviralsOrInterferonAlfa2aOrPeginterferonAlfa2aWithOrWithoutDirectActingAntivirals>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#PHP83774>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#PHP83774> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#TMp3tdPjHkKQJiv8cBzIbA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> ; 
                                                                                                                          rdfs:label "400 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>400 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """400 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> ; 
                                                                                                                          rdfs:label "400 mg, to be taken in the morning and 600 mg, to be taken in the evening."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>400 mg, to be taken in the morning and 600 mg, to be taken in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """400 mg, to be taken in the morning and 600 mg, to be taken in the evening.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81105Kg> ; 
                                                                                                                          rdfs:label "600 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>600 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """600 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight106KgAndAbove> ; 
                                                                                                                          rdfs:label "600 mg, to be taken in the morning and 800 mg, to be taken in the evening."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>600 mg, to be taken in the morning and 800 mg, to be taken in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """600 mg, to be taken in the morning and 800 mg, to be taken in the evening.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithPeginterferonAlfa2bWithOrWithoutDirectActingAntivirals>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/copegus-tablets#PHP83774>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCGenotype2Or3NotPreviouslyTreatedOrPatientsInfectedWithHivAndHepatitisCInCombinationWithPeginterferonAlfa> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C genotype 2 or 3 (not previously treated), or patients infected with HIV and hepatitis C (in combination with peginterferon alfa)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                    nicebnf:hasTextContent """Chronic hepatitis C genotype 2 or 3 (not previously treated), or patients infected with HIV and hepatitis C (in combination with peginterferon alfa)

"""^^xsd:string;
                                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                    rdfs:label "chronic hepatitis c genotype 2 or 3 (not previously treated), or patients infected with hiv and hepatitis c (in combination with peginterferon alfa)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithDirectActingAntiviralsOrInterferonAlfa2aOrPeginterferonAlfa2aWithOrWithoutDirectActingAntivirals> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C (in combination with direct acting antivirals, or interferon alfa 2a, or peginterferon alfa 2a with or without direct acting antivirals)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                             nicebnf:hasTextContent """Chronic hepatitis C (in combination with direct acting antivirals, or interferon alfa 2a, or peginterferon alfa 2a with or without direct acting antivirals)

"""^^xsd:string;
                                                                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                             rdfs:label "chronic hepatitis c (in combination with direct acting antivirals, or interferon alfa 2a, or peginterferon alfa 2a with or without direct acting antivirals)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithPeginterferonAlfa2bWithOrWithoutDirectActingAntivirals> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C (in combination with peginterferon alfa 2b with or without direct acting antivirals)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                   nicebnf:hasTextContent """Chronic hepatitis C (in combination with peginterferon alfa 2b with or without direct acting antivirals)

"""^^xsd:string;
                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                   rdfs:label "chronic hepatitis c (in combination with peginterferon alfa 2b with or without direct acting antivirals)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight106KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                         rdfs:label "adult (body-weight 106 kg and above)"^^xsd:string;
                                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 65–80 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight75KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 75 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81105Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                   rdfs:label "adult (body-weight 81–105 kg)"^^xsd:string;
                                                                   rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 64 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo74Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 74 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/copper-t380-a> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/copper-t380-a#--W1NbHkoEqb9CzZO25vsQ>;
                                                                              nicebnf:hasTitle """<title>Copper T380 A<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "copper t380 a"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copper-t380-a#--W1NbHkoEqb9CzZO25vsQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 10 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/copper-t380-a#PHP105540>;
                                                                                                     nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 10 years.

"""^^xsd:string;
                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/copper-t380-a#PHP105540> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-sr#Z8ELJ9TrqEG0QwXlsA2KGw>;
                                                                            nicebnf:hasTitle """<title>Coracten<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "coracten sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-sr#PHP62499> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-sr#Z8ELJ9TrqEG0QwXlsA2KGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 10 mg twice daily, increased if necessary up to 40 mg twice daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 10 mg twice daily, increased if necessary up to 40 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 10 mg twice daily, increased if necessary up to 40 mg twice daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-sr#PHP62499>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-xl#1Gmu2sR9Y0yc9ug-a_98Gg>;
                                                                            nicebnf:hasTitle """<title>Coracten<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "coracten xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-xl#1Gmu2sR9Y0yc9ug-a_98Gg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 30 mg daily, increased if necessary up to 90 mg daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 30 mg daily, increased if necessary up to 90 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 30 mg daily, increased if necessary up to 90 mg daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-xl#PHP62040>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/coracten-xl#PHP62040> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-10000> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-10000#DPkuAVzHJ0i23JesL6NgWQ>;
                                                                            nicebnf:hasTitle """<title>Creon<tm tmtype=\"reg\" /> 10000</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "creon 10000"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-10000#DPkuAVzHJ0i23JesL6NgWQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-10000#PHP81826>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-10000#PHP81826> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-25000> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-25000#bCtVm0QbYUOUjQoAXAbWwg>;
                                                                            nicebnf:hasTitle """<title>Creon<tm tmtype=\"reg\" /> 25000</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "creon 25000"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-25000#PHP82414> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-25000#bCtVm0QbYUOUjQoAXAbWwg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-25000#PHP82414>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-40000> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-40000#jex7fIqep0G-syI9O8EHEw>;
                                                                            nicebnf:hasTitle """<title>Creon<tm tmtype=\"reg\" /> 40000</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "creon 40000"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-40000#PHP82481> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-40000#jex7fIqep0G-syI9O8EHEw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with each meal either taken whole or contents mixed with acidic fluid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-40000#PHP82481>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#hZbSQxqFJkK_psv46JLWxQ>;
                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#-gL8DlAQHk-R5h5hHv4vTg>;
                                                                            nicebnf:hasTitle """<title>Creon<tm tmtype=\"reg\" /> Micro</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "creon micro"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#-gL8DlAQHk-R5h5hHv4vTg> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>100 mg granules = one measured scoopful (scoop supplied with product).</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#PHP81891>;
                                                                                                   nicebnf:hasTextContent """Dose equivalence and conversion100 mg granules = one measured scoopful (scoop supplied with product).

"""^^xsd:string;
                                                                                                   a nicebnf:DoseEquivalence,
                                                                                                     nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#PHP81891> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#hZbSQxqFJkK_psv46JLWxQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                      rdfs:label "initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 100 mg, to be taken before each feed or meal; granules can be mixed with a small amount of milk or soft food and administered immediately (manufacturer recommends mixing with acidic liquid or pureed fruit before administration), granules should not be chewed before swallowing.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/creon-micro#PHP81891>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/crinone-vaginal-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/crinone-vaginal-gel#DAepgWAIR0qzosxFlbMh2Q>;
                                                                                    nicebnf:hasTitle """<title>Crinone<tm tmtype=\"reg\" /> vaginal gel</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "crinone vaginal gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/crinone-vaginal-gel#DAepgWAIR0qzosxFlbMh2Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "1 applicatorful daily, to be started either after documented ovulation or on day 18–21 of cycle, in vitro fertilisation, daily application continued for 30 days after laboratory evidence of pregnancy."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>1 applicatorful daily, to be started either after documented ovulation or on day 18–21 of cycle, in vitro fertilisation, daily application continued for 30 days after laboratory evidence of pregnancy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """1 applicatorful daily, to be started either after documented ovulation or on day 18–21 of cycle, in vitro fertilisation, daily application continued for 30 days after laboratory evidence of pregnancy.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#infertilityDueToInadequateLutealPhase>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/crinone-vaginal-gel#PHP104579>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/crinone-vaginal-gel#PHP104579> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#infertilityDueToInadequateLutealPhase> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Infertility due to inadequate luteal phase</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Infertility due to inadequate luteal phase

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "infertility due to inadequate luteal phase"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/crystacide> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/crystacide#XP-ne1ZugE6ALL93froTrQ>;
                                                                           nicebnf:hasTitle """<title>Crystacide<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "crystacide"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/crystacide#PHP85258> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/crystacide#XP-ne1ZugE6ALL93froTrQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                     rdfs:label "apply 2–3 times a day for up to 3 weeks."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Apply 2–3 times a day for up to 3 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Apply 2–3 times a day for up to 3 weeks.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "apply 2–3 times a day for up to 3 weeks."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Apply 2–3 times a day for up to 3 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Apply 2–3 times a day for up to 3 weeks.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#superficialBacterialSkinInfection>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/crystacide#PHP85258>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#superficialBacterialSkinInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Superficial bacterial skin infection</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Superficial bacterial skin infection

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "superficial bacterial skin infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cuplex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cuplex#Di7rgC8460i91g2yOnentw>;
                                                                       nicebnf:hasTitle """<title>Cuplex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "cuplex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cuplex#Di7rgC8460i91g2yOnentw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#calluses>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#corns>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#plantarAndMosaicWarts>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cuplex#PHP95904>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cuplex#PHP95904> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#calluses> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Calluses</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Calluses

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "calluses"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#corns> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Corns</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Corns

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "corns"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#plantarAndMosaicWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Plantar and mosaic warts</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Plantar and mosaic warts

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "plantar and mosaic warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cx-antiseptic-dusting-powder> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cx-antiseptic-dusting-powder#_MTEoXQiF0eqXqw1QMBiow>;
                                                                                             nicebnf:hasTitle "<title>CX antiseptic dusting powder</title>"^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "cx antiseptic dusting powder"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cx-antiseptic-dusting-powder#PHP99753> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cx-antiseptic-dusting-powder#_MTEoXQiF0eqXqw1QMBiow> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfection>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cx-antiseptic-dusting-powder#PHP99753>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """For skin disinfection

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "for skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyanokit> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyanokit#s1dn2D01_UGkmSZwgoGl1A>;
                                                                         nicebnf:hasTitle """<title>Cyanokit<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "cyanokit"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyanokit#PHP101706> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyanokit#s1dn2D01_UGkmSZwgoGl1A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight5KgAndAbove> ; 
                                                                                                                   rdfs:label "initially 70 mg/kg (max. per dose 5 g), to be given over 15 minutes, then 70 mg/kg (max. per dose 5 g) if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 70 mg/kg (max. per dose 5 g), to be given over 15 minutes, then 70 mg/kg (max. per dose 5 g) if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 70 mg/kg (max. per dose 5 g), to be given over 15 minutes, then 70 mg/kg (max. per dose 5 g) if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 5 g, to be given over 15 minutes, then 5 g if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 5 g, to be given over 15 minutes, then 5 g if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 5 g, to be given over 15 minutes, then 5 g if required, this second dose can be given over 15 minutes–2 hours depending on severity of poisoning and patient stability.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#poisoningWithCyanides>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyanokit#PHP101706>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#poisoningWithCyanides> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Poisoning with cyanides</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Poisoning with cyanides

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "poisoning with cyanides"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight5KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                       rdfs:label "child (body-weight 5 kg and above)"^^xsd:string;
                                                                       rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-10> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-10#si0FPcFv6UCHPYJAxIiadw>;
                                                                              nicebnf:hasTitle """<title>Cyclimorph-10<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "cyclimorph-10"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-10#PHP96666> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-10#si0FPcFv6UCHPYJAxIiadw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1 ml, do not repeat dose more often than every 4 hours; maximum 3 doses per day."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjectionOrByIntravenousInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePainShortTermUseOnly>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-10#PHP96666>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePainShortTermUseOnly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe pain (short-term use only)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Moderate to severe pain (short-term use only)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "moderate to severe pain (short-term use only)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjectionOrByIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                                                     rdfs:label "by subcutaneous injection, or by intramuscular injection, or by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-15> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-15#eIAT2buFcUuasCikTiQfIA>;
                                                                              nicebnf:hasTitle """<title>Cyclimorph-15<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "cyclimorph-15"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-15#PHP96644> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-15#eIAT2buFcUuasCikTiQfIA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1 ml, do not repeat dose more often than every 4 hours; maximum 3 doses per day."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1 mL, do not repeat dose more often than every 4 hours; maximum 3 doses per day.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjectionOrByIntravenousInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePainShortTermUseOnly>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclimorph-15#PHP96644>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePainShortTermUseOnly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe pain (short-term use only)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Moderate to severe pain (short-term use only)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "moderate to severe pain (short-term use only)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjectionOrByIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                                                     rdfs:label "by subcutaneous injection, or by intramuscular injection, or by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclo-progynova-2mg-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclo-progynova-2mg-tablets#x8yPndqRhkuDyg-rV5IoDA>;
                                                                                            nicebnf:hasTitle """<title>Cyclo-progynova<tm tmtype=\"reg\" /> 2mg tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                            rdfs:label "cyclo-progynova 2mg tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclo-progynova-2mg-tablets#PHP104748> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclo-progynova-2mg-tablets#x8yPndqRhkuDyg-rV5IoDA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                      rdfs:label "1 tablet daily for 11 days, white tablet to be taken; start on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 10 days, brown tablet to be taken, followed by a 7-day tablet free interval."^^xsd:string ; 
                                                                                                                                      nicebnf:hasDitaContent "<p>1 tablet daily for 11 days, white tablet to be taken; start on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 10 days, brown tablet to be taken, followed by a 7-day tablet free interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                      nicebnf:hasTextContent """1 tablet daily for 11 days, white tablet to be taken; start on day 5 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 10 days, brown tablet to be taken, followed by a 7-day tablet free interval.

"""^^xsd:string ; 
                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclo-progynova-2mg-tablets#PHP104748>;
                                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclogest-pessaries> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclogest-pessaries#gIrexQHBD0e-KQKB4TslAw>;
                                                                                    nicebnf:hasTitle """<title>Cyclogest<tm tmtype=\"reg\" /> pessaries</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "cyclogest pessaries"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclogest-pessaries#PHP104439> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclogest-pessaries#gIrexQHBD0e-KQKB4TslAw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "200–800 mg daily, doses above 200 mg to be given in 2 divided doses, for premenstrual syndrome start on day 12–14 and continue until onset of menstruation (but not recommended); rectally if barrier methods of contraception are used, in patients who have recently given birth or in those who suffer from vaginal infection or recurrent cystitis."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>200–800 mg daily, doses above 200 mg to be given in 2 divided doses, for premenstrual syndrome start on day 12–14 and continue until onset of menstruation (but not recommended); rectally if barrier methods of contraception are used, in patients who have recently given birth or in those who suffer from vaginal infection or recurrent cystitis.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """200–800 mg daily, doses above 200 mg to be given in 2 divided doses, for premenstrual syndrome start on day 12–14 and continue until onset of menstruation (but not recommended); rectally if barrier methods of contraception are used, in patients who have recently given birth or in those who suffer from vaginal infection or recurrent cystitis.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVaginaOrByRectum>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#postNatalDepression>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#premenstrualSyndrome>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cyclogest-pessaries#PHP104439>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#postNatalDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Post-natal depression</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Post-natal depression

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "post-natal depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#premenstrualSyndrome> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Premenstrual syndrome</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Premenstrual syndrome

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "premenstrual syndrome"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVaginaOrByRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                              rdfs:label "by vagina, or by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/cymbalta> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/cymbalta#1jJtD82H00OtVIYQBKaaKA>;
                                                                         nicebnf:hasTitle """<title>Cymbalta<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "cymbalta"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cymbalta#1jJtD82H00OtVIYQBKaaKA> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use for <ph outputclass=\"indication\">Diabetic neuropathy</ph></p>
  <p>The <i>Scottish Medicines Consortium</i> has advised (September 2006) that duloxetine (<i>Cymbalta</i><tm tmtype=\"reg\" />) should be restricted for use by specialists when other treatments for diabetic peripheral neuropathic pain are unsuitable or inadequate.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withOralUseForDiabeticNeuropathy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/cymbalta#PHP79417>;
                                                                                                nicebnf:hasTextContent """With oral use for Diabetic neuropathy

The Scottish Medicines Consortium has advised (September 2006) that duloxetine (Cymbalta) should be restricted for use by specialists when other treatments for diabetic peripheral neuropathic pain are unsuitable or inadequate.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/cymbalta#PHP79417> a nicebnf:NationalFunding.
<http://ld.nice.org.uk/ns/bnf/Indication#diabeticNeuropathy> a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "diabetic neuropathy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Route#oral> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                          rdfs:label "oral"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withOralUseForDiabeticNeuropathy> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#diabeticNeuropathy>;
                                                                            nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#oral>;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                            rdfs:label "with oral use for diabetic neuropathy"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#8vTwMeHXJ0Kj_xLhs9gzGw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#hCf5MkWCFkuS-MZAanz55g>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#pOl6iU8Y8EC1KayyKzRPOg>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#yBx0K8g-80KLO2d909c1jQ>;
                                                                                nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#owHjhk24wke_-73QNrk2uQ>;
                                                                                nicebnf:hasTitle """<title>Dalacin<tm tmtype=\"reg\" /> 2% cream</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "dalacin 2% cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#8vTwMeHXJ0Kj_xLhs9gzGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 applicatorful daily for 3–7 nights, dose to be administered at night."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 applicatorful daily for 3–7 nights, dose to be administered at night.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 applicatorful daily for 3–7 nights, dose to be administered at night.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bacterialVaginosis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101663>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101663> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101669> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101674> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#hCf5MkWCFkuS-MZAanz55g> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 applicatorful delivers a 5 g dose of clindamycin 2%.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101663>;
                                                                                                       nicebnf:hasTextContent """Dose equivalence and conversion1 applicatorful delivers a 5 g dose of clindamycin 2%.

"""^^xsd:string;
                                                                                                       a nicebnf:DoseEquivalence,
                                                                                                         nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#owHjhk24wke_-73QNrk2uQ> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Cervicitis</ph>; <ph outputclass=\"sideEffect\">irritation</ph>; <ph outputclass=\"sideEffect\">vaginitis</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#notKnown>;
                                                                                                       nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#cervicitis>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/SideEffect#irritation>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/SideEffect#vaginitis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101674>;
                                                                                                       nicebnf:hasTextContent """Cervicitis; irritation; vaginitis

"""^^xsd:string;
                                                                                                       a nicebnf:GeneralSideEffects,
                                                                                                         nicebnf:SideEffectGroup,
                                                                                                         nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#pOl6iU8Y8EC1KayyKzRPOg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Clindamycin 2% cream is poorly absorbed into the blood—low risk of systemic effects.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101674>;
                                                                                                       nicebnf:hasTextContent """Clindamycin 2% cream is poorly absorbed into the blood—low risk of systemic effects.

"""^^xsd:string;
                                                                                                       nicebnf:hasTitle "Systemic side-effects"^^xsd:string;
                                                                                                       a nicebnf:SideEffectAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#yBx0K8g-80KLO2d909c1jQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Damages latex condoms and diaphragms.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-2-cream#PHP101669>;
                                                                                                       nicebnf:hasTextContent """Damages latex condoms and diaphragms.

"""^^xsd:string;
                                                                                                       a nicebnf:ConceptionAndContraception.
<http://ld.nice.org.uk/ns/bnf/Frequency#notKnown> a nicebnf:Frequency;
                                                  rdfs:label "frequency not known"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#bacterialVaginosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bacterial vaginosis</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Bacterial vaginosis

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "bacterial vaginosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#cervicitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Cervicitis</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "Cervicitis"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "cervicitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#irritation> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">irritation</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "irritation"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "irritation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#vaginitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">vaginitis</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "vaginitis"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "vaginitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-lotion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-lotion#1DaU_h4GxEKNlS1M3bzNww>;
                                                                                 nicebnf:hasTitle """<title>Dalacin T<tm tmtype=\"reg\" /> lotion</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "dalacin t lotion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-lotion#1DaU_h4GxEKNlS1M3bzNww> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                           rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-lotion#PHP82083>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-lotion#PHP82083> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Acne vulgaris

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-solution#DCo82m_WSUOlDFHTPPUb8Q>;
                                                                                   nicebnf:hasTitle """<title>Dalacin T<tm tmtype=\"reg\" /> solution</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "dalacin t solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-solution#DCo82m_WSUOlDFHTPPUb8Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                             rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-solution#PHP82142>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dalacin-t-solution#PHP82142> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Acne vulgaris

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#aapjKDnzO0uPQkaL1xHWCg>,
                                                                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#opq5r64Kxka8sJxZ74eulA>,
                                                                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#yxzlqxiMvUioxI6Ljs5o1w>;
                                                                                                                         nicebnf:hasTitle "<title>Decan concentrate for solution for infusion 40ml bottles</title>"^^<rdf:XMLLiteral>;
                                                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                         rdfs:label "decan concentrate for solution for infusion 40ml bottles"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#PHP107302> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#PHP107338> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#aapjKDnzO0uPQkaL1xHWCg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to infusion solutions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#PHP107302>;
                                                                                                                                                nicebnf:hasTextContent """For addition to infusion solutions.

"""^^xsd:string;
                                                                                                                                                a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#opq5r64Kxka8sJxZ74eulA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For patients over 40 kg.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#PHP107338>;
                                                                                                                                                nicebnf:hasTextContent """For patients over 40 kg.

"""^^xsd:string;
                                                                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#yxzlqxiMvUioxI6Ljs5o1w> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Decan</i>
    <tm tmtype=\"reg\" /> solution contains trace elements Fe<sup>2+</sup>, Zn<sup>2+</sup>, Cu<sup>2+</sup>, Mn<sup>2+</sup>, F<sup>-</sup>, Co<sup>2+</sup>, I<sup>-</sup>, Se<sup>4+</sup>, Mo<sup>6+</sup>, Cr<sup>3+</sup>.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decan-concentrate-for-solution-for-infusion-40ml-bottles#PHP107338>;
                                                                                                                                                nicebnf:hasTextContent """Decan solution contains trace elements Fe2+, Zn2+, Cu2+, Mn2+, F-, Co2+, I-, Se4+, Mo6+, Cr3+.

"""^^xsd:string;
                                                                                                                                                a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#X6q2Qjh1kkC18fxhJ4NDnQ>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#wUoDNG0bLEiXZWma8aDC9g>;
                                                                                     nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#7iIwHZX3zk6NCV45TB7mhQ>;
                                                                                     nicebnf:hasTitle """<title>Decapeptyl<tm tmtype=\"reg\" /> SR 11.25mg</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "decapeptyl sr 11.25mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#7iIwHZX3zk6NCV45TB7mhQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Each vial includes an overage to allow accurate administration of an 11.25 mg dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#PHP79651>;
                                                                                                            nicebnf:hasTextContent """Each vial includes an overage to allow accurate administration of an 11.25 mg dose.

"""^^xsd:string;
                                                                                                            a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#PHP79628> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#PHP79651> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#X6q2Qjh1kkC18fxhJ4NDnQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "11.25 mg every 3 months for maximum 6 months (not to be repeated), to be started during first 5 days of menstrual cycle."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>11.25 mg every 3 months for maximum 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """11.25 mg every 3 months for maximum 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#PHP79628>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#wUoDNG0bLEiXZWma8aDC9g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "11.25 mg every 3 months."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>11.25 mg every 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """11.25 mg every 3 months.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression>,
                                                                                                                                  <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                                  <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                                  <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>,
                                                                                                                                  <http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-1125mg#PHP79628>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                           nicebnf:hasTextContent """Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

"""^^xsd:string;
                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                           rdfs:label "adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasTextContent """Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                            rdfs:label "adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced non-metastatic prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent """Locally advanced non-metastatic prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                        rdfs:label "locally advanced non-metastatic prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasTextContent """Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                rdfs:label "neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#P9CnUVij-0OddfHWu-WlNg>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#Ok_qkEcGcEyLxPe0Ws0e6Q>;
                                                                                    nicebnf:hasTitle """<title>Decapeptyl<tm tmtype=\"reg\" /> SR 22.5mg</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "decapeptyl sr 22.5mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#Ok_qkEcGcEyLxPe0Ws0e6Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Each vial includes an overage to allow accurate administration of a 22.5 mg dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#PHP79121>;
                                                                                                           nicebnf:hasTextContent """Each vial includes an overage to allow accurate administration of a 22.5 mg dose.

"""^^xsd:string;
                                                                                                           a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#P9CnUVij-0OddfHWu-WlNg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "22.5 mg every 6 months."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>22.5 mg every 6 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """22.5 mg every 6 months.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#PHP79015>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#PHP79015> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-225mg#PHP79121> a nicebnf:PrescribingAndDispensingInformations.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                           nicebnf:hasTextContent """Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

"""^^xsd:string;
                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                           rdfs:label "adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasTextContent """Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                            rdfs:label "adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced non-metastatic prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent """Locally advanced non-metastatic prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                        rdfs:label "locally advanced non-metastatic prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasTextContent """Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                rdfs:label "neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#0ztI55_ZykCMCtw5lzOJaQ>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#31jZPrr7pU2h4ERH3yd2vQ>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#DMoCvyfWqUW53AOqw-UrIA>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#y1Tp6PX6YEarPfZpmwgH5w>;
                                                                                  nicebnf:hasTitle """<title>Decapeptyl<tm tmtype=\"reg\" /> SR 3mg</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "decapeptyl sr 3mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#0ztI55_ZykCMCtw5lzOJaQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "3 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>3 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """3 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79622>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#31jZPrr7pU2h4ERH3yd2vQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "3 mg every 4 weeks."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>3 mg every 4 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """3 mg every 4 weeks.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79622>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#DMoCvyfWqUW53AOqw-UrIA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "3 mg every 4 weeks for at least 3 months, maximum duration of treatment 6 months (not to be repeated), to be started during first 5 days of menstrual cycle."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>3 mg every 4 weeks for at least 3 months, maximum duration of treatment 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """3 mg every 4 weeks for at least 3 months, maximum duration of treatment 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reductionInSizeOfFibroids>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79622>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79622> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79647> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#y1Tp6PX6YEarPfZpmwgH5w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Each vial includes an overage to allow accurate administration of 3 mg dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/decapeptyl-sr-3mg#PHP79647>;
                                                                                                         nicebnf:hasTextContent """Each vial includes an overage to allow accurate administration of 3 mg dose.

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadicalProstatectomyInPatientsWithLocallyAdvancedProstateCancerAtHighRiskOfDiseaseProgression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                           nicebnf:hasTextContent """Adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

"""^^xsd:string;
                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                           rdfs:label "adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyInHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasTextContent """Adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                            rdfs:label "adjuvant treatment to radiotherapy in high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedNonMetastaticProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced non-metastatic prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent """Locally advanced non-metastatic prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                        rdfs:label "locally advanced non-metastatic prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasTextContent """Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                rdfs:label "neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionInSizeOfFibroids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction in size of fibroids</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Reduction in size of fibroids

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "reduction in size of fibroids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/deltastab> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/deltastab#wL-YrSXVEU2SXzHbbdFm_A>;
                                                                          nicebnf:hasTitle """<title>Deltastab<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "deltastab"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/deltastab#PHP81004> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/deltastab#wL-YrSXVEU2SXzHbbdFm_A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "5–25 mg, dose according to size; not more than 3 joints should be treated on any one day; where appropriate may be repeated when relapse occurs, for details consult product literature."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>5–25 mg, dose according to size; not more than 3 joints should be treated on any one day; where appropriate may be repeated when relapse occurs, for details consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """5–25 mg, dose according to size; not more than 3 joints should be treated on any one day; where appropriate may be repeated when relapse occurs, for details consult product literature.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJoints>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/deltastab#PHP81004>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJoints> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Local inflammation of joints</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Local inflammation of joints

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "local inflammation of joints"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                     rdfs:label "by intra-articular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#XFM49HCMYkyfeklbInK0Ig>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#20il1eB3PUqBaupRY7MzoQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#afFXFeWicUWeGLPSPOqRWw>;
                                                                         nicebnf:hasTitle """<title>Dentinox<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "dentinox"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#20il1eB3PUqBaupRY7MzoQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The brand name <i>Dentinox</i><tm tmtype=\"reg\" /> is also used for other preparations including teething gel.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98167>;
                                                                                                nicebnf:hasTextContent """The brand name Dentinox is also used for other preparations including teething gel.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98061> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98147> a nicebnf:LessSuitableForPrescribings.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98167> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#XFM49HCMYkyfeklbInK0Ig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month1Year> ; 
                                                                                                                   rdfs:label "2.5 ml, to be taken with or after each feed; may be added to bottle feed; maximum 6 doses per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>2.5 mL, to be taken with or after each feed; may be added to bottle feed; maximum 6 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """2.5 mL, to be taken with or after each feed; may be added to bottle feed; maximum 6 doses per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#colic>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#windPains>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98061>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#afFXFeWicUWeGLPSPOqRWw> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Dentinox</i>
    <tm tmtype=\"reg\" /> colic drops are less suitable for prescribing (evidence of benefit in infantile colic uncertain).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dentinox#PHP98147>;
                                                                                                nicebnf:hasTextContent """Dentinox colic drops are less suitable for prescribing (evidence of benefit in infantile colic uncertain).

"""^^xsd:string;
                                                                                                a nicebnf:LessSuitableForPrescribing.
<http://ld.nice.org.uk/ns/bnf/Indication#colic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Colic</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Colic

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "colic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#windPains> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Wind pains</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Wind pains

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "wind pains"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month1Year> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                             rdfs:label "child 1 month–1 year"^^xsd:string;
                                                             rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#6bb7hzgfpEKpD3V1uLM3Fg>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#h1f9C3dY6U2WJRNdwFm2IA>;
                                                                             nicebnf:hasTitle """<title>Depo-Medrone<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "depo-medrone"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#6bb7hzgfpEKpD3V1uLM3Fg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "40–120 mg, then 40–120 mg after 2–3 weeks if required, to be injected into the gluteal muscle."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>40–120 mg, then 40–120 mg after 2–3 weeks if required, to be injected into the gluteal muscle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """40–120 mg, then 40–120 mg after 2–3 weeks if required, to be injected into the gluteal muscle.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#suppressionOfInflammatoryAndAllergicDisorders>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#PHP83844>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#PHP83844> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#h1f9C3dY6U2WJRNdwFm2IA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "4–80 mg, select dose according to size; where appropriate dose may be repeated at intervals of 7–35 days, for details consult product literature."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>4–80 mg, select dose according to size; where appropriate dose may be repeated at intervals of 7–35 days, for details consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """4–80 mg, select dose according to size; where appropriate dose may be repeated at intervals of 7–35 days, for details consult product literature.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/depo-medrone#PHP83844>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Local inflammation of joints and soft tissues</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Local inflammation of joints and soft tissues

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "local inflammation of joints and soft tissues"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#suppressionOfInflammatoryAndAllergicDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Suppression of inflammatory and allergic disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Suppression of inflammatory and allergic disorders

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "suppression of inflammatory and allergic disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by deep intramuscular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                     rdfs:label "by intra-articular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/depocyte> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/depocyte#6KGeGSFUOEGUTfqcoxmQVQ>;
                                                                         nicebnf:hasTitle """<title>DepoCyte<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "depocyte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/depocyte#6KGeGSFUOEGUTfqcoxmQVQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (July 2007) that liposomal cytarabine suspension (<i>DepoCyte</i><tm tmtype=\"reg\" />) is not recommended for use within NHS Scotland for the intrathecal treatment of lymphomatous meningitis.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/depocyte#PHP79811>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (July 2007) that liposomal cytarabine suspension (DepoCyte) is not recommended for use within NHS Scotland for the intrathecal treatment of lymphomatous meningitis.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/depocyte#PHP79811> a nicebnf:NationalFunding.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/deponit> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/deponit#APeqqwmXb0qwHgihISWVdg>;
                                                                        nicebnf:hasTitle """<title>Deponit<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "deponit"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/deponit#APeqqwmXb0qwHgihISWVdg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "one ‘5’ or one ‘10’ patch to be applied to lateral chest wall, upper arm, thigh, abdomen, or shoulder; increase to two ‘10’ patches every 24 hours if necessary, to be replaced every 24 hours, siting replacement patch on different area."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>One ‘5’ or one ‘10’ patch to be applied to lateral chest wall, upper arm, thigh, abdomen, or shoulder; increase to two ‘10’ patches every 24 hours if necessary, to be replaced every 24 hours, siting replacement patch on different area.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """One ‘5’ or one ‘10’ patch to be applied to lateral chest wall, upper arm, thigh, abdomen, or shoulder; increase to two ‘10’ patches every 24 hours if necessary, to be replaced every 24 hours, siting replacement patch on different area.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/deponit#PHP63839>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/deponit#PHP63839> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#H_4otIeFAkiqhe2K5cT2pQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#UA8tUrrR7EKmIfwe1blwIw>;
                                                                        nicebnf:hasTitle """<title>Dermalo<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "dermalo"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#H_4otIeFAkiqhe2K5cT2pQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                  rdfs:label "5–10 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5–10 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5–10 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                  rdfs:label "15–20 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>15–20 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """15–20 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "15–20 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>15–20 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """15–20 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dermatitis>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#PHP105759>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#PHP105759> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#UA8tUrrR7EKmIfwe1blwIw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                  rdfs:label "15–20 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>15–20 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """15–20 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermalo#PHP105759>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Dermatitis

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Dry skin conditions including eczema

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "dry skin conditions including eczema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermatonics-once-heel-balm> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermatonics-once-heel-balm#P5Kfxk2UsUWG-d1crU1-Qg>;
                                                                                           nicebnf:hasTitle """<title>Dermatonics Once Heel Balm<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "dermatonics once heel balm"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermatonics-once-heel-balm#P5Kfxk2UsUWG-d1crU1-Qg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                     rdfs:label "apply daily."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Apply daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Apply daily.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "apply daily."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Apply daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Apply daily.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinOnSolesOfFeet>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermatonics-once-heel-balm#PHP106241>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermatonics-once-heel-balm#PHP106241> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinOnSolesOfFeet> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin on soles of feet</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Dry skin on soles of feet

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "dry skin on soles of feet"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-200-shower-emollient> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-200-shower-emollient#0Q4U3MTSFkuTFeJ7Z9bqHw>;
                                                                                            nicebnf:hasTitle """<title>Dermol<tm tmtype=\"reg\" /> 200 shower emollient</title>"""^^<rdf:XMLLiteral>;
                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                            rdfs:label "dermol 200 shower emollient"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-200-shower-emollient#0Q4U3MTSFkuTFeJ7Z9bqHw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                      rdfs:label "to be applied to the skin or used as a soap substitute."^^xsd:string ; 
                                                                                                                                      nicebnf:hasDitaContent "<p>To be applied to the skin or used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                      nicebnf:hasTextContent """To be applied to the skin or used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-200-shower-emollient#PHP106136>;
                                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-200-shower-emollient#PHP106136> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry and pruritic skin conditions including eczema and dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Dry and pruritic skin conditions including eczema and dermatitis

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "dry and pruritic skin conditions including eczema and dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-600-bath-emollient> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-600-bath-emollient#mIL_xr5nkUiFFXv4dOBGvA>;
                                                                                          nicebnf:hasTitle """<title>Dermol<tm tmtype=\"reg\" /> 600<tm tmtype=\"reg\" /> Bath Emollient</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "dermol 600 bath emollient"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-600-bath-emollient#PHP106193> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-600-bath-emollient#mIL_xr5nkUiFFXv4dOBGvA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> ; 
                                                                                                                                    rdfs:label "5–15 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>5–15 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """5–15 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "15–30 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>15–30 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """15–30 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-600-bath-emollient#PHP106193>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry and pruritic skin conditions including eczema and dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Dry and pruritic skin conditions including eczema and dermatitis

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "dry and pruritic skin conditions including eczema and dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child123Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 1–23 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-wash-emulsion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-wash-emulsion#4iFJnEYpaEKpg6cG2SCQjA>;
                                                                                     nicebnf:hasTitle """<title>Dermol<tm tmtype=\"reg\" /> wash emulsion</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "dermol wash emulsion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-wash-emulsion#4iFJnEYpaEKpg6cG2SCQjA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                               rdfs:label "to be applied to the skin or used as a soap substitute."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>To be applied to the skin or used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """To be applied to the skin or used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "to be applied to the skin or used as a soap substitute."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>To be applied to the skin or used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """To be applied to the skin or used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-wash-emulsion#PHP106212>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dermol-wash-emulsion#PHP106212> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dryAndPruriticSkinConditionsIncludingEczemaAndDermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry and pruritic skin conditions including eczema and dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Dry and pruritic skin conditions including eczema and dermatitis

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "dry and pruritic skin conditions including eczema and dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/df118-forte> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/df118-forte#OKzGT2b_t0G-VPGY7LW0_Q>;
                                                                            nicebnf:hasTitle """<title>DF118 Forte<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "df118 forte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/df118-forte#OKzGT2b_t0G-VPGY7LW0_Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                      rdfs:label "40–80 mg 3 times a day; maximum 240 mg per day."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>40–80 mg 3 times a day; maximum 240 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """40–80 mg 3 times a day; maximum 240 mg per day.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "40–80 mg 3 times a day; maximum 240 mg per day."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>40–80 mg 3 times a day; maximum 240 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """40–80 mg 3 times a day; maximum 240 mg per day.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severePain>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/df118-forte#PHP80313>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/df118-forte#PHP80313> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#severePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Severe pain

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "severe pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-retard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-retard#BQsejaQOTECGCq7VESipzA>;
                                                                                nicebnf:hasTitle """<title>Diclomax Retard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "diclomax retard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-retard#BQsejaQOTECGCq7VESipzA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 capsule once daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 capsule once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 capsule once daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteGout>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-retard#PHP82743>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-retard#PHP82743> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteGout> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute gout</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Acute gout

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "acute gout"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                    nicebnf:hasTextContent """Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders

"""^^xsd:string;
                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                    rdfs:label "pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-sr#QDYUNXSefUSGrlCSVEZUWA>;
                                                                            nicebnf:hasTitle """<title>Diclomax SR<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "diclomax sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-sr#PHP82675> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-sr#QDYUNXSefUSGrlCSVEZUWA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "1 capsule 1–2 times a day, alternatively 2 capsules once daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>1 capsule 1–2 times a day, alternatively 2 capsules once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """1 capsule 1–2 times a day, alternatively 2 capsules once daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteGout>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diclomax-sr#PHP82675>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteGout> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute gout</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Acute gout

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "acute gout"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                    nicebnf:hasTextContent """Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders

"""^^xsd:string;
                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                    rdfs:label "pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#BJgT4TNqSEyMYPZ8KSy7xw>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#OmVUk3jyDU-G1-5YbOt_qg>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#hc6c0oB17kivyhhIBKztGQ>;
                                                                             nicebnf:hasTitle """<title>Dilcardia<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "dilcardia sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#BJgT4TNqSEyMYPZ8KSy7xw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 90 mg twice daily; increased if necessary to 180 mg twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 90 mg twice daily; increased if necessary to 180 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 90 mg twice daily; increased if necessary to 180 mg twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                       rdfs:label "initially 60 mg twice daily; increased if necessary to 90 mg twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 60 mg twice daily; increased if necessary to 90 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 60 mg twice daily; increased if necessary to 90 mg twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62568>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#OmVUk3jyDU-G1-5YbOt_qg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 60 mg twice a day; maximum 90 mg twice a day.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62551>;
                                                                                                    nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 60 mg twice a day; maximum 90 mg twice a day.

"""^^xsd:string;
                                                                                                    a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62545> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62551> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62568> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#hc6c0oB17kivyhhIBKztGQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 60 mg twice a day; maximum 90 mg twice a day.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilcardia-sr#PHP62545>;
                                                                                                    nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 60 mg twice a day; maximum 90 mg twice a day.

"""^^xsd:string;
                                                                                                    a nicebnf:DoseAdjustment.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-sr#QVQeP1NJm0W5jYvKSFBcnw>;
                                                                          nicebnf:hasTitle """<title>Dilzem<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "dilzem sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-sr#PHP62134> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-sr#QVQeP1NJm0W5jYvKSFBcnw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 90 mg twice daily; increased if necessary up to 180 mg twice daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 90 mg twice daily; increased if necessary up to 180 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 90 mg twice daily; increased if necessary up to 180 mg twice daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "initially 60 mg twice daily; increased if necessary up to 180 mg twice daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 60 mg twice daily; increased if necessary up to 180 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 60 mg twice daily; increased if necessary up to 180 mg twice daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-sr#PHP62134>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#ALXsC0BkokO8zkchoqa9cQ>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#VovV_8TmPEmEsm3m5eIYuQ>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#bTTnVIFzh06RjDw-IA8U8w>;
                                                                          nicebnf:hasTitle """<title>Dilzem<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "dilzem xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#ALXsC0BkokO8zkchoqa9cQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 180 mg daily; increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 180 mg daily; increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 180 mg daily; increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "initially 120 mg daily; increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 120 mg daily; increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 120 mg daily; increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60592>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60559> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60579> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60592> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#VovV_8TmPEmEsm3m5eIYuQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60579>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#bTTnVIFzh06RjDw-IA8U8w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dilzem-xl#PHP60559>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#A2MJnBm9a0G3PpCHmPjcuQ>;
                                                                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#dCGpWOZFB0OxYzbcznGupw>,
                                                                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#sqQsqeVBiE-22jGE0Nc7nQ>;
                                                                                                                                  nicebnf:hasTitle "<title>Dipeptiven 20g/100ml concentrate for solution for infusion bottles</title>"^^<rdf:XMLLiteral>;
                                                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                                  rdfs:label "dipeptiven 20g/100ml concentrate for solution for infusion bottles"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#A2MJnBm9a0G3PpCHmPjcuQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                                            rdfs:label "300–400 mg/kg daily, dose not to exceed 20% of total amino acid intake."^^xsd:string ; 
                                                                                                                                                                            nicebnf:hasDitaContent "<p>300–400 mg/kg daily, dose not to exceed 20% of total amino acid intake.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                                            nicebnf:hasTextContent """300–400 mg/kg daily, dose not to exceed 20% of total amino acid intake.

"""^^xsd:string ; 
                                                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#aminoAcidSupplementForHypercatabolicOrHypermetabolicStates>;
                                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107236>;
                                                                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107236> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107303> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107344> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#dCGpWOZFB0OxYzbcznGupw> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to infusion solutions containing amino acids.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107303>;
                                                                                                                                                         nicebnf:hasTextContent """For addition to infusion solutions containing amino acids.

"""^^xsd:string;
                                                                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#sqQsqeVBiE-22jGE0Nc7nQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Dipeptiven</i>
    <tm tmtype=\"reg\" /> solution contains N(2)-L-alanyl-L-glutamine 200 mg/mL (providing L-alanine 82 mg, L-glutamine 134.6 mg).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dipeptiven-20g100ml-concentrate-for-solution-for-infusion-bottles#PHP107344>;
                                                                                                                                                         nicebnf:hasTextContent """Dipeptiven solution contains N(2)-L-alanyl-L-glutamine 200 mg/mL (providing L-alanine 82 mg, L-glutamine 134.6 mg).

"""^^xsd:string;
                                                                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#aminoAcidSupplementForHypercatabolicOrHypermetabolicStates> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Amino acid supplement for hypercatabolic or hypermetabolic states</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Amino acid supplement for hypercatabolic or hypermetabolic states

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "amino acid supplement for hypercatabolic or hypermetabolic states"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#EqkeCPZ22EaWnvpyKf6gvw>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#2GLhDXs98EqaILQzVm9I8A>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#wppJ8rbU10mZcZXUNCT29A>;
                                                                                    nicebnf:hasTitle """<title>Diprosalic<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "diprosalic ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#2GLhDXs98EqaILQzVm9I8A> nicebnf:hasDitaContent """<section outputclass=\"potency\">
  <title>Potency</title>
  <p>Betamethasone (as dipropionate) 0.05% with salicylic acid 3%: potent.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#PHP96343>;
                                                                                                           nicebnf:hasTextContent """PotencyBetamethasone (as dipropionate) 0.05% with salicylic acid 3%: potent.

"""^^xsd:string;
                                                                                                           a nicebnf:IndicationsAndDoseSection,
                                                                                                             nicebnf:Potency.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#EqkeCPZ22EaWnvpyKf6gvw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                              rdfs:label "apply 1–2 times a day, max. 60 g per week."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Apply 1–2 times a day, max. 60 g per week.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Apply 1–2 times a day, max. 60 g per week.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "apply 1–2 times a day, max. 60 g per week."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Apply 1–2 times a day, max. 60 g per week.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Apply 1–2 times a day, max. 60 g per week.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#severeInflammatorySkinDisordersSuchAsEczemasUnresponsiveToLessPotentCorticosteroids>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#PHP96343>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#PHP96343> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#PHP96371> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#wppJ8rbU10mZcZXUNCT29A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be counselled on application of betamethasone and salicylic acid preparations.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-ointment#PHP96371>;
                                                                                                           nicebnf:hasTextContent """Patients or carers should be counselled on application of betamethasone and salicylic acid preparations.

"""^^xsd:string;
                                                                                                           a nicebnf:GeneralPatientAdvice,
                                                                                                             nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeInflammatorySkinDisordersSuchAsEczemasUnresponsiveToLessPotentCorticosteroids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</p>"""^^<rdf:XMLLiteral>;
                                                                                                                              nicebnf:hasTextContent """Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids

"""^^xsd:string;
                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                              rdfs:label "severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#zgrM42gjCU6n4CbZmOuIkw>;
                                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#ALM-d9Kq0Ueb-Ws0WLrTag>,
                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#l4r_hvADLU6u_5eeSmZ_zQ>;
                                                                                             nicebnf:hasTitle """<title>Diprosalic<tm tmtype=\"reg\" /> scalp application</title>"""^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "diprosalic scalp application"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#ALM-d9Kq0Ueb-Ws0WLrTag> nicebnf:hasDitaContent """<section outputclass=\"potency\">
  <title>Potency</title>
  <p>Betamethasone (as dipropionate) 0.05% with salicylic acid 2%: potent.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#PHP96506>;
                                                                                                                    nicebnf:hasTextContent """PotencyBetamethasone (as dipropionate) 0.05% with salicylic acid 2%: potent.

"""^^xsd:string;
                                                                                                                    a nicebnf:IndicationsAndDoseSection,
                                                                                                                      nicebnf:Potency.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#PHP96506> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#PHP96526> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#l4r_hvADLU6u_5eeSmZ_zQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be counselled on application of betamethasone and salicylic acid scalp application.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#PHP96526>;
                                                                                                                    nicebnf:hasTextContent """Patients or carers should be counselled on application of betamethasone and salicylic acid scalp application.

"""^^xsd:string;
                                                                                                                    a nicebnf:PatientAndCarerAdvice,
                                                                                                                      nicebnf:PatientResources.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#zgrM42gjCU6n4CbZmOuIkw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                       rdfs:label "apply 1–2 times a day, apply a few drops."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1–2 times a day, apply a few drops.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Apply 1–2 times a day, apply a few drops.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "apply 1–2 times a day, apply a few drops."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1–2 times a day, apply a few drops.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Apply 1–2 times a day, apply a few drops.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>,
                                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#severeInflammatorySkinDisordersSuchAsEczemasUnresponsiveToLessPotentCorticosteroids>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/diprosalic-scalp-application#PHP96506>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeInflammatorySkinDisordersSuchAsEczemasUnresponsiveToLessPotentCorticosteroids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</p>"""^^<rdf:XMLLiteral>;
                                                                                                                              nicebnf:hasTextContent """Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids

"""^^xsd:string;
                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                              rdfs:label "severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dithrocream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dithrocream#zYXUprvNZk-j_JQBfmch3Q>;
                                                                            nicebnf:hasTitle """<title>Dithrocream<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "dithrocream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dithrocream#PHP84970> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dithrocream#zYXUprvNZk-j_JQBfmch3Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "for application to skin or scalp, 0.1–0.5% cream suitable for overnight treatment, 1–2% cream for maximum 1 hour (consult product literature)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>For application to skin or scalp, 0.1–0.5% cream suitable for overnight treatment, 1–2% cream for maximum 1 hour (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """For application to skin or scalp, 0.1–0.5% cream suitable for overnight treatment, 1–2% cream for maximum 1 hour (consult product literature).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#subacuteAndChronicPsoriasis>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dithrocream#PHP84970>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#subacuteAndChronicPsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Subacute and chronic psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Subacute and chronic psoriasis

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "subacute and chronic psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dolenio> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dolenio#f-3k3W6uikeRxKypoQzspQ>;
                                                                        nicebnf:hasTitle """<title>Dolenio<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "dolenio"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dolenio#PHP84002> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dolenio#f-3k3W6uikeRxKypoQzspQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 tablet once daily, review treatment if no benefit after 2–3 months."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 tablet once daily, review treatment if no benefit after 2–3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 tablet once daily, review treatment if no benefit after 2–3 months.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dolenio#PHP84002>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic relief of mild to moderate osteoarthritis of the knee</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Symptomatic relief of mild to moderate osteoarthritis of the knee

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "symptomatic relief of mild to moderate osteoarthritis of the knee"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#1nFE1k0wnkasYOatlP7Wfw>,
                                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#Ouv0s-70GU2rDe83Nrjqag>;
                                                                                                   nicebnf:hasTitle """<title>Doublebase<tm tmtype=\"reg\" /> emollient bath additive</title>"""^^<rdf:XMLLiteral>;
                                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                   rdfs:label "doublebase emollient bath additive"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#1nFE1k0wnkasYOatlP7Wfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                             rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#PHP106242>;
                                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#Ouv0s-70GU2rDe83Nrjqag> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                                             rdfs:label "5–10 ml/bath."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>5–10 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """5–10 mL/bath.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                             rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                             rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis>;
                                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#PHP106242>;
                                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-bath-additive#PHP106242> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including dermatitis and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Dry skin conditions including dermatitis and ichthyosis

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "dry skin conditions including dermatitis and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-shower-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-shower-gel#_QGqxrPI8E22r8M6wal73w>;
                                                                                                nicebnf:hasTitle """<title>Doublebase<tm tmtype=\"reg\" /> emollient shower gel</title>"""^^<rdf:XMLLiteral>;
                                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                rdfs:label "doublebase emollient shower gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-shower-gel#PHP106725> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-shower-gel#_QGqxrPI8E22r8M6wal73w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                          rdfs:label "to be applied to wet or dry skin and rinse, or apply to dry skin after showering."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>To be applied to wet or dry skin and rinse, or apply to dry skin after showering.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """To be applied to wet or dry skin and rinse, or apply to dry skin after showering.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "to be applied to wet or dry skin and rinse, or apply to dry skin after showering."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>To be applied to wet or dry skin and rinse, or apply to dry skin after showering.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """To be applied to wet or dry skin and rinse, or apply to dry skin after showering.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryChappedOrItchySkinConditions>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/doublebase-emollient-shower-gel#PHP106725>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryChappedOrItchySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, chapped, or itchy skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """Dry, chapped, or itchy skin conditions

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "dry, chapped, or itchy skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#QrD-qRn_tEyBNPLjLwZXyw>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#fcW_zWgyoUuMOKukB8BuKQ>;
                                                                            nicebnf:hasTitle """<title>Dovobet<tm tmtype=\"reg\" /> gel</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "dovobet gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#PHP96254> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#QrD-qRn_tEyBNPLjLwZXyw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "apply once daily for 8 weeks; if necessary, treatment may be continued beyond 8 weeks or repeated, on the advice of a specialist, apply to maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Apply once daily for 8 weeks; if necessary, treatment may be continued beyond 8 weeks or repeated, on the advice of a specialist, apply to maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Apply once daily for 8 weeks; if necessary, treatment may be continued beyond 8 weeks or repeated, on the advice of a specialist, apply to maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePlaquePsoriasis>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#PHP96254>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#fcW_zWgyoUuMOKukB8BuKQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "apply 1–4 g once daily usual duration of therapy 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, shampoo off after leaving on scalp overnight or during day, when different preparations containing calcipotriol used together, maximum total calcipotriol 5 mg in any one week."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Apply 1–4 g once daily usual duration of therapy 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, shampoo off after leaving on scalp overnight or during day, when different preparations containing calcipotriol used together, maximum total calcipotriol 5 mg in any one week.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Apply 1–4 g once daily usual duration of therapy 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, shampoo off after leaving on scalp overnight or during day, when different preparations containing calcipotriol used together, maximum total calcipotriol 5 mg in any one week.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#scalpPsoriasis>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-gel#PHP96254>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePlaquePsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate plaque psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Mild to moderate plaque psoriasis

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "mild to moderate plaque psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#scalpPsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Scalp psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Scalp psoriasis

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "scalp psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-ointment#YZ1hjwdli0Sezs9fF_i7-A>;
                                                                                 nicebnf:hasTitle """<title>Dovobet<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "dovobet ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-ointment#PHP96197> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-ointment#YZ1hjwdli0Sezs9fF_i7-A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "apply once daily for 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, apply to a maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Apply once daily for 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, apply to a maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Apply once daily for 4 weeks; if necessary, treatment may be continued beyond 4 weeks or repeated, on the advice of a specialist, apply to a maximum 30% of body surface, when different preparations containing calcipotriol used together, max. total calcipotriol 5 mg in any one week; maximum 15 g per day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#stablePlaquePsoriasis>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dovobet-ointment#PHP96197>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#stablePlaquePsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Stable plaque psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Stable plaque psoriasis

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "stable plaque psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/duodopa> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/duodopa#5MsWcO5ek06fm_9v2wYR5Q>;
                                                                        nicebnf:hasTitle """<title>Duodopa<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "duodopa"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duodopa#5MsWcO5ek06fm_9v2wYR5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "administered as intestinal gel, for use with enteral tube (consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Administered as intestinal gel, for use with enteral tube (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Administered as intestinal gel, for use with enteral tube (consult product literature).

"""^^xsd:string];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severeParkinsonSDiseaseInadequatelyControlledByOtherPreparations>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duodopa#PHP81036>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duodopa#PHP81036> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#severeParkinsonSDiseaseInadequatelyControlledByOtherPreparations> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe Parkinson's disease inadequately controlled by other preparations</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Severe Parkinson's disease inadequately controlled by other preparations

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "severe parkinson's disease inadequately controlled by other preparations"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/duofilm> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/duofilm#fuahnVupOEqhLQYnDkO1FQ>;
                                                                        nicebnf:hasTitle """<title>Duofilm<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "duofilm"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duofilm#PHP96034> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duofilm#fuahnVupOEqhLQYnDkO1FQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#plantarAndMosaicWarts>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duofilm#PHP96034>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#plantarAndMosaicWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Plantar and mosaic warts</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Plantar and mosaic warts

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "plantar and mosaic warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#2Y8XhCWUtkeIJZ8vwTw09A>,
                                                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#gA-tCgoLF0SJ4IlmlIBI_Q>,
                                                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#k4rzS8ApkkW5nqwgaA1xbg>;
                                                                                                            nicebnf:hasTitle """<title>DuoResp Spiromax<tm tmtype=\"reg\" /> 160micrograms/ 4.5micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                            rdfs:label "duoresp spiromax 160micrograms/ 4.5micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#2Y8XhCWUtkeIJZ8vwTw09A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                      rdfs:label "2 inhalations daily in 1–2 divided doses, increased if necessary to 2 inhalations twice daily. 1 inhalation (max. per dose 6 inhalations) as required, for relief of symptoms, a total daily dose of up to 12 inhalations can be used for a limited time but medical assessment is recommended if more than 8 inhalations daily are needed."^^xsd:string ; 
                                                                                                                                                      nicebnf:hasDitaContent "<p>2 inhalations daily in 1–2 divided doses, increased if necessary to 2 inhalations twice daily. 1 inhalation (max. per dose 6 inhalations) as required, for relief of symptoms, a total daily dose of up to 12 inhalations can be used for a limited time but medical assessment is recommended if more than 8 inhalations daily are needed.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                      nicebnf:hasTextContent """2 inhalations daily in 1–2 divided doses, increased if necessary to 2 inhalations twice daily. 1 inhalation (max. per dose 6 inhalations) as required, for relief of symptoms, a total daily dose of up to 12 inhalations can be used for a limited time but medical assessment is recommended if more than 8 inhalations daily are needed.

"""^^xsd:string ; 
                                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy>;
                                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#PHP107791>;
                                                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#PHP107791> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#gA-tCgoLF0SJ4IlmlIBI_Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                      rdfs:label "2 inhalations twice daily."^^xsd:string ; 
                                                                                                                                                      nicebnf:hasDitaContent "<p>2 inhalations twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                      nicebnf:hasTextContent """2 inhalations twice daily.

"""^^xsd:string ; 
                                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted>;
                                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#PHP107791>;
                                                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#k4rzS8ApkkW5nqwgaA1xbg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                      rdfs:label "1–2 inhalations twice daily, increased if necessary up to 4 inhalations twice daily."^^xsd:string ; 
                                                                                                                                                      nicebnf:hasDitaContent "<p>1–2 inhalations twice daily, increased if necessary up to 4 inhalations twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                      nicebnf:hasTextContent """1–2 inhalations twice daily, increased if necessary up to 4 inhalations twice daily.

"""^^xsd:string ; 
                                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy>;
                                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-160micrograms-45micrograms#PHP107791>;
                                                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma, maintenance and reliever therapy</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Asthma, maintenance and reliever therapy

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "asthma, maintenance and reliever therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma maintenance therapy</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Asthma maintenance therapy

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "asthma maintenance therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt; 50% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 50% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 50% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#FIo3RFUtvkaMgBPvPsHr_w>,
                                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#zC7n1vth-0eLQjGRMKuIQg>;
                                                                                                           nicebnf:hasTitle """<title>DuoResp Spiromax<tm tmtype=\"reg\" /> 320micrograms/ 9micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                           rdfs:label "duoresp spiromax 320micrograms/ 9micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#FIo3RFUtvkaMgBPvPsHr_w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                     rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                                     nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                     nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#PHP107790>;
                                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#PHP107790> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#zC7n1vth-0eLQjGRMKuIQg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                     rdfs:label "1 inhalation twice dailyincreased if necessary up to 2 inhalations twice daily."^^xsd:string ; 
                                                                                                                                                     nicebnf:hasDitaContent "<p>1 inhalation twice dailyIncreased if necessary up to 2 inhalations twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                     nicebnf:hasTextContent """1 inhalation twice dailyIncreased if necessary up to 2 inhalations twice daily.

"""^^xsd:string ; 
                                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/duoresp-spiromax-320micrograms-9micrograms#PHP107790>;
                                                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma maintenance therapy</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Asthma maintenance therapy

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "asthma maintenance therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt; 50% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 50% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 50% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#U4tL5y2fgU2WqG_JOyMv1Q>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#BbBTz020-0Kkxhzef4qWsA>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#DZesj_mXA0GcIHdfo0aTqQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#UzXV8f8lx0CjEas6OKTyTg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#hS9eIBz9_kmrXAYi_W5bjQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#rTeDqzRUeE2xv6Lvm9l3Rg>;
                                                                         nicebnf:hasTitle """<title>Dyloject<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "dyloject"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#BbBTz020-0Kkxhzef4qWsA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "75 mg twice daily for maximum 2 days, to be administered into the gluteal muscle."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>75 mg twice daily for maximum 2 days, to be administered into the gluteal muscle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """75 mg twice daily for maximum 2 days, to be administered into the gluteal muscle.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPainAndPostoperativePainSevereCases>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#DZesj_mXA0GcIHdfo0aTqQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "75 mg, then 75 mg after 30 minutes if required."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>75 mg, then 75 mg after 30 minutes if required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """75 mg, then 75 mg after 30 minutes if required.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#uretericColic>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82653> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#U4tL5y2fgU2WqG_JOyMv1Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (February 2008) that <i>Dyloject</i><tm tmtype=\"reg\" /> is accepted for restricted use within NHS Scotland for the treatment or prevention of postoperative pain by intravenous injection in supervised healthcare settings.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82653>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (February 2008) that Dyloject is accepted for restricted use within NHS Scotland for the treatment or prevention of postoperative pain by intravenous injection in supervised healthcare settings.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#UzXV8f8lx0CjEas6OKTyTg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "75 mg every 4–6 hours if required for maximum 2 days; maximum 150 mg per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>75 mg every 4–6 hours if required for maximum 2 days; maximum 150 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """75 mg every 4–6 hours if required for maximum 2 days; maximum 150 mg per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acutePostoperativePainInSupervisedSettings>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#hS9eIBz9_kmrXAYi_W5bjQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "25–50 mg, to be given after surgery; further doses given after 4–6 hours if necessary; maximum 150 mg in 24 hours for 2 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>25–50 mg, to be given after surgery; further doses given after 4–6 hours if necessary; maximum 150 mg in 24 hours for 2 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """25–50 mg, to be given after surgery; further doses given after 4–6 hours if necessary; maximum 150 mg in 24 hours for 2 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPostoperativePain>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#rTeDqzRUeE2xv6Lvm9l3Rg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "75 mg once daily for maximum 2 days, to be administered into the gluteal muscle."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>75 mg once daily for maximum 2 days, to be administered into the gluteal muscle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """75 mg once daily for maximum 2 days, to be administered into the gluteal muscle.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPainAndPostoperativePain>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/dyloject#PHP82610>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPainAndPostoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute exacerbations of pain and postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Acute exacerbations of pain and postoperative pain

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "acute exacerbations of pain and postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPainAndPostoperativePainSevereCases> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute exacerbations of pain and postoperative pain (severe cases)</p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasTextContent """Acute exacerbations of pain and postoperative pain (severe cases)

"""^^xsd:string;
                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                  rdfs:label "acute exacerbations of pain and postoperative pain (severe cases)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#acutePostoperativePainInSupervisedSettings> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute postoperative pain (in supervised settings)</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Acute postoperative pain (in supervised settings)

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "acute postoperative pain (in supervised settings)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPostoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Prevention of postoperative pain

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "prevention of postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#uretericColic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ureteric colic</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Ureteric colic

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "ureteric colic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by deep intramuscular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#3kWS2klA40qgXk1-shGlJQ>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#oWiAuI-2D02XSuPbN1wC3g>;
                                                                             nicebnf:hasTitle """<title>E45<tm tmtype=\"reg\" /> bath oil</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "e45 bath oil"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#3kWS2klA40qgXk1-shGlJQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                       rdfs:label "15 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>15 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """15 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderlyAssociatedWithDrySkin>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#PHP106315>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#PHP106315> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#oWiAuI-2D02XSuPbN1wC3g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                       rdfs:label "5–10 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>5–10 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """5–10 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "15 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>15 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """15 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "15 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>15 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """15 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endogenousAndExogenousEczemaXerodermaAndIchthyosis>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-bath-oil#PHP106315>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#endogenousAndExogenousEczemaXerodermaAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endogenous and exogenous eczema, xeroderma, and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Endogenous and exogenous eczema, xeroderma, and ichthyosis

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "endogenous and exogenous eczema, xeroderma, and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderlyAssociatedWithDrySkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly associated with dry skin</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Pruritus of the elderly associated with dry skin

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "pruritus of the elderly associated with dry skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-itch-relief-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-itch-relief-cream#n4rZ7agdZUy4LlN1UfulEg>;
                                                                                      nicebnf:hasTitle """<title>E45<tm tmtype=\"reg\" /> Itch Relief Cream</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "e45 itch relief cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-itch-relief-cream#PHP106277> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-itch-relief-cream#n4rZ7agdZUy4LlN1UfulEg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-itch-relief-cream#PHP106277>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling, and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling, and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling, and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#C1L3fZsTx0mHc9zg5jzuHA>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#ZduuWWeqDUyOi50Q3Q8dtg>;
                                                                               nicebnf:hasTitle """<title>E45<tm tmtype=\"reg\" /> wash cream</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "e45 wash cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#C1L3fZsTx0mHc9zg5jzuHA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                         rdfs:label "to be used as a soap substitute."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>To be used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """To be used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "to be used as a soap substitute."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>To be used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """To be used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endogenousAndExogenousEczemaXerodermaAndIchthyosis>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#PHP106285>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#PHP106285> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#ZduuWWeqDUyOi50Q3Q8dtg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                         rdfs:label "to be used as a soap substitute."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>To be used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """To be used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderlyAssociatedWithDrySkin>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/e45-wash-cream#PHP106285>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#endogenousAndExogenousEczemaXerodermaAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endogenous and exogenous eczema, xeroderma, and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Endogenous and exogenous eczema, xeroderma, and ichthyosis

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "endogenous and exogenous eczema, xeroderma, and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderlyAssociatedWithDrySkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly associated with dry skin</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Pruritus of the elderly associated with dry skin

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "pruritus of the elderly associated with dry skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#XxpuDkaCREaIqIpsDIxCYg>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#YBFNKJdinE2DsxodBFwWfg>;
                                                                                     nicebnf:hasTitle """<title>Easyhaler<tm tmtype=\"reg\" /> Salbutamol</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "easyhaler salbutamol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#PHP82586> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#XxpuDkaCREaIqIpsDIxCYg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "200 micrograms."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>200 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """200 micrograms.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#PHP82586>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#YBFNKJdinE2DsxodBFwWfg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "initially 100–200 micrograms, increased if necessary to 400 micrograms; maximum 800 micrograms per day."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>Initially 100–200 micrograms, increased if necessary to 400 micrograms; maximum 800 micrograms per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """Initially 100–200 micrograms, increased if necessary to 400 micrograms; maximum 800 micrograms per day.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/easyhaler-salbutamol#PHP82586>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Acute bronchospasm

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "acute bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Prophylaxis of allergen- or exercise-induced bronchospasm

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "prophylaxis of allergen- or exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/efcortesol> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/efcortesol#e2ddY_ItLUObUectFZCE8w>;
                                                                           nicebnf:hasTitle """<title>Efcortesol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "efcortesol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/efcortesol#PHP84453> a nicebnf:LessSuitableForPrescribings.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/efcortesol#e2ddY_ItLUObUectFZCE8w> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Efcortesol</i>
    <tm tmtype=\"reg\" /> is less suitable for prescribing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/efcortesol#PHP84453>;
                                                                                                  nicebnf:hasTextContent """Efcortesol is less suitable for prescribing.

"""^^xsd:string;
                                                                                                  a nicebnf:LessSuitableForPrescribing.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#O6RhHdEzXkeFc4x-537gJQ>;
                                                                          nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#TyYFTzn2I0meGXRtEvSnMA>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#JF8UyaC9h0OUSP1POBOxmA>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#h0HIC03410KsqhWLT8JT-A>;
                                                                          nicebnf:hasTitle """<title>Effentora<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "effentora"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#JF8UyaC9h0OUSP1POBOxmA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Place tablet between cheek and gum and leave to dissolve; if more than 1 tablet required, place second tablet on the other side of the mouth; tablet may alternatively be placed under the tongue (sublingually).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98307>;
                                                                                                 nicebnf:hasTextContent """Place tablet between cheek and gum and leave to dissolve; if more than 1 tablet required, place second tablet on the other side of the mouth; tablet may alternatively be placed under the tongue (sublingually).

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#O6RhHdEzXkeFc4x-537gJQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised that <i>Effentora</i><tm tmtype=\"reg\" /> buccal tablets should be restricted for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short acting opioids are unsuitable.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98314>;
                                                                                                 nicebnf:hasTextContent """The Scottish Medicines Consortium has advised that Effentora buccal tablets should be restricted for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short acting opioids are unsuitable.

"""^^xsd:string;
                                                                                                 a nicebnf:FundingDecision,
                                                                                                   nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98294> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98307> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98311> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98314> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#TyYFTzn2I0meGXRtEvSnMA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 100 micrograms, then 100 micrograms after 30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain during titration."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 100 micrograms, then 100 micrograms after 30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain during titration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 100 micrograms, then 100 micrograms after 30 minutes if required, dose to be adjusted according to response—consult product literature, no more than 2 dose units for each pain episode; max. 800 micrograms per episode of breakthrough pain; leave at least 4 hours between treatment of episodes of breakthrough pain during titration.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingSublingualTablets>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98294>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#h0HIC03410KsqhWLT8JT-A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer <i>Effentora</i><tm tmtype=\"reg\" /> buccal tablets.</p>
  <p>Patients should be advised not to eat or drink until the tablet is completely dissolved; after 30 minutes, if any remnants remain, they may be swallowed with a glass of water. Patients with a dry mouth should be advised to drink water to moisten the buccal mucosa before administration of the tablets; if appropriate effervescence does not occur, a switch of therapy may be advised.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/effentora#PHP98311>;
                                                                                                 nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Effentora buccal tablets.

Patients should be advised not to eat or drink until the tablet is completely dissolved; after 30 minutes, if any remnants remain, they may be swallowed with a glass of water. Patients with a dry mouth should be advised to drink water to moisten the buccal mucosa before administration of the tablets; if appropriate effervescence does not occur, a switch of therapy may be advised.

"""^^xsd:string;
                                                                                                 a nicebnf:GeneralPatientAdvice,
                                                                                                   nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Breakthrough pain in patients receiving opioid therapy for chronic cancer pain

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "breakthrough pain in patients receiving opioid therapy for chronic cancer pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingSublingualTablets> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                         rdfs:label "by mouth using sublingual tablets"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elantan-la> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elantan-la#V--bBz0BIUmAHgejKoxs4A>;
                                                                           nicebnf:hasTitle """<title>Elantan<tm tmtype=\"reg\" /> LA</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "elantan la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elantan-la#PHP60288> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elantan-la#V--bBz0BIUmAHgejKoxs4A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "1 capsule daily, then increased if necessary to 2 capsules daily, dose to be taken in the morning."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>1 capsule daily, then increased if necessary to 2 capsules daily, dose to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """1 capsule daily, then increased if necessary to 2 capsules daily, dose to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elantan-la#PHP60288>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-1-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-1-mg#qAN0Jixm2Uy0AJTXYSV0Yg>;
                                                                                  nicebnf:hasTitle """<title>Elleste-Duet<tm tmtype=\"reg\" /> 1-mg</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "elleste-duet 1-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-1-mg#PHP96249> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-1-mg#qAN0Jixm2Uy0AJTXYSV0Yg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 tablet daily for 16 days, white tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, green tablets to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, white tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, green tablets to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 tablet daily for 16 days, white tablet to be taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, green tablets to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-1-mg#PHP96249>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-2-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-2-mg#G1sYB_1USkmdkkxrFdr9Iw>;
                                                                                  nicebnf:hasTitle """<title>Elleste-Duet<tm tmtype=\"reg\" /> 2-mg</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "elleste-duet 2-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-2-mg#G1sYB_1USkmdkkxrFdr9Iw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 tablet daily for 16 days, orange tablet to be taken, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, grey tablet to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, orange tablet to be taken, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, grey tablet to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 tablet daily for 16 days, orange tablet to be taken, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), then 1 tablet daily for 12 days, grey tablet to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-2-mg#PHP96331>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-2-mg#PHP96331> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-conti> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-conti#smMDRuq0Rk2mv8VEKXFntg>;
                                                                                   nicebnf:hasTitle """<title>Elleste-Duet<tm tmtype=\"reg\" /> Conti</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "elleste-duet conti"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-conti#PHP95907> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-conti#smMDRuq0Rk2mv8VEKXFntg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily continuous basis, if changing from cyclical hrt begin treatment at the end of scheduled bleed."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet daily continuous basis, if changing from cyclical HRT begin treatment at the end of scheduled bleed.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily continuous basis, if changing from cyclical HRT begin treatment at the end of scheduled bleed.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-duet-conti#PHP95907>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-1-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-1-mg#k1ILagV1LUuFU_NP441ghg>;
                                                                                  nicebnf:hasTitle """<title>Elleste-Solo<tm tmtype=\"reg\" /> 1-mg</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "elleste-solo 1-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-1-mg#PHP97556> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-1-mg#k1ILagV1LUuFU_NP441ghg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 mg daily, starting on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 mg daily, starting on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 mg daily, starting on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-1-mg#PHP97556>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-2-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-2-mg#LqOaULAEk0CEzOsgRGHXcA>;
                                                                                  nicebnf:hasTitle """<title>Elleste-Solo<tm tmtype=\"reg\" /> 2-mg</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "elleste-solo 2-mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-2-mg#LqOaULAEk0CEzOsgRGHXcA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "2 mg daily, started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be given with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>2 mg daily, started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be given with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """2 mg daily, started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be given with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsNotControlledWithLowerStrength>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-2-mg#PHP97618>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-2-mg#PHP97618> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsNotControlledWithLowerStrength> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms not controlled with lower strength</p>"""^^<rdf:XMLLiteral>;
                                                                                           nicebnf:hasTextContent """Menopausal symptoms not controlled with lower strength

"""^^xsd:string;
                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                           rdfs:label "menopausal symptoms not controlled with lower strength"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#ElBQ15bUR0OetBq0qFbgLQ>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#ZU7tSqvNq0aeGs9_8uYYXQ>;
                                                                                nicebnf:hasTitle """<title>Elleste Solo<tm tmtype=\"reg\" /> MX</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "elleste solo mx"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#ElBQ15bUR0OetBq0qFbgLQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with mx 80, subsequently adjust according to response."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>MX 80</i>, subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with MX 80, subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#PHP97435>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#PHP97435> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#ZU7tSqvNq0aeGs9_8uYYXQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with mx 40, subsequently adjust according to response."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>MX 40</i>, subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with MX 40, subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/elleste-solo-mx#PHP97435>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#LO01eI7idkmz550cCD1Xow>;
                                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#mjxERq5UeUu548c_-BSV7Q>;
                                                                                       nicebnf:hasTitle """<title>Emerade<tm tmtype=\"reg\" /> 150 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "emerade 150 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#LO01eI7idkmz550cCD1Xow> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> ; 
                                                                                                                                 rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> ; 
                                                                                                                                 rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#PHP98936>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#PHP98936> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#PHP99018> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#mjxERq5UeUu548c_-BSV7Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>0.35 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-150-micrograms#PHP99018>;
                                                                                                              nicebnf:hasTextContent """0.35 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                              a nicebnf:GeneralPatientAdvice,
                                                                                                                nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "child (body-weight 15–30 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "child (body-weight up to 15 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#MP_fzLfgn0OtRd_JXXhlgg>;
                                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#Z79O-WopeEeG9NLI5_jbRQ>;
                                                                                       nicebnf:hasTitle """<title>Emerade<tm tmtype=\"reg\" /> 300 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "emerade 300 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#MP_fzLfgn0OtRd_JXXhlgg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> ; 
                                                                                                                                 rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> ; 
                                                                                                                                 rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#PHP98937>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#PHP98937> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#PHP99015> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#Z79O-WopeEeG9NLI5_jbRQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>0.2 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-300-micrograms#PHP99015>;
                                                                                                              nicebnf:hasTextContent """0.2 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                              a nicebnf:PatientAndCarerAdvice,
                                                                                                                nicebnf:PatientResources.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "child (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#TUzfTJxdFEOyvJOa0DhFIA>;
                                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#NYfD1FDdcEeapi9eyvM4Zg>;
                                                                                       nicebnf:hasTitle """<title>Emerade<tm tmtype=\"reg\" /> 500 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "emerade 500 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#NYfD1FDdcEeapi9eyvM4Zg> nicebnf:hasDitaContent """<sectiondiv>
  <p>No solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#PHP99020>;
                                                                                                              nicebnf:hasTextContent """No solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                              a nicebnf:GeneralPatientAdvice,
                                                                                                                nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#PHP98938> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#PHP99020> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#TUzfTJxdFEOyvJOa0DhFIA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                 rdfs:label "500 micrograms, then 500 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>500 micrograms, then 500 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """500 micrograms, then 500 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "500 micrograms, then 500 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>500 micrograms, then 500 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """500 micrograms, then 500 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministrationForPatientsAtRiskOfSevereAnaphylaxis>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emerade-500-micrograms#PHP98938>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministrationForPatientsAtRiskOfSevereAnaphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration for patients at risk of severe anaphylaxis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasTextContent """Acute anaphylaxis (for self-administration for patients at risk of severe anaphylaxis)

"""^^xsd:string;
                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                    rdfs:label "acute anaphylaxis (for self-administration for patients at risk of severe anaphylaxis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/emulsiderm> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/emulsiderm#SQKfHnT8AEWaYNosK8dr-w>;
                                                                           nicebnf:hasTitle """<title>Emulsiderm<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "emulsiderm"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emulsiderm#PHP105760> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/emulsiderm#SQKfHnT8AEWaYNosK8dr-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "7–30 ml/bath, alternatively, to be rubbed into dry skin until absorbed."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>7–30 mL/bath, alternatively, to be rubbed into dry skin until absorbed.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """7–30 mL/bath, alternatively, to be rubbed into dry skin until absorbed.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaAndIchthyosis>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/emulsiderm#PHP105760>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Dry skin conditions including eczema and ichthyosis

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "dry skin conditions including eczema and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/en-de-kay-fluorinse> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/en-de-kay-fluorinse#cPETtv5UpUWR9NXsRPK2ZA>;
                                                                                    nicebnf:hasTitle """<title>En-De-Kay<tm tmtype=\"reg\" /> Fluorinse</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "en-de-kay fluorinse"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/en-de-kay-fluorinse#PHP104702> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/en-de-kay-fluorinse#cPETtv5UpUWR9NXsRPK2ZA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "5 drops daily, dilute 5 drops to 10 ml of water, alternatively (by mouth) 20 drops once weekly, dilute 20 drops to 10 ml."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>5 drops daily, dilute 5 drops to 10 mL of water, alternatively (by mouth) 20 drops once weekly, dilute 20 drops to 10 mL.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """5 drops daily, dilute 5 drops to 10 mL of water, alternatively (by mouth) 20 drops once weekly, dilute 20 drops to 10 mL.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByMouthUsingMouthwash>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCarriesForIndividualsWhoAreCariesProneOrMedicallyCompromised>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/en-de-kay-fluorinse#PHP104702>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDentalCarriesForIndividualsWhoAreCariesProneOrMedicallyCompromised> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of dental carries for individuals who are caries prone or medically compromised</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Prophylaxis of dental carries for individuals who are caries prone or medically compromised

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "prophylaxis of dental carries for individuals who are caries prone or medically compromised"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByMouthUsingMouthwash> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                          rdfs:label "initially by mouth using mouthwash"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#5vu2xXVvb0GS2fUXnCT6sw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#9aD0mYnS_UGTIdbT71nL1g>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#V-FcAW89kESJtFIhRyUuNw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#VNc1MZed5k2UtuurOAK1Yw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#WvYGychDQ06c7JOUIiV1yA>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#eyVglYixEEu-1e8m1WWD9A>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#wrl2F8Qxdke_0SXnURUK-g>;
                                                                          nicebnf:hasTitle """<title>Engerix B<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "engerix b"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#5vu2xXVvb0GS2fUXnCT6sw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "20 micrograms for 1 dose, then 20 micrograms after 7 days for 1 dose, followed by 20 micrograms after 14 days for 1 dose, followed by 20 micrograms for 1 dose, to be given 12 months after the first dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms for 1 dose, then 20 micrograms after 7 days for 1 dose, followed by 20 micrograms after 14 days for 1 dose, followed by 20 micrograms for 1 dose, to be given 12 months after the first dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms for 1 dose, then 20 micrograms after 7 days for 1 dose, followed by 20 micrograms after 14 days for 1 dose, followed by 20 micrograms for 1 dose, to be given 12 months after the first dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedScheduleInExceptionalCasesEGForTravellersDepartingWithin1Month>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#9aD0mYnS_UGTIdbT71nL1g> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionForNeonatesBornToHepatitisBSurfaceAntigenPositiveMother>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#V-FcAW89kESJtFIhRyUuNw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1115Years> ; 
                                                                                                                    rdfs:label "20 micrograms for 1 dose, followed by 20 micrograms after 6 months, this schedule is not suitable if high risk of infection between doses or if compliance with second dose uncertain, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms for 1 dose, followed by 20 micrograms after 6 months, this schedule is not suitable if high risk of infection between doses or if compliance with second dose uncertain, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms for 1 dose, followed by 20 micrograms after 6 months, this schedule is not suitable if high risk of infection between doses or if compliance with second dose uncertain, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAlternativeAcceleratedSchedule>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#VNc1MZed5k2UtuurOAK1Yw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                    rdfs:label "10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                    rdfs:label "20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms every 1 month for 3 months, followed by 20 micrograms after 10 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedSchedule>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#WvYGychDQ06c7JOUIiV1yA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                    rdfs:label "10 micrograms every 1 month for 2 months, followed by 10 micrograms after 5 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>10 micrograms every 1 month for 2 months, followed by 10 micrograms after 5 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """10 micrograms every 1 month for 2 months, followed by 10 micrograms after 5 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                    rdfs:label "40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """40 micrograms every 1 month for 3 months, followed by 40 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingHaemodialysisPatients>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#eyVglYixEEu-1e8m1WWD9A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                    rdfs:label "10 micrograms for 1 dose, then 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>10 micrograms for 1 dose, then 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """10 micrograms for 1 dose, then 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                    rdfs:label "20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """20 micrograms for 1 dose, then 20 micrograms after 1 month for 1 dose, followed by 20 micrograms after 5 months for 1 dose, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfection>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#wrl2F8Qxdke_0SXnURUK-g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                    rdfs:label "10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """10 micrograms every 1 month for 3 months, followed by 10 micrograms after 10 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection in older children; anterolateral thigh is preferred site in infants and young children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingHaemodialysisPatientsAcceleratedSchedule>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/engerix-b#PHP81428>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis B infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis b infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedSchedule> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (accelerated schedule)</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Immunisation against hepatitis B infection (accelerated schedule)

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "immunisation against hepatitis b infection (accelerated schedule)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedScheduleInExceptionalCasesEGForTravellersDepartingWithin1Month> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (accelerated schedule in exceptional cases, e.g. for travellers departing within 1 month)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                          nicebnf:hasTextContent """Immunisation against hepatitis B infection (accelerated schedule in exceptional cases, e.g. for travellers departing within 1 month)

"""^^xsd:string;
                                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                          rdfs:label "immunisation against hepatitis b infection (accelerated schedule in exceptional cases, e.g. for travellers departing within 1 month)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAlternativeAcceleratedSchedule> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection, alternative accelerated schedule</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Immunisation against hepatitis B infection, alternative accelerated schedule

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "immunisation against hepatitis b infection, alternative accelerated schedule"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionForNeonatesBornToHepatitisBSurfaceAntigenPositiveMother> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (for neonates born to hepatitis B surface antigen-positive mother)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                        nicebnf:hasTextContent """Immunisation against hepatitis B infection (for neonates born to hepatitis B surface antigen-positive mother)

"""^^xsd:string;
                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                        rdfs:label "immunisation against hepatitis b infection (for neonates born to hepatitis b surface antigen-positive mother)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingHaemodialysisPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (in renal insufficiency, including haemodialysis patients)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                   nicebnf:hasTextContent """Immunisation against hepatitis B infection (in renal insufficiency, including haemodialysis patients)

"""^^xsd:string;
                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                   rdfs:label "immunisation against hepatitis b infection (in renal insufficiency, including haemodialysis patients)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingHaemodialysisPatientsAcceleratedSchedule> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (in renal insufficiency, including haemodialysis patients (accelerated schedule))</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                      nicebnf:hasTextContent """Immunisation against hepatitis B infection (in renal insufficiency, including haemodialysis patients (accelerated schedule))

"""^^xsd:string;
                                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                      rdfs:label "immunisation against hepatitis b infection (in renal insufficiency, including haemodialysis patients (accelerated schedule))"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1115Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 11–15 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–15 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#on_x_4daxUSlNLh_eOMu0g>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#py5kAvtK70iaK1IwUMlaIw>;
                                                                                  nicebnf:hasTitle """<title>Entocort<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "entocort capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#PHP83850> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#PHP83868> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#on_x_4daxUSlNLh_eOMu0g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "9 mg once daily for up to 8 weeks; reduce dose for the last 2–4 weeks of treatment, to be taken in the morning."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>9 mg once daily for up to 8 weeks; reduce dose for the last 2–4 weeks of treatment, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """9 mg once daily for up to 8 weeks; reduce dose for the last 2–4 weeks of treatment, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#PHP83850>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#py5kAvtK70iaK1IwUMlaIw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dispense modified-release capsules in original container (contains desiccant).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-capsules#PHP83868>;
                                                                                                         nicebnf:hasTextContent """Dispense modified-release capsules in original container (contains desiccant).

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateCrohnSDiseaseAffectingTheIleumOrAscendingColon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate Crohn's disease affecting the ileum or ascending colon</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasTextContent """Mild to moderate Crohn's disease affecting the ileum or ascending colon

"""^^xsd:string;
                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                       rdfs:label "mild to moderate crohn's disease affecting the ileum or ascending colon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-enema> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-enema#HOiqs3L9nEi3eYy-MidtnQ>;
                                                                               nicebnf:hasTitle """<title>Entocort<tm tmtype=\"reg\" /> enema</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "entocort enema"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-enema#HOiqs3L9nEi3eYy-MidtnQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "1 enema daily for 4 weeks, to be administered at bedtime."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 enema daily for 4 weeks, to be administered at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 enema daily for 4 weeks, to be administered at bedtime.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ulcerativeColitisInvolvingRectalAndRectoSigmoidDisease>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-enema#PHP83882>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/entocort-enema#PHP83882> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#ulcerativeColitisInvolvingRectalAndRectoSigmoidDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ulcerative colitis involving rectal and recto-sigmoid disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasTextContent """Ulcerative colitis involving rectal and recto-sigmoid disease

"""^^xsd:string;
                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                 rdfs:label "ulcerative colitis involving rectal and recto-sigmoid disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#0IZn0BtBkkO4pbJaNVJRAw>,
                                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#TDRsryVn1EGKj1BkL7ztwA>,
                                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#coNBuBLFqEG70wDGUM5-7A>;
                                                                                                  nicebnf:hasTitle """<title>Envarsus<tm tmtype=\"reg\" /> modified-release tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                  rdfs:label "envarsus modified-release tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#0IZn0BtBkkO4pbJaNVJRAw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                            rdfs:label "170 micrograms/kg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>170 micrograms/kg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """170 micrograms/kg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingRenalTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#PHP108016>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#PHP108016> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#TDRsryVn1EGKj1BkL7ztwA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                            rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#rejectionTherapy>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#PHP108016>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#coNBuBLFqEG70wDGUM5-7A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                            rdfs:label "110–130 micrograms/kg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>110–130 micrograms/kg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """110–130 micrograms/kg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/envarsus-modified-release-tablets#PHP108016>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                         rdfs:label "prophylaxis of graft rejection following liver transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingRenalTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following renal transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasTextContent """Prophylaxis of graft rejection following renal transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                         rdfs:label "prophylaxis of graft rejection following renal transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#rejectionTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Rejection therapy</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Rejection therapy

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "rejection therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#AIAZM_JGW0CkpMZIrpx2Gw>;
                                                                       nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#D8e5zYPJF0uMe_2CZz7zFQ>;
                                                                       nicebnf:hasTitle """<title>Enzira<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "enzira"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#AIAZM_JGW0CkpMZIrpx2Gw> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#child59YearsIncreasedRiskOfFeverUseAlternativeInfluenzaVaccineIfAvailable>;
                                                                                              nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Child 5–9 years (increased risk of fever)—use alternative influenza vaccine if available</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#PHP97800>;
                                                                                              nicebnf:hasTextContent """Child 5–9 years (increased risk of fever)—use alternative influenza vaccine if available

"""^^xsd:string;
                                                                                              a nicebnf:CautionsGroup,
                                                                                                nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#D8e5zYPJF0uMe_2CZz7zFQ> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#childUnder5YearsIncreasedRiskOfFebrileConvulsions>;
                                                                                              nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Child under 5 years—increased risk of febrile convulsions</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#PHP97808>;
                                                                                              nicebnf:hasTextContent """Child under 5 years—increased risk of febrile convulsions

"""^^xsd:string;
                                                                                              a nicebnf:ContraindicationsGroup,
                                                                                                nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#PHP97800> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/enzira#PHP97808> a nicebnf:ContraIndications.
<http://ld.nice.org.uk/ns/bnf/Caution#child59YearsIncreasedRiskOfFeverUseAlternativeInfluenzaVaccineIfAvailable> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Child 5–9 years (increased risk of fever)—use alternative influenza vaccine if available</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasTextContent "Child 5–9 years (increased risk of fever)—use alternative influenza vaccine if available"^^xsd:string;
                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                 rdfs:label "child 5–9 years (increased risk of fever)—use alternative influenza vaccine if available"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Contraindication#childUnder5YearsIncreasedRiskOfFebrileConvulsions> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Child under 5 years—increased risk of febrile convulsions</ph>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasTextContent "Child under 5 years—increased risk of febrile convulsions"^^xsd:string;
                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                                  rdfs:label "child under 5 years—increased risk of febrile convulsions"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#gscVyZ-PrkeU3vBnjHp0CQ>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#j7wBHrDAYkurcfppCkifsw>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#SXitxcHg9U-_i0y9u5kgmA>;
                                                                       nicebnf:hasTitle """<title>Epaxal<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "epaxal"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#PHP100450> a nicebnf:AllergyAndCrossSensitivity.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#PHP81338> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#SXitxcHg9U-_i0y9u5kgmA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Epaxal</i>
    <tm tmtype=\"reg\" /> contains influenza virus haemagglutinin grown in the allantoic cavity of chick embryos, therefore contra-indicated in those hypersensitive to eggs or chicken protein.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#PHP100450>;
                                                                                              nicebnf:hasTextContent """Epaxal contains influenza virus haemagglutinin grown in the allantoic cavity of chick embryos, therefore contra-indicated in those hypersensitive to eggs or chicken protein.

"""^^xsd:string;
                                                                                              a nicebnf:AllergyAndCrossSensitivityCrossSensitivity.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#gscVyZ-PrkeU3vBnjHp0CQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 4 years if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#PHP81338>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#j7wBHrDAYkurcfppCkifsw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 1–6 months, dose given as booster; booster dose may be delayed by up to 4 years in adults if not given after recommended interval following primary dose. The deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfectionSplenectomisedPatients>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epaxal#PHP81338>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis A infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis a infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfectionSplenectomisedPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection (splenectomised patients)</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasTextContent """Immunisation against hepatitis A infection (splenectomised patients)

"""^^xsd:string;
                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                       rdfs:label "immunisation against hepatitis a infection (splenectomised patients)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chrono> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chrono#_pZ-5hhFGEiLIIQlFeDyYw>;
                                                                              nicebnf:hasTitle """<title>Epilim Chrono<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "epilim chrono"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chrono#PHP81466> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chrono#_pZ-5hhFGEiLIIQlFeDyYw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "total daily dose to be given in 1–2 divided doses (consult product literature)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Total daily dose to be given in 1–2 divided doses (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Total daily dose to be given in 1–2 divided doses (consult product literature).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chrono#PHP81466>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """All forms of epilepsy

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "all forms of epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#K9NuN5A9yE2WFim1tW-Hxw>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#-VPGo6SD1E-KEThL-JHWzg>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#9f_TIyGOM0esg6C9hxRyCw>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#dan-6e6NQEaItkq3U1erbw>;
                                                                                    nicebnf:hasTitle """<title>Epilim Chronosphere<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "epilim chronosphere"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#-VPGo6SD1E-KEThL-JHWzg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients and carers should be counselled on the administration of granules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81493>;
                                                                                                           nicebnf:hasTextContent """Patients and carers should be counselled on the administration of granules.

"""^^xsd:string;
                                                                                                           a nicebnf:GeneralPatientAdvice,
                                                                                                             nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#9f_TIyGOM0esg6C9hxRyCw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Prescribe dose to the nearest whole 50-mg sachet.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81496>;
                                                                                                           nicebnf:hasTextContent """Prescribe dose to the nearest whole 50-mg sachet.

"""^^xsd:string;
                                                                                                           a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#K9NuN5A9yE2WFim1tW-Hxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "total daily dose to be given in 1–2 divided doses (consult product literature)."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Total daily dose to be given in 1–2 divided doses (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Total daily dose to be given in 1–2 divided doses (consult product literature).

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81483>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81483> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81491> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81493> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81496> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#dan-6e6NQEaItkq3U1erbw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Granules may be mixed with soft food or drink that is cold or at room temperature, and swallowed immediately without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-chronosphere#PHP81491>;
                                                                                                           nicebnf:hasTextContent """Granules may be mixed with soft food or drink that is cold or at room temperature, and swallowed immediately without chewing.

"""^^xsd:string;
                                                                                                           a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """All forms of epilepsy

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "all forms of epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-syrup> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-syrup#12Pwtn6DZEmbjeWUMbDeDw>;
                                                                             nicebnf:hasTitle """<title>Epilim<tm tmtype=\"reg\" /> syrup</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "epilim syrup"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-syrup#12Pwtn6DZEmbjeWUMbDeDw> nicebnf:hasDitaContent """<sectiondiv>
  <p>May be diluted, preferably in Syrup BP; use within 14 days.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-syrup#PHP98357>;
                                                                                                    nicebnf:hasTextContent """May be diluted, preferably in Syrup BP; use within 14 days.

"""^^xsd:string;
                                                                                                    a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epilim-syrup#PHP98357> a nicebnf:DirectionsForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#AZGWQwZI-06wL3e0Ni0bVw>;
                                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#vQsMpNgJv0-JY62StyXfLQ>;
                                                                                          nicebnf:hasTitle """<title>EpiPen<tm tmtype=\"reg\" /> Auto-injector 0.3mg</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "epipen auto-injector 0.3mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#AZGWQwZI-06wL3e0Ni0bVw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> ; 
                                                                                                                                    rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> ; 
                                                                                                                                    rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#PHP83306>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#PHP83306> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#PHP83320> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#vQsMpNgJv0-JY62StyXfLQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>1.7 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-auto-injector-03mg#PHP83320>;
                                                                                                                 nicebnf:hasTextContent """1.7 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                                 a nicebnf:GeneralPatientAdvice,
                                                                                                                   nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "child (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#s1P734Rbg0mqSIqpBP6bnQ>;
                                                                                              nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#xX4t8bvcd0qSnzO9NP5rkQ>;
                                                                                              nicebnf:hasTitle """<title>EpiPen<tm tmtype=\"reg\" /> Jr Auto-injector 0.15mg</title>"""^^<rdf:XMLLiteral>;
                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                              rdfs:label "epipen jr auto-injector 0.15mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#PHP83274> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#PHP83284> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#s1P734Rbg0mqSIqpBP6bnQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> ; 
                                                                                                                                        rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                                        nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                        nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> ; 
                                                                                                                                        rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children."^^xsd:string ; 
                                                                                                                                        nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                        nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.

"""^^xsd:string ; 
                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#PHP83274>;
                                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#xX4t8bvcd0qSnzO9NP5rkQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>1.7 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epipen-jr-auto-injector-015mg#PHP83284>;
                                                                                                                     nicebnf:hasTextContent """1.7 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                                     a nicebnf:GeneralPatientAdvice,
                                                                                                                       nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "child (body-weight 15–30 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "child (body-weight up to 15 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#OalPIrAI-EWIIvloiueSqw>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#qsShz179bk-9OTSHdMuZxg>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#-FaS0B4hEkiOOSnhC99W6Q>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#VeHd2ojkSUi6Wq4NUssPDQ>;
                                                                                  nicebnf:hasTitle """<title>Episenta<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "episenta capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#-FaS0B4hEkiOOSnhC99W6Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of capsule may be mixed with cold soft food or drink and swallowed immediately without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81266>;
                                                                                                         nicebnf:hasTextContent """Contents of capsule may be mixed with cold soft food or drink and swallowed immediately without chewing.

"""^^xsd:string;
                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#OalPIrAI-EWIIvloiueSqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mania>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81258>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81258> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81266> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81268> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#VeHd2ojkSUi6Wq4NUssPDQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients and carers should be counselled on the administration of capsules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81268>;
                                                                                                         nicebnf:hasTextContent """Patients and carers should be counselled on the administration of capsules.

"""^^xsd:string;
                                                                                                         a nicebnf:GeneralPatientAdvice,
                                                                                                           nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#qsShz179bk-9OTSHdMuZxg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "total daily dose to be given in 1–2 divided doses (consult product literature)."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Total daily dose to be given in 1–2 divided doses (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Total daily dose to be given in 1–2 divided doses (consult product literature).

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-capsules#PHP81258>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """All forms of epilepsy

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "all forms of epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mania</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Mania

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#aXMe4HLvgEaqgH6p0kYWlQ>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#uLT5mEdsb0SyHGLLjTLO4w>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#QgRF16ari0a_H3uRwps0oQ>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#v_8t6avmpke85TnVd1nf0g>;
                                                                                  nicebnf:hasTitle """<title>Episenta<tm tmtype=\"reg\" /> granules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "episenta granules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81274> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81282> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81284> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#QgRF16ari0a_H3uRwps0oQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients and carers should be counselled on the administration of granules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81284>;
                                                                                                         nicebnf:hasTextContent """Patients and carers should be counselled on the administration of granules.

"""^^xsd:string;
                                                                                                         a nicebnf:GeneralPatientAdvice,
                                                                                                           nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#aXMe4HLvgEaqgH6p0kYWlQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Initially 750 mg daily in 1–2 divided doses, adjusted according to response, usual dose 1–2 g daily in 1–2 divided doses, doses greater than 45 mg/kg daily require careful monitoring.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mania>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81274>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#uLT5mEdsb0SyHGLLjTLO4w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "total daily dose to be given in 1–2 divided doses (consult product literature)."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Total daily dose to be given in 1–2 divided doses (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Total daily dose to be given in 1–2 divided doses (consult product literature).

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81274>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#v_8t6avmpke85TnVd1nf0g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Granules may be mixed with cold soft food or drink and swallowed immediately without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/episenta-granules#PHP81282>;
                                                                                                         nicebnf:hasTextContent """Granules may be mixed with cold soft food or drink and swallowed immediately without chewing.

"""^^xsd:string;
                                                                                                         a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """All forms of epilepsy

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "all forms of epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mania</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Mania

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epival> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#dcPxCpwpi0SHdZm7s57Yqw>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#Z6KLK2yQeEmVsdyf_RsWdA>;
                                                                       nicebnf:hasTitle """<title>Epival<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "epival"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#PHP81290> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#PHP81298> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#Z6KLK2yQeEmVsdyf_RsWdA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablets may be halved but not crushed or chewed.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#PHP81298>;
                                                                                              nicebnf:hasTextContent """Tablets may be halved but not crushed or chewed.

"""^^xsd:string;
                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#dcPxCpwpi0SHdZm7s57Yqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "total daily dose to be given in 1–2 divided doses (consult product literature)."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Total daily dose to be given in 1–2 divided doses (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Total daily dose to be given in 1–2 divided doses (consult product literature).

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epival#PHP81290>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allFormsOfEpilepsy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">All forms of epilepsy</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """All forms of epilepsy

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "all forms of epilepsy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-oral-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-oral-solution#DNVoojl2ikKREJqbMociyg>;
                                                                                     nicebnf:hasTitle """<title>Epivir<tm tmtype=\"reg\" /> oral solution</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "epivir oral solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-oral-solution#DNVoojl2ikKREJqbMociyg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "150 mg every 12 hours, alternatively 300 mg once daily."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>150 mg every 12 hours, alternatively 300 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """150 mg every 12 hours, alternatively 300 mg once daily.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hivInfectionInCombinationWithOtherAntiretroviralDrugs>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-oral-solution#PHP83682>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-oral-solution#PHP83682> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#hivInfectionInCombinationWithOtherAntiretroviralDrugs> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretroviral drugs</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """HIV infection in combination with other antiretroviral drugs

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "hiv infection in combination with other antiretroviral drugs"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-tablets#Bop12bNZ50mlFMTCxxIPfw>;
                                                                               nicebnf:hasTitle """<title>Epivir<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "epivir tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-tablets#Bop12bNZ50mlFMTCxxIPfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "150 mg every 12 hours, alternatively 300 mg once daily."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>150 mg every 12 hours, alternatively 300 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """150 mg every 12 hours, alternatively 300 mg once daily.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hivInfectionInCombinationWithOtherAntiretroviralDrugs>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-tablets#PHP83636>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/epivir-tablets#PHP83636> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#hivInfectionInCombinationWithOtherAntiretroviralDrugs> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretroviral drugs</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """HIV infection in combination with other antiretroviral drugs

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "hiv infection in combination with other antiretroviral drugs"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#Enx1qfIFwE--3sRgcGO3fg>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#Fx5PzKRjzUSzQxXmKbGdmg>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#K-zDZSdlF0O4zSBbfoTXMA>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#_veZlXDHfUaFYeXnf0WJ8g>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#jUOgDF47eUG1he9AoOSEQw>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#qkujD1l8qkS0AWnITn0C5A>;
                                                                                          nicebnf:hasTitle """<title>Eprex<tm tmtype=\"reg\" /> pre-filled syringes</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "eprex pre-filled syringes"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#Enx1qfIFwE--3sRgcGO3fg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 ml per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. discontinue approximately 4 weeks after ending chemotherapy."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 mL per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. Discontinue approximately 4 weeks after ending chemotherapy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 150 units/kg 3 times a week, alternatively initially 450 units/kg once weekly, increased to 300 units/kg 3 times a week, increased if appropriate rise in haemoglobin (or reticulocyte count) not achieved after 4 weeks; discontinue if inadequate response after 4 weeks at higher dose, subcutaneous injection maximum 1 mL per injection site, reduce dose by approximately 25–50% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose. Discontinue approximately 4 weeks after ending chemotherapy.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaInAdultsReceivingCancerChemotherapy>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#Fx5PzKRjzUSzQxXmKbGdmg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 ml per injection site."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 mL per injection site.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """600 units/kg once weekly for 3 weeks before surgery and on day of surgery, alternatively 300 units/kg daily for 15 days starting 10 days before surgery, consult product literature for details, subcutaneous injection maximum 1 mL per injection site.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateAnaemiaHaemoglobinConcentration1013G100MLBeforeElectiveOrthopaedicSurgeryInAdultsWithExpectedModerateBloodLossToReduceExposureToAllogeneicBloodTransfusionOrIfAutologousTransfusionUnavailable>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#K-zDZSdlF0O4zSBbfoTXMA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """600 units/kg twice weekly for 3 weeks before surgery, consult product literature for details and advice on ensuring high iron stores, intravenous injection to be given over 1–5 minutes.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toIncreaseYieldOfAutologousBloodToAvoidHomologousBloodInPredonationProgrammeInModerateAnaemiaEitherWhenLargeVolumeOfBloodRequiredOrWhenSufficientBloodCannotBeSavedForElectiveMajorSurgery>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#_veZlXDHfUaFYeXnf0WJ8g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 ml per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 50 units/kg twice weekly; maintenance 25–50 units/kg twice weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrBySubcutaneousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInAdultsOnPeritonealDialysis>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#jUOgDF47eUG1he9AoOSEQw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 75–300 units/kg once weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 ml per injection site, maintenance dose can be given as a single dose or in divided doses, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 75–300 units/kg once weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, maintenance dose can be given as a single dose or in divided doses, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 50 units/kg 3 times a week, adjusted in steps of 25 units/kg 3 times a week, dose adjusted according to response at intervals of at least 4 weeks; maintenance 75–300 units/kg once weekly, intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, maintenance dose can be given as a single dose or in divided doses, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrBySubcutaneousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInPatientsOnHaemodialysis>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#qkujD1l8qkS0AWnITn0C5A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 ml per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 ml over 4 weeks or if haemoglobin concentration exceeds 12 g/100 ml; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 50 units/kg 3 times a week, increased in steps of 25 units/kg 3 times a week, adjusted according to response, dose to be increased at intervals of at least 4 weeks; maintenance 17–33 units/kg 3 times a week (max. per dose 200 units/kg 3 times a week), intravenous route preferred, intravenous injection to be given over 1–5 minutes, subcutaneous injection, maximum 1 mL per injection site, reduce dose by approximately 25% if rise in haemoglobin concentration exceeds 2 g/100 mL over 4 weeks or if haemoglobin concentration exceeds 12 g/100 mL; if haemoglobin concentration continues to rise, despite dose reduction, suspend treatment until haemoglobin concentration decreases and then restart at a dose approximately 25% lower than the previous dose.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrBySubcutaneousInjection>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severeSymptomaticAnaemiaOfRenalOriginInAdultsWithRenalInsufficiencyNotYetOnDialysis>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eprex-pre-filled-syringes#PHP104581>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateAnaemiaHaemoglobinConcentration1013G100MLBeforeElectiveOrthopaedicSurgeryInAdultsWithExpectedModerateBloodLossToReduceExposureToAllogeneicBloodTransfusionOrIfAutologousTransfusionUnavailable> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate anaemia (haemoglobin concentration 10–13 g/100 mL) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                 nicebnf:hasTextContent """Moderate anaemia (haemoglobin concentration 10–13 g/100 mL) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable

"""^^xsd:string;
                                                                                                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                 rdfs:label "moderate anaemia (haemoglobin concentration 10–13 g/100 ml) before elective orthopaedic surgery in adults with expected moderate blood loss to reduce exposure to allogeneic blood transfusion or if autologous transfusion unavailable"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeSymptomaticAnaemiaOfRenalOriginInAdultsWithRenalInsufficiencyNotYetOnDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                              nicebnf:hasTextContent """Severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis

"""^^xsd:string;
                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                              rdfs:label "severe symptomatic anaemia of renal origin in adults with renal insufficiency not yet on dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInAdultsOnPeritonealDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "symptomatic anaemia associated with chronic renal failure in adults on peritoneal dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaAssociatedWithChronicRenalFailureInPatientsOnHaemodialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia associated with chronic renal failure in patients on haemodialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                       nicebnf:hasTextContent """Symptomatic anaemia associated with chronic renal failure in patients on haemodialysis

"""^^xsd:string;
                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                       rdfs:label "symptomatic anaemia associated with chronic renal failure in patients on haemodialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticAnaemiaInAdultsReceivingCancerChemotherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic anaemia in adults receiving cancer chemotherapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Symptomatic anaemia in adults receiving cancer chemotherapy

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "symptomatic anaemia in adults receiving cancer chemotherapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#toIncreaseYieldOfAutologousBloodToAvoidHomologousBloodInPredonationProgrammeInModerateAnaemiaEitherWhenLargeVolumeOfBloodRequiredOrWhenSufficientBloodCannotBeSavedForElectiveMajorSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                     nicebnf:hasTextContent """To increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery

"""^^xsd:string;
                                                                                                                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                     rdfs:label "to increase yield of autologous blood (to avoid homologous blood) in predonation programme in moderate anaemia either when large volume of blood required or when sufficient blood cannot be saved for elective major surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrBySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                           rdfs:label "by intravenous injection, or by subcutaneous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#JYtpi0BIT0-lEqnBl70cCQ>;
                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#8H3fYlhwG0yNbfickvUwdQ>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#cS0b8eUtFUabGjoOajxy6w>;
                                                                           nicebnf:hasTitle """<title>Equasym<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "equasym xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#8H3fYlhwG0yNbfickvUwdQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of capsule can be sprinkled on a tablespoon of apple sauce (then swallowed immediately without chewing).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98125>;
                                                                                                  nicebnf:hasTextContent """Contents of capsule can be sprinkled on a tablespoon of apple sauce (then swallowed immediately without chewing).

"""^^xsd:string;
                                                                                                  a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#JYtpi0BIT0-lEqnBl70cCQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                                     rdfs:label "initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; maximum 100 mg per day."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; maximum 100 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 10 mg once daily, dose to be taken in the morning before breakfast; increased gradually at weekly intervals if necessary; maximum 100 mg per day.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98059>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98059> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98125> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98165> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#cS0b8eUtFUabGjoOajxy6w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Consists of an immediate-release component (30% of the dose) and a modified-release component (70% of the dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/equasym-xl#PHP98165>;
                                                                                                  nicebnf:hasTextContent """Consists of an immediate-release component (30% of the dose) and a modified-release component (70% of the dose).

"""^^xsd:string;
                                                                                                  a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Attention deficit hyperactivity disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Attention deficit hyperactivity disorder

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "attention deficit hyperactivity disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#TzM0TAWm4keRWPWcxNdumA>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#hD4cXD6iY02CMx_kxGG3Rg>;
                                                                             nicebnf:hasTitle """<title>Estraderm MX<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "estraderm mx"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#PHP97554> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#TzM0TAWm4keRWPWcxNdumA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with mx50; subsequently adjust according to response."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with <i>MX50</i>; subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with MX50; subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#PHP97554>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#hD4cXD6iY02CMx_kxGG3Rg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with mx25 for first 3 months; subsequently adjust according to response."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with <i>MX25</i> for first 3 months; subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus, initiate therapy with MX25 for first 3 months; subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/estraderm-mx#PHP97554>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#DzGID95-m0OTPb3Xpm840Q>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#rLJzTbD_Q0q-kEfz7jQwDA>;
                                                                         nicebnf:hasTitle """<title>Estradot<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "estradot"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#DzGID95-m0OTPb3Xpm840Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with 50 patch; subsequently adjust according to response."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>50 patch</i>; subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with 50 patch; subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#PHP97632>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#PHP97632> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#rLJzTbD_Q0q-kEfz7jQwDA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with 25 patch for 3 months; subsequently adjust according to response."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>25 patch</i> for 3 months; subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with 25 patch for 3 months; subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/estradot#PHP97632>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/estring> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/estring#pMrYD3S0hEa1m48n0pV41Q>;
                                                                        nicebnf:hasTitle """<title>Estring<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "estring"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estring#PHP101944> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/estring#pMrYD3S0hEa1m48n0pV41Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "to be inserted into upper third of vagina and worn continuously; replace after 3 months; max. duration of continuous treatment 2 years."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>To be inserted into upper third of vagina and worn continuously; replace after 3 months; max. duration of continuous treatment 2 years.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """To be inserted into upper third of vagina and worn continuously; replace after 3 months; max. duration of continuous treatment 2 years.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#postmenopausalUrogenitalConditionsNotSuitableForVasomotorSymptomsOrOsteoporosisProphylaxis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/estring#PHP101944>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#postmenopausalUrogenitalConditionsNotSuitableForVasomotorSymptomsOrOsteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postmenopausal urogenital conditions (not suitable for vasomotor symptoms or osteoporosis prophylaxis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Postmenopausal urogenital conditions (not suitable for vasomotor symptoms or osteoporosis prophylaxis)

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "postmenopausal urogenital conditions (not suitable for vasomotor symptoms or osteoporosis prophylaxis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/etrivex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/etrivex#H2xb9AVkW0i4NWANQH6brg>;
                                                                        nicebnf:hasTitle """<title>Etrivex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "etrivex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/etrivex#H2xb9AVkW0i4NWANQH6brg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply once daily maximum duration of treatment 4 weeks, to be applied thinly then rinsed off after 15 minutes; frequency of application should be reduced after clinical improvement."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply once daily maximum duration of treatment 4 weeks, to be applied thinly then rinsed off after 15 minutes; frequency of application should be reduced after clinical improvement.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply once daily maximum duration of treatment 4 weeks, to be applied thinly then rinsed off after 15 minutes; frequency of application should be reduced after clinical improvement.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateScalpPsoriasis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/etrivex#PHP84403>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/etrivex#PHP84403> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateScalpPsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate scalp psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent """Moderate scalp psoriasis

"""^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                 rdfs:label "moderate scalp psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-cream#uvyfIWXngEiExdpLylkpJg>;
                                                                                        nicebnf:hasTitle """<title>Eucerin<tm tmtype=\"reg\" /> Intensive cream</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "eucerin intensive cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-cream#PHP106332> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-cream#uvyfIWXngEiExdpLylkpJg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                  rdfs:label "apply twice daily, to be applied thinly and rubbed into area."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly and rubbed into area.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Apply twice daily, to be applied thinly and rubbed into area.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "apply twice daily, to be applied thinly and rubbed into area."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly and rubbed into area.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """Apply twice daily, to be applied thinly and rubbed into area.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaIchthyosisXerodermaAndHyperkeratosis>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-cream#PHP106332>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaIchthyosisXerodermaAndHyperkeratosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema, ichthyosis, xeroderma, and hyperkeratosis</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Dry skin conditions including eczema, ichthyosis, xeroderma, and hyperkeratosis

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "dry skin conditions including eczema, ichthyosis, xeroderma, and hyperkeratosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-lotion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-lotion#13MXBAv5lEmxyTEu5Ln2yw>;
                                                                                         nicebnf:hasTitle """<title>Eucerin<tm tmtype=\"reg\" /> Intensive lotion</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "eucerin intensive lotion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-lotion#13MXBAv5lEmxyTEu5Ln2yw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                   rdfs:label "apply twice daily, to be applied sparingly and rubbed into area."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily, to be applied sparingly and rubbed into area.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """Apply twice daily, to be applied sparingly and rubbed into area.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "apply twice daily, to be applied sparingly and rubbed into area."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily, to be applied sparingly and rubbed into area.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """Apply twice daily, to be applied sparingly and rubbed into area.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaIchthyosisXerodermaAndHyperkeratosis>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-lotion#PHP105763>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/eucerin-intensive-lotion#PHP105763> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaIchthyosisXerodermaAndHyperkeratosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema, ichthyosis, xeroderma and hyperkeratosis</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Dry skin conditions including eczema, ichthyosis, xeroderma and hyperkeratosis

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "dry skin conditions including eczema, ichthyosis, xeroderma and hyperkeratosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-conti> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-conti#p5-gv5EL-k-uoqB5-qnpGw>;
                                                                             nicebnf:hasTitle """<title>Evorel<tm tmtype=\"reg\" /> Conti</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "evorel conti"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-conti#PHP96115> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-conti#p5-gv5EL-k-uoqB5-qnpGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply 1 patch twice weekly continuously."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply 1 patch twice weekly continuously.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-conti#PHP96115>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#yVh645b1AkWtaMlT27jCMQ>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#q1S5FAG0EUadObZYOtIhiw>;
                                                                             nicebnf:hasTitle """<title>Evorel<tm tmtype=\"reg\" /> Sequi</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "evorel sequi"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#PHP95902> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#PHP95982> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#q1S5FAG0EUadObZYOtIhiw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients and carers should be advised on the application of <i>Evorel</i><tm tmtype=\"reg\" /> Sequi patches.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#PHP95982>;
                                                                                                    nicebnf:hasTextContent """Patients and carers should be advised on the application of Evorel Sequi patches.

"""^^xsd:string;
                                                                                                    a nicebnf:GeneralPatientAdvice,
                                                                                                      nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#yVh645b1AkWtaMlT27jCMQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply 1 patch twice weekly for 2 weeks, evorel 50 patch to be applied and started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), then apply 1 patch twice weekly, evorel conti patch to be applied, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent """<p>Apply 1 patch twice weekly for 2 weeks, <i>Evorel</i><tm tmtype=\"reg\" /> 50 patch to be applied and started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), then apply 1 patch twice weekly, <i>Evorel</i><tm tmtype=\"reg\" /> Conti patch to be applied, subsequent courses are repeated without interval.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply 1 patch twice weekly for 2 weeks, Evorel 50 patch to be applied and started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), then apply 1 patch twice weekly, Evorel Conti patch to be applied, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel-sequi#PHP95902>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel#JJfRFU7qj0Om0y97Y8oTWg>;
                                                                       nicebnf:hasTitle """<title>Evorel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "evorel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel#JJfRFU7qj0Om0y97Y8oTWg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, therapy should be initiated with evorel 50 patch; subsequently adjust according to response; dose may be reduced to evorel 25 patch after first month if necessary for menopausal symptoms only."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, therapy should be initiated with <i>Evorel 50</i> patch; subsequently adjust according to response; dose may be reduced to <i>Evorel 25</i> patch after first month if necessary for menopausal symptoms <b>only</b>.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, therapy should be initiated with Evorel 50 patch; subsequently adjust according to response; dose may be reduced to Evorel 25 patch after first month if necessary for menopausal symptoms only.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel#PHP97666>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/evorel#PHP97666> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#07z8FLsdaU2h-qPongYCOg>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#hxeaVVY7ikWhVKIVMqfTVA>;
                                                                               nicebnf:hasTitle """<title>Exelon<tm tmtype=\"reg\" /> patches</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "exelon patches"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#07z8FLsdaU2h-qPongYCOg> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (October 2007) that <i>Exelon</i><tm tmtype=\"reg\" /> patches should be restricted for use in patients with moderately severe Alzheimer’s disease under the conditions of the NICE guidance (September 2007) and when a transdermal patch is an appropriate choice of formulation.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#PHP81254>;
                                                                                                      nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (October 2007) that Exelon patches should be restricted for use in patients with moderately severe Alzheimer’s disease under the conditions of the NICE guidance (September 2007) and when a transdermal patch is an appropriate choice of formulation.

"""^^xsd:string;
                                                                                                      a nicebnf:FundingDecision,
                                                                                                        nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#PHP81252> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#PHP81254> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#hxeaVVY7ikWhVKIVMqfTVA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Advise patients and carers of patch administration instructions, particularly to remove the previous day's patch before applying the new patch—consult product literature.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/exelon-patches#PHP81252>;
                                                                                                      nicebnf:hasTextContent """Advise patients and carers of patch administration instructions, particularly to remove the previous day's patch before applying the new patch—consult product literature.

"""^^xsd:string;
                                                                                                      a nicebnf:GeneralPatientAdvice,
                                                                                                        nicebnf:PatientAndCarerAdvice.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/exorex-lotion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/exorex-lotion#u21HES02cUOdynp8b_7dvQ>;
                                                                              nicebnf:hasTitle """<title>Exorex<tm tmtype=\"reg\" /> lotion</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "exorex lotion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exorex-lotion#PHP107137> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/exorex-lotion#u21HES02cUOdynp8b_7dvQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "apply 2–3 times a day, to be applied to skin or scalp. can be diluted with a few drops of water before applying."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Apply 2–3 times a day, to be applied to skin or scalp. Can be diluted with a few drops of water before applying.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Apply 2–3 times a day, to be applied to skin or scalp. Can be diluted with a few drops of water before applying.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/exorex-lotion#PHP107137>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#zI7yRJKhS0CRn5P7LUS_UQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#LppzB47EokG0_5W6bPLlIQ>;
                                                                        nicebnf:hasTitle """<title>Extavia<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "extavia"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#LppzB47EokG0_5W6bPLlIQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>An auto-injector device (<i>ExtaviPro<tm tmtype=\"reg\" /> 30G</i>) is supplied as part of the <i>ExtaviPro<tm tmtype=\"reg\" /> 30G</i> kit.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#PHP79478>;
                                                                                               nicebnf:hasTextContent """An auto-injector device (ExtaviPro 30G) is supplied as part of the ExtaviPro 30G kit.

"""^^xsd:string;
                                                                                               a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#PHP79448> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#PHP79478> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#zI7yRJKhS0CRn5P7LUS_UQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#forSecondaryProgressiveMultipleSclerosisWithActiveDisease>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/extavia#PHP79448>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forSecondaryProgressiveMultipleSclerosisWithActiveDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For secondary progressive multiple sclerosis with active disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """For secondary progressive multiple sclerosis with active disease

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "for secondary progressive multiple sclerosis with active disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#4uTlj86Y2kKelweX26ZQTg>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#WSP12LyBG0ueeIq7vWk98A>;
                                                                                   nicebnf:hasTitle """<title>Femoston<tm tmtype=\"reg\" /> 1 mg/10 mg</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "femoston 1 mg/10 mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#4uTlj86Y2kKelweX26ZQTg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval, femoston 1 mg/10 mg given initially and femoston 2 mg/ 10 mg substituted if symptoms not controlled."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent """<p>1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval, <i>Femoston<tm tmtype=\"reg\" /> 1 mg/10 mg</i> given initially and <i>Femoston<tm tmtype=\"reg\" /> 2 mg/ 10 mg</i> substituted if symptoms not controlled.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval, Femoston 1 mg/10 mg given initially and Femoston 2 mg/ 10 mg substituted if symptoms not controlled.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#PHP96458>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#PHP96458> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#WSP12LyBG0ueeIq7vWk98A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily for 14 days, white tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, grey tablet to be taken, subsequent courses repeated without interval.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-1-mg10-mg#PHP96458>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#IxyHPxd2Qk-38wyXWaA1WA>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#ZK0BETkXb0ukvKJvM8hPrA>;
                                                                                   nicebnf:hasTitle """<title>Femoston<tm tmtype=\"reg\" /> 2 mg/10 mg</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "femoston 2 mg/10 mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#IxyHPxd2Qk-38wyXWaA1WA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#PHP96500>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#PHP96500> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#ZK0BETkXb0ukvKJvM8hPrA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval, femoston 1 mg/10 mg given initially and femoston 2 mg/ 10 mg substituted if symptoms not controlled."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent """<p>1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval, <i>Femoston<tm tmtype=\"reg\" /> 1 mg/10 mg</i> given initially and <i>Femoston<tm tmtype=\"reg\" /> 2 mg/ 10 mg</i> substituted if symptoms not controlled.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily for 14 days, red tablet to be taken and started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), then 1 tablet daily for 14 days, yellow tablet to be taken, subsequent courses repeated without interval, Femoston 1 mg/10 mg given initially and Femoston 2 mg/ 10 mg substituted if symptoms not controlled.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-2-mg10-mg#PHP96500>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-05-mg25mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-05-mg25mg#WFIxJsZp80CNspAhT3Wo0w>;
                                                                                         nicebnf:hasTitle """<title>Femoston<tm tmtype=\"reg\" />-conti 0.5 mg/2.5mg</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "femoston-conti 0.5 mg/2.5mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-05-mg25mg#PHP95906> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-05-mg25mg#WFIxJsZp80CNspAhT3Wo0w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "1 tablet daily continuously, if changing from cyclical hrt begin treatment the day after finishing oestrogen plus progestogen phase."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """1 tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-05-mg25mg#PHP95906>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-1-mg5mg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-1-mg5mg#u0tAU4Bj3U28N1NbqUU2Sg>;
                                                                                       nicebnf:hasTitle """<title>Femoston<tm tmtype=\"reg\" />-conti 1 mg/5mg</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "femoston-conti 1 mg/5mg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-1-mg5mg#PHP96067> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-1-mg5mg#u0tAU4Bj3U28N1NbqUU2Sg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 tablet daily continuously, if changing from cyclical hrt begin treatment the day after finishing oestrogen plus progestogen phase."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 tablet daily continuously, if changing from cyclical HRT begin treatment the day after finishing oestrogen plus progestogen phase.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femoston-conti-1-mg5mg#PHP96067>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-conti> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-conti#HxQtvvptTU-DpXg_14mazw>;
                                                                               nicebnf:hasTitle """<title>FemSeven Conti<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "femseven conti"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-conti#HxQtvvptTU-DpXg_14mazw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply 1 patch once weekly continuously."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply 1 patch once weekly continuously.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply 1 patch once weekly continuously.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-conti#PHP104664>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-conti#PHP104664> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-sequi> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-sequi#XlCJxAgtHE-Cgxs_KG10_A>;
                                                                               nicebnf:hasTitle """<title>FemSeven Sequi<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "femseven sequi"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-sequi#PHP106721> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-sequi#XlCJxAgtHE-Cgxs_KG10_A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply 1 patch once weekly for 2 weeks, phase 1 patches to be applied, then apply 1 patch once weekly for 2 weeks, phase 2 patches to be applied, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply 1 patch once weekly for 2 weeks, phase 1 patches to be applied, then apply 1 patch once weekly for 2 weeks, phase 2 patches to be applied, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply 1 patch once weekly for 2 weeks, phase 1 patches to be applied, then apply 1 patch once weekly for 2 weeks, phase 2 patches to be applied, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven-sequi#PHP106721>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven#MrTErTfFgU2K985Yk1wTXw>;
                                                                         nicebnf:hasTitle """<title>FemSeven<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "femseven"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven#MrTErTfFgU2K985Yk1wTXw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1 patch once weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with femseven 50 patches for the first few months, subsequently adjust according to response."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1 patch once weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>FemSeven 50</i> patches for the first few months, subsequently adjust according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1 patch once weekly continuously, to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with FemSeven 50 patches for the first few months, subsequently adjust according to response.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven#PHP97717>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/femseven#PHP97717> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fenbid-forte> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fenbid-forte#_SkYPgPltEe98uPlzz0T9w>;
                                                                             nicebnf:hasTitle """<title>Fenbid<tm tmtype=\"reg\" /> Forte</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "fenbid forte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fenbid-forte#PHP84083> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fenbid-forte#_SkYPgPltEe98uPlzz0T9w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply up to 4 times a day, therapy should be reviewed after 14 days."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply up to 4 times a day, therapy should be reviewed after 14 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply up to 4 times a day, therapy should be reviewed after 14 days.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#painReliefInMusculoskeletalConditions>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#treatmentInKneeOrHandOsteoarthritisAdjunct>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fenbid-forte#PHP84083>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#painReliefInMusculoskeletalConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain relief in musculoskeletal conditions</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Pain relief in musculoskeletal conditions

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "pain relief in musculoskeletal conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentInKneeOrHandOsteoarthritisAdjunct> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment in knee or hand osteoarthritis (adjunct)</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Treatment in knee or hand osteoarthritis (adjunct)

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "treatment in knee or hand osteoarthritis (adjunct)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fendrix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fendrix#lkgJX0b75k2zKd8GD3GkLA>;
                                                                        nicebnf:hasTitle """<title>Fendrix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "fendrix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fendrix#PHP81761> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fendrix#lkgJX0b75k2zKd8GD3GkLA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                  rdfs:label "20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """20 micrograms every 1 month for 3 months, followed by 20 micrograms after 4 months for 1 dose, immunisation schedule and booster doses may need to be adjusted in those with low antibody concentration, deltoid muscle is preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingPreHaemodialysisAndHaemodialysisPatients>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fendrix#PHP81761>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionInRenalInsufficiencyIncludingPreHaemodialysisAndHaemodialysisPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection in renal insufficiency (including pre-haemodialysis and haemodialysis patients)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                      nicebnf:hasTextContent """Immunisation against hepatitis B infection in renal insufficiency (including pre-haemodialysis and haemodialysis patients)

"""^^xsd:string;
                                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                      rdfs:label "immunisation against hepatitis b infection in renal insufficiency (including pre-haemodialysis and haemodialysis patients)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/feospan> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/feospan#VXQwGfTwO0WcZmDAxCFVkg>;
                                                                        nicebnf:hasTitle """<title>Feospan<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "feospan"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/feospan#PHP81037> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/feospan#VXQwGfTwO0WcZmDAxCFVkg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                  rdfs:label "1 capsule daily, capsule can be opened and sprinkled on food."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 capsule daily, capsule can be opened and sprinkled on food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 capsule daily, capsule can be opened and sprinkled on food.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1–2 capsules daily, capsule can be opened and sprinkled on food."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1–2 capsules daily, capsule can be opened and sprinkled on food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1–2 capsules daily, capsule can be opened and sprinkled on food.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemia>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/feospan#PHP81037>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Iron-deficiency anaemia

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "iron-deficiency anaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ferrograd> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ferrograd#lJwIsf9Az0C-51gUpVHyIA>;
                                                                          nicebnf:hasTitle """<title>Ferrograd<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "ferrograd"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ferrograd#PHP81069> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ferrograd#lJwIsf9Az0C-51gUpVHyIA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                    rdfs:label "1 tablet daily, dose to be taken before food."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 tablet daily, dose to be taken before food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 tablet daily, dose to be taken before food.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1 tablet daily, dose to be taken before food."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 tablet daily, dose to be taken before food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 tablet daily, dose to be taken before food.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylacticAndTherapeutic>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ferrograd#PHP81069>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylacticAndTherapeutic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (prophylactic and therapeutic)</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Iron-deficiency anaemia (prophylactic and therapeutic)

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "iron-deficiency anaemia (prophylactic and therapeutic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#qAzYzXXeI02jocCwuP1R_Q>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#sH2COeH4BkSZ-jwg0t8-5Q>;
                                                                         nicebnf:hasTitle """<title>Fersaday<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "fersaday"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#PHP81100> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#qAzYzXXeI02jocCwuP1R_Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "322 mg twice daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>322 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """322 mg twice daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#PHP81100>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#sH2COeH4BkSZ-jwg0t8-5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "322 mg daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>322 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """322 mg daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fersaday#PHP81100>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (prophylactic)</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Iron-deficiency anaemia (prophylactic)

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "iron-deficiency anaemia (prophylactic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (therapeutic)</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Iron-deficiency anaemia (therapeutic)

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "iron-deficiency anaemia (therapeutic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#Hh3VhTLGiEGRA_0_XYX_Xw>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#LMxkRUfyxkyYMBEwj808fQ>;
                                                                        nicebnf:hasTitle """<title>Finacea<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "finacea"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#Hh3VhTLGiEGRA_0_XYX_Xw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply twice daily, discontinue if no improvement after 2 months."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily, discontinue if no improvement after 2 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply twice daily, discontinue if no improvement after 2 months.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#papulopustularRosacea>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#PHP81955>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#LMxkRUfyxkyYMBEwj808fQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                  rdfs:label "apply twice daily, discontinue if no improvement after 1 month."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily, discontinue if no improvement after 1 month.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply twice daily, discontinue if no improvement after 1 month.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply twice daily, discontinue if no improvement after 1 month."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily, discontinue if no improvement after 1 month.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply twice daily, discontinue if no improvement after 1 month.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#facialAcneVulgaris>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#PHP81955>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/finacea#PHP81955> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#facialAcneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Facial acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Facial acne vulgaris

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "facial acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#papulopustularRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Papulopustular rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Papulopustular rosacea

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "papulopustular rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flebogamma-dif> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/flebogamma-dif#ALDmasoYP0KUTa7PLGM5ig>;
                                                                               nicebnf:hasTitle """<title>Flebogamma<tm tmtype=\"reg\" /> DIF</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "flebogamma dif"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flebogamma-dif#ALDmasoYP0KUTa7PLGM5ig> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#hereditaryFructoseIntoleranceContainsSorbitol>;
                                                                                                      nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Hereditary fructose intolerance (contains sorbitol)</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flebogamma-dif#PHP98048>;
                                                                                                      nicebnf:hasTextContent """Hereditary fructose intolerance (contains sorbitol)

"""^^xsd:string;
                                                                                                      a nicebnf:ContraindicationsGroup,
                                                                                                        nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flebogamma-dif#PHP98048> a nicebnf:ContraIndications.
<http://ld.nice.org.uk/ns/bnf/Contraindication#hereditaryFructoseIntoleranceContainsSorbitol> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Hereditary fructose intolerance (contains sorbitol)</ph>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent "Hereditary fructose intolerance (contains sorbitol)"^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                              rdfs:label "hereditary fructose intolerance (contains sorbitol)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleet-ready-to-use-enema> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleet-ready-to-use-enema#1sViovFSi0mYb7gnaijrvA>;
                                                                                         nicebnf:hasTitle """<title>Fleet<tm tmtype=\"reg\" /> ready-to-use enema</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "fleet ready-to-use enema"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleet-ready-to-use-enema#1sViovFSi0mYb7gnaijrvA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "118 ml."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>118 mL.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """118 mL.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeAbdominalRadiologicalProcedures>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeEndoscopy>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeSurgery>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleet-ready-to-use-enema#PHP96864>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleet-ready-to-use-enema#PHP96864> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeAbdominalRadiologicalProcedures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before abdominal radiological procedures</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasTextContent """Bowel evacuation before abdominal radiological procedures

"""^^xsd:string;
                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                               rdfs:label "bowel evacuation before abdominal radiological procedures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeEndoscopy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before endoscopy</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Bowel evacuation before endoscopy

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "bowel evacuation before endoscopy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before surgery</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Bowel evacuation before surgery

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "bowel evacuation before surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#601S6QCWfk2MsUL9pG778Q>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#5gMsBdYKnkORgSqs2jon3w>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#Emui1bC5bkuWL2Xiwl02cQ>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#Gt9mfrsP3UCyXnVJpZ702A>;
                                                                                  nicebnf:hasTitle """<title>Fleet<tm tmtype=\"reg\" />phospho-soda</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "fleetphospho-soda"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#5gMsBdYKnkORgSqs2jon3w> nicebnf:hasDitaContent """<section outputclass=\"pharmacokinetics\">
  <title>Pharmacokinetics</title>
  <p>Onset of action is within half to 6 hours of first dose.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96984>;
                                                                                                         nicebnf:hasTextContent """PharmacokineticsOnset of action is within half to 6 hours of first dose.

"""^^xsd:string;
                                                                                                         a nicebnf:IndicationsAndDoseSection,
                                                                                                           nicebnf:Pharmacokinetics.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#601S6QCWfk2MsUL9pG778Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "45 ml twice daily, each dose must be diluted with half a glass (120 ml) of cold water, followed by one full glass (240 ml) of cold water, timing of doses is dependent on the time of the procedure, for morning procedure, the first dose should be taken at 7 a.m. and second at 7 p.m. on day before the procedure.; for afternoon procedure, first dose should be taken at 7 p.m. on day before and second dose at 7 a.m. on day of the procedure."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>45 mL twice daily, each dose must be diluted with half a glass (120 mL) of cold water, followed by one full glass (240 mL) of cold water, timing of doses is dependent on the time of the procedure, for morning procedure, the first dose should be taken at 7 a.m. and second at 7 p.m. on day before the procedure.; for afternoon procedure, first dose should be taken at 7 p.m. on day before and second dose at 7 a.m. on day of the procedure.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """45 mL twice daily, each dose must be diluted with half a glass (120 mL) of cold water, followed by one full glass (240 mL) of cold water, timing of doses is dependent on the time of the procedure, for morning procedure, the first dose should be taken at 7 a.m. and second at 7 p.m. on day before the procedure.; for afternoon procedure, first dose should be taken at 7 p.m. on day before and second dose at 7 a.m. on day of the procedure.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeColonicSurgery>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeColonoscopy>,
                                                                                                                               <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeRadiologicalExamination>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96984>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#Emui1bC5bkuWL2Xiwl02cQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Intake of solid food should be stopped for at least 6 hours before starting treatment and until procedure completed.</p>
  <p>Patients or carers should be advised that adequate hydration should be maintained during treatment.</p>
  <p>Patients or carers should be given advice on administration of <i>Fleet Phospho-soda</i><tm tmtype=\"reg\" /> oral solution.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96994>;
                                                                                                         nicebnf:hasTextContent """Intake of solid food should be stopped for at least 6 hours before starting treatment and until procedure completed.

Patients or carers should be advised that adequate hydration should be maintained during treatment.

Patients or carers should be given advice on administration of Fleet Phospho-soda oral solution.

"""^^xsd:string;
                                                                                                         a nicebnf:GeneralPatientAdvice,
                                                                                                           nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#Gt9mfrsP3UCyXnVJpZ702A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Copious intake of water or other clear fluids (e.g. clear soup, strained fruit juice without pulp, black tea or coffee) recommended until midnight before morning procedure and until 8 a.m. before afternoon procedure. At least one glass (approx 240 mL) of water or other clear fluid should also be taken immediately before each dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96992>;
                                                                                                         nicebnf:hasTextContent """Copious intake of water or other clear fluids (e.g. clear soup, strained fruit juice without pulp, black tea or coffee) recommended until midnight before morning procedure and until 8 a.m. before afternoon procedure. At least one glass (approx 240 mL) of water or other clear fluid should also be taken immediately before each dose.

"""^^xsd:string;
                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96984> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96992> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fleetphospho-soda#PHP96994> a nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeColonicSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before colonic surgery</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Bowel evacuation before colonic surgery

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "bowel evacuation before colonic surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeColonoscopy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before colonoscopy</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Bowel evacuation before colonoscopy

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "bowel evacuation before colonoscopy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationBeforeRadiologicalExamination> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation before radiological examination</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Bowel evacuation before radiological examination

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "bowel evacuation before radiological examination"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-300> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-300#MqTh0Bm8LUWu2iecyHywNQ>;
                                                                            nicebnf:hasTitle """<title>Flexi-T<tm tmtype=\"reg\" /> 300</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "flexi-t 300"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-300#MqTh0Bm8LUWu2iecyHywNQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length over 5 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-300#PHP105486>;
                                                                                                   nicebnf:hasTextContent """For uterine length over 5 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                   a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-300#PHP105486> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-380> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-380#XcNdlNcyo0eNQ6zRapAs5A>;
                                                                            nicebnf:hasTitle """<title>Flexi-T<tm tmtype=\"reg\" />+ 380</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "flexi-t+ 380"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-380#PHP105585> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-380#XcNdlNcyo0eNQ6zRapAs5A> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length over 6 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexi-t-380#PHP105585>;
                                                                                                   nicebnf:hasTextContent """For uterine length over 6 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                   a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexitol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexitol#sXasmib5iUqQIhDg27O0Mg>;
                                                                         nicebnf:hasTitle """<title>Flexitol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "flexitol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexitol#PHP105762> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flexitol#sXasmib5iUqQIhDg27O0Mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                   rdfs:label "apply 1–2 times a day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1–2 times a day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinOnSolesOfFeetAndHeels>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flexitol#PHP105762>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinOnSolesOfFeetAndHeels> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin on soles of feet and heels</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Dry skin on soles of feet and heels

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "dry skin on soles of feet and heels"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#9xzACJUlREiNXW9tnKs2EA>,
                                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#XHH7lfWCgEW4ozCdvG4UGw>;
                                                                              nicebnf:hasTitle """<title>Fluarix tetra<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "fluarix tetra"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#9xzACJUlREiNXW9tnKs2EA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Ovalbumin content less than 100 nanograms/mL.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#PHP97995>;
                                                                                                     nicebnf:hasTextContent """Ovalbumin content less than 100 nanograms/mL.

"""^^xsd:string;
                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#PHP97970> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#PHP97995> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#XHH7lfWCgEW4ozCdvG4UGw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Not licensed for use in children under 3 years of age.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluarix-tetra#PHP97970>;
                                                                                                     nicebnf:hasTextContent """Not licensed for use in children under 3 years of age.

"""^^xsd:string;
                                                                                                     a nicebnf:UnlicencedUse.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#q2r3mhR08026vTlgSuw5aw>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#3fGFmmJOVU2yOjDJStmVVA>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#Cxsq_Uq--UKlqwCPBA9KBg>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#i-iRUReID0KdMLenK4CY-g>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#lOzkzAbjEk6IzlmllaC_rQ>;
                                                                             nicebnf:hasTitle """<title>Fluenz Tetra<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "fluenz tetra"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#3fGFmmJOVU2yOjDJStmVVA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid antivirals for at least 2 weeks after immunisation; avoid immunisation for at least 48 hours after stopping the antiviral.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97807>;
                                                                                                    nicebnf:hasTextContent """Avoid antivirals for at least 2 weeks after immunisation; avoid immunisation for at least 48 hours after stopping the antiviral.

"""^^xsd:string;
                                                                                                    nicebnf:hasTitle "Concomitant use with antivirals"^^xsd:string;
                                                                                                    a nicebnf:ImportantAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#Cxsq_Uq--UKlqwCPBA9KBg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid in pregnancy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97854>;
                                                                                                    nicebnf:hasTextContent """Avoid in pregnancy.

"""^^xsd:string;
                                                                                                    a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97807> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97854> a nicebnf:Pregnancy.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97859> a nicebnf:BreastFeeding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97902> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#i-iRUReID0KdMLenK4CY-g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid in breast-feeding.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97859>;
                                                                                                    nicebnf:hasTextContent """Avoid in breast-feeding.

"""^^xsd:string;
                                                                                                    a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#lOzkzAbjEk6IzlmllaC_rQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid close contact with severely immunocompromised patients for 1–2 weeks after vaccination.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97902>;
                                                                                                    nicebnf:hasTextContent """Avoid close contact with severely immunocompromised patients for 1–2 weeks after vaccination.

"""^^xsd:string;
                                                                                                    a nicebnf:GeneralPatientAdvice,
                                                                                                      nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#q2r3mhR08026vTlgSuw5aw> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#activeWheezing>,
                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Contraindication#concomitantUseWithAntiviralTherapyForInfluenza>,
                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Contraindication#severeAsthma>;
                                                                                                    nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Active wheezing</ph>; <ph outputclass=\"contraindication\">concomitant use with antiviral therapy for influenza</ph>; <ph outputclass=\"contraindication\">severe asthma</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluenz-tetra#PHP97807>;
                                                                                                    nicebnf:hasTextContent """Active wheezing; concomitant use with antiviral therapy for influenza; severe asthma

"""^^xsd:string;
                                                                                                    a nicebnf:ContraindicationsGroup,
                                                                                                      nicebnf:GeneralContraindications.
<http://ld.nice.org.uk/ns/bnf/Contraindication#activeWheezing> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Active wheezing</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "Active wheezing"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                               rdfs:label "active wheezing"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Contraindication#concomitantUseWithAntiviralTherapyForInfluenza> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">concomitant use with antiviral therapy for influenza</ph>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasTextContent "concomitant use with antiviral therapy for influenza"^^xsd:string;
                                                                                               a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                               rdfs:label "concomitant use with antiviral therapy for influenza"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Contraindication#severeAsthma> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">severe asthma</ph>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent "severe asthma"^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                             rdfs:label "severe asthma"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-125> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-125#QvpE2O7HN0uWPH7Oxei6kw>;
                                                                              nicebnf:hasTitle """<title>Flutiform<tm tmtype=\"reg\" /> 125</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "flutiform 125"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-125#PHP102168> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-125#QvpE2O7HN0uWPH7Oxei6kw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                        rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-125#PHP102168>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-250> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-250#axgjZuPD_Eei1S7RK_S4uw>;
                                                                              nicebnf:hasTitle """<title>Flutiform<tm tmtype=\"reg\" /> 250</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "flutiform 250"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-250#PHP102189> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-250#axgjZuPD_Eei1S7RK_S4uw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-250#PHP102189>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-50> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-50#4_gyLZQxgUKgTpyLdye0bA>;
                                                                             nicebnf:hasTitle """<title>Flutiform<tm tmtype=\"reg\" /> 50</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "flutiform 50"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-50#4_gyLZQxgUKgTpyLdye0bA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-50#PHP101939>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/flutiform-50#PHP101939> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluvirin> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluvirin#zyB-K2Ef5kG3lZC2PYiN2w>;
                                                                         nicebnf:hasTitle """<title>Fluvirin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "fluvirin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluvirin#PHP97871> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fluvirin#zyB-K2Ef5kG3lZC2PYiN2w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Not licensed for use in children under 4 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fluvirin#PHP97871>;
                                                                                                nicebnf:hasTextContent """Not licensed for use in children under 4 years.

"""^^xsd:string;
                                                                                                a nicebnf:UnlicencedUse.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#uNm5z7xFbUKvgAo1MpmDGw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#N__-KH9V6UO9svhXJYeyxw>;
                                                                                nicebnf:hasTitle """<title>Fortipine<tm tmtype=\"reg\" /> LA 40</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "fortipine la 40"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#N__-KH9V6UO9svhXJYeyxw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Take with or just after food, or a meal.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#PHP61283>;
                                                                                                       nicebnf:hasTextContent """Take with or just after food, or a meal.

"""^^xsd:string;
                                                                                                       a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#PHP61283> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#PHP61618> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#uNm5z7xFbUKvgAo1MpmDGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "initially 40 mg once daily, increased if necessary to 80 mg daily in 1–2 divided doses."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 40 mg once daily, increased if necessary to 80 mg daily in 1–2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 40 mg once daily, increased if necessary to 80 mg daily in 1–2 divided doses.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fortipine-la-40#PHP61618>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#bB61iuGN0UenEuDoZgvzug>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#fy_oBrG5EUOg6xXjxnzouw>;
                                                                                           nicebnf:hasTitle """<title>Fragmin<tm tmtype=\"reg\" /> graduated syringes</title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "fragmin graduated syringes"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#PHP59384> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#bB61iuGN0UenEuDoZgvzug> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for up to 8 days."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for up to 8 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for up to 8 days.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#unstableCoronaryArteryDiseaseIncludingNonStSegmentElevationMyocardialInfarction>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#PHP59384>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#fy_oBrG5EUOg6xXjxnzouw> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#patientsWithUnstableCoronaryArteryDiseaseIncludingNonStSegmentElevationMyocardialInfarctionAwaitingAngiographyOrRevascularisationAndHavingAlreadyHad8DaysTreatmentWithDalteparin>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-graduated-syringes#PHP59384>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#patientsWithUnstableCoronaryArteryDiseaseIncludingNonStSegmentElevationMyocardialInfarctionAwaitingAngiographyOrRevascularisationAndHavingAlreadyHad8DaysTreatmentWithDalteparin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Patients with unstable coronary artery disease (including non-ST-segment-elevation myocardial infarction) awaiting angiography or revascularisation and having already had 8 days treatment with dalteparin</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                           nicebnf:hasTextContent """Patients with unstable coronary artery disease (including non-ST-segment-elevation myocardial infarction) awaiting angiography or revascularisation and having already had 8 days treatment with dalteparin

"""^^xsd:string;
                                                                                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                           rdfs:label "patients with unstable coronary artery disease (including non-st-segment-elevation myocardial infarction) awaiting angiography or revascularisation and having already had 8 days treatment with dalteparin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#unstableCoronaryArteryDiseaseIncludingNonStSegmentElevationMyocardialInfarction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Unstable coronary artery disease (including non-ST-segment-elevation myocardial infarction)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Unstable coronary artery disease (including non-ST-segment-elevation myocardial infarction)

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "unstable coronary artery disease (including non-st-segment-elevation myocardial infarction)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#-NmEW6ZUW0KVR8JY67LL5Q>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#2PMCZe9QkUa3dP6pjlV16Q>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#M1NCnpygokC7zRcopY9OCw>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#UuBgljnOskePRKMKaiAiIw>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#b0J4Ej_yIkuP9mu3IbJKzA>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#eAiLY_KiskKMR-xIW35fPA>;
                                                                                             nicebnf:hasTitle """<title>Fragmin<tm tmtype=\"reg\" /> single-dose syringes</title>"""^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "fragmin single-dose syringes"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#-NmEW6ZUW0KVR8JY67LL5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 2500 units for 1 dose, dose to be given 1–2 hours before surgery, then 2500 units every 24 hours."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 2500 units for 1 dose, dose to be given 1–2 hours before surgery, then 2500 units every 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 2500 units for 1 dose, dose to be given 1–2 hours before surgery, then 2500 units every 24 hours.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInSurgicalPatientsModerateRisk>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#2PMCZe9QkUa3dP6pjlV16Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "5000 units every 24 hours."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>5000 units every 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """5000 units every 24 hours.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInMedicalPatients>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#M1NCnpygokC7zRcopY9OCw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight4045Kg> ; 
                                                                                                                                       rdfs:label "7500 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>7500 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """7500 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight4656Kg> ; 
                                                                                                                                       rdfs:label "10 000 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>10 000 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """10 000 units once daily for 30 days, then 7500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5768Kg> ; 
                                                                                                                                       rdfs:label "12 500 units once daily for 30 days, then 10 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>12 500 units once daily for 30 days, then 10 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """12 500 units once daily for 30 days, then 10 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6982Kg> ; 
                                                                                                                                       rdfs:label "15 000 units once daily for 30 days, then 12 500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>15 000 units once daily for 30 days, then 12 500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """15 000 units once daily for 30 days, then 12 500 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight8398Kg> ; 
                                                                                                                                       rdfs:label "18 000 units once daily for 30 days, then 15 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>18 000 units once daily for 30 days, then 15 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """18 000 units once daily for 30 days, then 15 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight99KgAndAbove> ; 
                                                                                                                                       rdfs:label "18 000 units once daily for 30 days, then 18 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>18 000 units once daily for 30 days, then 18 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """18 000 units once daily for 30 days, then 18 000 units once daily for a further 5 months, interrupt treatment or reduce dose in chemotherapy-induced thrombocytopenia—consult product literature.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#extendedTreatmentAndProphylaxisOfVenousThromboembolismInPatientsWithSolidTumours>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#UuBgljnOskePRKMKaiAiIw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> ; 
                                                                                                                                       rdfs:label "5000 units twice daily, use body-weight in early pregnancy to calculate the dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>5000 units twice daily, use body-weight in early pregnancy to calculate the dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """5000 units twice daily, use body-weight in early pregnancy to calculate the dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5069Kg> ; 
                                                                                                                                       rdfs:label "6000 units twice daily, use body-weight in early pregnancy to calculate the dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>6000 units twice daily, use body-weight in early pregnancy to calculate the dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """6000 units twice daily, use body-weight in early pregnancy to calculate the dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight7089Kg> ; 
                                                                                                                                       rdfs:label "8000 units twice daily, use body-weight in early pregnancy to calculate the dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>8000 units twice daily, use body-weight in early pregnancy to calculate the dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """8000 units twice daily, use body-weight in early pregnancy to calculate the dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight90KgAndAbove> ; 
                                                                                                                                       rdfs:label "10 000 units twice daily, use body-weight in early pregnancy to calculate the dose."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>10 000 units twice daily, use body-weight in early pregnancy to calculate the dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """10 000 units twice daily, use body-weight in early pregnancy to calculate the dose.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfVenousThromboembolismInPregnancy>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#b0J4Ej_yIkuP9mu3IbJKzA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 2500 units for 1 dose, dose to be administered 1–2 hours before surgery, followed by 2500 units after 8–12 hours, then 5000 units every 24 hours, alternatively initially 5000 units for 1 dose, dose to be given on the evening before surgery, followed by 5000 units after 24 hours, then 5000 units every 24 hours."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 2500 units for 1 dose, dose to be administered 1–2 hours before surgery, followed by 2500 units after 8–12 hours, then 5000 units every 24 hours, alternatively initially 5000 units for 1 dose, dose to be given on the evening before surgery, followed by 5000 units after 24 hours, then 5000 units every 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 2500 units for 1 dose, dose to be administered 1–2 hours before surgery, followed by 2500 units after 8–12 hours, then 5000 units every 24 hours, alternatively initially 5000 units for 1 dose, dose to be given on the evening before surgery, followed by 5000 units after 24 hours, then 5000 units every 24 hours.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInSurgicalPatientsHighRisk>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#eAiLY_KiskKMR-xIW35fPA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo45Kg> ; 
                                                                                                                                       rdfs:label "7500 units daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>7500 units daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """7500 units daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight4656Kg> ; 
                                                                                                                                       rdfs:label "10 000 units daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>10 000 units daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """10 000 units daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5768Kg> ; 
                                                                                                                                       rdfs:label "12 500 units daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>12 500 units daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """12 500 units daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6982Kg> ; 
                                                                                                                                       rdfs:label "15 000 units daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>15 000 units daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """15 000 units daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight83KgAndAbove> ; 
                                                                                                                                       rdfs:label "18 000 units daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>18 000 units daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """18 000 units daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatment>,
                                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatment>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin-single-dose-syringes#PHP59719>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#extendedTreatmentAndProphylaxisOfVenousThromboembolismInPatientsWithSolidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                                                           nicebnf:hasTextContent """Extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours

"""^^xsd:string;
                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                           rdfs:label "extended treatment and prophylaxis of venous thromboembolism in patients with solid tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInMedicalPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in medical patients</p>"""^^<rdf:XMLLiteral>;
                                                                                           nicebnf:hasTextContent """Prophylaxis of deep-vein thrombosis in medical patients

"""^^xsd:string;
                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                           rdfs:label "prophylaxis of deep-vein thrombosis in medical patients"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInSurgicalPatientsHighRisk> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in surgical patients—high risk</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Prophylaxis of deep-vein thrombosis in surgical patients—high risk

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "prophylaxis of deep-vein thrombosis in surgical patients—high risk"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisInSurgicalPatientsModerateRisk> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis in surgical patients—moderate risk</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Prophylaxis of deep-vein thrombosis in surgical patients—moderate risk

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "prophylaxis of deep-vein thrombosis in surgical patients—moderate risk"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis, with oral anticoagulant treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasTextContent """Treatment of deep-vein thrombosis, with oral anticoagulant treatment

"""^^xsd:string;
                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                      rdfs:label "treatment of deep-vein thrombosis, with oral anticoagulant treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of pulmonary embolism, with oral anticoagulant treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Treatment of pulmonary embolism, with oral anticoagulant treatment

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "treatment of pulmonary embolism, with oral anticoagulant treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfVenousThromboembolismInPregnancy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of venous thromboembolism in pregnancy</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Treatment of venous thromboembolism in pregnancy

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "treatment of venous thromboembolism in pregnancy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight4045Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 40–45 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight4656Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 46–56 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5069Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 50–69 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5768Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 57–68 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6982Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 69–82 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight7089Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 70–89 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight8398Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 83–98 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight83KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 83 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight90KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 90 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight99KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 99 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo45Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 45 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 49 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#BjH5r4MAYEy7_iiwjPuWIQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#S8MOyc-j4EGUFXh1Orsg2A>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#fDpOdspgYEC0rfIPI0XNyg>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#rJVXRx5Eb0-QtfavhEiUiA>;
                                                                        nicebnf:hasTitle """<title>Fragmin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "fragmin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#BjH5r4MAYEy7_iiwjPuWIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "100 units/kg twice daily until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>100 units/kg twice daily until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """100 units/kg twice daily until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatmentInPatientsAtIncreasedRiskOfHaemorrhage>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatmentInPatientsAtIncreaseRiskOfHaemorrhage>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#PHP59683>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#PHP59683> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#S8MOyc-j4EGUFXh1Orsg2A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheDeviceAsAFlush>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfClottingInExtracorporealCircuits>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#PHP59683>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#fDpOdspgYEC0rfIPI0XNyg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for 5–8 days."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for 5–8 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """120 units/kg every 12 hours (max. per dose 10 000 units twice daily) for 5–8 days.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#unstableCoronaryArteryDisease>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#PHP59683>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#rJVXRx5Eb0-QtfavhEiUiA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "200 units/kg daily (max. per dose 18 000 units) until adequate oral anticoagulation established."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>200 units/kg daily (max. per dose 18 000 units) until adequate oral anticoagulation established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """200 units/kg daily (max. per dose 18 000 units) until adequate oral anticoagulation established.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatment>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatment>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fragmin#PHP59683>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfClottingInExtracorporealCircuits> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of clotting in extracorporeal circuits</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Prevention of clotting in extracorporeal circuits

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "prevention of clotting in extracorporeal circuits"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis, with oral anticoagulant treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasTextContent """Treatment of deep-vein thrombosis, with oral anticoagulant treatment

"""^^xsd:string;
                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                      rdfs:label "treatment of deep-vein thrombosis, with oral anticoagulant treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosisWithOralAnticoagulantTreatmentInPatientsAtIncreasedRiskOfHaemorrhage> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis, with oral anticoagulant treatment (in patients at increased risk of haemorrhage)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                            nicebnf:hasTextContent """Treatment of deep-vein thrombosis, with oral anticoagulant treatment (in patients at increased risk of haemorrhage)

"""^^xsd:string;
                                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                            rdfs:label "treatment of deep-vein thrombosis, with oral anticoagulant treatment (in patients at increased risk of haemorrhage)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of pulmonary embolism, with oral anticoagulant treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Treatment of pulmonary embolism, with oral anticoagulant treatment

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "treatment of pulmonary embolism, with oral anticoagulant treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolismWithOralAnticoagulantTreatmentInPatientsAtIncreaseRiskOfHaemorrhage> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of pulmonary embolism, with oral anticoagulant treatment (in patients at increase risk of haemorrhage)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Treatment of pulmonary embolism, with oral anticoagulant treatment (in patients at increase risk of haemorrhage)

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "treatment of pulmonary embolism, with oral anticoagulant treatment (in patients at increase risk of haemorrhage)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#unstableCoronaryArteryDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Unstable coronary artery disease</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Unstable coronary artery disease

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "unstable coronary artery disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheDeviceAsAFlush> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                               rdfs:label "to the device as a flush"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#uSCvEFD-NE-ACe71HFd2Zw>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#5Y5vDxgoHEGMf64CUYQH_g>;
                                                                          nicebnf:hasTitle """<title>Fungizone<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "fungizone"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#5Y5vDxgoHEGMf64CUYQH_g> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <b>Amphotericin (as sodium deoxycholate complex)</b>
  </p>
  <p>For <i>intravenous infusion</i> (<i>Fungizone</i><tm tmtype=\"reg\" />), give intermittently <i>in</i> Glucose 5%. Reconstitute each vial with 10 mL water of injections and shake immediately to produce a 5 mg/mL colloidal solution; dilute further in infusion fluid to a concentration of 100 micrograms/mL; pH of the glucose must not be below 4.2 (check each container—consult product literature for details of the buffer); infuse over 2–4 hours, or longer if not tolerated (initial test dose of 1 mg over 20–30 minutes); begin infusion immediately after dilution; protect from light; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or use separate line; an in-line filter (pore size no less than 1 micron) may be used.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#PHP83524>;
                                                                                                 nicebnf:hasTextContent """Amphotericin (as sodium deoxycholate complex)

For intravenous infusion (Fungizone), give intermittently in Glucose 5%. Reconstitute each vial with 10 mL water of injections and shake immediately to produce a 5 mg/mL colloidal solution; dilute further in infusion fluid to a concentration of 100 micrograms/mL; pH of the glucose must not be below 4.2 (check each container—consult product literature for details of the buffer); infuse over 2–4 hours, or longer if not tolerated (initial test dose of 1 mg over 20–30 minutes); begin infusion immediately after dilution; protect from light; incompatible with sodium chloride solutions, flush existing intravenous line with glucose 5% or use separate line; an in-line filter (pore size no less than 1 micron) may be used.

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#PHP83510> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#PHP83524> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#uSCvEFD-NE-ACe71HFd2Zw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "test dose 1 mg, to be given over 20–30 minutes, then 250 micrograms/kg daily, gradually increased over 2–4 days, increased if tolerated to 1 mg/kg daily, max. (severe infection) 1.5 mg/kg daily or on alternate days. prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250 micrograms/kg daily and increase gradually."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Test dose 1 mg, to be given over 20–30 minutes, then 250 micrograms/kg daily, gradually increased over 2–4 days, increased if tolerated to 1 mg/kg daily, max. (severe infection) 1.5 mg/kg daily or on alternate days. Prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250 micrograms/kg daily and increase gradually.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Test dose 1 mg, to be given over 20–30 minutes, then 250 micrograms/kg daily, gradually increased over 2–4 days, increased if tolerated to 1 mg/kg daily, max. (severe infection) 1.5 mg/kg daily or on alternate days. Prolonged treatment usually necessary; if interrupted for longer than 7 days recommence at 250 micrograms/kg daily and increase gradually.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#systemicFungalInfections>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fungizone#PHP83510>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#systemicFungalInfections> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Systemic fungal infections</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Systemic fungal infections

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "systemic fungal infections"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#xYlWP1y24kaLUwMsnGRhAA>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#vQftFfMPVkC2JHA6i2Qc-A>;
                                                                        nicebnf:hasTitle """<title>Fybogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "fybogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#PHP83991> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#vQftFfMPVkC2JHA6i2Qc-A> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 sachet equivalent to 2 level 5 ml spoonfuls.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#PHP83991>;
                                                                                               nicebnf:hasTextContent """Dose equivalence and conversion1 sachet equivalent to 2 level 5 ml spoonfuls.

"""^^xsd:string;
                                                                                               a nicebnf:DoseEquivalence,
                                                                                                 nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#xYlWP1y24kaLUwMsnGRhAA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                  rdfs:label "2.5–5 ml twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>2.5–5 mL twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """2.5–5 mL twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                  rdfs:label "1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 ml twice daily, dose to be made up in water, preferably taken after food."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 mL twice daily, dose to be made up in water, preferably taken after food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 mL twice daily, dose to be made up in water, preferably taken after food.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 ml twice daily, dose to be made up in water, preferably taken after food."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 mL twice daily, dose to be made up in water, preferably taken after food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 sachet twice daily, dose to be made up in water, preferably taken after food, alternatively 10 mL twice daily, dose to be made up in water, preferably taken after food.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/fybogel#PHP83991>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#0G91-5NwdEafykng3yiLUw>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#P8OUXWpEeESRiL0LJqy6iQ>;
                                                                                nicebnf:hasTitle """<title>Galfer<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "galfer capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#0G91-5NwdEafykng3yiLUw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                          rdfs:label "305 mg daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>305 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """305 mg daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "305 mg daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>305 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """305 mg daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#PHP81131>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#P8OUXWpEeESRiL0LJqy6iQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                          rdfs:label "305 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>305 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """305 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "305 mg twice daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>305 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """305 mg twice daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#PHP81131>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-capsules#PHP81131> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (prophylactic)</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Iron-deficiency anaemia (prophylactic)

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "iron-deficiency anaemia (prophylactic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (therapeutic)</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Iron-deficiency anaemia (therapeutic)

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "iron-deficiency anaemia (therapeutic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#5zUjbM6dOEa1AQ76Z7i4ag>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#hxswt-2bPEGmfiqy7fQ6IA>;
                                                                             nicebnf:hasTitle """<title>Galfer<tm tmtype=\"reg\" /> syrup</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "galfer syrup"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#5zUjbM6dOEa1AQ76Z7i4ag> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                       rdfs:label "0.25 ml/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses, prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed; supplementation is started 4–6 weeks after birth and continued until mixed feeding is established; maximum 20 ml per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>0.25 mL/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses, prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed; supplementation is started 4–6 weeks after birth and continued until mixed feeding is established; maximum 20 mL per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """0.25 mL/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses, prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed; supplementation is started 4–6 weeks after birth and continued until mixed feeding is established; maximum 20 mL per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "10 ml once daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>10 mL once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """10 mL once daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "10 ml once daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>10 mL once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """10 mL once daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylaxis>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#PHP81163>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#PHP81163> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#hxswt-2bPEGmfiqy7fQ6IA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                       rdfs:label "0.25 ml/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses; maximum 20 ml per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>0.25 mL/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses; maximum 20 mL per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """0.25 mL/kilogram twice daily, the total daily dose may alternatively be given in 3 divided doses; maximum 20 mL per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "10 ml 1–2 times a day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>10 mL 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """10 mL 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "10 ml 1–2 times a day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>10 mL 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """10 mL 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/galfer-syrup#PHP81163>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (prophylaxis)</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Iron-deficiency anaemia (prophylaxis)

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "iron-deficiency anaemia (prophylaxis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia (therapeutic)</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Iron-deficiency anaemia (therapeutic)

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "iron-deficiency anaemia (therapeutic)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gammaplex> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/gammaplex#IS4teCIPVkqCRG39zFa5HA>;
                                                                          nicebnf:hasTitle """<title>Gammaplex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "gammaplex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gammaplex#IS4teCIPVkqCRG39zFa5HA> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#hereditaryFructoseIntoleranceContainsSorbitol>;
                                                                                                 nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Hereditary fructose intolerance (contains sorbitol)</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gammaplex#PHP98242>;
                                                                                                 nicebnf:hasTextContent """Hereditary fructose intolerance (contains sorbitol)

"""^^xsd:string;
                                                                                                 a nicebnf:ContraindicationsGroup,
                                                                                                   nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gammaplex#PHP98242> a nicebnf:ContraIndications.
<http://ld.nice.org.uk/ns/bnf/Contraindication#hereditaryFructoseIntoleranceContainsSorbitol> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Hereditary fructose intolerance (contains sorbitol)</ph>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent "Hereditary fructose intolerance (contains sorbitol)"^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                              rdfs:label "hereditary fructose intolerance (contains sorbitol)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gamunex> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/gamunex#6uqIfHs_ZUau8tM2Gaj5oQ>;
                                                                        nicebnf:hasTitle """<title>Gamunex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "gamunex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gamunex#6uqIfHs_ZUau8tM2Gaj5oQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Use Glucose 5% intravenous infusion if dilution prior to infusion is required.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gamunex#PHP97993>;
                                                                                               nicebnf:hasTextContent """Use Glucose 5% intravenous infusion if dilution prior to infusion is required.

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gamunex#PHP97993> a nicebnf:DirectionsForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ganfort-single-use> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/ganfort-single-use#S5NieTfzHEaLYc0P6UHXkQ>;
                                                                                   nicebnf:hasTitle """<title>Ganfort<tm tmtype=\"reg\" /> single use</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "ganfort single use"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ganfort-single-use#PHP95207> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ganfort-single-use#S5NieTfzHEaLYc0P6UHXkQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The Scottish Medicines Consortium has advised (October 2013) that <i>Ganfort</i><tm tmtype=\"reg\" /> unit dose eye drops are accepted for restricted use within NHS Scotland for the reduction of intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension insufficiently responsive to topical beta-blockers or prostaglandin analogues who have proven sensitivity to preservatives.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ganfort-single-use#PHP95207>;
                                                                                                          nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (October 2013) that Ganfort unit dose eye drops are accepted for restricted use within NHS Scotland for the reduction of intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension insufficiently responsive to topical beta-blockers or prostaglandin analogues who have proven sensitivity to preservatives.

"""^^xsd:string;
                                                                                                          a nicebnf:FundingDecision,
                                                                                                            nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#0lIMmfU_NUKYjI9Yh51saA>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#6GR0TYjWlEWYowk7qBXw6Q>;
                                                                         nicebnf:hasTitle """<title>Gardasil<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "gardasil"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#0lIMmfU_NUKYjI9Yh51saA> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalCervicalVulvarAndVaginalAndAnalLesionsCervicalAndAnalCancersAndGenitalWarts>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#PHP81946>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#6GR0TYjWlEWYowk7qBXw6Q> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalCervicalVulvarAndVaginalAndAnalLesionsCervicalAndAnalCancersAndGenitalWartsAlternativeSchedule>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#PHP81946>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gardasil#PHP81946> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalCervicalVulvarAndVaginalAndAnalLesionsCervicalAndAnalCancersAndGenitalWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of premalignant genital (cervical, vulvar and vaginal) and anal lesions, cervical and anal cancers, and genital warts</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                     nicebnf:hasTextContent """Prevention of premalignant genital (cervical, vulvar and vaginal) and anal lesions, cervical and anal cancers, and genital warts

"""^^xsd:string;
                                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                     rdfs:label "prevention of premalignant genital (cervical, vulvar and vaginal) and anal lesions, cervical and anal cancers, and genital warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPremalignantGenitalCervicalVulvarAndVaginalAndAnalLesionsCervicalAndAnalCancersAndGenitalWartsAlternativeSchedule> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of premalignant genital (cervical, vulvar, and vaginal) and anal lesions, cervical and anal cancers, and genital warts (alternative schedule)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                        nicebnf:hasTextContent """Prevention of premalignant genital (cervical, vulvar, and vaginal) and anal lesions, cervical and anal cancers, and genital warts (alternative schedule)

"""^^xsd:string;
                                                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                        rdfs:label "prevention of premalignant genital (cervical, vulvar, and vaginal) and anal lesions, cervical and anal cancers, and genital warts (alternative schedule)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gaviscon-infant-powder-sachets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gaviscon-infant-powder-sachets#gZMQWvgXKkKphQoKdl5D5g>;
                                                                                               nicebnf:hasTitle """<title>Gaviscon Infant<tm tmtype=\"reg\" /> powder sachets</title>"""^^<rdf:XMLLiteral>;
                                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                                               rdfs:label "gaviscon infant powder sachets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gaviscon-infant-powder-sachets#PHP107008> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gaviscon-infant-powder-sachets#gZMQWvgXKkKphQoKdl5D5g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2YearsBodyWeightUpTo45Kg> ; 
                                                                                                                                         rdfs:label "1 dose as required, to be mixed with feeds (or water, for breast-fed infants); maximum 6 doses per day."^^xsd:string ; 
                                                                                                                                         nicebnf:hasDitaContent "<p>1 dose as required, to be mixed with feeds (or water, for breast-fed infants); maximum 6 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                         nicebnf:hasTextContent """1 dose as required, to be mixed with feeds (or water, for breast-fed infants); maximum 6 doses per day.

"""^^xsd:string ; 
                                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2YearsBodyWeight45KgAndAbove> ; 
                                                                                                                                         rdfs:label "2 doses as required, to be mixed with feeds (or water, for breast-fed infants); maximum 12 doses per day."^^xsd:string ; 
                                                                                                                                         nicebnf:hasDitaContent "<p>2 doses as required, to be mixed with feeds (or water, for breast-fed infants); maximum 12 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                         nicebnf:hasTextContent """2 doses as required, to be mixed with feeds (or water, for breast-fed infants); maximum 12 doses per day.

"""^^xsd:string ; 
                                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#managementOfGastroOesophagealRefluxDisease>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gaviscon-infant-powder-sachets#PHP107008>;
                                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#managementOfGastroOesophagealRefluxDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Management of gastro-oesophageal reflux disease</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Management of gastro-oesophageal reflux disease

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "management of gastro-oesophageal reflux disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2YearsBodyWeight45KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                                    rdfs:label "child 1 month–2 years (body-weight 4.5 kg and above)"^^xsd:string;
                                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2YearsBodyWeightUpTo45Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                                rdfs:label "child 1 month–2 years (body-weight up to 4.5 kg)"^^xsd:string;
                                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#C8_ioOtoNUifrDSF6y0JGw>,
                                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#muJ89s2SxEO0pf48cFr4eg>;
                                                                                        nicebnf:hasTitle """<title>Genotropin<tm tmtype=\"reg\" /> preparations</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "genotropin preparations"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#C8_ioOtoNUifrDSF6y0JGw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Cartridges are for use with <i>Genotropin</i><tm tmtype=\"reg\" /> Pen device (non-NHS but available free of charge from clinics).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#PHP84711>;
                                                                                                               nicebnf:hasTextContent """Cartridges are for use with Genotropin Pen device (non-NHS but available free of charge from clinics).

"""^^xsd:string;
                                                                                                               a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#PHP84706> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#PHP84711> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#muJ89s2SxEO0pf48cFr4eg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/genotropin-preparations#PHP84706>;
                                                                                                               nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                               a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#DE9iX5dtpECbc-2oDFqnZA>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#yEV0-4YuHESoN0fZ6VfY5w>;
                                                                                               nicebnf:hasTitle """<title>Gestone<tm tmtype=\"reg\" /> solution for injection</title>"""^^<rdf:XMLLiteral>;
                                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                                               rdfs:label "gestone solution for injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#DE9iX5dtpECbc-2oDFqnZA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                         rdfs:label "5–10 mg daily for 5–10 days until 2 days before expected onset of menstruation, to be administered into buttocks."^^xsd:string ; 
                                                                                                                                         nicebnf:hasDitaContent "<p>5–10 mg daily for 5–10 days until 2 days before expected onset of menstruation, to be administered into buttocks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                         nicebnf:hasTextContent """5–10 mg daily for 5–10 days until 2 days before expected onset of menstruation, to be administered into buttocks.

"""^^xsd:string ; 
                                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dysfunctionalUterineBleeding>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#PHP104636>;
                                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#PHP104636> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#yEV0-4YuHESoN0fZ6VfY5w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                         rdfs:label "25–100 mg 2–7 times a week from day 15, or day of embryo or gamete transfer, until 8–16 weeks of pregnancy, to be administered into buttocks; maximum 200 mg per day."^^xsd:string ; 
                                                                                                                                         nicebnf:hasDitaContent "<p>25–100 mg 2–7 times a week from day 15, or day of embryo or gamete transfer, until 8–16 weeks of pregnancy, to be administered into buttocks; maximum 200 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                         nicebnf:hasTextContent """25–100 mg 2–7 times a week from day 15, or day of embryo or gamete transfer, until 8–16 weeks of pregnancy, to be administered into buttocks; maximum 200 mg per day.

"""^^xsd:string ; 
                                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#recurrentMiscarriageDueToInadequateLutealPhaseButNotRecommendedOrFollowingInVitroFertilisationOrGameteIntraFallopianTransfer>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gestone-solution-for-injection#PHP104636>;
                                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dysfunctionalUterineBleeding> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dysfunctional uterine bleeding</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Dysfunctional uterine bleeding

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "dysfunctional uterine bleeding"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#recurrentMiscarriageDueToInadequateLutealPhaseButNotRecommendedOrFollowingInVitroFertilisationOrGameteIntraFallopianTransfer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Recurrent miscarriage due to inadequate luteal phase (but not recommended) or following in vitro fertilisation or gamete intra-fallopian transfer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                       nicebnf:hasTextContent """Recurrent miscarriage due to inadequate luteal phase (but not recommended) or following in vitro fertilisation or gamete intra-fallopian transfer

"""^^xsd:string;
                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                       rdfs:label "recurrent miscarriage due to inadequate luteal phase (but not recommended) or following in vitro fertilisation or gamete intra-fallopian transfer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by deep intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/glucophage-sr> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/glucophage-sr#oZFfQMm-6k2gyzGn712s-w>;
                                                                              nicebnf:hasTitle """<title>Glucophage<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "glucophage sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glucophage-sr#PHP84414> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glucophage-sr#oZFfQMm-6k2gyzGn712s-w> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (September 2009) that <i>Glucophage</i><tm tmtype=\"reg\" /><i>SR</i> is accepted for restricted use within NHS Scotland for the treatment of type 2 diabetes mellitus in adult patients who are intolerant of standard-release metformin, and in whom the prolonged-release tablet allows the use of a dose of metformin not previously tolerated, or in patients for whom a once daily preparation offers a clinically significant benefit.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/glucophage-sr#PHP84414>;
                                                                                                     nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (September 2009) that GlucophageSR is accepted for restricted use within NHS Scotland for the treatment of type 2 diabetes mellitus in adult patients who are intolerant of standard-release metformin, and in whom the prolonged-release tablet allows the use of a dose of metformin not previously tolerated, or in patients for whom a once daily preparation offers a clinically significant benefit.

"""^^xsd:string;
                                                                                                     a nicebnf:FundingDecision,
                                                                                                       nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/glusartel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/glusartel#5n3IXlYN-UChcvNSnil1xw>;
                                                                          nicebnf:hasTitle """<title>Glusartel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "glusartel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glusartel#5n3IXlYN-UChcvNSnil1xw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1 sachet once daily, dose to be dissolved in at least 250 ml of water, review treatment if no benefit after 2–3 months."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 sachet once daily, dose to be dissolved in at least 250 mL of water, review treatment if no benefit after 2–3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 sachet once daily, dose to be dissolved in at least 250 mL of water, review treatment if no benefit after 2–3 months.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/glusartel#PHP84039>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glusartel#PHP84039> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefOfMildToModerateOsteoarthritisOfTheKnee> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic relief of mild to moderate osteoarthritis of the knee</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Symptomatic relief of mild to moderate osteoarthritis of the knee

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "symptomatic relief of mild to moderate osteoarthritis of the knee"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#64JVCIfuu0Sb9jDyRe5G_Q>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#9869lcm1AUSZtlwdf2884Q>;
                                                                                nicebnf:hasTitle """<title>Glycophos<tm tmtype=\"reg\" /> vials</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "glycophos vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#64JVCIfuu0Sb9jDyRe5G_Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to <i>Vamin</i><tm tmtype=\"reg\" /> and <i>Vaminolact</i><tm tmtype=\"reg\" /> solutions, and glucose intravenous infusions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#PHP107532>;
                                                                                                       nicebnf:hasTextContent """For addition to Vamin and Vaminolact solutions, and glucose intravenous infusions.

"""^^xsd:string;
                                                                                                       a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#9869lcm1AUSZtlwdf2884Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Glycophos</i>
    <tm tmtype=\"reg\" /> Sterile Concentrate solution contains phosphate 20 mmol, Na<sup>+</sup> 40 mmol/20 mL.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#PHP107548>;
                                                                                                       nicebnf:hasTextContent """Glycophos Sterile Concentrate solution contains phosphate 20 mmol, Na+ 40 mmol/20 mL.

"""^^xsd:string;
                                                                                                       a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#PHP107532> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glycophos-vials#PHP107548> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/glypressin-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/glypressin-injection#8FX4mlpda0CDH9x_5syeYg>;
                                                                                     nicebnf:hasTitle """<title>Glypressin<tm tmtype=\"reg\" /> injection</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "glypressin injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glypressin-injection#8FX4mlpda0CDH9x_5syeYg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo50Kg> ; 
                                                                                                                               rdfs:label "initially 2 mg every 4 hours until bleeding controlled, then reduced to 1 mg every 4 hours if required, maximum duration 48 hours."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>Initially 2 mg every 4 hours until bleeding controlled, then reduced to 1 mg every 4 hours if required, maximum duration 48 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """Initially 2 mg every 4 hours until bleeding controlled, then reduced to 1 mg every 4 hours if required, maximum duration 48 hours.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> ; 
                                                                                                                               rdfs:label "initially 2 mg every 4 hours until bleeding controlled, reduced if not tolerated to 1 mg every 4 hours, maximum duration 48 hours."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>Initially 2 mg every 4 hours until bleeding controlled, reduced if not tolerated to 1 mg every 4 hours, maximum duration 48 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """Initially 2 mg every 4 hours until bleeding controlled, reduced if not tolerated to 1 mg every 4 hours, maximum duration 48 hours.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bleedingFromOesophagealVarices>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/glypressin-injection#PHP85365>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/glypressin-injection#PHP85365> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#bleedingFromOesophagealVarices> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bleeding from oesophageal varices</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Bleeding from oesophageal varices

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "bleeding from oesophageal varices"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 50 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo50Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 50 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#FLJIx2R4QE-UzznQk2Gglw>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#pZYwtBo--UeM-OkZ46wq-w>;
                                                                                 nicebnf:hasTitle """<title>Gonapeptyl Depot<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "gonapeptyl depot"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#FLJIx2R4QE-UzznQk2Gglw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "3.75 mg every 4 weeks."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>3.75 mg every 4 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """3.75 mg every 4 weeks.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByDeepIntramuscularInjection>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#advancedProstateCancer>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#PHP79161>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#PHP79161> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#pZYwtBo--UeM-OkZ46wq-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "3.75 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>3.75 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """3.75 mg every 4 weeks maximum duration of 6 months (not to be repeated), to be started during first 5 days of menstrual cycle.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByDeepIntramuscularInjection>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#reductionInSizeOfFibroids>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gonapeptyl-depot#PHP79161>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#advancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent """Advanced prostate cancer

"""^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                 rdfs:label "advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionInSizeOfFibroids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction in size of fibroids</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Reduction in size of fibroids

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "reduction in size of fibroids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByDeepIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                                 rdfs:label "by subcutaneous injection, or by deep intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynefix> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynefix#FGzdc4_f6UG0hSz2NBmtgw>;
                                                                        nicebnf:hasTitle """<title>GyneFix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "gynefix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynefix#FGzdc4_f6UG0hSz2NBmtgw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Suitable for all uterine sizes; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynefix#PHP105482>;
                                                                                               nicebnf:hasTextContent """Suitable for all uterine sizes; replacement every 5 years.

"""^^xsd:string;
                                                                                               a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynefix#PHP105482> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#Sme7WS9mrUG1ye1j1cY1fw>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#ugKAMoKv2USZZebzzPlppw>;
                                                                       nicebnf:hasTitle """<title>Gynest<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "gynest"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#PHP101423> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#PHP101443> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#Sme7WS9mrUG1ye1j1cY1fw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 1 applicatorful daily until improvement occurrs, dose to be applied preferably in the evening, reduced to 1 applicatorful twice weekly, attempts to discontinue should be made at 3–6 month intervals with re-examination."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 1 applicatorful daily until improvement occurrs, dose to be applied preferably in the evening, reduced to 1 applicatorful twice weekly, attempts to discontinue should be made at 3–6 month intervals with re-examination.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 1 applicatorful daily until improvement occurrs, dose to be applied preferably in the evening, reduced to 1 applicatorful twice weekly, attempts to discontinue should be made at 3–6 month intervals with re-examination.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitisShortTermUse>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#PHP101423>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#ugKAMoKv2USZZebzzPlppw> nicebnf:hasDitaContent """<sectiondiv>
  <p>May damage latex condoms and diaphragms.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gynest#PHP101443>;
                                                                                              nicebnf:hasTextContent """May damage latex condoms and diaphragms.

"""^^xsd:string;
                                                                                              a nicebnf:ConceptionAndContraception.
<http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitisShortTermUse> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-cream#bYtCj72dskGWr5ql80YLsQ>;
                                                                                   nicebnf:hasTitle """<title>Gyno-Pevaryl<tm tmtype=\"reg\" /> cream</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "gyno-pevaryl cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-cream#PHP97659> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-cream#bYtCj72dskGWr5ql80YLsQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 applicatorful daily for at least 14 days, dose to be inserted vaginally at night and (to the skin) apply daily for at least 14 days, to be applied to vulva at night, course can be repeated once if necessary."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 applicatorful daily for at least 14 days, dose to be inserted vaginally at night and (to the skin) apply daily for at least 14 days, to be applied to vulva at night, course can be repeated once if necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 applicatorful daily for at least 14 days, dose to be inserted vaginally at night and (to the skin) apply daily for at least 14 days, to be applied to vulva at night, course can be repeated once if necessary.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByVaginaUsingVaginalCream>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-cream#PHP97659>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Vaginal and vulval candidiasis</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Vaginal and vulval candidiasis

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "vaginal and vulval candidiasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByVaginaUsingVaginalCream> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                              rdfs:label "initially by vagina using vaginal cream"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-once> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-once#2XYF39GEokyz0R1OucGTMw>;
                                                                                  nicebnf:hasTitle """<title>Gyno-Pevaryl<tm tmtype=\"reg\" /> Once</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "gyno-pevaryl once"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-once#2XYF39GEokyz0R1OucGTMw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 pessary for 1 dose, pessary to be inserted at night, dose to be repeated once if necessary."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 pessary for 1 dose, pessary to be inserted at night, dose to be repeated once if necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 pessary for 1 dose, pessary to be inserted at night, dose to be repeated once if necessary.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-once#PHP97431>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-once#PHP97431> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Vaginal and vulval candidiasis</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Vaginal and vulval candidiasis

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "vaginal and vulval candidiasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-pessary> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-pessary#GASEl_sqnU6q3Qsop4rn4Q>;
                                                                                     nicebnf:hasTitle """<title>Gyno-Pevaryl<tm tmtype=\"reg\" /> pessary</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "gyno-pevaryl pessary"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-pessary#GASEl_sqnU6q3Qsop4rn4Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "1 pessary daily for 3 days, pessary to be inserted at night, course can be repeated once if necessary."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>1 pessary daily for 3 days, pessary to be inserted at night, course can be repeated once if necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """1 pessary daily for 3 days, pessary to be inserted at night, course can be repeated once if necessary.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-pessary#PHP97682>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/gyno-pevaryl-pessary#PHP97682> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#vaginalAndVulvalCandidiasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Vaginal and vulval candidiasis</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Vaginal and vulval candidiasis

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "vaginal and vulval candidiasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/haelan-tape> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/haelan-tape#yDwa3j-AsEGYusIsQ2DHyA>;
                                                                            nicebnf:hasTitle """<title>Haelan<tm tmtype=\"reg\" /> tape</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "haelan tape"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/haelan-tape#PHP84762> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/haelan-tape#yDwa3j-AsEGYusIsQ2DHyA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                      rdfs:label "cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Cut tape to fit lesion, apply to clean, dry skin shorn of hair, usually for 12 hours daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicLocalisedRecalcitrantDermatosesButNotAcuteOrWeeping>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/haelan-tape#PHP84762>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicLocalisedRecalcitrantDermatosesButNotAcuteOrWeeping> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic localised recalcitrant dermatoses (but not acute or weeping)</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Chronic localised recalcitrant dermatoses (but not acute or weeping)

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "chronic localised recalcitrant dermatoses (but not acute or weeping)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#ErOjoe4dm022XzMYQzUgAQ>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#GPrkUbrrukeHV_CYadomyw>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#ZmzmZ0GaIUupnGlF_dlnNg>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#gi1bdQCj8U62HkjcuaaaXQ>;
                                                                                nicebnf:hasTitle """<title>Half Securon<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "half securon sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#ErOjoe4dm022XzMYQzUgAQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "240 mg twice daily, may sometimes be reduced to once daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>240 mg twice daily, may sometimes be reduced to once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """240 mg twice daily, may sometimes be reduced to once daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#PHP62691>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#GPrkUbrrukeHV_CYadomyw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#PHP62691>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#PHP62691> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#ZmzmZ0GaIUupnGlF_dlnNg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#PHP62691>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#gi1bdQCj8U62HkjcuaaaXQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening or 120 mg 3 times daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening <i>or</i> 120 mg 3 times daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening or 120 mg 3 times daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAfterMyocardialInfarctionWhereBetaBlockersNotAppropriate>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-securon-sr#PHP62691>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension (in patients new to verapamil)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Hypertension (in patients new to verapamil)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "hypertension (in patients new to verapamil)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAfterMyocardialInfarctionWhereBetaBlockersNotAppropriate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis after myocardial infarction where beta-blockers not appropriate</p>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasTextContent """Prophylaxis after myocardial infarction where beta-blockers not appropriate

"""^^xsd:string;
                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                              rdfs:label "prophylaxis after myocardial infarction where beta-blockers not appropriate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-sinemet-cr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-sinemet-cr#9EyXodJC3kqJ8P8gfZYgqw>;
                                                                                nicebnf:hasTitle """<title>Half Sinemet<tm tmtype=\"reg\" /> CR</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "half sinemet cr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-sinemet-cr#9EyXodJC3kqJ8P8gfZYgqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseForFineAdjustmentOfSinemetCrDose>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/half-sinemet-cr#PHP81101>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/half-sinemet-cr#PHP81101> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseForFineAdjustmentOfSinemetCrDose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease (for fine adjustment of Sinemet<tm tmtype=\"reg\" /> CR dose)</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Parkinson's disease (for fine adjustment of Sinemet CR dose)

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "parkinson's disease (for fine adjustment of sinemet cr dose)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#alg1NtDt2E6X8OJYKOb3Uw>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#zE__BSWt-EOrsHoQncx92w>;
                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#7ff822SBT0G4tQHNuopkDg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#HgX_9JcB2EWvezqf_qYr_A>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#exlwXsans0yaj2Zbc92s8g>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#uS4lSl2Ou02ANoqTA0jTVA>;
                                                                           nicebnf:hasTitle """<title>Hapoctasin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "hapoctasin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#7ff822SBT0G4tQHNuopkDg> nicebnf:hasDitaContent """<section outputclass=\"pharmacokinetics\">
  <title>Pharmacokinetics</title>
  <p>It may take approximately 25 hours for the plasma-buprenorphine concentration to decrease by 50% after patch is removed.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98279>;
                                                                                                  nicebnf:hasTextContent """PharmacokineticsIt may take approximately 25 hours for the plasma-buprenorphine concentration to decrease by 50% after patch is removed.

"""^^xsd:string;
                                                                                                  a nicebnf:IndicationsAndDoseSection,
                                                                                                    nicebnf:Pharmacokinetics.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#HgX_9JcB2EWvezqf_qYr_A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after no longer than 72 hours and siting replacement patch on a different area (avoid same area for at least 7 days).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98288>;
                                                                                                  nicebnf:hasTextContent """Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after no longer than 72 hours and siting replacement patch on a different area (avoid same area for at least 7 days).

"""^^xsd:string;
                                                                                                  a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98279> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98286> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98288> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98291> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#alg1NtDt2E6X8OJYKOb3Uw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "the initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>The initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at <i>same time</i> to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """The initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98279>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#exlwXsans0yaj2Zbc92s8g> nicebnf:hasDitaContent """<sectiondiv>
  <p>In view of the long duration of action, patients who have severe side-effects should be monitored for up to 25 hours after removing patch.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98286>;
                                                                                                  nicebnf:hasTextContent """In view of the long duration of action, patients who have severe side-effects should be monitored for up to 25 hours after removing patch.

"""^^xsd:string;
                                                                                                  a nicebnf:SideEffectAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#uS4lSl2Ou02ANoqTA0jTVA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer buprenorphine transdermal patches.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98291>;
                                                                                                  nicebnf:hasTextContent """Patients or carers should be given advice on how to administer buprenorphine transdermal patches.

"""^^xsd:string;
                                                                                                  a nicebnf:GeneralPatientAdvice,
                                                                                                    nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#zE__BSWt-EOrsHoQncx92w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 35 micrograms/hour up to every 72 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 35 micrograms/hour up to every 72 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at <i>same time</i> to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 35 micrograms/hour up to every 72 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 72 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hapoctasin#PHP98279>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                       nicebnf:hasTextContent """Moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                       rdfs:label "moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasTextContent """Moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                    rdfs:label "moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                 nicebnf:hasTextContent """Severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                 rdfs:label "severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                              nicebnf:hasTextContent """Severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                              rdfs:label "severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by transdermal application using patches"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/havrix-monodose> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/havrix-monodose#BTMY8arQgEejkqMt0qQEdQ>;
                                                                                nicebnf:hasTitle """<title>Havrix Monodose<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "havrix monodose"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/havrix-monodose#BTMY8arQgEejkqMt0qQEdQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> ; 
                                                                                                                          rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                          rdfs:label "initially 1 ml for 1 dose, then 1 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "initially 1 ml for 1 dose, then 1 ml after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 6–12 months, dose given as booster; booster dose may be delayed by up to 3 years if not given after recommended interval following primary dose, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/havrix-monodose#PHP81363>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/havrix-monodose#PHP81363> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis A infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis a infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–15 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#AkYY5xn5f0eiLCxDEFHhpQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#B7v86VthAU23z_WS2wddqw>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#GG2syhw0KUuGuTCb3Fh_Zw>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#jCW_ZdLi0EeQ8WYjcr73Yg>;
                                                                         nicebnf:hasTitle """<title>HBvaxPRO<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "hbvaxpro"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#AkYY5xn5f0eiLCxDEFHhpQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                   rdfs:label "5 micrograms for 1 dose, followed by 5 micrograms after 1 month for 1 dose, then 5 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>5 micrograms for 1 dose, followed by 5 micrograms after 1 month for 1 dose, then 5 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """5 micrograms for 1 dose, followed by 5 micrograms after 1 month for 1 dose, then 5 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                   rdfs:label "10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """10 micrograms for 1 dose, followed by 10 micrograms after 1 month for 1 dose, followed by 10 micrograms after 5 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfection>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#PHP81824>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#B7v86VthAU23z_WS2wddqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                   rdfs:label "40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """40 micrograms every 1 month for 2 months, followed by 40 micrograms after 5 months for 1 dose, booster doses may be required in those with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHaemodialysisPatients>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#PHP81824>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#GG2syhw0KUuGuTCb3Fh_Zw> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#neonateBornToHepatitisBSurfaceAntigenPositiveMother>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#PHP81824>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#PHP81824> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#jCW_ZdLi0EeQ8WYjcr73Yg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> ; 
                                                                                                                   rdfs:label "5 micrograms every 1 month for 3 months, followed by 5 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>5 micrograms every 1 month for 3 months, followed by 5 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """5 micrograms every 1 month for 3 months, followed by 5 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; anterolateral thigh is preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                   rdfs:label "10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """10 micrograms every 1 month for 3 months, followed by 10 micrograms after 9 months for 1 dose, booster doses may be required in immunocompromised patients with low antibody concentration, deltoid muscle is preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedSchedule>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hbvaxpro#PHP81824>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHaemodialysisPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic haemodialysis patients</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Chronic haemodialysis patients

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "chronic haemodialysis patients"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis B infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis b infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisBInfectionAcceleratedSchedule> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis B infection (accelerated schedule)</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Immunisation against hepatitis B infection (accelerated schedule)

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "immunisation against hepatitis b infection (accelerated schedule)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neonateBornToHepatitisBSurfaceAntigenPositiveMother> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neonate born to hepatitis B surface antigen-positive mother</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent """Neonate born to hepatitis B surface antigen-positive mother

"""^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                              rdfs:label "neonate born to hepatitis b surface antigen-positive mother"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month15Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–15 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hepatyrix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hepatyrix#sfgO-NFcsUiyisP_faDi7w>;
                                                                          nicebnf:hasTitle """<title>Hepatyrix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "hepatyrix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hepatyrix#PHP96866> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hepatyrix#sfgO-NFcsUiyisP_faDi7w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                    rdfs:label "1 ml for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). the subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1 ml for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). the subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndTyphoidInfectionPrimaryCourse>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hepatyrix#PHP96866>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndTyphoidInfectionPrimaryCourse> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and typhoid infection (primary course)</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Immunisation against hepatitis A and typhoid infection (primary course)

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "immunisation against hepatitis a and typhoid infection (primary course)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/herceptin-solution-for-injection> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/herceptin-solution-for-injection#5az797ild0Wj0B6MhyjfLw>;
                                                                                                 nicebnf:hasTitle """<title>Herceptin<tm tmtype=\"reg\" /> solution for injection</title>"""^^<rdf:XMLLiteral>;
                                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                 rdfs:label "herceptin solution for injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/herceptin-solution-for-injection#5az797ild0Wj0B6MhyjfLw> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (December 2013) that subcutaneous trastuzumab injection (<i>Herceptin</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland for the treatment of adults with HER2 positive metastatic breast cancer and early breast cancer, when used within licensed indications excluding use in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer, not previously treated with trastuzumab.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/herceptin-solution-for-injection#PHP98276>;
                                                                                                                        nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (December 2013) that subcutaneous trastuzumab injection (Herceptin) is accepted for restricted use within NHS Scotland for the treatment of adults with HER2 positive metastatic breast cancer and early breast cancer, when used within licensed indications excluding use in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer, not previously treated with trastuzumab.

"""^^xsd:string;
                                                                                                                        a nicebnf:FundingDecision,
                                                                                                                          nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/herceptin-solution-for-injection#PHP98276> a nicebnf:NationalFunding.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibi-liquid-hand-rub> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibi-liquid-hand-rub#jP7JcPDQlkafT6jITvY9uw>;
                                                                                     nicebnf:hasTitle """<title>Hibi<tm tmtype=\"reg\" /> liquid hand rub+</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "hibi liquid hand rub+"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibi-liquid-hand-rub#PHP99752> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibi-liquid-hand-rub#jP7JcPDQlkafT6jITvY9uw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                               rdfs:label "to be used undiluted (consult product literature)."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>To be used undiluted (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """To be used undiluted (consult product literature).

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "to be used undiluted (consult product literature)."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>To be used undiluted (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """To be used undiluted (consult product literature).

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#handAndSkinDisinfection>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibi-liquid-hand-rub#PHP99752>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#handAndSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hand and skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Hand and skin disinfection

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "hand and skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibiscrub> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibiscrub#z6XsGxSx_EqWdobwxSJPWA>;
                                                                          nicebnf:hasTitle """<title>Hibiscrub<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "hibiscrub"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibiscrub#PHP99751> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibiscrub#z6XsGxSx_EqWdobwxSJPWA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                    rdfs:label "use as alternative to soap (consult product literature)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Use as alternative to soap (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Use as alternative to soap (consult product literature).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "use as alternative to soap (consult product literature)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Use as alternative to soap (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Use as alternative to soap (consult product literature).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#generalHandAndSkinDisinfection>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#preOperativeHandAndSkinDisinfection>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibiscrub#PHP99751>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#generalHandAndSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">General hand and skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """General hand and skin disinfection

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "general hand and skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preOperativeHandAndSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pre-operative hand and skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Pre-operative hand and skin disinfection

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "pre-operative hand and skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-obstetric> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-obstetric#ybIWwa2b1E2zBfEcxj9OoQ>;
                                                                                   nicebnf:hasTitle """<title>Hibitane Obstetric<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "hibitane obstetric"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-obstetric#PHP99748> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-obstetric#ybIWwa2b1E2zBfEcxj9OoQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "to be applied to skin around vulva and perineum and to hands of midwife or doctor."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>To be applied to skin around vulva and perineum and to hands of midwife or doctor.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """To be applied to skin around vulva and perineum and to hands of midwife or doctor.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forUseInObstetricsAndGynaecologyAsAnAntisepticAndLubricant>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-obstetric#PHP99748>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forUseInObstetricsAndGynaecologyAsAnAntisepticAndLubricant> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For use in obstetrics and gynaecology as an antiseptic and lubricant</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """For use in obstetrics and gynaecology as an antiseptic and lubricant

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "for use in obstetrics and gynaecology as an antiseptic and lubricant"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#RvO_jLf2-Uue1BJbSd1RVQ>;
                                                                                                     nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#DqN9o2wG80eil47aCmIn3Q>;
                                                                                                     nicebnf:hasTitle """<title>HiBiTane <tm tmtype=\"reg\" /> Plus 5% concentrate solution</title>"""^^<rdf:XMLLiteral>;
                                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                     rdfs:label "hibitane  plus 5% concentrate solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#DqN9o2wG80eil47aCmIn3Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>For pre-operative skin preparation, dilute 1 in 10 (0.5%) with alcohol 70%. For general skin disinfection, dilute 1 in 100 (0.05%) with water. Alcoholic solutions not suitable for use before diathermy or on neonatal skin.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#PHP107061>;
                                                                                                                            nicebnf:hasTextContent """For pre-operative skin preparation, dilute 1 in 10 (0.5%) with alcohol 70%. For general skin disinfection, dilute 1 in 100 (0.05%) with water. Alcoholic solutions not suitable for use before diathermy or on neonatal skin.

"""^^xsd:string;
                                                                                                                            a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#PHP107004> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#PHP107061> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#RvO_jLf2-Uue1BJbSd1RVQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                               rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                               nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                               nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#generalAndPreOperativeSkinDisinfection>;
                                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hibitane-plus-5-concentrate-solution#PHP107004>;
                                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#generalAndPreOperativeSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">General and pre-operative skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """General and pre-operative skin disinfection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "general and pre-operative skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hizentra> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/hizentra#NkCvMY1UIUSTeMD4qTLiiA>;
                                                                         nicebnf:hasTitle """<title>Hizentra<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "hizentra"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hizentra#NkCvMY1UIUSTeMD4qTLiiA> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#hyperprolinaemiaContainsProline>;
                                                                                                nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Hyperprolinaemia (contains <ph outputclass=\"sc\"></ph>-proline)</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hizentra#PHP97809>;
                                                                                                nicebnf:hasTextContent """Hyperprolinaemia (contains -proline)

"""^^xsd:string;
                                                                                                a nicebnf:ContraindicationsGroup,
                                                                                                  nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hizentra#PHP97809> a nicebnf:ContraIndications.
<http://ld.nice.org.uk/ns/bnf/Contraindication#hyperprolinaemiaContainsProline> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Hyperprolinaemia (contains <ph outputclass=\"sc\"></ph>-proline)</ph>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent "Hyperprolinaemia (contains -proline)"^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                rdfs:label "hyperprolinaemia (contains -proline)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/humatrope> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/humatrope#am6grUs040yOwm_XrKplpg>;
                                                                          nicebnf:hasTitle """<title>Humatrope<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "humatrope"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/humatrope#PHP81793> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/humatrope#am6grUs040yOwm_XrKplpg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Cartridges for use by subcutaneous injection.</p>
  <p>Powder for reconstitution for use by subcutaneous or intramuscular injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/humatrope#PHP81793>;
                                                                                                 nicebnf:hasTextContent """Cartridges for use by subcutaneous injection.

Powder for reconstitution for use by subcutaneous or intramuscular injection.

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-solution#F8USraqHFkeSqoUYsfuDRQ>;
                                                                                nicebnf:hasTitle """<title>Hydrex<tm tmtype=\"reg\" /> solution</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "hydrex solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-solution#F8USraqHFkeSqoUYsfuDRQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                          rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forPreOperativeSkinDisinfection>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-solution#PHP99888>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-solution#PHP99888> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#forPreOperativeSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For pre-operative skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """For pre-operative skin disinfection

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "for pre-operative skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-surgical-scrub> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-surgical-scrub#AQ3cYkMALEaOQOi3WRObYw>;
                                                                                      nicebnf:hasTitle """<title>Hydrex<tm tmtype=\"reg\" /> surgical scrub</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "hydrex surgical scrub"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-surgical-scrub#AQ3cYkMALEaOQOi3WRObYw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forPreOperativeHandAndSkinDisinfection>,
                                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#generalHandDisinfection>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-surgical-scrub#PHP99910>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrex-surgical-scrub#PHP99910> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#forPreOperativeHandAndSkinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For pre-operative hand and skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """For pre-operative hand and skin disinfection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "for pre-operative hand and skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#generalHandDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">General hand disinfection</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """General hand disinfection

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "general hand disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrocortistab> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrocortistab#WXitqRUtb0uDtevzC5u_qw>;
                                                                               nicebnf:hasTitle """<title>Hydrocortistab<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "hydrocortistab"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrocortistab#PHP80948> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrocortistab#WXitqRUtb0uDtevzC5u_qw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "5–50 mg, select dose according to size of patient and joint; where appropriate dose may be repeated at intervals of 21 days. not more than 3 joints should be treated on any one day, for details consult product literature."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>5–50 mg, select dose according to size of patient and joint; where appropriate dose may be repeated at intervals of 21 days. Not more than 3 joints should be treated on any one day, for details consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """5–50 mg, select dose according to size of patient and joint; where appropriate dose may be repeated at intervals of 21 days. Not more than 3 joints should be treated on any one day, for details consult product literature.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydrocortistab#PHP80948>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Local inflammation of joints and soft tissues</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Local inflammation of joints and soft tissues

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "local inflammation of joints and soft tissues"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                     rdfs:label "by intra-articular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#KMGji9J3B0-BfVEp9Y5NDQ>,
                                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#WW7JUwen2UueP1ggxS1pEg>;
                                                                                                   nicebnf:hasTitle """<title>Hydromol<tm tmtype=\"reg\" /> bath and shower emollient</title>"""^^<rdf:XMLLiteral>;
                                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                   rdfs:label "hydromol bath and shower emollient"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#KMGji9J3B0-BfVEp9Y5NDQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                                             rdfs:label "0.5–2 capfuls/bath, alternatively apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>0.5–2 capfuls/bath, alternatively apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """0.5–2 capfuls/bath, alternatively apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                             rdfs:label "1–3 capfuls/bath, alternatively apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """1–3 capfuls/bath, alternatively apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                             rdfs:label "1–3 capfuls/bath, alternatively apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """1–3 capfuls/bath, alternatively apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions>,
                                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Indication#eczema>,
                                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Indication#ichthyosis>;
                                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#PHP105761>;
                                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#PHP105761> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#WW7JUwen2UueP1ggxS1pEg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                             rdfs:label "1–3 capfuls/bath, alternatively apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """1–3 capfuls/bath, alternatively apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-bath-and-shower-emollient#PHP105761>;
                                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Dry skin conditions

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "dry skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#eczema> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Eczema</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Eczema

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "eczema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ichthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Ichthyosis

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-intensive> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-intensive#usw3f1az9kOfOCgk2pyCUw>;
                                                                                   nicebnf:hasTitle """<title>Hydromol<tm tmtype=\"reg\" /> Intensive</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "hydromol intensive"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-intensive#PHP105764> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-intensive#usw3f1az9kOfOCgk2pyCUw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                             rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/hydromol-intensive#PHP105764>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ibugel-forte> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ibugel-forte#lomiFrMQWUau-8hQ6wJt9g>;
                                                                             nicebnf:hasTitle """<title>Ibugel<tm tmtype=\"reg\" /> Forte</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "ibugel forte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ibugel-forte#PHP84203> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ibugel-forte#lomiFrMQWUau-8hQ6wJt9g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply up to 3 times a day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply up to 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply up to 3 times a day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#painReliefInMusculoskeletalConditions>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#treatmentInKneeOrHandOsteoarthritisAdjunct>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ibugel-forte#PHP84203>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#painReliefInMusculoskeletalConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain relief in musculoskeletal conditions</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Pain relief in musculoskeletal conditions

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "pain relief in musculoskeletal conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentInKneeOrHandOsteoarthritisAdjunct> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment in knee or hand osteoarthritis (adjunct)</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Treatment in knee or hand osteoarthritis (adjunct)

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "treatment in knee or hand osteoarthritis (adjunct)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/imdur> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/imdur#P1CD3mITeUq5K5GuRt2MhA>;
                                                                      nicebnf:hasTitle """<title>Imdur<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "imdur"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/imdur#P1CD3mITeUq5K5GuRt2MhA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 0.5 tablet daily, to be taken if headache occurs; 1 tablet daily, then increased if necessary to 2 tablets daily, dose to be taken in the morning."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily, to be taken if headache occurs; 1 tablet daily, then increased if necessary to 2 tablets daily, dose to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 0.5 tablet daily, to be taken if headache occurs; 1 tablet daily, then increased if necessary to 2 tablets daily, dose to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/imdur#PHP59922>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/imdur#PHP59922> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/imuderm-emollient> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/imuderm-emollient#opUvvTqURU6QYMBHBuwGtg>;
                                                                                  nicebnf:hasTitle """<title>ImuDERM<tm tmtype=\"reg\" /> emollient</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "imuderm emollient"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/imuderm-emollient#PHP108442> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/imuderm-emollient#opUvvTqURU6QYMBHBuwGtg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "apply to skin or use as a soap substitute."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Apply to skin or use as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Apply to skin or use as a soap substitute.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisOrDermatitis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/imuderm-emollient#PHP108442>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisOrDermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema, psoriasis or dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Dry skin conditions including eczema, psoriasis or dermatitis

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "dry skin conditions including eczema, psoriasis or dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/indivina-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/indivina-tablets#Ugekn6t0W0uC49k2Z3ZcoA>;
                                                                                 nicebnf:hasTitle """<title>Indivina<tm tmtype=\"reg\" /> Tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "indivina tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/indivina-tablets#PHP96704> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/indivina-tablets#Ugekn6t0W0uC49k2Z3ZcoA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 1/2.5 mg daily taken continuously, adjust according to response, to be started at end of scheduled bleed if changing from cyclical hrt."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 1/2.5 mg daily taken continuously, adjust according to response, to be started at end of scheduled bleed if changing from cyclical HRT.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 1/2.5 mg daily taken continuously, adjust according to response, to be started at end of scheduled bleed if changing from cyclical HRT.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver3YearsPreviously>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver3YearsPreviously>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/indivina-tablets#PHP96704>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver3YearsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 3 years previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                   nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 3 years previously

"""^^xsd:string;
                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                   rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 3 years previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver3YearsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 3 years previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                        nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 3 years previously

"""^^xsd:string;
                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                        rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 3 years previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#S2TBeGUmxUaDMuQybg1vKg>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#RA40yHUjKU2U2D5anvrL9A>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#Zn4lCXVsi0eaLt86RnWEZQ>;
                                                                        nicebnf:hasTitle """<title>Infacol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "infacol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98196> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98239> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98241> a nicebnf:LessSuitableForPrescribings.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#RA40yHUjKU2U2D5anvrL9A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on use of the <i>Infacol</i><tm tmtype=\"reg\" /> dropper.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98239>;
                                                                                               nicebnf:hasTextContent """Patients or carers should be given advice on use of the Infacol dropper.

"""^^xsd:string;
                                                                                               a nicebnf:GeneralPatientAdvice,
                                                                                                 nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#S2TBeGUmxUaDMuQybg1vKg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month1Year> ; 
                                                                                                                  rdfs:label "0.5–1 ml, to be taken before feeds."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5–1 mL, to be taken before feeds.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5–1 mL, to be taken before feeds.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#colic>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#windPains>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98196>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#Zn4lCXVsi0eaLt86RnWEZQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Infacol</i>
    <tm tmtype=\"reg\" /> is less suitable for prescribing (evidence of benefit in infantile colic uncertain).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/infacol#PHP98241>;
                                                                                               nicebnf:hasTextContent """Infacol is less suitable for prescribing (evidence of benefit in infantile colic uncertain).

"""^^xsd:string;
                                                                                               a nicebnf:LessSuitableForPrescribing.
<http://ld.nice.org.uk/ns/bnf/Indication#colic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Colic</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Colic

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "colic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#windPains> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Wind pains</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Wind pains

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "wind pains"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month1Year> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                             rdfs:label "child 1 month–1 year"^^xsd:string;
                                                             rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#7Qin-n6Z1EicVtg7CyuO4w>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#TJe0ihX_MU-nsUrt85zLUg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#rx4LZoy8NkGXuiDuV-MSyg>;
                                                                                      nicebnf:hasTitle """<title>Innohep<tm tmtype=\"reg\" /> 10,000 units/mL</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "innohep 10,000 units/ml"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#7Qin-n6Z1EicVtg7CyuO4w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "3500 units for 1 dose, dose to be given 2 hours before surgery, then 3500 units every 24 hours."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>3500 units for 1 dose, dose to be given 2 hours before surgery, then 3500 units every 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """3500 units for 1 dose, dose to be given 2 hours before surgery, then 3500 units every 24 hours.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisGeneralSurgery>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#PHP59299>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#PHP59299> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#TJe0ihX_MU-nsUrt85zLUg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheDeviceAsAFlush>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfClottingInExtracorporealCircuits>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#PHP59299>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#rx4LZoy8NkGXuiDuV-MSyg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "initially 50 units/kg for 1 dose, dose to be given 2 hours before surgery, then 50 units/kg every 24 hours, alternatively initially 4500 units for 1 dose, dose to be given 12 hours before surgery, then 4500 units every 24 hours."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>Initially 50 units/kg for 1 dose, dose to be given 2 hours before surgery, then 50 units/kg every 24 hours, alternatively initially 4500 units for 1 dose, dose to be given 12 hours before surgery, then 4500 units every 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """Initially 50 units/kg for 1 dose, dose to be given 2 hours before surgery, then 50 units/kg every 24 hours, alternatively initially 4500 units for 1 dose, dose to be given 12 hours before surgery, then 4500 units every 24 hours.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisOrthopaedicSurgery>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-10000-unitsml#PHP59299>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfClottingInExtracorporealCircuits> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of clotting in extracorporeal circuits</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Prevention of clotting in extracorporeal circuits

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "prevention of clotting in extracorporeal circuits"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisGeneralSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis (general surgery)</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Prophylaxis of deep-vein thrombosis (general surgery)

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "prophylaxis of deep-vein thrombosis (general surgery)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfDeepVeinThrombosisOrthopaedicSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of deep-vein thrombosis (orthopaedic surgery)</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Prophylaxis of deep-vein thrombosis (orthopaedic surgery)

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "prophylaxis of deep-vein thrombosis (orthopaedic surgery)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheDeviceAsAFlush> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                               rdfs:label "to the device as a flush"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#4A87tKsXrUWzCIsEOLruag>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#ovfi9xFps0ubSDzwIg_s7g>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#s-UiZi9j80qZR0ieoJddlQ>;
                                                                                      nicebnf:hasTitle """<title>Innohep<tm tmtype=\"reg\" /> 20,000 units/mL</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "innohep 20,000 units/ml"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#4A87tKsXrUWzCIsEOLruag> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "175 units/kg once daily, dose based on early pregnancy body-weight, treatment regimens do not require anticoagulation monitoring."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>175 units/kg once daily, dose based on early pregnancy body-weight, treatment regimens do not require anticoagulation monitoring.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """175 units/kg once daily, dose based on early pregnancy body-weight, treatment regimens do not require anticoagulation monitoring.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfVenousThromboembolismInPregnancy>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#PHP59247>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#PHP59247> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#ovfi9xFps0ubSDzwIg_s7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "175 units/kg once daily for up to 6 months."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>175 units/kg once daily for up to 6 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """175 units/kg once daily for up to 6 months.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#extendedTreatmentOfVenousThromboembolismInPatientsWithSolidTumours>,
                                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfVenousThromboembolismInPatientsWithSolidTumours>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#PHP59247>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#s-UiZi9j80qZR0ieoJddlQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "175 units/kg once daily until adequate oral anticoagulation established, treatment regimens do not require anticoagulation monitoring."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>175 units/kg once daily until adequate oral anticoagulation established, treatment regimens do not require anticoagulation monitoring.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """175 units/kg once daily until adequate oral anticoagulation established, treatment regimens do not require anticoagulation monitoring.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosis>,
                                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolism>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/innohep-20000-unitsml#PHP59247>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#extendedTreatmentOfVenousThromboembolismInPatientsWithSolidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Extended treatment of venous thromboembolism in patients with solid tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                                             nicebnf:hasTextContent """Extended treatment of venous thromboembolism in patients with solid tumours

"""^^xsd:string;
                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                             rdfs:label "extended treatment of venous thromboembolism in patients with solid tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfVenousThromboembolismInPatientsWithSolidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of venous thromboembolism in patients with solid tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasTextContent """Prophylaxis of venous thromboembolism in patients with solid tumours

"""^^xsd:string;
                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                       rdfs:label "prophylaxis of venous thromboembolism in patients with solid tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfDeepVeinThrombosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of deep-vein thrombosis</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Treatment of deep-vein thrombosis

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "treatment of deep-vein thrombosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfPulmonaryEmbolism> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of pulmonary embolism</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Treatment of pulmonary embolism

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "treatment of pulmonary embolism"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfVenousThromboembolismInPregnancy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of venous thromboembolism in pregnancy</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Treatment of venous thromboembolism in pregnancy

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "treatment of venous thromboembolism in pregnancy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#NTwV58jDl0S5OfgA5-H1rg>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#0bVkiU5xz0Kljz5Qm4LG9w>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#-X1g-6Yp4ECf0ODIXeuojQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#jsPkS3QNT0mPe4w5XYJURQ>;
                                                                         nicebnf:hasTitle """<title>Instanyl<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "instanyl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#-X1g-6Yp4ECf0ODIXeuojQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid concomitant use of other nasal preparations.</p>
  <p>Patients or carers should be given advice on how to administer <i>Instanyl</i><tm tmtype=\"reg\" /> spray.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79795>;
                                                                                                nicebnf:hasTextContent """Avoid concomitant use of other nasal preparations.

Patients or carers should be given advice on how to administer Instanyl spray.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralPatientAdvice,
                                                                                                  nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#0bVkiU5xz0Kljz5Qm4LG9w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 50 micrograms, dose to be administered into one nostril, then 50 micrograms after 10 minutes if required, dose to be adjusted according to response, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 50 micrograms, dose to be administered into one nostril, then 50 micrograms after 10 minutes if required, dose to be adjusted according to response, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 50 micrograms, dose to be administered into one nostril, then 50 micrograms after 10 minutes if required, dose to be adjusted according to response, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79719>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#NTwV58jDl0S5OfgA5-H1rg> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised that <i>Instanyl</i><tm tmtype=\"reg\" /> nasal spray should be restricted for use within NHS Scotland for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short-acting opioids are unsuitable.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79815>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised that Instanyl nasal spray should be restricted for use within NHS Scotland for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short-acting opioids are unsuitable.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79719> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79785> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79795> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79815> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#jsPkS3QNT0mPe4w5XYJURQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patient should sit or stand during administration.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/instanyl#PHP79785>;
                                                                                                nicebnf:hasTextContent """Patient should sit or stand during administration.

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Breakthrough pain in patients receiving opioid therapy for chronic cancer pain

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "breakthrough pain in patients receiving opioid therapy for chronic cancer pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#Ixn7VhezSUuBQqR_FuELgg>;
                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#1aUj3AfZ90qUb7hDTb0phQ>;
                                                                            nicebnf:hasTitle """<title>IntronA<tm tmtype=\"reg\" /> pen</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "introna pen"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#1aUj3AfZ90qUb7hDTb0phQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Each 1.5-mL multidose cartridge delivers 12 doses of 0.1 mL i.e. a total of 1.2 mL.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#PHP80827>;
                                                                                                   nicebnf:hasTextContent """Each 1.5-mL multidose cartridge delivers 12 doses of 0.1 mL i.e. a total of 1.2 mL.

"""^^xsd:string;
                                                                                                   nicebnf:hasTitle "IntronA injection pen for subcutaneous injection"^^xsd:string;
                                                                                                   a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#Ixn7VhezSUuBQqR_FuELgg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "(consult local protocol)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>(consult local protocol).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """(consult local protocol).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemiaAsMonotherapyOrInCombinationWithCytarabine>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#follicularLymphoma>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#lymphOrLiverMetastasesOfCarcinoidTumour>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionInMultipleMyeloma>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#PHP80796>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#PHP80796> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-pen#PHP80827> a nicebnf:DirectionsForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct to surgery in malignant melanoma</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Adjunct to surgery in malignant melanoma

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "adjunct to surgery in malignant melanoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis B</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis B

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis b"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis C

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis c"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemiaAsMonotherapyOrInCombinationWithCytarabine> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                nicebnf:hasTextContent """Chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)

"""^^xsd:string;
                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                rdfs:label "chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#follicularLymphoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Follicular lymphoma</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Follicular lymphoma

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "follicular lymphoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hairy cell leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hairy cell leukaemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hairy cell leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#lymphOrLiverMetastasesOfCarcinoidTumour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Lymph or liver metastases of carcinoid tumour</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Lymph or liver metastases of carcinoid tumour

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "lymph or liver metastases of carcinoid tumour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionInMultipleMyeloma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission in multiple myeloma</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Maintenance of remission in multiple myeloma

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "maintenance of remission in multiple myeloma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#xbLLyxEx1EekBRWzg8w0hA>;
                                                                              nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#sbP0krrGOEa65hHj50JMig>;
                                                                              nicebnf:hasTitle """<title>IntronA<tm tmtype=\"reg\" /> vials</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "introna vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#PHP80797> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#PHP80828> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#sbP0krrGOEa65hHj50JMig> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>IntronA</i>
    <tm tmtype=\"reg\" /> injection vials for subcutaneous injection or intravenous infusion.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#PHP80828>;
                                                                                                     nicebnf:hasTextContent """IntronA injection vials for subcutaneous injection or intravenous infusion.

"""^^xsd:string;
                                                                                                     a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#xbLLyxEx1EekBRWzg8w0hA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "(consult local protocol)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>(consult local protocol).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """(consult local protocol).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntravenousInfusion>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemiaAsMonotherapyOrInCombinationWithCytarabine>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#follicularLymphoma>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#lymphOrLiverMetastasesOfCarcinoidTumour>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionInMultipleMyeloma>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/introna-vials#PHP80797>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct to surgery in malignant melanoma</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Adjunct to surgery in malignant melanoma

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "adjunct to surgery in malignant melanoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis B</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis B

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis b"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis C

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis c"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemiaAsMonotherapyOrInCombinationWithCytarabine> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                nicebnf:hasTextContent """Chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)

"""^^xsd:string;
                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                rdfs:label "chronic myelogenous leukaemia (as monotherapy or in combination with cytarabine)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#follicularLymphoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Follicular lymphoma</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Follicular lymphoma

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "follicular lymphoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hairy cell leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hairy cell leukaemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hairy cell leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#lymphOrLiverMetastasesOfCarcinoidTumour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Lymph or liver metastases of carcinoid tumour</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Lymph or liver metastases of carcinoid tumour

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "lymph or liver metastases of carcinoid tumour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionInMultipleMyeloma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission in multiple myeloma</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Maintenance of remission in multiple myeloma

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "maintenance of remission in multiple myeloma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                          rdfs:label "by subcutaneous injection, or by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/invita-d3-25000units1ml-oral-solution-consilient-health-ltd> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/invita-d3-25000units1ml-oral-solution-consilient-health-ltd#R4QHqa__gE-vdO6n-KzO2g>;
                                                                                                                            nicebnf:hasTitle """<title>InVita D3<tm tmtype=\"reg\" /> 25,000units/1ml oral solution (Consilient Health Ltd)</title>"""^^<rdf:XMLLiteral>;
                                                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                            rdfs:label "invita d3 25,000units/1ml oral solution (consilient health ltd)"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/invita-d3-25000units1ml-oral-solution-consilient-health-ltd#PHP105060> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/invita-d3-25000units1ml-oral-solution-consilient-health-ltd#R4QHqa__gE-vdO6n-KzO2g> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>
  <p>May be mixed with a small amount of cold or lukewarm food immediately before administration.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withOralUse>;
                                                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/invita-d3-25000units1ml-oral-solution-consilient-health-ltd#PHP105060>;
                                                                                                                                                   nicebnf:hasTextContent """With oral use

May be mixed with a small amount of cold or lukewarm food immediately before administration.

"""^^xsd:string;
                                                                                                                                                   a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Route#oral> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                          rdfs:label "oral"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withOralUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#oral>;
                                                       a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "with oral use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#RGISMOQWwUymkIHjN0dx-A>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#wA6BZWo8WEeXW2aMylQ0Pw>;
                                                                       nicebnf:hasTitle """<title>Ipocol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "ipocol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#PHP83258> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#RGISMOQWwUymkIHjN0dx-A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#PHP83258>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#wA6BZWo8WEeXW2aMylQ0Pw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "1.2–2.4 g daily in divided doses."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>1.2–2.4 g daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """1.2–2.4 g daily in divided doses.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ipocol#PHP83258>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#nm-6hl4sO0ahX_U_xM6VqQ>,
                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#uIGgh7VaX0yJMTAQsIXsXg>;
                                                                              nicebnf:hasTitle """<title>Ironorm<tm tmtype=\"reg\" /> Drops</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "ironorm drops"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#PHP107003> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#nm-6hl4sO0ahX_U_xM6VqQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "4 ml 1–2 times a day."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>4 mL 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """4 mL 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#PHP107003>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#uIGgh7VaX0yJMTAQsIXsXg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "2.4–4.8 ml daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>2.4–4.8 mL daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """2.4–4.8 mL daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ironorm-drops#PHP107003>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaProphylactic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron-deficiency anaemia, prophylactic</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Iron-deficiency anaemia, prophylactic

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "iron-deficiency anaemia, prophylactic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ironDeficiencyAnaemiaTherapeutic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Iron deficiency anaemia, therapeutic</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Iron deficiency anaemia, therapeutic

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "iron deficiency anaemia, therapeutic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/isib-60xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/isib-60xl#CpF6CTx1rEyDn5CNwslTOA>;
                                                                          nicebnf:hasTitle """<title>Isib<tm tmtype=\"reg\" /> 60XL</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "isib 60xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isib-60xl#CpF6CTx1rEyDn5CNwslTOA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 0.5 tablet daily for 2–4 days, to be taken if headache occurs, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily for 2–4 days, to be taken if headache occurs, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 0.5 tablet daily for 2–4 days, to be taken if headache occurs, then 1 tablet daily, increased if necessary to 2 tablets daily, dose to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/isib-60xl#PHP63861>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isib-60xl#PHP63861> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ismo-retard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ismo-retard#oX3amdIje06pDwLb6j4_sQ>;
                                                                            nicebnf:hasTitle """<title>Ismo Retard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "ismo retard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ismo-retard#PHP63471> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ismo-retard#oX3amdIje06pDwLb6j4_sQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "1 tablet daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>1 tablet daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """1 tablet daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ismo-retard#PHP63471>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/isodur> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/isodur#nKo5zOT0rEWkgEfn1cqvHw>;
                                                                       nicebnf:hasTitle """<title>Isodur<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "isodur"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isodur#PHP62963> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isodur#nKo5zOT0rEWkgEfn1cqvHw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "25–50 mg daily, then increased if necessary to 50–100 mg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>25–50 mg daily, then increased if necessary to 50–100 mg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """25–50 mg daily, then increased if necessary to 50–100 mg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/isodur#PHP62963>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/isotard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/isotard#Jc7iO31PKUKVCiuATioNhw>;
                                                                        nicebnf:hasTitle """<title>Isotard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "isotard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isotard#Jc7iO31PKUKVCiuATioNhw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "25–60 mg daily, if headaches occur with 60 mg tablet, half a 60 mg tablet may be given for 2–4 days, then increased if necessary to 50–120 mg daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>25–60 mg daily, if headaches occur with 60 mg tablet, half a 60 mg tablet may be given for 2–4 days, then increased if necessary to 50–120 mg daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """25–60 mg daily, if headaches occur with 60 mg tablet, half a 60 mg tablet may be given for 2–4 days, then increased if necessary to 50–120 mg daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/isotard#PHP62562>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/isotard#PHP62562> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#bIvOImH1jUScIH9ViApMaA>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#O9KC6giFB0-DRBVX3FOoew>;
                                                                               nicebnf:hasTitle """<title>Ispagel<tm tmtype=\"reg\" /> Orange</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "ispagel orange"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#O9KC6giFB0-DRBVX3FOoew> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 sachet equivalent to 2 level 5 ml spoonsful.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#PHP84055>;
                                                                                                      nicebnf:hasTextContent """Dose equivalence and conversion1 sachet equivalent to 2 level 5 ml spoonsful.

"""^^xsd:string;
                                                                                                      a nicebnf:DoseEquivalence,
                                                                                                        nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#PHP84055> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#bIvOImH1jUScIH9ViApMaA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                         rdfs:label "2.5–5 ml twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>2.5–5 mL twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """2.5–5 mL twice daily, dose to be given as a half or whole level spoonful in water, preferably after meals.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                         rdfs:label "1 sachet 1–3 times a day, dose to be given in water preferably after meals, alternatively 10 ml 1–3 times a day, dose to be given as level spoonsful in water, preferably after meals."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 sachet 1–3 times a day, dose to be given in water preferably after meals, alternatively 10 mL 1–3 times a day, dose to be given as level spoonsful in water, preferably after meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 sachet 1–3 times a day, dose to be given in water preferably after meals, alternatively 10 mL 1–3 times a day, dose to be given as level spoonsful in water, preferably after meals.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "1 sachet 1–3 times a day, dose to be made up in water, preferably taken after food."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 sachet 1–3 times a day, dose to be made up in water, preferably taken after food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 sachet 1–3 times a day, dose to be made up in water, preferably taken after food.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ispagel-orange#PHP84055>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#SUYUR90lHk6yPvhBqNK9eg>;
                                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#_wcrJuwFlU-PCkczLxGj9Q>;
                                                                                                  nicebnf:hasTitle """<title>Jaydess <tm tmtype=\"reg\" /> 13.5mg intrauterine device</title>"""^^<rdf:XMLLiteral>;
                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                  rdfs:label "jaydess  13.5mg intrauterine device"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#PHP107904> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#PHP107930> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#SUYUR90lHk6yPvhBqNK9eg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                                            rdfs:label "insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester termination; postpartum insertions should be delayed until at least 6 weeks after delivery (12 weeks if uterus involution is substantially delayed); effective for 3 years."^^xsd:string ; 
                                                                                                                                            nicebnf:hasDitaContent "<p>Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester termination; postpartum insertions should be delayed until at least 6 weeks after delivery (12 weeks if uterus involution is substantially delayed); effective for 3 years.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                            nicebnf:hasTextContent """Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester termination; postpartum insertions should be delayed until at least 6 weeks after delivery (12 weeks if uterus involution is substantially delayed); effective for 3 years.

"""^^xsd:string ; 
                                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#contraception>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#PHP107904>;
                                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#_wcrJuwFlU-PCkczLxGj9Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>When system is removed (and not immediately replaced) and pregnancy is not desired, remove within 7 days of the onset of menstruation; additional precautions (e.g. barrier methods) should be used if the system is removed at some other time during the cycle and there is intercourse within 7 days.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jaydess-135mg-intrauterine-device#PHP107930>;
                                                                                                                         nicebnf:hasTextContent """When system is removed (and not immediately replaced) and pregnancy is not desired, remove within 7 days of the onset of menstruation; additional precautions (e.g. barrier methods) should be used if the system is removed at some other time during the cycle and there is intercourse within 7 days.

"""^^xsd:string;
                                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#contraception> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Contraception</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Contraception

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "contraception"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                           rdfs:label "females of childbearing potential"^^xsd:string;
                                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#AZC5aRx1aUuZJFGl-QEI3Q>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#V3VLK0ID3EGP_o2PcoTUiw>;
                                                                                    nicebnf:hasTitle """<title>Jext<tm tmtype=\"reg\" /> 150 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "jext 150 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#AZC5aRx1aUuZJFGl-QEI3Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> ; 
                                                                                                                              rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> ; 
                                                                                                                              rdfs:label "150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """150 micrograms, then 150 micrograms after 5–15 minutes as required, on the basis of a dose of 10 micrograms/kg, 300 micrograms may be more appropriate for some children.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#PHP83338>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#PHP83338> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#PHP83365> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#V3VLK0ID3EGP_o2PcoTUiw> nicebnf:hasDitaContent """<sectiondiv>
  <p>1.25 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-150-micrograms#PHP83365>;
                                                                                                           nicebnf:hasTextContent """1.25 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                           a nicebnf:GeneralPatientAdvice,
                                                                                                             nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight1530Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "child (body-weight 15–30 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeightUpTo15Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "child (body-weight up to 15 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#Beu905iLZkqMRe0NNY18ig>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#fr3fq1RYYUu88MfU1teYBg>;
                                                                                    nicebnf:hasTitle """<title>Jext<tm tmtype=\"reg\" /> 300 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "jext 300 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#Beu905iLZkqMRe0NNY18ig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> ; 
                                                                                                                              rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> ; 
                                                                                                                              rdfs:label "300 micrograms, then 300 micrograms after 5–15 minutes as required."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>300 micrograms, then 300 micrograms after 5–15 minutes as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """300 micrograms, then 300 micrograms after 5–15 minutes as required.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#PHP83382>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#PHP83382> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#PHP83399> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#fr3fq1RYYUu88MfU1teYBg> nicebnf:hasDitaContent """<sectiondiv>
  <p>1.1 mL of the solution remains in the auto-injector device after use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jext-300-micrograms#PHP83399>;
                                                                                                           nicebnf:hasTextContent """1.1 mL of the solution remains in the auto-injector device after use.

"""^^xsd:string;
                                                                                                           a nicebnf:GeneralPatientAdvice,
                                                                                                             nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteAnaphylaxisForSelfAdministration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute anaphylaxis (for self-administration)</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Acute anaphylaxis (for self-administration)

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "acute anaphylaxis (for self-administration)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#childBodyWeight30KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "child (body-weight 30 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/jinarc> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/jinarc#KiiiLK5E_06hOPStnavNuQ>;
                                                                       nicebnf:hasTitle """<title>Jinarc <tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "jinarc"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jinarc#KiiiLK5E_06hOPStnavNuQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 60 mg daily in 2 divided doses for at least a week, 45 mg in the morning before breakfast, and then 15 mg taken 8 hours later; increased to 90 mg daily in 2 divided doses for at least a week, 60 mg n the morning before breakfast, and then 30 mg taken 8 hours later, then increased if tolerated to 120 mg daily in 2 divided doses, 90 mg in the morning before breakfast, and then 30 mg taken 8 hours later, dose titration should be performed cautiously; patients may down-titrate to lower doses based on tolerability."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 60 mg daily in 2 divided doses for at least a week, 45 mg in the morning before breakfast, and then 15 mg taken 8 hours later; increased to 90 mg daily in 2 divided doses for at least a week, 60 mg n the morning before breakfast, and then 30 mg taken 8 hours later, then increased if tolerated to 120 mg daily in 2 divided doses, 90 mg in the morning before breakfast, and then 30 mg taken 8 hours later, dose titration should be performed cautiously; patients may down-titrate to lower doses based on tolerability.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 60 mg daily in 2 divided doses for at least a week, 45 mg in the morning before breakfast, and then 15 mg taken 8 hours later; increased to 90 mg daily in 2 divided doses for at least a week, 60 mg n the morning before breakfast, and then 30 mg taken 8 hours later, then increased if tolerated to 120 mg daily in 2 divided doses, 90 mg in the morning before breakfast, and then 30 mg taken 8 hours later, dose titration should be performed cautiously; patients may down-titrate to lower doses based on tolerability.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#autosomalDominantPolycysticKidneyDiseaseInAdultsWithCkdStage1To3AtInitiationOfTreatmentWithEvidenceOfRapidlyProgressingDiseaseInitiatedByASpecialist>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/jinarc#PHP109107>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/jinarc#PHP109107> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#autosomalDominantPolycysticKidneyDiseaseInAdultsWithCkdStage1To3AtInitiationOfTreatmentWithEvidenceOfRapidlyProgressingDiseaseInitiatedByASpecialist> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Autosomal dominant polycystic kidney disease in adults with CKD stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease (initiated by a specialist)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                               nicebnf:hasTextContent """Autosomal dominant polycystic kidney disease in adults with CKD stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease (initiated by a specialist)

"""^^xsd:string;
                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                               rdfs:label "autosomal dominant polycystic kidney disease in adults with ckd stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease (initiated by a specialist)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/kapake-15500> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/kapake-15500#HKLjN-sbsEqi1UEQdiKmwQ>;
                                                                             nicebnf:hasTitle """<title>Kapake<tm tmtype=\"reg\" /> 15/500</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "kapake 15/500"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kapake-15500#HKLjN-sbsEqi1UEQdiKmwQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "2 tablets every 4–6 hours as required; maximum 8 tablets per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>2 tablets every 4–6 hours as required; maximum 8 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """2 tablets every 4–6 hours as required; maximum 8 tablets per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePain>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/kapake-15500#PHP79953>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kapake-15500#PHP79953> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate pain</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Mild to moderate pain

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "mild to moderate pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/kenalog-vials> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/kenalog-vials#1U0pG1GfmECri4IXnQ8qKw>;
                                                                              nicebnf:hasTitle """<title>Kenalog<tm tmtype=\"reg\" /> vials</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "kenalog vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kenalog-vials#1U0pG1GfmECri4IXnQ8qKw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "5–40 mg (max. per dose 80 mg), for further details consult product literature, select dose according to size. for doses below 5 mg use adcortylintra-articular/intradermal injection, where appropriate dose may be repeated when relapse occurs."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent """<p>5–40 mg (max. per dose 80 mg), for further details consult product literature, select dose according to size. For doses below 5 mg use <i>Adcortyl</i><tm tmtype=\"reg\" /><i>Intra-articular/Intradermal</i> injection, where appropriate dose may be repeated when relapse occurs.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """5–40 mg (max. per dose 80 mg), for further details consult product literature, select dose according to size. For doses below 5 mg use AdcortylIntra-articular/Intradermal injection, where appropriate dose may be repeated when relapse occurs.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/kenalog-vials#PHP97428>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kenalog-vials#PHP97428> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#localInflammationOfJointsAndSoftTissues> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Local inflammation of joints and soft tissues</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Local inflammation of joints and soft tissues

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "local inflammation of joints and soft tissues"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArticularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                     rdfs:label "by intra-articular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#OrkgS1hdQEiRYE16bZqq_w>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#pVn6m9BDKEujV22uF3mJNQ>;
                                                                                nicebnf:hasTitle """<title>Ketovite<tm tmtype=\"reg\" /> liquid</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "ketovite liquid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#OrkgS1hdQEiRYE16bZqq_w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "5 ml daily, use with ketovitetablets for complete vitamin supplementation."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent """<p>5 mL daily, use with <i>Ketovite</i><tm tmtype=\"reg\" /><i>Tablets</i> for complete vitamin supplementation.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """5 mL daily, use with KetoviteTablets for complete vitamin supplementation.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctInRestrictedSpecialisedOrSyntheticDiets>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVitaminDeficiencyInDisordersOfCarbohydrateOrAminoAcidMetabolism>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#PHP107447>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#PHP107447> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#PHP107478> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#pVn6m9BDKEujV22uF3mJNQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Ketovite</i>
    <tm tmtype=\"reg\" /> liquid may be mixed with milk, cereal, or fruit juice.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-liquid#PHP107478>;
                                                                                                       nicebnf:hasTextContent """Ketovite liquid may be mixed with milk, cereal, or fruit juice.

"""^^xsd:string;
                                                                                                       a nicebnf:GeneralPatientAdvice,
                                                                                                         nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctInRestrictedSpecialisedOrSyntheticDiets> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct in restricted, specialised, or synthetic diets</p>"""^^<rdf:XMLLiteral>;
                                                                                         nicebnf:hasTextContent """Adjunct in restricted, specialised, or synthetic diets

"""^^xsd:string;
                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                         rdfs:label "adjunct in restricted, specialised, or synthetic diets"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVitaminDeficiencyInDisordersOfCarbohydrateOrAminoAcidMetabolism> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism</p>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasTextContent """Prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism

"""^^xsd:string;
                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                      rdfs:label "prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#KA149iz8XECgGduPibtKIg>;
                                                                                 nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#nhbEtdKeOkGPChU9zkNkYw>;
                                                                                 nicebnf:hasTitle """<title>Ketovite<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "ketovite tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#KA149iz8XECgGduPibtKIg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "1 tablet 3 times a day, use with ketoviteliquid for complete vitamin supplementation."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent """<p>1 tablet 3 times a day, use with <i>Ketovite</i><tm tmtype=\"reg\" /><i>Liquid</i> for complete vitamin supplementation.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """1 tablet 3 times a day, use with KetoviteLiquid for complete vitamin supplementation.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctInRestrictedSpecialisedOrSyntheticDiets>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVitaminDeficiencyInDisordersOfCarbohydrateOrAminoAcidMetabolism>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#PHP107448>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#PHP107448> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#PHP107476> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#nhbEtdKeOkGPChU9zkNkYw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablets may be crushed immediately before use.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ketovite-tablets#PHP107476>;
                                                                                                        nicebnf:hasTextContent """Tablets may be crushed immediately before use.

"""^^xsd:string;
                                                                                                        a nicebnf:GeneralPatientAdvice,
                                                                                                          nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctInRestrictedSpecialisedOrSyntheticDiets> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct in restricted, specialised, or synthetic diets</p>"""^^<rdf:XMLLiteral>;
                                                                                         nicebnf:hasTextContent """Adjunct in restricted, specialised, or synthetic diets

"""^^xsd:string;
                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                         rdfs:label "adjunct in restricted, specialised, or synthetic diets"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVitaminDeficiencyInDisordersOfCarbohydrateOrAminoAcidMetabolism> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism</p>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasTextContent """Prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism

"""^^xsd:string;
                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                      rdfs:label "prevention of vitamin deficiency in disorders of carbohydrate or amino-acid metabolism"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/kiovig> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/kiovig#HqSouhewKU6k41eQcK0j_g>;
                                                                       nicebnf:hasTitle """<title>Kiovig<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "kiovig"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kiovig#HqSouhewKU6k41eQcK0j_g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Use Glucose 5% intravenous infusion if dilution prior to infusion is required.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/kiovig#PHP97886>;
                                                                                              nicebnf:hasTextContent """Use Glucose 5% intravenous infusion if dilution prior to infusion is required.

"""^^xsd:string;
                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kiovig#PHP97886> a nicebnf:DirectionsForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliofem> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/kliofem#vmX8dYdHFk2pwvurc9BPQA>;
                                                                        nicebnf:hasTitle """<title>Kliofem<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "kliofem"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliofem#PHP96035> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliofem#vmX8dYdHFk2pwvurc9BPQA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical hrt."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical HRT.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical HRT.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/kliofem#PHP96035>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliovance> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/kliovance#3Y8pN9-uc0e9cGoCO6K4hQ>;
                                                                          nicebnf:hasTitle """<title>Kliovance<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "kliovance"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliovance#3Y8pN9-uc0e9cGoCO6K4hQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical hrt."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical HRT.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 tablet daily continuously, to be started at end of scheduled bleed if changing from cyclical HRT.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/kliovance#PHP95909>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/kliovance#PHP95909> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#QMtKLBoHfU278Xpw2y-xMg>;
                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#FNlJ6napy0WLbKnQx-lsjg>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#L2ISYvEcFU-5iQNoq4OzzQ>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#dcq_X380Mk6LBRN6wo79BA>;
                                                                            nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#urNQpLGMoEGjUdbZ3hIMsQ>;
                                                                            nicebnf:hasTitle """<title>Konakion<tm tmtype=\"reg\" /> MM</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "konakion mm"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#FNlJ6napy0WLbKnQx-lsjg> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>
  <p>For <i>intravenous infusion</i> (<i>Konakion</i><tm tmtype=\"reg\" /><i>MM</i>), give intermittently in Glucose 5%; dilute with 55 mL; may be injected into lower part of infusion apparatus.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80980>;
                                                                                                   nicebnf:hasTextContent """With intravenous use

For intravenous infusion (KonakionMM), give intermittently in Glucose 5%; dilute with 55 mL; may be injected into lower part of infusion apparatus.

"""^^xsd:string;
                                                                                                   a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#L2ISYvEcFU-5iQNoq4OzzQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Caution—glycocholic acid may displace bilirubin.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80965>;
                                                                                                   nicebnf:hasTextContent """Caution—glycocholic acid may displace bilirubin.

"""^^xsd:string;
                                                                                                   a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80962> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80965> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80972> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80980> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#QMtKLBoHfU278Xpw2y-xMg> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#reduceDoseInElderly>;
                                                                                                   nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">reduce dose in elderly</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80962>;
                                                                                                   nicebnf:hasTextContent """reduce dose in elderly

"""^^xsd:string;
                                                                                                   a nicebnf:CautionsGroup,
                                                                                                     nicebnf:CautionsWithRoutes.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#dcq_X380Mk6LBRN6wo79BA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Konakion</i>
    <tm tmtype=\"reg\" />
    <i>MM</i> may be administered by slow intravenous injection or by intravenous infusion in glucose 5%; <b>not</b> for intramuscular injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80980>;
                                                                                                   nicebnf:hasTextContent """KonakionMM may be administered by slow intravenous injection or by intravenous infusion in glucose 5%; not for intramuscular injection.

"""^^xsd:string;
                                                                                                   a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#urNQpLGMoEGjUdbZ3hIMsQ> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Anaphylactoid reactions</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#notKnown>;
                                                                                                   nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#anaphylactoidReactions>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/konakion-mm#PHP80972>;
                                                                                                   nicebnf:hasTextContent """Anaphylactoid reactions

"""^^xsd:string;
                                                                                                   a nicebnf:GeneralSideEffects,
                                                                                                     nicebnf:SideEffectGroup,
                                                                                                     nicebnf:SideEffectsGroup.
<http://ld.nice.org.uk/ns/bnf/Caution#reduceDoseInElderly> nicebnf:hasDitaContent """<ph outputclass=\"caution\">reduce dose in elderly</ph>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent "reduce dose in elderly"^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                           rdfs:label "reduce dose in elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#notKnown> a nicebnf:Frequency;
                                                  rdfs:label "frequency not known"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Route#intravenous> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                                 rdfs:label "intravenous"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#anaphylactoidReactions> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Anaphylactoid reactions</ph>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent "Anaphylactoid reactions"^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                 rdfs:label "anaphylactoid reactions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#intravenous>;
                                                              a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                              rdfs:label "with intravenous use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/laryngojet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/laryngojet#zrGR-1eZIkCExZpkTpMIqw>;
                                                                           nicebnf:hasTitle """<title>Laryngojet<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "laryngojet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/laryngojet#PHP82756> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/laryngojet#zrGR-1eZIkCExZpkTpMIqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "40–200 mg, to be given as a single dose sprayed, instilled (if a cavity), or applied with a swab (reduce dose according to size, age and condition of patient); usual dose 160 mg."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>40–200 mg, to be given as a single dose sprayed, instilled (if a cavity), or applied with a swab (reduce dose according to size, age and condition of patient); usual dose 160 mg.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """40–200 mg, to be given as a single dose sprayed, instilled (if a cavity), or applied with a swab (reduce dose according to size, age and condition of patient); usual dose 160 mg.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anaesthesiaOfMucousMembranesOfOropharynxTracheaOrRespiratoryTract>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/laryngojet#PHP82756>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anaesthesiaOfMucousMembranesOfOropharynxTracheaOrRespiratoryTract> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Anaesthesia of mucous membranes of oropharynx, trachea, or respiratory tract</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Anaesthesia of mucous membranes of oropharynx, trachea, or respiratory tract

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "anaesthesia of mucous membranes of oropharynx, trachea, or respiratory tract"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                             rdfs:label "to mucous membranes"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/leustat> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/leustat#c1T9xrhmXkSAMCRbyQpocg>;
                                                                        nicebnf:hasTitle """<title>Leustat<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "leustat"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/leustat#PHP81306> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/leustat#c1T9xrhmXkSAMCRbyQpocg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature or local protocols)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature or local protocols).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature or local protocols).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bCellChronicLymphocyticLeukaemiaInPatientsWhoHaveFailedToRespondToStandardRegimensContainingAnAlkylatingAgent>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/leustat#PHP81306>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#bCellChronicLymphocyticLeukaemiaInPatientsWhoHaveFailedToRespondToStandardRegimensContainingAnAlkylatingAgent> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">B-cell chronic lymphocytic leukaemia in patients who have failed to respond to standard regimens containing an alkylating agent</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                        nicebnf:hasTextContent """B-cell chronic lymphocytic leukaemia in patients who have failed to respond to standard regimens containing an alkylating agent

"""^^xsd:string;
                                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                        rdfs:label "b-cell chronic lymphocytic leukaemia in patients who have failed to respond to standard regimens containing an alkylating agent"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hairy cell leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hairy cell leukaemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hairy cell leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/levitra-orodispersible-tablets> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/levitra-orodispersible-tablets#gxSlSn6Dn0yS8CvqyOCfdg>;
                                                                                               nicebnf:hasTitle """<title>Levitra<tm tmtype=\"reg\" /> orodispersible tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                                               rdfs:label "levitra orodispersible tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levitra-orodispersible-tablets#PHP80845> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levitra-orodispersible-tablets#gxSlSn6Dn0yS8CvqyOCfdg> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (September 2011) that vardenafil orodispersible tablets (<i>Levitra</i><tm tmtype=\"reg\" />) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/levitra-orodispersible-tablets#PHP80845>;
                                                                                                                      nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (September 2011) that vardenafil orodispersible tablets (Levitra) are accepted for restricted use within NHS Scotland for men for whom an orodispersible tablet is an appropriate formulation.

"""^^xsd:string;
                                                                                                                      a nicebnf:FundingDecision,
                                                                                                                        nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/levonelle-one-step> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/levonelle-one-step#QVYUPCBOSE2M8j2flgnX5Q>;
                                                                                   nicebnf:hasTitle """<title>Levonelle<tm tmtype=\"reg\" /> One Step</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "levonelle one step"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levonelle-one-step#PHP79582> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levonelle-one-step#QVYUPCBOSE2M8j2flgnX5Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Can be sold to women over 16 years; when supplying emergency contraception to the public, pharmacists should refer to guidance issued by the Royal Pharmaceutical Society.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/levonelle-one-step#PHP79582>;
                                                                                                          nicebnf:hasTextContent """Can be sold to women over 16 years; when supplying emergency contraception to the public, pharmacists should refer to guidance issued by the Royal Pharmaceutical Society.

"""^^xsd:string;
                                                                                                          a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/levosert-20micrograms24hours-intrauterine-device> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/levosert-20micrograms24hours-intrauterine-device#hrxB4q32iUWisHoBTAtgYg>;
                                                                                                                 nicebnf:hasTitle """<title>Levosert <tm tmtype=\"reg\" /> 20micrograms/24hours intrauterine device</title>"""^^<rdf:XMLLiteral>;
                                                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                 rdfs:label "levosert  20micrograms/24hours intrauterine device"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levosert-20micrograms24hours-intrauterine-device#PHP108699> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/levosert-20micrograms24hours-intrauterine-device#hrxB4q32iUWisHoBTAtgYg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                                                           rdfs:label "insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester abortion; postpartum insertions should be delayed until at least 6 weeks after delivery; effective for 3 years."^^xsd:string ; 
                                                                                                                                                           nicebnf:hasDitaContent "<p>Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester abortion; postpartum insertions should be delayed until at least 6 weeks after delivery; effective for 3 years.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                           nicebnf:hasTextContent """Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or immediately after first-trimester abortion; postpartum insertions should be delayed until at least 6 weeks after delivery; effective for 3 years.

"""^^xsd:string ; 
                                                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraUterineAdministration>];
                                                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#contraception>,
                                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#menorrhagia>;
                                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/levosert-20micrograms24hours-intrauterine-device#PHP108699>;
                                                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#contraception> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Contraception</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Contraception

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "contraception"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#menorrhagia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menorrhagia</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Menorrhagia

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "menorrhagia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                           rdfs:label "females of childbearing potential"^^xsd:string;
                                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraUterineAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by intra-uterine administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#gAMyHyma3E-XVu5ja1BwKA>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#9B3rI6nMakKXFIZMiqfsSw>;
                                                                          nicebnf:hasTitle """<title>Li-Liquid<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "li-liquid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#9B3rI6nMakKXFIZMiqfsSw> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>Lithium citrate tetrahydrate 509 mg is equivalent to lithium carbonate 200 mg.</p>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#PHP79219>;
                                                                                                 nicebnf:hasTextContent """Dose equivalence and conversionLithium citrate tetrahydrate 509 mg is equivalent to lithium carbonate 200 mg.

Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseEquivalence,
                                                                                                   nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#PHP79219> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#gAMyHyma3E-XVu5ja1BwKA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> ; 
                                                                                                                    rdfs:label "initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> ; 
                                                                                                                    rdfs:label "initially 1.018–3.054 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1.018–3.054 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 1.018–3.054 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/li-liquid#PHP79219>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Treatment and prophylaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "treatment and prophylaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Treatment and prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "treatment and prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment and prophylaxis of mania

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment and prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Treatment and prophylaxis of recurrent depression

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "treatment and prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 50 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 49 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#4MMkv3XfHkGoUOsV0yAy9w>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#_iyBlMgsiEanqLgU7ZzWIA>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#shXJRX_1uUCgpW9FLPdvvA>;
                                                                         nicebnf:hasTitle """<title>Liskonum<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "liskonum"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#4MMkv3XfHkGoUOsV0yAy9w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 450 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 450 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 450 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                   rdfs:label "initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#PHP79386>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#PHP79386> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#_iyBlMgsiEanqLgU7ZzWIA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 450–675 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 450–675 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 450–675 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                   rdfs:label "initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 225 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#PHP79386>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#shXJRX_1uUCgpW9FLPdvvA> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/liskonum#PHP79386>;
                                                                                                nicebnf:hasTextContent """Dose equivalence and conversionPreparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                a nicebnf:DoseEquivalence,
                                                                                                  nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Prophylaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "prophylaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Prophylaxis of mania

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Prophylaxis of recurrent depression

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Treatment of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "treatment of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Treatment of bipolar disorder

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "treatment of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mania</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Treatment of mania

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "treatment of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment of recurrent depression

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/litak> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/litak#1OGP6MoURESdDzhEvkY6hA>;
                                                                      nicebnf:hasTitle """<title>Litak<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "litak"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/litak#1OGP6MoURESdDzhEvkY6hA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "(consult product literature or local protocols)."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>(consult product literature or local protocols).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """(consult product literature or local protocols).

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/litak#PHP81322>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/litak#PHP81322> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hairy cell leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hairy cell leukaemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hairy cell leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/lmx-4> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/lmx-4#IRVL6TYeKkyLh6qvU4JvMw>;
                                                                      nicebnf:hasTitle """<title>LMX 4<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "lmx 4"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lmx-4#IRVL6TYeKkyLh6qvU4JvMw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child12Months> ; 
                                                                                                                rdfs:label "apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 60 minutes, remove cream with gauze and perform procedure after approximately 5 minutes."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 60 minutes, remove cream with gauze and perform procedure after approximately 5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 60 minutes, remove cream with gauze and perform procedure after approximately 5 minutes.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child311Months> ; 
                                                                                                                rdfs:label "apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 4 hours, remove cream with gauze and perform procedure after approximately 5 minutes."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 4 hours, remove cream with gauze and perform procedure after approximately 5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Apply up to 1 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 4 hours, remove cream with gauze and perform procedure after approximately 5 minutes.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                rdfs:label "apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Apply 1–2.5 g, apply thick layer to small area (2.5 cm × 2.5 cm) of non-irritated skin at least 30 minutes before procedure; may be applied under an occlusive dressing; max. application time 5 hours, remove cream with gauze and perform procedure after approximately 5 minutes.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anaesthesiaBeforeVenousCannulationOrVenepuncture>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/lmx-4#PHP82828>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lmx-4#PHP82828> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#anaesthesiaBeforeVenousCannulationOrVenepuncture> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Anaesthesia before venous cannulation or venepuncture</p>"""^^<rdf:XMLLiteral>;
                                                                                           nicebnf:hasTextContent """Anaesthesia before venous cannulation or venepuncture

"""^^xsd:string;
                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                           rdfs:label "anaesthesia before venous cannulation or venepuncture"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child12Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–2 months"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child311Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 3–11 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/load-375> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/load-375#do6GphlbH0apLogr2XpBvQ>;
                                                                         nicebnf:hasTitle """<title>Load<tm tmtype=\"reg\" /> 375</title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "load 375"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/load-375#PHP105654> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/load-375#do6GphlbH0apLogr2XpBvQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length over 7 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/load-375#PHP105654>;
                                                                                                nicebnf:hasTextContent """For uterine length over 7 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/loron-520> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/loron-520#PTvZ7FWF2U-8rUecMi-50w>;
                                                                          nicebnf:hasTitle """<title>Loron 520<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "loron 520"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/loron-520#PHP82155> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/loron-520#PTvZ7FWF2U-8rUecMi-50w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 2 tablets daily in 1–2 divided doses, increased if necessary up to 4 tablets daily."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 2 tablets daily in 1–2 divided doses, increased if necessary up to 4 tablets daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 2 tablets daily in 1–2 divided doses, increased if necessary up to 4 tablets daily.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteolyticLesionsHypercalcaemiaAndBonePainAssociatedWithSkeletalMetastasesInPatientsWithBreastCancerOrMultipleMyeloma>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/loron-520#PHP82155>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#osteolyticLesionsHypercalcaemiaAndBonePainAssociatedWithSkeletalMetastasesInPatientsWithBreastCancerOrMultipleMyeloma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteolytic lesions, hypercalcaemia and bone pain associated with skeletal metastases in patients with breast cancer or multiple myeloma</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                nicebnf:hasTextContent """Osteolytic lesions, hypercalcaemia and bone pain associated with skeletal metastases in patients with breast cancer or multiple myeloma

"""^^xsd:string;
                                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                rdfs:label "osteolytic lesions, hypercalcaemia and bone pain associated with skeletal metastases in patients with breast cancer or multiple myeloma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/lpl-634> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/lpl-634#Ze9owzvl90yIT-7REKshxw>;
                                                                        nicebnf:hasTitle """<title>LPL 63.4<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "lpl 63.4"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lpl-634#PHP105897> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lpl-634#Ze9owzvl90yIT-7REKshxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                  rdfs:label "0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                  rdfs:label "1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/lpl-634#PHP105897>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Dry skin conditions

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "dry skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/lubion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/lubion#Y6Lk9oNSI0aAZOMdCQtSIQ>;
                                                                       nicebnf:hasTitle """<title>Lubion<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "lubion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lubion#PHP101560> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lubion#Y6Lk9oNSI0aAZOMdCQtSIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "25 mg once daily from day of oocyte retrieval up to week 12 of pregnancy."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>25 mg once daily from day of oocyte retrieval up to week 12 of pregnancy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """25 mg once daily from day of oocyte retrieval up to week 12 of pregnancy.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#supplementationOfLutealPhaseDuringAssistedReproductiveTechnologyArtTreatmentInWomenForWhomVaginalPreparationsAreInappropriate>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/lubion#PHP101560>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#supplementationOfLutealPhaseDuringAssistedReproductiveTechnologyArtTreatmentInWomenForWhomVaginalPreparationsAreInappropriate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Supplementation of luteal phase during assisted reproductive technology (ART) treatment in women for whom vaginal preparations are inappropriate</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                        nicebnf:hasTextContent """Supplementation of luteal phase during assisted reproductive technology (ART) treatment in women for whom vaginal preparations are inappropriate

"""^^xsd:string;
                                                                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                        rdfs:label "supplementation of luteal phase during assisted reproductive technology (art) treatment in women for whom vaginal preparations are inappropriate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                             rdfs:label "by subcutaneous injection, or by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/lumigan> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/lumigan#YG4bhnU830ScWT-QfHnbUA>;
                                                                        nicebnf:hasTitle """<title>Lumigan<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "lumigan"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lumigan#PHP78765> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/lumigan#YG4bhnU830ScWT-QfHnbUA> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (March 2013) that bimatoprost 300 micrograms/mL preservative-free eye drops (<i>Lumigan</i><tm tmtype=\"reg\" /> single-dose eye drops) are accepted for restricted use within NHS Scotland for the reduction of elevated intra-ocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers) in adults who have proven sensitivity to benzalkonium chloride.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/lumigan#PHP78765>;
                                                                                               nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (March 2013) that bimatoprost 300 micrograms/mL preservative-free eye drops (Lumigan single-dose eye drops) are accepted for restricted use within NHS Scotland for the reduction of elevated intra-ocular pressure in chronic open-angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers) in adults who have proven sensitivity to benzalkonium chloride.

"""^^xsd:string;
                                                                                               a nicebnf:FundingDecision,
                                                                                                 nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#EvLzC-6PZU-b0bEv95v4MQ>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#F3FeFGPlCkmA6omzEqpHkA>;
                                                                       nicebnf:hasTitle """<title>Maalox<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "maalox"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#EvLzC-6PZU-b0bEv95v4MQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1417Years> ; 
                                                                                                                 rdfs:label "10–20 ml, to be taken 20–60 minutes after meals, and at bedtime or when required."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>10–20 mL, to be taken 20–60 minutes after meals, and at bedtime or when required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """10–20 mL, to be taken 20–60 minutes after meals, and at bedtime or when required.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "10–20 ml, to be taken 20–60 minutes after meals, and at bedtime or when required."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>10–20 mL, to be taken 20–60 minutes after meals, and at bedtime or when required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """10–20 mL, to be taken 20–60 minutes after meals, and at bedtime or when required.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dyspepsia>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#PHP96619>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#F3FeFGPlCkmA6omzEqpHkA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Maalox<tm tmtype=\"reg\" /> suspension is low in sodium.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#PHP96632>;
                                                                                              nicebnf:hasTextContent """Maalox suspension is low in sodium.

"""^^xsd:string;
                                                                                              a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#PHP96619> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/maalox#PHP96632> a nicebnf:PrescribingAndDispensingInformations.
<http://ld.nice.org.uk/ns/bnf/Indication#dyspepsia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dyspepsia</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Dyspepsia

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "dyspepsia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1417Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 14–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#4wo9PBSQQkOdQq4mcQvCjw>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#TYj44j6kpkiWQHzOjxDiNA>;
                                                                         nicebnf:hasTitle """<title>Malarone<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "malarone"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#4wo9PBSQQkOdQq4mcQvCjw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight1120Kg> ; 
                                                                                                                   rdfs:label "1 tablet once daily for 3 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet once daily for 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 tablet once daily for 3 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight2130Kg> ; 
                                                                                                                   rdfs:label "2 tablets once daily for 3 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>2 tablets once daily for 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """2 tablets once daily for 3 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight3140Kg> ; 
                                                                                                                   rdfs:label "3 tablets once daily for 3 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>3 tablets once daily for 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """3 tablets once daily for 3 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight41KgAndAbove> ; 
                                                                                                                   rdfs:label "4 tablets once daily for 3 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>4 tablets once daily for 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """4 tablets once daily for 3 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteUncomplicatedFalciparumMalaria>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfNonFalciparumMalaria>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#PHP98934>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#PHP98934> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#TYj44j6kpkiWQHzOjxDiNA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight40KgAndAbove> ; 
                                                                                                                   rdfs:label "1 tablet daily, to be started 1–2 days before entering endemic area and continued for 1 week after leaving."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet daily, to be started 1–2 days before entering endemic area and continued for 1 week after leaving.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 tablet daily, to be started 1–2 days before entering endemic area and continued for 1 week after leaving.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfFalciparumMalariaParticularlyWhereResistanceToOtherAntimalarialDrugsSuspected>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/malarone#PHP98934>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfFalciparumMalariaParticularlyWhereResistanceToOtherAntimalarialDrugsSuspected> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of falciparum malaria, particularly where resistance to other antimalarial drugs suspected</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Prophylaxis of falciparum malaria, particularly where resistance to other antimalarial drugs suspected

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "prophylaxis of falciparum malaria, particularly where resistance to other antimalarial drugs suspected"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteUncomplicatedFalciparumMalaria> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute uncomplicated falciparum malaria</p>"""^^<rdf:XMLLiteral>;
                                                                                         nicebnf:hasTextContent """Treatment of acute uncomplicated falciparum malaria

"""^^xsd:string;
                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                         rdfs:label "treatment of acute uncomplicated falciparum malaria"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfNonFalciparumMalaria> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of non-falciparum malaria</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """Treatment of non-falciparum malaria

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "treatment of non-falciparum malaria"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight1120Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 11–20 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight2130Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 21–30 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight3140Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 31–40 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight40KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 40 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight41KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 41 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/marcain-heavy> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/marcain-heavy#4KzK-SYFOE2iqMtCTzDpCA>;
                                                                              nicebnf:hasTitle """<title>Marcain Heavy<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "marcain heavy"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/marcain-heavy#4KzK-SYFOE2iqMtCTzDpCA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "10–20 mg."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>10–20 mg.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """10–20 mg.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntrathecalInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#intrathecalAnaesthesiaForSurgery>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/marcain-heavy#PHP82618>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/marcain-heavy#PHP82618> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#intrathecalAnaesthesiaForSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Intrathecal anaesthesia for surgery</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Intrathecal anaesthesia for surgery

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "intrathecal anaesthesia for surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntrathecalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intrathecal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#lwLyHP98HUKBUFkOf0Xd7Q>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#8CFL8baODUao7XOQ68bwSA>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#rkT_WJztPEqFNO3kVhoIQA>;
                                                                             nicebnf:hasTitle """<title>Medikinet<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "medikinet xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#8CFL8baODUao7XOQ68bwSA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of capsule can be sprinkled on a tablespoon of apple sauce or yoghurt (then swallowed immediately without chewing).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98214>;
                                                                                                    nicebnf:hasTextContent """Contents of capsule can be sprinkled on a tablespoon of apple sauce or yoghurt (then swallowed immediately without chewing).

"""^^xsd:string;
                                                                                                    a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98182> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98214> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98233> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#lwLyHP98HUKBUFkOf0Xd7Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                                       rdfs:label "initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; increased if necessary up to 2.1 mg/kg daily, licensed max. dose is 60 mg daily, to be increased to higher dose only under direction of specialist; discontinue if no response after 1 month; maximum 90 mg per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; maximum 100 mg per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; maximum 100 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 10 mg once daily, dose to be taken in the morning with breakfast; adjusted at weekly intervals according to response; maximum 100 mg per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98182>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#rkT_WJztPEqFNO3kVhoIQA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Consists of an immediate-release component (50% of the dose) and a modified-release component (50% of the dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/medikinet-xl#PHP98233>;
                                                                                                    nicebnf:hasTextContent """Consists of an immediate-release component (50% of the dose) and a modified-release component (50% of the dose).

"""^^xsd:string;
                                                                                                    a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#attentionDeficitHyperactivityDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Attention deficit hyperactivity disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Attention deficit hyperactivity disorder

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "attention deficit hyperactivity disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#LZhULJUqGEms-6UiVNenmQ>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#eKHb75Guq0a2Xr66Es8oBQ>;
                                                                       nicebnf:hasTitle """<title>Menveo<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "menveo"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#LZhULJUqGEms-6UiVNenmQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child311Months> ; 
                                                                                                                 rdfs:label "0.5 ml every 1 month for 2 doses, dose preferably injected into deltoid region."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>0.5 mL every 1 month for 2 doses, dose preferably injected into deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """0.5 mL every 1 month for 2 doses, dose preferably injected into deltoid region.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                 rdfs:label "0.5 ml for 1 dose, dose preferably injected into deltoid region."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>0.5 mL for 1 dose, dose preferably injected into deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """0.5 mL for 1 dose, dose preferably injected into deltoid region.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "0.5 ml for 1 dose, dose preferably injected into deltoid region."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>0.5 mL for 1 dose, dose preferably injected into deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """0.5 mL for 1 dose, dose preferably injected into deltoid region.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstNeisseriaMeningitidis>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#PHP100224>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#PHP100224> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#PHP100245> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#eKHb75Guq0a2Xr66Es8oBQ> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">In children</p>
  <p>
    <i>Menveo</i>
    <tm tmtype=\"reg\" /> is not licensed for use in children under 2 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#inChildren>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/menveo#PHP100245>;
                                                                                              nicebnf:hasTextContent """In children

Menveo is not licensed for use in children under 2 years.

"""^^xsd:string;
                                                                                              a nicebnf:UnlicencedUse.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstNeisseriaMeningitidis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against <ph outputclass=\"organism\"><i>Neisseria meningitidis</i></ph></p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Immunisation against Neisseria meningitidis

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "immunisation against neisseria meningitidis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child311Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 3–11 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#inChildren> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                      rdfs:label "in children"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/methadose> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/methadose#IjUfXglqcEqeHEfr6i79IQ>;
                                                                          nicebnf:hasTitle """<title>Methadose<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "methadose"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/methadose#IjUfXglqcEqeHEfr6i79IQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The final strength of the methadone mixture to be dispensed to the patient must be specified on the prescription.</p>
  <p>
    <b>Important</b>—care is required in prescribing and dispensing the <b>correct strength</b> since any confusion could lead to an overdose; this preparation should be dispensed only <b>after dilution</b> as appropriate with <i>Methadose</i><tm tmtype=\"reg\" /> Diluent (life of diluted solution 3 months) and is for drug dependent persons.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/methadose#PHP81223>;
                                                                                                 nicebnf:hasTextContent """The final strength of the methadone mixture to be dispensed to the patient must be specified on the prescription.

Important—care is required in prescribing and dispensing the correct strength since any confusion could lead to an overdose; this preparation should be dispensed only after dilution as appropriate with Methadose Diluent (life of diluted solution 3 months) and is for drug dependent persons.

"""^^xsd:string;
                                                                                                 a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/methadose#PHP81223> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#2_2McBySIUuWDAyo9zjpNQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#5Hx3YzN3HEihNJKBM0XZYA>;
                                                                         nicebnf:hasTitle """<title>Metrogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "metrogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#2_2McBySIUuWDAyo9zjpNQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply twice daily for 8–9 weeks, to be applied thinly."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily for 8–9 weeks, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily for 8–9 weeks, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#PHP84130>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#5Hx3YzN3HEihNJKBM0XZYA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1–2 times a day, to be applied to clean wound and covered with non-adherent dressing.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#malodorousFungatingTumours>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#PHP84130>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrogel#PHP84130> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute inflammatory exacerbation of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Acute inflammatory exacerbation of rosacea

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "acute inflammatory exacerbation of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#malodorousFungatingTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Malodorous fungating tumours</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Malodorous fungating tumours

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "malodorous fungating tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrosa> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrosa#IvrdvhFetECod9kRJK9K5w>;
                                                                        nicebnf:hasTitle """<title>Metrosa<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "metrosa"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrosa#IvrdvhFetECod9kRJK9K5w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply twice daily for up to 8 weeks, to be applied thinly."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily for up to 8 weeks, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply twice daily for up to 8 weeks, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationOfRosacea>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/metrosa#PHP84155>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/metrosa#PHP84155> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute exacerbation of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Acute exacerbation of rosacea

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "acute exacerbation of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#IkkYTffPiEW8-4L2T9Uf2A>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#KeBZN6L0Ek2i2uTAIt66aw>;
                                                                            nicebnf:hasTitle """<title>Mezavant<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "mezavant xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#IkkYTffPiEW8-4L2T9Uf2A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "2.4 g once daily, increased if necessary to 4.8 g once daily, review treatment at 8 weeks."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>2.4 g once daily, increased if necessary to 4.8 g once daily, review treatment at 8 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """2.4 g once daily, increased if necessary to 4.8 g once daily, review treatment at 8 weeks.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#PHP83290>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#KeBZN6L0Ek2i2uTAIt66aw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "2.4 g once daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>2.4 g once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """2.4 g once daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#PHP83290>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mezavant-xl#PHP83290> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#AZqiAJKwf0S1Qk9C6LhRQQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#Y3LTaARrdkqV-NBWRRAeWA>;
                                                                        nicebnf:hasTitle """<title>Micanol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "micanol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#AZqiAJKwf0S1Qk9C6LhRQQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply once daily, for application to skin or scalp, to be applied for up to 30 minutes, apply 1% cream, if necessary 3% cream can be used under medical supervision."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply once daily, for application to skin or scalp, to be applied for up to 30 minutes, apply 1% cream, if necessary 3% cream can be used under medical supervision.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply once daily, for application to skin or scalp, to be applied for up to 30 minutes, apply 1% cream, if necessary 3% cream can be used under medical supervision.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#subacuteAndChronicPsoriasis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#PHP81760>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#PHP81760> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#PHP81795> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#Y3LTaARrdkqV-NBWRRAeWA> nicebnf:hasDitaContent """<sectiondiv>
  <p>At the end of contact time, use plenty of lukewarm (not hot) water to rinse off cream; soap may be used after the cream has been rinsed off; use shampoo before applying cream to scalp and if necessary after cream has been rinsed off.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/micanol#PHP81795>;
                                                                                               nicebnf:hasTextContent """At the end of contact time, use plenty of lukewarm (not hot) water to rinse off cream; soap may be used after the cream has been rinsed off; use shampoo before applying cream to scalp and if necessary after cream has been rinsed off.

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#subacuteAndChronicPsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Subacute and chronic psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Subacute and chronic psoriasis

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "subacute and chronic psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/micolette> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/micolette#UoRUyo0F1EOXevpMMWEoOQ>;
                                                                          nicebnf:hasTitle """<title>Micolette<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "micolette"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micolette#PHP101630> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micolette#UoRUyo0F1EOXevpMMWEoOQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> ; 
                                                                                                                    rdfs:label "5–10 ml for 1 dose."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>5–10 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """5–10 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "5–10 ml for 1 dose."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>5–10 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """5–10 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/micolette#PHP101630>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 3–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/micralax> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/micralax#wq2k7K_pJUm0o16gQ5WnDA>;
                                                                         nicebnf:hasTitle """<title>Micralax<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "micralax"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micralax#PHP101559> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/micralax#wq2k7K_pJUm0o16gQ5WnDA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> ; 
                                                                                                                   rdfs:label "5 ml for 1 dose."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>5 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """5 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "5 ml for 1 dose."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>5 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """5 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/micralax#PHP101559>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 3–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#jUbu0eKsr0a7haQdNrLh2Q>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#bG8KTd3LB0Kcm-AgW6aqiw>;
                                                                          nicebnf:hasTitle """<title>Migraleve<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "migraleve"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#PHP96863> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#PHP96952> a nicebnf:LessSuitableForPrescribings.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#bG8KTd3LB0Kcm-AgW6aqiw> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Migraleve</i>
    <tm tmtype=\"reg\" /> is less suitable for prescribing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#PHP96952>;
                                                                                                 nicebnf:hasTextContent """Migraleve is less suitable for prescribing.

"""^^xsd:string;
                                                                                                 a nicebnf:LessSuitableForPrescribing.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#jUbu0eKsr0a7haQdNrLh2Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1214Years> ; 
                                                                                                                    rdfs:label "initially 1 tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1 tablet every 4 hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1 tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1 tablet every 4 hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 1 tablet, (pink tablet) to be taken at onset of attack, or if it is imminent, followed by 1 tablet every 4 hours if required, (yellow tablet) to be taken following initial dose; maximum 1 pink and 3 yellow tablets in 24 hours.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                    rdfs:label "initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 2 tablets, (pink tablets) to be taken at onset of attack or if it is imminent, followed by 2 tablets every 4 hours if required, (yellow tablets) to be taken following initial dose; maximum 2 pink and 6 yellow tablets in 24 hours.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteMigraine>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/migraleve#PHP96863>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteMigraine> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute migraine</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Acute migraine

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "acute migraine"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1214Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–14 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/mini-tt380-slimline> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/mini-tt380-slimline#wc0nZhVfp0WQrza2o9zV_A>;
                                                                                    nicebnf:hasTitle """<title>Mini TT380<tm tmtype=\"reg\" /> Slimline</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "mini tt380 slimline"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mini-tt380-slimline#PHP105481> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mini-tt380-slimline#wc0nZhVfp0WQrza2o9zV_A> nicebnf:hasDitaContent """<sectiondiv>
  <p>For minimum uterine length 5 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mini-tt380-slimline#PHP105481>;
                                                                                                           nicebnf:hasTextContent """For minimum uterine length 5 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                           a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#MgPVE1eVGkqPl5Wla1Y0Bg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#gR6lq1YokUODUGLr7DmnWQ>;
                                                                         nicebnf:hasTitle """<title>Minitran<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "minitran"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#MgPVE1eVGkqPl5Wla1Y0Bg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "one ‘5’ patch to be applied to chest or upper arm; replace every 24 hours, siting replacement patch on different area, dose to be adjusted according to response."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>One ‘5’ patch to be applied to chest or upper arm; replace every 24 hours, siting replacement patch on different area, dose to be adjusted according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """One ‘5’ patch to be applied to chest or upper arm; replace every 24 hours, siting replacement patch on different area, dose to be adjusted according to response.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#PHP61414>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#PHP61414> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#gR6lq1YokUODUGLr7DmnWQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfVenousPatency5PatchOnly>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/minitran#PHP61414>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfVenousPatency5PatchOnly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of venous patency (‘5’ patch only)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Maintenance of venous patency (‘5’ patch only)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "maintenance of venous patency (‘5’ patch only)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/mintec> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/mintec#WE_I_EXiZU-aac5WPaI66A>;
                                                                       nicebnf:hasTitle """<title>Mintec<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "mintec"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mintec#PHP83094> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mintec#WE_I_EXiZU-aac5WPaI66A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "1–2 capsules 3 times a day for up to 2–3 months if necessary, dose to be taken before meals, swallowed whole with water."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>1–2 capsules 3 times a day for up to 2–3 months if necessary, dose to be taken before meals, swallowed whole with water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """1–2 capsules 3 times a day for up to 2–3 months if necessary, dose to be taken before meals, swallowed whole with water.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfAbdominalColicAndDistensionParticularlyInIrritableBowelSyndrome>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mintec#PHP83094>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfAbdominalColicAndDistensionParticularlyInIrritableBowelSyndrome> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of abdominal colic and distension, particularly in irritable bowel syndrome</p>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasTextContent """Relief of abdominal colic and distension, particularly in irritable bowel syndrome

"""^^xsd:string;
                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                  rdfs:label "relief of abdominal colic and distension, particularly in irritable bowel syndrome"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#DpCKURxUGk6IvSam9PffxA>;
                                                                                                              nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#imGMRe15mkGeMlH_-7vJEw>,
                                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#wLLix-2KdECTxYLyd-deVg>;
                                                                                                              nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#zVvcczDcA0ORM1Aqoo4EUQ>;
                                                                                                              nicebnf:hasTitle """<title>Mirena<tm tmtype=\"reg\" />20micrograms/24hours intrauterine device</title>"""^^<rdf:XMLLiteral>;
                                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                              rdfs:label "mirena20micrograms/24hours intrauterine device"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#DpCKURxUGk6IvSam9PffxA> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#advancedUterineAtrophy>;
                                                                                                                                     nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Advanced uterine atrophy</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107901>;
                                                                                                                                     nicebnf:hasTextContent """Advanced uterine atrophy

"""^^xsd:string;
                                                                                                                                     a nicebnf:CautionsGroup,
                                                                                                                                       nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107901> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107905> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107931> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#imGMRe15mkGeMlH_-7vJEw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                                                        rdfs:label "insert during last days of menstruation or withdrawal bleeding or at any time if amenorrhoeic; effective for 4 years."^^xsd:string ; 
                                                                                                                                                        nicebnf:hasDitaContent "<p>Insert during last days of menstruation or withdrawal bleeding or at any time if amenorrhoeic; effective for 4 years.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                        nicebnf:hasTextContent """Insert during last days of menstruation or withdrawal bleeding or at any time if amenorrhoeic; effective for 4 years.

"""^^xsd:string ; 
                                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraUterineAdministration>];
                                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfEndometrialHyperplasiaDuringOestrogenReplacementTherapy>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107905>;
                                                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#wLLix-2KdECTxYLyd-deVg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                                                        rdfs:label "insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or any time if reasonably certain woman is not pregnant and there is no risk of conception (additional precautions (e.g. barrier methods) necessary for next 7 days), or immediately after first-trimester termination by curettage; postpartum insertions should be delayed until at least 4 weeks after delivery; effective for 5 years."^^xsd:string ; 
                                                                                                                                                        nicebnf:hasDitaContent "<p>Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or any time if reasonably certain woman is not pregnant and there is no risk of conception (additional precautions (e.g. barrier methods) necessary for next 7 days), or immediately after first-trimester termination by curettage; postpartum insertions should be delayed until at least 4 weeks after delivery; effective for 5 years.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                        nicebnf:hasTextContent """Insert into uterine cavity within 7 days of onset of menstruation, or any time if replacement, or any time if reasonably certain woman is not pregnant and there is no risk of conception (additional precautions (e.g. barrier methods) necessary for next 7 days), or immediately after first-trimester termination by curettage; postpartum insertions should be delayed until at least 4 weeks after delivery; effective for 5 years.

"""^^xsd:string ; 
                                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraUterineAdministration>];
                                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#contraception>,
                                                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#menorrhagia>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107905>;
                                                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#zVvcczDcA0ORM1Aqoo4EUQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>When system is removed (and not immediately replaced) and pregnancy is not desired, remove during the first few days of menstruation, otherwise additional precautions (e.g. barrier methods) should be used for at least 7 days before removal.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mirena20micrograms24hours-intrauterine-device#PHP107931>;
                                                                                                                                     nicebnf:hasTextContent """When system is removed (and not immediately replaced) and pregnancy is not desired, remove during the first few days of menstruation, otherwise additional precautions (e.g. barrier methods) should be used for at least 7 days before removal.

"""^^xsd:string;
                                                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Caution#advancedUterineAtrophy> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Advanced uterine atrophy</ph>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent "Advanced uterine atrophy"^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                              rdfs:label "advanced uterine atrophy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#contraception> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Contraception</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Contraception

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "contraception"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#menorrhagia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menorrhagia</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Menorrhagia

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "menorrhagia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfEndometrialHyperplasiaDuringOestrogenReplacementTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of endometrial hyperplasia during oestrogen replacement therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasTextContent """Prevention of endometrial hyperplasia during oestrogen replacement therapy

"""^^xsd:string;
                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                              rdfs:label "prevention of endometrial hyperplasia during oestrogen replacement therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                           rdfs:label "females of childbearing potential"^^xsd:string;
                                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraUterineAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by intra-uterine administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-50200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-50200#qChnN1rI9kSjkbq38q1SXg>;
                                                                              nicebnf:hasTitle """<title>Misofen<tm tmtype=\"reg\" /> 50/200</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "misofen 50/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-50200#PHP95340> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-50200#qChnN1rI9kSjkbq38q1SXg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1 tablet 2–3 times a day, take with food."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1 tablet 2–3 times a day, take with food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1 tablet 2–3 times a day, take with food.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-50200#PHP95340>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                    nicebnf:hasTextContent """Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis

"""^^xsd:string;
                                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                    rdfs:label "prophylaxis against nsaid-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-75200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-75200#TR8t7ob-wkOycWdhvystmA>;
                                                                              nicebnf:hasTitle """<title>Misofen<tm tmtype=\"reg\" /> 75/200</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "misofen 75/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-75200#PHP95440> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-75200#TR8t7ob-wkOycWdhvystmA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1 tablet twice daily, take with food."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1 tablet twice daily, take with food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1 tablet twice daily, take with food.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/misofen-75200#PHP95440>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAgainstNsaidInducedGastroduodenalUlcerationInPatientsRequiringDiclofenacForRheumatoidArthritisOrOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                    nicebnf:hasTextContent """Prophylaxis against NSAID-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis

"""^^xsd:string;
                                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                    rdfs:label "prophylaxis against nsaid-induced gastroduodenal ulceration in patients requiring diclofenac for rheumatoid arthritis or osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PoxeIIKws0SZIMHlqefYIA>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#1sVBtyr2fEmfTnQ2SqMsKw>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#BpQaQ56UEkSCUj0GG4KT_g>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#E6ZaiwciZUCuoM5Bh-DBKQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#FKk0iTN8J0KqrtvvBh0O2w>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#TwOQ4O6DBE6otQcexRzCHA>;
                                                                         nicebnf:hasTitle """<title>Modigraf<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "modigraf"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#1sVBtyr2fEmfTnQ2SqMsKw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#BpQaQ56UEkSCUj0GG4KT_g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#rejectionTherapy>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#E6ZaiwciZUCuoM5Bh-DBKQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#FKk0iTN8J0KqrtvvBh0O2w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79816> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PoxeIIKws0SZIMHlqefYIA> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (November 2010) that tacrolimus granules for oral suspension (<i>Modigraf</i><tm tmtype=\"reg\" />) are accepted for restricted use within NHS Scotland in patients for whom tacrolimus is an appropriate choice of immunosuppressive therapy and where small changes (less than 500 micrograms) in dosing increments are required (such as, in paediatric patients) or seriously ill patients who are unable to swallow tacrolimus capsules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79816>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (November 2010) that tacrolimus granules for oral suspension (Modigraf) are accepted for restricted use within NHS Scotland in patients for whom tacrolimus is an appropriate choice of immunosuppressive therapy and where small changes (less than 500 micrograms) in dosing increments are required (such as, in paediatric patients) or seriously ill patients who are unable to swallow tacrolimus capsules.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#TwOQ4O6DBE6otQcexRzCHA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modigraf#PHP79716>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#rejectionTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Rejection therapy</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Rejection therapy

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "rejection therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/modisal-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/modisal-xl#Bg-mQ0puVkufVXx4edGpLg>;
                                                                           nicebnf:hasTitle """<title>Modisal<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "modisal xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modisal-xl#Bg-mQ0puVkufVXx4edGpLg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 0.5 tablet once daily for 2–4 days, to minimise the possibility of headache; 1 tablet once daily, then increased if necessary to 2 tablets once daily, dose to be taken in the morning."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 0.5 tablet once daily for 2–4 days, to minimise the possibility of headache; 1 tablet once daily, then increased if necessary to 2 tablets once daily, dose to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 0.5 tablet once daily for 2–4 days, to minimise the possibility of headache; 1 tablet once daily, then increased if necessary to 2 tablets once daily, dose to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/modisal-xl#PHP63850>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/modisal-xl#PHP63850> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-sr#PpXzian4hUuCbSQQx4D0Zg>;
                                                                           nicebnf:hasTitle """<title>Monomax<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "monomax sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-sr#PHP62001> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-sr#PpXzian4hUuCbSQQx4D0Zg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "40–60 mg daily, increased if necessary to 120 mg daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>40–60 mg daily, increased if necessary to 120 mg daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """40–60 mg daily, increased if necessary to 120 mg daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-sr#PHP62001>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-xl#l8updWdaOEumlpW1Vrjz0w>;
                                                                           nicebnf:hasTitle """<title>Monomax<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "monomax xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-xl#PHP61778> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-xl#l8updWdaOEumlpW1Vrjz0w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomax-xl#PHP61778>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomil-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomil-xl#fo8iW5spEk-TwEQc5hK_xQ>;
                                                                           nicebnf:hasTitle """<title>Monomil<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "monomil xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomil-xl#PHP61569> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monomil-xl#fo8iW5spEk-TwEQc5hK_xQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 0.5 tablet daily for 2–4 days, to minimise possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monomil-xl#PHP61569>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#9H2hfAzej0SoG7Ucekhruw>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#GJateHBFkEy4vcuhEMSgQA>;
                                                                         nicebnf:hasTitle """<title>Monopost<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "monopost"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#9H2hfAzej0SoG7Ucekhruw> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (June 2013) that <i>Monopost </i><tm tmtype=\"reg\" /> is accepted for restricted use within NHS Scotland for the reduction of elevated intra-ocular pressure in patients with open-angle glaucoma and ocular hypertension who have proven sensitivity to benzalkonium chloride.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#PHP79206>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (June 2013) that Monopost  is accepted for restricted use within NHS Scotland for the reduction of elevated intra-ocular pressure in patients with open-angle glaucoma and ocular hypertension who have proven sensitivity to benzalkonium chloride.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#GJateHBFkEy4vcuhEMSgQA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Before initiating treatment, patients should be warned of a possible change in eye colour as an increase in the brown pigment in the iris can occur, which may be permanent; particular care is required in those with mixed coloured irides and those receiving treatment to one eye only. Changes in eyelashes and vellus hair can also occur, and patients should also be advised to avoid repeated contact of the eye drop solution with skin as this can lead to hair growth or skin pigmentation.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#PHP79196>;
                                                                                                nicebnf:hasTextContent """Before initiating treatment, patients should be warned of a possible change in eye colour as an increase in the brown pigment in the iris can occur, which may be permanent; particular care is required in those with mixed coloured irides and those receiving treatment to one eye only. Changes in eyelashes and vellus hair can also occur, and patients should also be advised to avoid repeated contact of the eye drop solution with skin as this can lead to hair growth or skin pigmentation.

"""^^xsd:string;
                                                                                                nicebnf:hasTitle "Changes in eye colour"^^xsd:string;
                                                                                                a nicebnf:GeneralPatientAdvice,
                                                                                                  nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#PHP79196> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monopost#PHP79206> a nicebnf:NationalFunding.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/monosorb-xl60> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/monosorb-xl60#Ibp8ior6_ki4mhj7Fb1_ag>;
                                                                              nicebnf:hasTitle """<title>Monosorb<tm tmtype=\"reg\" /> XL60</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "monosorb xl60"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monosorb-xl60#Ibp8ior6_ki4mhj7Fb1_ag> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 0.5 tablet daily for the first 2–4 days, to minimise the possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 0.5 tablet daily for the first 2–4 days, to minimise the possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 0.5 tablet daily for the first 2–4 days, to minimise the possibility of headache, then 1 tablet daily, increased if necessary to 2 tablets daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/monosorb-xl60#PHP63872>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/monosorb-xl60#PHP63872> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/motifene> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/motifene#e3B8bveHf0yG48eA2DV0Cg>;
                                                                         nicebnf:hasTitle """<title>Motifene<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "motifene"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/motifene#PHP99747> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/motifene#e3B8bveHf0yG48eA2DV0Cg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1 capsule 1–2 times a day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 capsule 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 capsule 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteGout>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/motifene#PHP99747>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteGout> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute gout</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Acute gout

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "acute gout"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                    nicebnf:hasTextContent """Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders

"""^^xsd:string;
                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                    rdfs:label "pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#TwnJOXJDzk6lMISFarpxAg>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#_3QxjRg-sUGbNJzbYAmUSA>;
                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#JizJdLaqTUyoA-ghEE1wgA>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#vV43mK-NBESWeMD8jD5ozQ>;
                                                                             nicebnf:hasTitle """<title>Movicol-Half<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "movicol-half"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#JizJdLaqTUyoA-ghEE1wgA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer <i>Movicol-Half</i><tm tmtype=\"reg\" /> oral powder.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98535>;
                                                                                                    nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Movicol-Half oral powder.

"""^^xsd:string;
                                                                                                    a nicebnf:GeneralPatientAdvice,
                                                                                                      nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98484> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98526> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98535> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#TwnJOXJDzk6lMISFarpxAg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 8 sachets daily on first day, then increased in steps of 4 sachets daily, total daily dose to be drunk within 6 hours, after disimpaction, switch to maintenance laxative therapy; maximum 16 sachets per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98484>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#_3QxjRg-sUGbNJzbYAmUSA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                       rdfs:label "2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """2–6 sachets daily in divided doses usually for up to 2 weeks; maintenance 2–4 sachets daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98484>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#vV43mK-NBESWeMD8jD5ozQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of each sachet to be dissolved in quarter of a glass (approx. 60–65 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 6 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-half#PHP98526>;
                                                                                                    nicebnf:hasTextContent """Contents of each sachet to be dissolved in quarter of a glass (approx. 60–65 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 6 hours.

"""^^xsd:string;
                                                                                                    a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic constipation</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Chronic constipation

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "chronic constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Faecal impaction</p>"""^^<rdf:XMLLiteral>;
                                                          nicebnf:hasTextContent """Faecal impaction

"""^^xsd:string;
                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                          rdfs:label "faecal impaction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#O9bNcwZ-NEGVKFqmRzUVCw>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#7C9Tv9Cw-Eu9mmEVwqGAOg>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#_N3q4h4fdEWkg3gm5c4ozw>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#nCu81CH3DEWIrPz8LsenWQ>;
                                                                               nicebnf:hasTitle """<title>Movicol<tm tmtype=\"reg\" /> liquid</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "movicol liquid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#7C9Tv9Cw-Eu9mmEVwqGAOg> nicebnf:hasDitaContent """<sectiondiv>
  <p>25 mL of oral concentrate to be diluted with half a glass (approx. 100 mL) of water. After dilution the solution should be discarded if unused after 24 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98525>;
                                                                                                      nicebnf:hasTextContent """25 mL of oral concentrate to be diluted with half a glass (approx. 100 mL) of water. After dilution the solution should be discarded if unused after 24 hours.

"""^^xsd:string;
                                                                                                      a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#O9bNcwZ-NEGVKFqmRzUVCw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                         rdfs:label "25 ml 1–3 times a day usually for up to 2 weeks; maintenance 25 ml 1–2 times a day."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>25 mL 1–3 times a day usually for up to 2 weeks; maintenance 25 mL 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """25 mL 1–3 times a day usually for up to 2 weeks; maintenance 25 mL 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "25 ml 1–3 times a day usually for up to 2 weeks; maintenance 25 ml 1–2 times a day."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>25 mL 1–3 times a day usually for up to 2 weeks; maintenance 25 mL 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """25 mL 1–3 times a day usually for up to 2 weeks; maintenance 25 mL 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98486>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98486> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98525> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98534> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98550> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#_N3q4h4fdEWkg3gm5c4ozw> nicebnf:hasDitaContent """<sectiondiv>
  <p>25 mL of oral concentrate when diluted with 100 mL water provides K<sup>+</sup> 5.4 mmol/litre.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98550>;
                                                                                                      nicebnf:hasTextContent """25 mL of oral concentrate when diluted with 100 mL water provides K+ 5.4 mmol/litre.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#nCu81CH3DEWIrPz8LsenWQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be counselled on how to take <i>Movicol</i><tm tmtype=\"reg\" /> oral solution.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-liquid#PHP98534>;
                                                                                                      nicebnf:hasTextContent """Patients or carers should be counselled on how to take Movicol oral solution.

"""^^xsd:string;
                                                                                                      a nicebnf:GeneralPatientAdvice,
                                                                                                        nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic constipation</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Chronic constipation

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "chronic constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#97PDLsIN3UehifGd7DHoIQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#I7oVtPZ3J0WzjXWbMkunbA>;
                                                                                    nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#qVnKg5i3J0CacAjp8d-caA>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#sPVar6dwnUGr4iRzgOmpmQ>,
                                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#sxyil14BqkGCX9ozgDqVPA>;
                                                                                    nicebnf:hasTitle """<title>Movicol<tm tmtype=\"reg\" /> oral powder</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "movicol oral powder"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#97PDLsIN3UehifGd7DHoIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                              rdfs:label "1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """1–3 sachets daily in divided doses usually for up to 2 weeks; maintenance 1–2 sachets daily.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98487>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#I7oVtPZ3J0WzjXWbMkunbA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                              rdfs:label "initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be drunk within a 6 hour period, after disimpaction, switch to maintenance laxative therapy if required; maximum 8 sachets per day.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98487>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98487> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98523> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98536> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98552> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#qVnKg5i3J0CacAjp8d-caA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Amount of potassium chloride varies according to flavour of <i>Movicol</i><tm tmtype=\"reg\" /> as follows:</p>
  <p>plain-flavour (sugar-free) = 50.2 mg/sachet; lime and lemon flavour = 46.6 mg/sachet; chocolate flavour = 31.7 mg/sachet. 1 sachet when reconstituted with 125 mL water provides K<sup>+</sup> 5.4 mmol/litre.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98552>;
                                                                                                           nicebnf:hasTextContent """Amount of potassium chloride varies according to flavour of Movicol as follows:

plain-flavour (sugar-free) = 50.2 mg/sachet; lime and lemon flavour = 46.6 mg/sachet; chocolate flavour = 31.7 mg/sachet. 1 sachet when reconstituted with 125 mL water provides K+ 5.4 mmol/litre.

"""^^xsd:string;
                                                                                                           a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#sPVar6dwnUGr4iRzgOmpmQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be counselled on how to take <i>Movicol</i><tm tmtype=\"reg\" /> oral powder.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98536>;
                                                                                                           nicebnf:hasTextContent """Patients or carers should be counselled on how to take Movicol oral powder.

"""^^xsd:string;
                                                                                                           a nicebnf:GeneralPatientAdvice,
                                                                                                             nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#sxyil14BqkGCX9ozgDqVPA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of each sachet to be dissolved in half a glass (approx. 125 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 6 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-oral-powder#PHP98523>;
                                                                                                           nicebnf:hasTextContent """Contents of each sachet to be dissolved in half a glass (approx. 125 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 6 hours.

"""^^xsd:string;
                                                                                                           a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic constipation</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Chronic constipation

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "chronic constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Faecal impaction</p>"""^^<rdf:XMLLiteral>;
                                                          nicebnf:hasTextContent """Faecal impaction

"""^^xsd:string;
                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                          rdfs:label "faecal impaction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#8W8VSm75-kKL4_0Ia1zJAg>;
                                                                                   nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#ekMDBLQ7yUiErRSqt9Rggg>;
                                                                                   nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#NajQxAcFl06ERSiCzC-tLg>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#sJwMtK3yXU2q8Sb9u6oHuw>;
                                                                                   nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#YIOgyFjv8ku-CzaC1RynLQ>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#mnVUSev4g0-7seugz1eIVA>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#qt0TO4_v4k-5egZeFGrEIg>;
                                                                                   nicebnf:hasTitle """<title>Movicol-Paediatric<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "movicol-paediatric"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#8W8VSm75-kKL4_0Ia1zJAg> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#impairedConsciousnessWithHighDoses>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Caution#impairedGagReflexWithHighDoses>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Caution#refluxOesophagitisWithHighDoses>;
                                                                                                          nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Impaired consciousness (with high doses)</ph>; <ph outputclass=\"caution\">impaired gag reflex (with high doses)</ph>; <ph outputclass=\"caution\">reflux oesophagitis (with high doses)</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98473>;
                                                                                                          nicebnf:hasTextContent """Impaired consciousness (with high doses); impaired gag reflex (with high doses); reflux oesophagitis (with high doses)

"""^^xsd:string;
                                                                                                          a nicebnf:CautionsGroup,
                                                                                                            nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#NajQxAcFl06ERSiCzC-tLg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child25Years> ; 
                                                                                                                             rdfs:label "1 sachet daily, adjust dose to produce regular soft stools; maximum 4 sachets per day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 sachet daily, adjust dose to produce regular soft stools; maximum 4 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 sachet daily, adjust dose to produce regular soft stools; maximum 4 sachets per day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                             rdfs:label "2 sachets daily, adjust dose to produce regular soft stools; maximum 4 sachets per day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>2 sachets daily, adjust dose to produce regular soft stools; maximum 4 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """2 sachets daily, adjust dose to produce regular soft stools; maximum 4 sachets per day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation>,
                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfFaecalImpaction>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98485>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98473> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98482> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98485> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98520> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98527> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#YIOgyFjv8ku-CzaC1RynLQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Movicol</i>
    <tm tmtype=\"reg\" />
    <i>Paediatric</i> not licensed for use in faecal impaction in children under 5 years, or for chronic constipation in children under 2 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98520>;
                                                                                                          nicebnf:hasTextContent """MovicolPaediatric not licensed for use in faecal impaction in children under 5 years, or for chronic constipation in children under 2 years.

"""^^xsd:string;
                                                                                                          a nicebnf:UnlicencedUse.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#ekMDBLQ7yUiErRSqt9Rggg> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#cardiovascularImpairment>;
                                                                                                          nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Cardiovascular impairment</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98482>;
                                                                                                          nicebnf:hasTextContent """Cardiovascular impairment

"""^^xsd:string;
                                                                                                          a nicebnf:ContraindicationsGroup,
                                                                                                            nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#mnVUSev4g0-7seugz1eIVA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contents of each sachet to be dissolved in quarter of a glass (approx. 60–65 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 24 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98527>;
                                                                                                          nicebnf:hasTextContent """Contents of each sachet to be dissolved in quarter of a glass (approx. 60–65 mL) of water; after reconstitution the solution should be kept in a refrigerator and discarded if unused after 24 hours.

"""^^xsd:string;
                                                                                                          a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#qt0TO4_v4k-5egZeFGrEIg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Contra-indicated in renal impairment.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98482>;
                                                                                                          nicebnf:hasTextContent """Contra-indicated in renal impairment.

"""^^xsd:string;
                                                                                                          a nicebnf:ContraindicationsRenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#sJwMtK3yXU2q8Sb9u6oHuw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> ; 
                                                                                                                             rdfs:label "initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be taken over a 12-hour period, after disimpaction, switch to maintenance laxative therapy; maximum 12 sachets per day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be taken over a 12-hour period, after disimpaction, switch to maintenance laxative therapy; maximum 12 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 4 sachets daily on first day, then increased in steps of 2 sachets daily, total daily dose to be taken over a 12-hour period, after disimpaction, switch to maintenance laxative therapy; maximum 12 sachets per day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/movicol-paediatric#PHP98485>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Caution#impairedConsciousnessWithHighDoses> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Impaired consciousness (with high doses)</ph>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent "Impaired consciousness (with high doses)"^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                          rdfs:label "impaired consciousness (with high doses)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#impairedGagReflexWithHighDoses> nicebnf:hasDitaContent """<ph outputclass=\"caution\">impaired gag reflex (with high doses)</ph>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent "impaired gag reflex (with high doses)"^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                      rdfs:label "impaired gag reflex (with high doses)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#refluxOesophagitisWithHighDoses> nicebnf:hasDitaContent """<ph outputclass=\"caution\">reflux oesophagitis (with high doses)</ph>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent "reflux oesophagitis (with high doses)"^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                       rdfs:label "reflux oesophagitis (with high doses)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Contraindication#cardiovascularImpairment> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Cardiovascular impairment</ph>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent "Cardiovascular impairment"^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                         rdfs:label "cardiovascular impairment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicConstipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic constipation</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Chronic constipation

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "chronic constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#faecalImpaction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Faecal impaction</p>"""^^<rdf:XMLLiteral>;
                                                          nicebnf:hasTextContent """Faecal impaction

"""^^xsd:string;
                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                          rdfs:label "faecal impaction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfFaecalImpaction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of faecal impaction</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Prevention of faecal impaction

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "prevention of faecal impaction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child25Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                         rdfs:label "child 2–5 years"^^xsd:string;
                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 5–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#ZD2t3-FtZU2ukQ8zaA-4Mg>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#TL3OIQq7E0CTHesBxf2r0A>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#kcw7ylwJVUymPHn16hR1Kg>;
                                                                         nicebnf:hasTitle """<title>Moviprep<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "moviprep"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100223> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100247> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100263> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#TL3OIQq7E0CTHesBxf2r0A> nicebnf:hasDitaContent """<sectiondiv>
  <p>1 pair of sachets (A+B) when reconstituted with 1 litre of water provides Na<sup>+</sup> 181.6  mmol (Na<sup>+</sup> 56.2 mmol absorbable), K<sup>+</sup> 14.2 mmol, Cl<sup>–</sup> 59.8 mmol.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100263>;
                                                                                                nicebnf:hasTextContent """1 pair of sachets (A+B) when reconstituted with 1 litre of water provides Na+ 181.6  mmol (Na+ 56.2 mmol absorbable), K+ 14.2 mmol, Cl– 59.8 mmol.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#ZD2t3-FtZU2ukQ8zaA-4Mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1 litre daily for 2 doses: first dose of reconstituted solution taken on the evening before procedure and the second dose on the morning of procedure, alternatively 2 litres daily for 1 dose; reconstituted solution to be taken on the evening before the procedure, treatment should be completed at least 1 hour before colonoscopy."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 litre daily for 2 doses: first dose of reconstituted solution taken on the evening before procedure and the second dose on the morning of procedure, alternatively 2 litres daily for 1 dose; reconstituted solution to be taken on the evening before the procedure, treatment should be completed at least 1 hour before colonoscopy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 litre daily for 2 doses: first dose of reconstituted solution taken on the evening before procedure and the second dose on the morning of procedure, alternatively 2 litres daily for 1 dose; reconstituted solution to be taken on the evening before the procedure, treatment should be completed at least 1 hour before colonoscopy.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationForSurgeryColonoscopyOrRadiologicalExamination>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100223>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#kcw7ylwJVUymPHn16hR1Kg> nicebnf:hasDitaContent """<sectiondiv>
  <p>One pair of sachets (A and B) should be reconstituted in 1 litre of water and taken over 1–2 hours.</p>
  <p>1 litre of other clear fluid should also be taken during treatment.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/moviprep#PHP100247>;
                                                                                                nicebnf:hasTextContent """One pair of sachets (A and B) should be reconstituted in 1 litre of water and taken over 1–2 hours.

1 litre of other clear fluid should also be taken during treatment.

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationForSurgeryColonoscopyOrRadiologicalExamination> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation for surgery, colonoscopy or radiological examination</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Bowel evacuation for surgery, colonoscopy or radiological examination

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "bowel evacuation for surgery, colonoscopy or radiological examination"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#yWxnvCwENEyd4PUkYcSuww>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#e-ZluXKbmEeXA9B25vgBvQ>;
                                                                        nicebnf:hasTitle """<title>Mucogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "mucogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#PHP96636> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#PHP96658> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#e-ZluXKbmEeXA9B25vgBvQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Mucogel<tm tmtype=\"reg\" /> suspension is low in sodium.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#PHP96658>;
                                                                                               nicebnf:hasTextContent """Mucogel suspension is low in sodium.

"""^^xsd:string;
                                                                                               a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#yWxnvCwENEyd4PUkYcSuww> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                  rdfs:label "10–20 ml 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>10–20 mL 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """10–20 mL 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "10–20 ml 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>10–20 mL 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """10–20 mL 3 times a day, to be taken 20–60 minutes after meals, and at bedtime, or when required.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dyspepsia>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/mucogel#PHP96636>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dyspepsia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dyspepsia</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Dyspepsia

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "dyspepsia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/multi-safe-375> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/multi-safe-375#TOr7NAhs2k-diuXSrtN_wA>;
                                                                               nicebnf:hasTitle """<title>Multi-Safe<tm tmtype=\"reg\" /> 375</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "multi-safe 375"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/multi-safe-375#PHP105485> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/multi-safe-375#TOr7NAhs2k-diuXSrtN_wA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length over 6–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/multi-safe-375#PHP105485>;
                                                                                                      nicebnf:hasTextContent """For uterine length over 6–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/multiload-cu375> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/multiload-cu375#XHstntMcTU-ZOkUixEzocQ>;
                                                                                nicebnf:hasTitle """<title>Multiload<tm tmtype=\"reg\" /> Cu375</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "multiload cu375"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/multiload-cu375#PHP105483> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/multiload-cu375#XHstntMcTU-ZOkUixEzocQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/multiload-cu375#PHP105483>;
                                                                                                       nicebnf:hasTextContent """For uterine length 6–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                       a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#6P6BrMOTrUChvjsSFqV1WA>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#asNredK6lkya0fcKOH4DrQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#cSzBeHYqvUicLMDa4JueyQ>;
                                                                         nicebnf:hasTitle """<title>Myfortic<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "myfortic"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#6P6BrMOTrUChvjsSFqV1WA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "720 mg twice daily, to be started within 72 hours of transplantation."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>720 mg twice daily, to be started within 72 hours of transplantation.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """720 mg twice daily, to be started within 72 hours of transplantation.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#renalTransplantation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#PHP80156>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#PHP80156> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#PHP80170> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#asNredK6lkya0fcKOH4DrQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises that men should use condoms during treatment and for 13 weeks after last dose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#PHP80170>;
                                                                                                nicebnf:hasTextContent """Manufacturer advises that men should use condoms during treatment and for 13 weeks after last dose.

"""^^xsd:string;
                                                                                                a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#cSzBeHYqvUicLMDa4JueyQ> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>Mycophenolic acid 720 mg is approximately equivalent to mycophenolate mofetil 1 g but avoid unnecessary switching because of pharmacokinetic differences.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/myfortic#PHP80156>;
                                                                                                nicebnf:hasTextContent """Dose equivalence and conversionMycophenolic acid 720 mg is approximately equivalent to mycophenolate mofetil 1 g but avoid unnecessary switching because of pharmacokinetic differences.

"""^^xsd:string;
                                                                                                a nicebnf:DoseEquivalence,
                                                                                                  nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#renalTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Renal transplantation</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Renal transplantation

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "renal transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/myocet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/myocet#oJ9G1Eo7dUS7OyL5OyeGLw>;
                                                                       nicebnf:hasTitle """<title>Myocet<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "myocet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myocet#PHP79929> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/myocet#oJ9G1Eo7dUS7OyL5OyeGLw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forUseWithCyclophosphamideForMetastaticBreastCancer>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/myocet#PHP79929>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forUseWithCyclophosphamideForMetastaticBreastCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For use with cyclophosphamide for metastatic breast cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent """For use with cyclophosphamide for metastatic breast cancer

"""^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                              rdfs:label "for use with cyclophosphamide for metastatic breast cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/neo-safe-t380> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/neo-safe-t380#bKdwVihxTku07_eUJBkv3A>;
                                                                              nicebnf:hasTitle """<title>Neo-Safe<tm tmtype=\"reg\" /> T380</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "neo-safe t380"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/neo-safe-t380#PHP105549> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/neo-safe-t380#bKdwVihxTku07_eUJBkv3A> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/neo-safe-t380#PHP105549>;
                                                                                                     nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                     a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nifedipress-mr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nifedipress-mr#Ym5xREIHuk2u94sSM5glHw>;
                                                                               nicebnf:hasTitle """<title>Nifedipress<tm tmtype=\"reg\" /> MR</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "nifedipress mr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nifedipress-mr#PHP61095> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nifedipress-mr#Ym5xREIHuk2u94sSM5glHw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "10 mg twice daily, adjusted according to response to 40 mg twice daily."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>10 mg twice daily, adjusted according to response to 40 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """10 mg twice daily, adjusted according to response to 40 mg twice daily.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nifedipress-mr#PHP61095>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nimenrix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nimenrix#RsZw8B6ovESyYuriOIiO7g>;
                                                                         nicebnf:hasTitle """<title>Nimenrix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "nimenrix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nimenrix#PHP100225> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nimenrix#RsZw8B6ovESyYuriOIiO7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                   rdfs:label "0.5 ml for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1–2 years), then 0.5 ml after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of neisseria meningitidis serogroup a infection."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>0.5 mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1–2 years), then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """0.5 mL for 1 dose, to be injected preferably into deltoid region (or anterolateral thigh in child 1–2 years), then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "0.5 ml for 1 dose, to be injected preferably into deltoid region, then 0.5 ml after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of neisseria meningitidis serogroup a infection."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>0.5 mL for 1 dose, to be injected preferably into deltoid region, then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of <i>Neisseria meningitidis</i> serogroup A infection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """0.5 mL for 1 dose, to be injected preferably into deltoid region, then 0.5 mL after 1 year if required for 1 dose, second dose should be considered in those who continue to be at risk of Neisseria meningitidis serogroup A infection.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstNeisseriaMeningitidis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nimenrix#PHP100225>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstNeisseriaMeningitidis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against <ph outputclass=\"organism\"><i>Neisseria meningitidis</i></ph></p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Immunisation against Neisseria meningitidis

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "immunisation against neisseria meningitidis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nitro-dur> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nitro-dur#HsM9z3_ikU-D0cG7oLIBEg>;
                                                                          nicebnf:hasTitle """<title>Nitro-Dur<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "nitro-dur"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nitro-dur#HsM9z3_ikU-D0cG7oLIBEg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "one ‘0.2mg/h’ patch to be applied to chest or outer upper arm and replaced every 24 hours, siting replacement patch on different area, dose adjusted according to response; maximum 15 mg per day."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>One ‘0.2mg/h’ patch to be applied to chest or outer upper arm and replaced every 24 hours, siting replacement patch on different area, dose adjusted according to response; maximum 15 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """One ‘0.2mg/h’ patch to be applied to chest or outer upper arm and replaced every 24 hours, siting replacement patch on different area, dose adjusted according to response; maximum 15 mg per day.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nitro-dur#PHP61016>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nitro-dur#PHP61016> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#8lInCJlF_0uP7kwCirw11g>,
                                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#eHqNbNS3D0G_ObXplrrzVw>;
                                                                                         nicebnf:hasTitle """<title>Norditropin<tm tmtype=\"reg\" /> preparations</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "norditropin preparations"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#8lInCJlF_0uP7kwCirw11g> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#PHP81858>;
                                                                                                                nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                                a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#PHP81858> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#PHP81879> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#eHqNbNS3D0G_ObXplrrzVw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Cartridges are for use with appropriate <i>NordiPen</i><tm tmtype=\"reg\" /> device (non-NHS but available free of charge from clinics).</p>
  <p>Multidose disposable prefilled pens for use with <i>NovoFine</i><tm tmtype=\"reg\" /> or <i>NovoTwist</i><tm tmtype=\"reg\" /> needles.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/norditropin-preparations#PHP81879>;
                                                                                                                nicebnf:hasTextContent """Cartridges are for use with appropriate NordiPen device (non-NHS but available free of charge from clinics).

Multidose disposable prefilled pens for use with NovoFine or NovoTwist needles.

"""^^xsd:string;
                                                                                                                a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nova-t-380> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/nova-t-380#dPnAOIE39kWp47PwtiKbZA>;
                                                                           nicebnf:hasTitle """<title>Nova-T<tm tmtype=\"reg\" /> 380</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "nova-t 380"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nova-t-380#PHP105484> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nova-t-380#dPnAOIE39kWp47PwtiKbZA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nova-t-380#PHP105484>;
                                                                                                  nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                  a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-ag> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-ag#MS-Cy5mFZkyUSxJ4OsBgxQ>;
                                                                                  nicebnf:hasTitle """<title>Novaplus T 380<tm tmtype=\"reg\" /> Ag</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "novaplus t 380 ag"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-ag#MS-Cy5mFZkyUSxJ4OsBgxQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>‘<i>Mini</i>’ size for minimum uterine length 5 cm; ‘<i>Normal</i>’ size for uterine length 6.5–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-ag#PHP105616>;
                                                                                                         nicebnf:hasTextContent """‘Mini’ size for minimum uterine length 5 cm; ‘Normal’ size for uterine length 6.5–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-ag#PHP105616> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-cu> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-cu#R1vyQJvV3EWFlTy1thrQMg>;
                                                                                  nicebnf:hasTitle """<title>Novaplus T 380<tm tmtype=\"reg\" /> Cu</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "novaplus t 380 cu"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-cu#PHP105479> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-cu#R1vyQJvV3EWFlTy1thrQMg> nicebnf:hasDitaContent """<sectiondiv>
  <p>‘<i>Mini</i>’ size for minimum uterine length 5 cm; ‘<i>Normal</i>’ size for uterine length 6.5–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/novaplus-t-380-cu#PHP105479>;
                                                                                                         nicebnf:hasTextContent """‘Mini’ size for minimum uterine length 5 cm; ‘Normal’ size for uterine length 6.5–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/novofem> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/novofem#r_ssXdYdW0ytbOe3fq9iBA>;
                                                                        nicebnf:hasTitle """<title>Novofem<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "novofem"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novofem#PHP96568> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/novofem#r_ssXdYdW0ytbOe3fq9iBA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 tablet daily for 16 days, red tablets to be taken, then 1 tablet daily for 12 days, white tablets to be taken, subsequent courses are repeated without interval; start treatment with red tablet at any time or if changing from cyclical hrt, start treatment the day after finishing oestrogen plus progestogen phase."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 tablet daily for 16 days, red tablets to be taken, then 1 tablet daily for 12 days, white tablets to be taken, subsequent courses are repeated without interval; start treatment with red tablet at any time or if changing from cyclical HRT, start treatment the day after finishing oestrogen plus progestogen phase.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 tablet daily for 16 days, red tablets to be taken, then 1 tablet daily for 12 days, white tablets to be taken, subsequent courses are repeated without interval; start treatment with red tablet at any time or if changing from cyclical HRT, start treatment the day after finishing oestrogen plus progestogen phase.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/novofem#PHP96568>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#6S3UmUuvDUeRZFHost_OoQ>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#QTmZiOUOXk-NSAd12EkPng>;
                                                                                        nicebnf:hasTitle """<title>Nuelin SA<tm tmtype=\"reg\" /> 175mg tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "nuelin sa 175mg tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#6S3UmUuvDUeRZFHost_OoQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "175–350 mg every 12 hours."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>175–350 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """175–350 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>,
                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction>,
                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#PHP82823>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#PHP82823> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#QTmZiOUOXk-NSAd12EkPng> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                                  rdfs:label "175 mg every 12 hours."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>175 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """175 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>],
                                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                  rdfs:label "175–350 mg every 12 hours."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>175–350 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """175–350 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-175mg-tablets#PHP82823>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic asthma</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Chronic asthma

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "chronic asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reversible airways obstruction</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Reversible airways obstruction

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "reversible airways obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe acute asthma</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Severe acute asthma

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "severe acute asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by mouth using modified-release medicines"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#b9P8N46yAE-etBAuznhgOQ>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#cJkNoKKfnkW6_pv52Stn4g>;
                                                                                      nicebnf:hasTitle """<title>Nuelin SA<tm tmtype=\"reg\" /> 250 tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "nuelin sa 250 tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#PHP97432> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#b9P8N46yAE-etBAuznhgOQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "250–500 mg every 12 hours."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>250–500 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """250–500 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>,
                                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction>,
                                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#PHP97432>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#cJkNoKKfnkW6_pv52Stn4g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                                rdfs:label "125–250 mg every 12 hours."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>125–250 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """125–250 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                rdfs:label "250–500 mg every 12 hours."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>250–500 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """250–500 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuelin-sa-250-tablets#PHP97432>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic asthma</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Chronic asthma

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "chronic asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reversible airways obstruction</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Reversible airways obstruction

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "reversible airways obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe acute asthma</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Severe acute asthma

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "severe acute asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by mouth using modified-release medicines"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutraplus> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutraplus#gB1aUe1et0qtw0_lRtPF2Q>;
                                                                          nicebnf:hasTitle """<title>Nutraplus<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "nutraplus"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutraplus#PHP106163> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutraplus#gB1aUe1et0qtw0_lRtPF2Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                    rdfs:label "apply 2–3 times a day."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply 2–3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply 2–3 times a day.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply 2–3 times a day."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply 2–3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply 2–3 times a day.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutraplus#PHP106163>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#dryScalingAndItchingSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry, scaling and itching skin</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Dry, scaling and itching skin

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "dry, scaling and itching skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutrizym-22-gastro-resistant-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutrizym-22-gastro-resistant-capsules#gVVaAsWHCU2BhcdfGYy4EA>;
                                                                                                      nicebnf:hasTitle """<title>Nutrizym 22<tm tmtype=\"reg\" />  gastro-resistant capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                      rdfs:label "nutrizym 22  gastro-resistant capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutrizym-22-gastro-resistant-capsules#PHP107007> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutrizym-22-gastro-resistant-capsules#gVVaAsWHCU2BhcdfGYy4EA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                rdfs:label "initially 1–2 capsules, dose to be taken with meals and 1 capsule as required, dose to be taken with snacks, doses should be swallowed whole or contents taken with water or mixed with soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                                                nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken with meals and 1 capsule as required, dose to be taken with snacks, doses should be swallowed whole or contents taken with water or mixed with soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken with meals and 1 capsule as required, dose to be taken with snacks, doses should be swallowed whole or contents taken with water or mixed with soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutrizym-22-gastro-resistant-capsules#PHP107007>;
                                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#eBA7oTjaEkyRrKkwl6p0cg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#ycGxWZzK0UGEThGI9-dArA>;
                                                                           nicebnf:hasTitle """<title>NutropinAq<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "nutropinaq"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#PHP81926> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#PHP81943> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#eBA7oTjaEkyRrKkwl6p0cg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use with <i>NutropinAq</i><tm tmtype=\"reg\" /> Pen device (non-NHS but available free of charge from clinics).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#PHP81943>;
                                                                                                  nicebnf:hasTextContent """For use with NutropinAq Pen device (non-NHS but available free of charge from clinics).

"""^^xsd:string;
                                                                                                  a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#ycGxWZzK0UGEThGI9-dArA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nutropinaq#PHP81926>;
                                                                                                  nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                  a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuvelle-continuous> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuvelle-continuous#N6Q0g7RajUa_tVh9XSO-iw>;
                                                                                   nicebnf:hasTitle """<title>Nuvelle<tm tmtype=\"reg\" /> Continuous</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "nuvelle continuous"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuvelle-continuous#N6Q0g7RajUa_tVh9XSO-iw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet daily continuously, if changing from cyclical hrt, start treatment the day after finishing oestrogen plus progestogen phase."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet daily continuously, if changing from cyclical HRT, start treatment the day after finishing oestrogen plus progestogen phase.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet daily continuously, if changing from cyclical HRT, start treatment the day after finishing oestrogen plus progestogen phase.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>,
                                                                                                                                <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/nuvelle-continuous#PHP96384>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/nuvelle-continuous#PHP96384> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "menopausal symptoms in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusWhoseLastMenstrualPeriodOccurredOver12MonthsPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "osteoporosis prophylaxis in women with a uterus whose last menstrual period occurred over 12 months previously"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/occlusal> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/occlusal#5xyhMAa3rEigkzT_U2_0Lg>;
                                                                         nicebnf:hasTitle """<title>Occlusal<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "occlusal"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/occlusal#5xyhMAa3rEigkzT_U2_0Lg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                   rdfs:label "apply daily, treatment may need to be continued for up to 3 months."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply daily, treatment may need to be continued for up to 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply daily, treatment may need to be continued for up to 3 months.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply daily, treatment may need to be continued for up to 3 months."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply daily, treatment may need to be continued for up to 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply daily, treatment may need to be continued for up to 3 months.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#commonAndPlantarWarts>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/occlusal#PHP82277>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/occlusal#PHP82277> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#commonAndPlantarWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Common and plantar warts</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Common and plantar warts

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "common and plantar warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/octagam> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/octagam#SwW2aA1J_UaKwFeUrkRCfA>;
                                                                        nicebnf:hasTitle """<title>Octagam<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "octagam"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/octagam#PHP98302> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/octagam#SwW2aA1J_UaKwFeUrkRCfA> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#falselyElevatedResultsWithBloodGlucoseTestingSystemsContainsMaltose>;
                                                                                               nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Falsely elevated results with blood glucose testing systems (contains maltose)</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/octagam#PHP98302>;
                                                                                               nicebnf:hasTextContent """Falsely elevated results with blood glucose testing systems (contains maltose)

"""^^xsd:string;
                                                                                               a nicebnf:CautionsGroup,
                                                                                                 nicebnf:GeneralCautions.
<http://ld.nice.org.uk/ns/bnf/Caution#falselyElevatedResultsWithBloodGlucoseTestingSystemsContainsMaltose> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Falsely elevated results with blood glucose testing systems (contains maltose)</ph>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent "Falsely elevated results with blood glucose testing systems (contains maltose)"^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                           rdfs:label "falsely elevated results with blood glucose testing systems (contains maltose)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#8nVxkpRh-UOSh0QO07D9Mg>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#GzE3wgTA3ki-uavp8Gbjrw>;
                                                                       nicebnf:hasTitle """<title>Octasa<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "octasa"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#8nVxkpRh-UOSh0QO07D9Mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "2.4–4.8 g once daily, alternatively 2.4–4.8 g daily in divided doses, dose over 2.4 g daily in divided doses only."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>2.4–4.8 g once daily, alternatively 2.4–4.8 g daily in divided doses, dose over 2.4 g daily in divided doses only.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """2.4–4.8 g once daily, alternatively 2.4–4.8 g daily in divided doses, dose over 2.4 g daily in divided doses only.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#PHP83317>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#GzE3wgTA3ki-uavp8Gbjrw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "1.2–2.4 g once daily, alternatively daily in divided doses."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>1.2–2.4 g once daily, alternatively daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """1.2–2.4 g once daily, alternatively daily in divided doses.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitisAndCrohnSIleoColitis>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#PHP83317>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/octasa#PHP83317> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitisAndCrohnSIleoColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis and Crohn's ileo-colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis and Crohn's ileo-colitis

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "maintenance of remission of ulcerative colitis and crohn's ileo-colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#xL6kgtYbHEay20rUy9nDrA>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#zF4Q-2xUY0-A9b1Ozxcd3g>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#bg0O64i6mE2MSV1BRbjvXw>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#bi6-rhfNNUir4OY6h3SdQA>;
                                                                          nicebnf:hasTitle """<title>Oestrogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "oestrogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97430> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97512> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#bg0O64i6mE2MSV1BRbjvXw> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>
  <p>Apply gel to clean, dry, intact skin such as arms, shoulders or inner thighs and allow to dry for 5 minutes before covering with clothing. Not to be applied on or near breasts or on vulval region. Avoid skin contact with another person (particularly male) and avoid other skin products or washing the area for at least 1 hour after application.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withTopicalUse>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97512>;
                                                                                                 nicebnf:hasTextContent """With topical use

Apply gel to clean, dry, intact skin such as arms, shoulders or inner thighs and allow to dry for 5 minutes before covering with clothing. Not to be applied on or near breasts or on vulval region. Avoid skin contact with another person (particularly male) and avoid other skin products or washing the area for at least 1 hour after application.

"""^^xsd:string;
                                                                                                 a nicebnf:GeneralPatientAdvice,
                                                                                                   nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#bi6-rhfNNUir4OY6h3SdQA> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>2 measures is equivalent to estradiol 1.5 mg.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97430>;
                                                                                                 nicebnf:hasTextContent """Dose equivalence and conversion2 measures is equivalent to estradiol 1.5 mg.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseEquivalence,
                                                                                                   nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#xL6kgtYbHEay20rUy9nDrA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply 1.5 mg once daily continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply 1.5 mg once daily continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply 1.5 mg once daily continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97430>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#zF4Q-2xUY0-A9b1Ozxcd3g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply 1.5 mg once daily continuously, increased if necessary up to 3 mg after 1 month continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply 1.5 mg once daily continuously, increased if necessary up to 3 mg after 1 month continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply 1.5 mg once daily continuously, increased if necessary up to 3 mg after 1 month continuously, to be applied over an area twice that of the template provided, starting within 5 days of menstruation (or anytime if cycles have ceased or are infrequent), to be used with cyclical progestogen for at least 12 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oestrogel#PHP97430>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Route#topical> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                             rdfs:label "topical"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withTopicalUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#topical>;
                                                          a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                          rdfs:label "with topical use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#B6u7h6THfk-1HR4Bxxzdgw>;
                                                                     nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#lKegLEHXzE-0Y1ZpV2_KkQ>;
                                                                     nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#10iOeHPayUO0CEj3gkfHbQ>;
                                                                     nicebnf:hasTitle """<title>Ofev <tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                     rdfs:label "ofev"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#10iOeHPayUO0CEj3gkfHbQ> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Weight loss</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon>;
                                                                                            nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#weightLoss>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108731>;
                                                                                            nicebnf:hasTextContent """Weight loss

"""^^xsd:string;
                                                                                            a nicebnf:GeneralSideEffects,
                                                                                              nicebnf:SideEffectGroup,
                                                                                              nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#B6u7h6THfk-1HR4Bxxzdgw> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#theoreticalIncreasedRiskOfVenousThromboembolism>;
                                                                                            nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Theoretical increased risk of venous thromboembolism</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108690>;
                                                                                            nicebnf:hasTextContent """Theoretical increased risk of venous thromboembolism

"""^^xsd:string;
                                                                                            a nicebnf:CautionsGroup,
                                                                                              nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108690> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108702> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108731> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#lKegLEHXzE-0Y1ZpV2_KkQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "150 mg twice daily, reduced if not tolerated to 100 mg twice daily, for dose adjustments due to side-effects, consult product literature."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>150 mg twice daily, reduced if not tolerated to 100 mg twice daily, for dose adjustments due to side-effects, consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """150 mg twice daily, reduced if not tolerated to 100 mg twice daily, for dose adjustments due to side-effects, consult product literature.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfIdiopathicPulmonaryFibrosis>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ofev#PHP108702>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Caution#theoreticalIncreasedRiskOfVenousThromboembolism> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Theoretical increased risk of venous thromboembolism</ph>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent "Theoretical increased risk of venous thromboembolism"^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                       rdfs:label "theoretical increased risk of venous thromboembolism"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon> a nicebnf:Frequency;
                                                            rdfs:label "common or very common"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfIdiopathicPulmonaryFibrosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of idiopathic pulmonary fibrosis</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Treatment of idiopathic pulmonary fibrosis

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "treatment of idiopathic pulmonary fibrosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#weightLoss> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Weight loss</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "Weight loss"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "weight loss"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#iHRzzqwBBUiHZvqJaWHSDg>,
                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#sc4YiNaBGEqchUf3FD0naQ>;
                                                                                                nicebnf:hasTitle """<title>Oilatum<tm tmtype=\"reg\" /> emollient bath additive</title>"""^^<rdf:XMLLiteral>;
                                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                rdfs:label "oilatum emollient bath additive"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#PHP106353> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#iHRzzqwBBUiHZvqJaWHSDg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                          rdfs:label "1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#PHP106353>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#sc4YiNaBGEqchUf3FD0naQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                                          rdfs:label "apply 0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>Apply 0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """Apply 0.5–2 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                          rdfs:label "1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-emollient-bath-additive#PHP106353>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including dermatitis, and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Dry skin conditions including dermatitis, and ichthyosis

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "dry skin conditions including dermatitis, and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#b83RoTW7-EOCjZZNLTSc8A>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#wsNLAdZ1TEuExMgJSgbOeg>;
                                                                                             nicebnf:hasTitle """<title>Oilatum<tm tmtype=\"reg\" /> junior bath additive</title>"""^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "oilatum junior bath additive"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#PHP105936> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#b83RoTW7-EOCjZZNLTSc8A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                       rdfs:label "1–3 capfuls/bath, alternatively, apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#PHP105936>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#wsNLAdZ1TEuExMgJSgbOeg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                                       rdfs:label "0.5–2 capfuls/bath, alternatively, apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>0.5–2 capfuls/bath, alternatively, apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """0.5–2 capfuls/bath, alternatively, apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                       rdfs:label "1–3 capfuls/bath, alternatively, apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "1–3 capfuls/bath, alternatively, apply to wet skin and rinse."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>1–3 capfuls/bath, alternatively, apply to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """1–3 capfuls/bath, alternatively, apply to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-junior-bath-additive#PHP105936>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingDermatitisAndIchthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including dermatitis and ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Dry skin conditions including dermatitis and ichthyosis

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "dry skin conditions including dermatitis and ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-plus> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-plus#4QMVS0uQ4Uatq8K-k4Pomg>;
                                                                             nicebnf:hasTitle """<title>Oilatum<tm tmtype=\"reg\" /> Plus</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "oilatum plus"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-plus#4QMVS0uQ4Uatq8K-k4Pomg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Months> ; 
                                                                                                                       rdfs:label "1 ml/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>1 mL/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """1 mL/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                       rdfs:label "1–2 capfuls/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>1–2 capfuls/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """1–2 capfuls/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "1–2 capfuls/bath, not to be used undiluted."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>1–2 capfuls/bath, not to be used undiluted.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """1–2 capfuls/bath, not to be used undiluted.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#topicalTreatmentOfEczemaIncludingEczemaAtRiskFromInfection>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-plus#PHP105971>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oilatum-plus#PHP105971> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#topicalTreatmentOfEczemaIncludingEczemaAtRiskFromInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Topical treatment of eczema, including eczema at risk from infection</p>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasTextContent """Topical treatment of eczema, including eczema at risk from infection

"""^^xsd:string;
                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                     rdfs:label "topical treatment of eczema, including eczema at risk from infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 6–11 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#UMuhqt4P6kiL36oUsx2vww>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#u2fFMWhxQUqau4nP64SMuQ>;
                                                                          nicebnf:hasTitle """<title>Omnitrope<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "omnitrope"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#PHP81990> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#PHP82007> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#UMuhqt4P6kiL36oUsx2vww> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#PHP81990>;
                                                                                                 nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#u2fFMWhxQUqau4nP64SMuQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use with <i>Omnitrope Pen 5</i><tm tmtype=\"reg\" /> and <i>Omnitrope Pen 10</i><tm tmtype=\"reg\" /> devices (non-NHS but available free of charge from clinics).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/omnitrope#PHP82007>;
                                                                                                 nicebnf:hasTextContent """For use with Omnitrope Pen 5 and Omnitrope Pen 10 devices (non-NHS but available free of charge from clinics).

"""^^xsd:string;
                                                                                                 a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/optaflu> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/optaflu#c3Ir-y3mwUKJiITrq5HRnA>;
                                                                        nicebnf:hasTitle """<title>Optaflu<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "optaflu"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/optaflu#PHP101999> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/optaflu#c3Ir-y3mwUKJiITrq5HRnA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Not licensed for use in children and adolescents under 18 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/optaflu#PHP101999>;
                                                                                               nicebnf:hasTextContent """Not licensed for use in children and adolescents under 18 years.

"""^^xsd:string;
                                                                                               a nicebnf:UnlicencedUse.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#UPrGM56FWUOKE4-3hh7eIQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#XDB_efnvA0Oi9jwDHKYqeg>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#4rgtKzN3t0Wz7OmCbrCfgg>;
                                                                        nicebnf:hasTitle """<title>Ovestin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "ovestin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#4rgtKzN3t0Wz7OmCbrCfgg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Effect on latex condoms and diaphragms not yet known.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#PHP101587>;
                                                                                               nicebnf:hasTextContent """Effect on latex condoms and diaphragms not yet known.

"""^^xsd:string;
                                                                                               a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#PHP101578> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#PHP101587> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#UPrGM56FWUOKE4-3hh7eIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply 1 applicatorful daily for 2–3 weeks, then reduced to 1 applicatorful twice weekly, discontinue every 2–3 months for 4 weeks to assess need for further treatment."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply 1 applicatorful daily for 2–3 weeks, then reduced to 1 applicatorful twice weekly, discontinue every 2–3 months for 4 weeks to assess need for further treatment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply 1 applicatorful daily for 2–3 weeks, then reduced to 1 applicatorful twice weekly, discontinue every 2–3 months for 4 weeks to assess need for further treatment.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitisShortTermUse>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#PHP101578>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#XDB_efnvA0Oi9jwDHKYqeg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply 1 applicatorful daily for 2 weeks before surgery, resume 2 weeks after surgery."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply 1 applicatorful daily for 2 weeks before surgery, resume 2 weeks after surgery.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply 1 applicatorful daily for 2 weeks before surgery, resume 2 weeks after surgery.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#vaginalSurgeryForProlapseWhenThereIsEpithelialAtrophyInPostmenopausalWomenBeforeSurgery>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ovestin#PHP101578>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitisShortTermUse> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "improve the vaginal epithelium in menopausal atrophic vaginitis (short-term use)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#vaginalSurgeryForProlapseWhenThereIsEpithelialAtrophyInPostmenopausalWomenBeforeSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Vaginal surgery for prolapse when there is epithelial atrophy in postmenopausal women (before surgery)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasTextContent """Vaginal surgery for prolapse when there is epithelial atrophy in postmenopausal women (before surgery)

"""^^xsd:string;
                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                  rdfs:label "vaginal surgery for prolapse when there is epithelial atrophy in postmenopausal women (before surgery)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#Aps9zJqyDUqPyI9fGHNrVA>,
                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#BizJjF9e3UGT0c0GShKOPA>,
                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#S0D0h3EPZ0SlCRfM9WUYMg>,
                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#SlROT9_4102HmtzJhNJjDw>;
                                                                     nicebnf:hasTitle """<title>Oxis<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                     rdfs:label "oxis"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#Aps9zJqyDUqPyI9fGHNrVA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                               rdfs:label "6–12 micrograms, dose to be taken before exercise."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>6–12 micrograms, dose to be taken before exercise.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """6–12 micrograms, dose to be taken before exercise.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "12 micrograms, dose to be taken before exercise."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>12 micrograms, dose to be taken before exercise.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """12 micrograms, dose to be taken before exercise.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfExerciseInducedBronchospasm>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#PHP82447>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#BizJjF9e3UGT0c0GShKOPA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "12 micrograms 1–2 times a day (max. per dose 24 micrograms), for symptom relief additional doses up to maximum daily dose can be taken; maximum 48 micrograms per day."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>12 micrograms 1–2 times a day (max. per dose 24 micrograms), for symptom relief additional doses up to maximum daily dose can be taken; maximum 48 micrograms per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """12 micrograms 1–2 times a day (max. per dose 24 micrograms), for symptom relief additional doses up to maximum daily dose can be taken; maximum 48 micrograms per day.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDisease>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#PHP82447>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#PHP82447> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#S0D0h3EPZ0SlCRfM9WUYMg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                               rdfs:label "6–12 micrograms."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>6–12 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """6–12 micrograms.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "6–12 micrograms."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>6–12 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """6–12 micrograms.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfBronchospasm>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#PHP82447>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#SlROT9_4102HmtzJhNJjDw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                               rdfs:label "6–12 micrograms 1–2 times a day (max. per dose 12 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 48 micrograms per day."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>6–12 micrograms 1–2 times a day (max. per dose 12 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 48 micrograms per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """6–12 micrograms 1–2 times a day (max. per dose 12 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 48 micrograms per day.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                               rdfs:label "6–12 micrograms 1–2 times a day, increased if necessary up to 24 micrograms twice daily (max. per dose 36 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 72 micrograms per day."^^xsd:string ; 
                                                                                                               nicebnf:hasDitaContent "<p>6–12 micrograms 1–2 times a day, increased if necessary up to 24 micrograms twice daily (max. per dose 36 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 72 micrograms per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                               nicebnf:hasTextContent """6–12 micrograms 1–2 times a day, increased if necessary up to 24 micrograms twice daily (max. per dose 36 micrograms), occasionally doses up to the maximum daily may be needed, reassess treatment if additional doses required on more than 2 days a week; maximum 72 micrograms per day.

"""^^xsd:string ; 
                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>;
                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/oxis#PHP82447>;
                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic asthma</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Chronic asthma

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "chronic asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease</p>"""^^<rdf:XMLLiteral>;
                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease

"""^^xsd:string;
                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                             rdfs:label "chronic obstructive pulmonary disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Prophylaxis of exercise-induced bronchospasm

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "prophylaxis of exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Relief of bronchospasm

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "relief of bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/panadol-oa> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/panadol-oa#S-bzJlQlBE2QNHX1cVBfDQ>;
                                                                           nicebnf:hasTitle """<title>Panadol OA<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "panadol oa"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/panadol-oa#PHP79865> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/panadol-oa#S-bzJlQlBE2QNHX1cVBfDQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "1 g up to 4 times a day, dose not to be taken more often than every 4 hours."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>1 g up to 4 times a day, dose not to be taken more often than every 4 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """1 g up to 4 times a day, dose not to be taken more often than every 4 hours.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePain>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#pyrexia>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/panadol-oa#PHP79865>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModeratePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate pain</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Mild to moderate pain

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "mild to moderate pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pyrexia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pyrexia</p>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent """Pyrexia

"""^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                  rdfs:label "pyrexia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#uFjdhN6Yhkugsna2fPcxFQ>;
                                                                             nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#xl5UNOvGNkyIt9XO8qCQbg>;
                                                                             nicebnf:hasTitle """<title>Pancrease HL<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "pancrease hl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#PHP82542> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#PHP82544> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#uFjdhN6Yhkugsna2fPcxFQ> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#shouldNotBeUsedInChildrenAged15YearsOrLessWithCysticFibrosis>;
                                                                                                    nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Should not be used in children aged 15 years or less with cystic fibrosis</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#PHP82542>;
                                                                                                    nicebnf:hasTextContent """Should not be used in children aged 15 years or less with cystic fibrosis

"""^^xsd:string;
                                                                                                    a nicebnf:ContraindicationsGroup,
                                                                                                      nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#xl5UNOvGNkyIt9XO8qCQbg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                       rdfs:label "initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                      [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing)."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 1–2 capsules, dose to be taken during each meal and 1 capsule, to be taken with snacks, all doses either taken whole or contents mixed with slightly acidic liquid or soft food (then swallowed immediately without chewing).

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrease-hl#PHP82544>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Contraindication#shouldNotBeUsedInChildrenAged15YearsOrLessWithCysticFibrosis> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Should not be used in children aged 15 years or less with cystic fibrosis</ph>"""^^<rdf:XMLLiteral>;
                                                                                                             nicebnf:hasTextContent "Should not be used in children aged 15 years or less with cystic fibrosis"^^xsd:string;
                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                                             rdfs:label "should not be used in children aged 15 years or less with cystic fibrosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-powder> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-powder#i9ShzO1c3U2k299R8mZYqw>;
                                                                                 nicebnf:hasTitle """<title>Pancrex<tm tmtype=\"reg\" /> V powder</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "pancrex v powder"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-powder#PHP82349> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-powder#i9ShzO1c3U2k299R8mZYqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                           rdfs:label "0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.5–2 g, to be taken before or with meals, washed down or mixed with milk or water.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-powder#PHP82349>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets-forte> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets-forte#-Xn3ilmfO0eib5GF13TsLw>;
                                                                                        nicebnf:hasTitle """<title>Pancrex<tm tmtype=\"reg\" /> V tablets forte</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "pancrex v tablets forte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets-forte#-Xn3ilmfO0eib5GF13TsLw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                                  rdfs:label "6–10 tablets, to be taken before meals."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>6–10 tablets, to be taken before meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """6–10 tablets, to be taken before meals.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "6–10 tablets, to be taken before meals."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>6–10 tablets, to be taken before meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """6–10 tablets, to be taken before meals.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets-forte#PHP82279>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets-forte#PHP82279> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets#Ld9EU32W_UK0Bv0DohV3HQ>;
                                                                                  nicebnf:hasTitle """<title>Pancrex<tm tmtype=\"reg\" /> V tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "pancrex v tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets#Ld9EU32W_UK0Bv0DohV3HQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                            rdfs:label "5–15 tablets, to be taken before meals."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>5–15 tablets, to be taken before meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """5–15 tablets, to be taken before meals.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "5–15 tablets, to be taken before meals."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>5–15 tablets, to be taken before meals.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """5–15 tablets, to be taken before meals.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets#PHP82216>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v-tablets#PHP82216> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v#I54xH4rpYU-ERf_4tikW4Q>;
                                                                          nicebnf:hasTitle """<title>Pancrex<tm tmtype=\"reg\" /> V</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "pancrex v"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v#I54xH4rpYU-ERf_4tikW4Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child111Months> ; 
                                                                                                                    rdfs:label "1–2 capsules, contents of capsule to be mixed with feeds."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1–2 capsules, contents of capsule to be mixed with feeds.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1–2 capsules, contents of capsule to be mixed with feeds.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                    rdfs:label "2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """2–6 capsules, dose to be taken with each meal either swallowed whole or sprinkled on food.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v#PHP82099>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex-v#PHP82099> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child111Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 1–11 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex#HkmPkchkH02zXTb1vn0cKg>;
                                                                        nicebnf:hasTitle """<title>Pancrex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "pancrex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex#HkmPkchkH02zXTb1vn0cKg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                  rdfs:label "5–10 g, to be taken just before meals, washed down or mixed with milk or water."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5–10 g, to be taken just before meals, washed down or mixed with milk or water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5–10 g, to be taken just before meals, washed down or mixed with milk or water.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "5–10 g, to be taken just before meals, washed down or mixed with milk or water."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5–10 g, to be taken just before meals, washed down or mixed with milk or water.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5–10 g, to be taken just before meals, washed down or mixed with milk or water.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex#PHP82031>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pancrex#PHP82031> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#pancreaticInsufficiency> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pancreatic insufficiency</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Pancreatic insufficiency

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "pancreatic insufficiency"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#8tIPSAPZR0q5rZfKSHK05Q>;
                                                                        nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#lrz9lzC5eUey7gMbORId9Q>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#3vu6MuscYk-u-9x7EjiC5A>;
                                                                        nicebnf:hasTitle """<title>PecFent<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "pecfent"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#3vu6MuscYk-u-9x7EjiC5A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid concomitant use of other nasal preparations.</p>
  <p>Patients or carers should be given advice on how to administer <i>PecFent</i><tm tmtype=\"reg\" /> spray.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80065>;
                                                                                               nicebnf:hasTextContent """Avoid concomitant use of other nasal preparations.

Patients or carers should be given advice on how to administer PecFent spray.

"""^^xsd:string;
                                                                                               a nicebnf:GeneralPatientAdvice,
                                                                                                 nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#8tIPSAPZR0q5rZfKSHK05Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (September 2008) that <i>PecFent</i><tm tmtype=\"reg\" /> nasal spray should be restricted for use within NHS Scotland for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short-acting opioids are unsuitable.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80100>;
                                                                                               nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (September 2008) that PecFent nasal spray should be restricted for use within NHS Scotland for the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain, when other short-acting opioids are unsuitable.

"""^^xsd:string;
                                                                                               a nicebnf:FundingDecision,
                                                                                                 nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80023> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80065> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80100> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#lrz9lzC5eUey7gMbORId9Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 100 micrograms, adjusted according to response, dose to be administered into one nostril only, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 100 micrograms, adjusted according to response, dose to be administered into one nostril only, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 100 micrograms, adjusted according to response, dose to be administered into one nostril only, maximum 2 sprays for each pain episode and minimum 4 hours between treatment of each pain episode, if more than 4 breakthrough pain episodes daily, adjust background analgesia.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pecfent#PHP80023>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Breakthrough pain in patients receiving opioid therapy for chronic cancer pain

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "breakthrough pain in patients receiving opioid therapy for chronic cancer pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#788Vx6aHOUKc1UIUBumGMg>;
                                                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#1F-kmvgAx06UiVZ7UN2zVw>,
                                                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#GI01ytS63024nt-XoKOysw>,
                                                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#k3HwlyxGjE-8CIlI-cDKDg>;
                                                                                                           nicebnf:hasTitle "<title>Peditrace solution for infusion 10ml vials</title>"^^<rdf:XMLLiteral>;
                                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                           rdfs:label "peditrace solution for infusion 10ml vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#1F-kmvgAx06UiVZ7UN2zVw> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use in neonates (when kidney function established, usually second day of life), infants, and children.</p>
  <p>
    <i>Peditrace</i>
    <tm tmtype=\"reg\" /> solution contains traces of Zn<sup>2+</sup>, Cu<sup>2+</sup>, Mn<sup>2+</sup>, Se<sup>4+</sup>, F<sup>-</sup>, I<sup>-</sup>.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107337>;
                                                                                                                                  nicebnf:hasTextContent """For use in neonates (when kidney function established, usually second day of life), infants, and children.

Peditrace solution contains traces of Zn2+, Cu2+, Mn2+, Se4+, F-, I-.

"""^^xsd:string;
                                                                                                                                  a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#788Vx6aHOUKc1UIUBumGMg> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretion>,
                                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretionInCholestaticLiverDisease>,
                                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretionInMarkedlyReducedUrinaryExcretionCarefulBiochemicalMonitoringRequired>,
                                                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Caution#totalParenteralNutritionExceedingOneMonth>;
                                                                                                                                  nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Reduced biliary excretion</ph>; <ph outputclass=\"caution\">reduced biliary excretion in cholestatic liver disease</ph>; <ph outputclass=\"caution\">reduced biliary excretion in markedly reduced urinary excretion (careful biochemical monitoring required)</ph>; <ph outputclass=\"caution\">total parenteral nutrition exceeding one month</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107222>;
                                                                                                                                  nicebnf:hasTextContent """Reduced biliary excretion; reduced biliary excretion in cholestatic liver disease; reduced biliary excretion in markedly reduced urinary excretion (careful biochemical monitoring required); total parenteral nutrition exceeding one month

"""^^xsd:string;
                                                                                                                                  a nicebnf:CautionsGroup,
                                                                                                                                    nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#GI01ytS63024nt-XoKOysw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Measure serum manganese concentration and check liver function before commencing treatment and regularly during treatment—discontinue if manganese concentration raised or if cholestasis develops.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107222>;
                                                                                                                                  nicebnf:hasTextContent """Measure serum manganese concentration and check liver function before commencing treatment and regularly during treatment—discontinue if manganese concentration raised or if cholestasis develops.

"""^^xsd:string;
                                                                                                                                  nicebnf:hasTitle "Total parenteral nutrition exceeding one month"^^xsd:string;
                                                                                                                                  a nicebnf:ImportantAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107222> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107304> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107337> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#k3HwlyxGjE-8CIlI-cDKDg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to <i>Vaminolact</i><tm tmtype=\"reg\" />, <i>Vamin</i><tm tmtype=\"reg\" /><i>14 Electrolyte-Free</i> solutions, and glucose intravenous infusions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/peditrace-solution-for-infusion-10ml-vials#PHP107304>;
                                                                                                                                  nicebnf:hasTextContent """For addition to Vaminolact, Vamin14 Electrolyte-Free solutions, and glucose intravenous infusions.

"""^^xsd:string;
                                                                                                                                  a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretion> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Reduced biliary excretion</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "Reduced biliary excretion"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                               rdfs:label "reduced biliary excretion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretionInCholestaticLiverDisease> nicebnf:hasDitaContent """<ph outputclass=\"caution\">reduced biliary excretion in cholestatic liver disease</ph>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent "reduced biliary excretion in cholestatic liver disease"^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                        rdfs:label "reduced biliary excretion in cholestatic liver disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#reducedBiliaryExcretionInMarkedlyReducedUrinaryExcretionCarefulBiochemicalMonitoringRequired> nicebnf:hasDitaContent """<ph outputclass=\"caution\">reduced biliary excretion in markedly reduced urinary excretion (careful biochemical monitoring required)</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasTextContent "reduced biliary excretion in markedly reduced urinary excretion (careful biochemical monitoring required)"^^xsd:string;
                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                    rdfs:label "reduced biliary excretion in markedly reduced urinary excretion (careful biochemical monitoring required)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#totalParenteralNutritionExceedingOneMonth> nicebnf:hasDitaContent """<ph outputclass=\"caution\">total parenteral nutrition exceeding one month</ph>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent "total parenteral nutrition exceeding one month"^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                 rdfs:label "total parenteral nutrition exceeding one month"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pegasys> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pegasys#_pf5OYmFUUCwomWQvrcktA>;
                                                                        nicebnf:hasTitle """<title>Pegasys<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "pegasys"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pegasys#PHP80794> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pegasys#_pf5OYmFUUCwomWQvrcktA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavirinForChronicHepatitisC>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisB>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisCIfRibavirinNotToleratedOrContraIndicated>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pegasys#PHP80794>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavirinForChronicHepatitisC> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Combined with ribavirin for chronic hepatitis C</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Combined with ribavirin for chronic hepatitis C

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "combined with ribavirin for chronic hepatitis c"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisB> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Monotherapy for chronic hepatitis B</p>"""^^<rdf:XMLLiteral>;
                                                                          nicebnf:hasTextContent """Monotherapy for chronic hepatitis B

"""^^xsd:string;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                          rdfs:label "monotherapy for chronic hepatitis b"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisCIfRibavirinNotToleratedOrContraIndicated> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Monotherapy for chronic hepatitis C if ribavirin not tolerated or contra-indicated</p>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasTextContent """Monotherapy for chronic hepatitis C if ribavirin not tolerated or contra-indicated

"""^^xsd:string;
                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                  rdfs:label "monotherapy for chronic hepatitis c if ribavirin not tolerated or contra-indicated"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#MqC9DoGVZU65eiyXIT8btw>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#_sEgEnBOg0WOrid2_Z2wsA>;
                                                                                 nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#Cbby8mCKc0eePxrsf3pMYg>,
                                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#X_Hj9vDC4kSzfn57sdvxnA>;
                                                                                 nicebnf:hasTitle """<title>Pentasa<tm tmtype=\"reg\" /> granules</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "pentasa granules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#Cbby8mCKc0eePxrsf3pMYg> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">In children</p>
  <p>Contents of one sachet should be weighed and divided immediately before use; discard any remaining granules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#inChildren>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83406>;
                                                                                                        nicebnf:hasTextContent """In children

Contents of one sachet should be weighed and divided immediately before use; discard any remaining granules.

"""^^xsd:string;
                                                                                                        a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#MqC9DoGVZU65eiyXIT8btw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                           rdfs:label "7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                           rdfs:label "2 g once daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>2 g once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """2 g once daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "2 g once daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>2 g once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """2 g once daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83389>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83389> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83406> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#X_Hj9vDC4kSzfn57sdvxnA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Granules should be placed on tongue and washed down with water or orange juice without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83406>;
                                                                                                        nicebnf:hasTextContent """Granules should be placed on tongue and washed down with water or orange juice without chewing.

"""^^xsd:string;
                                                                                                        a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#_sEgEnBOg0WOrid2_Z2wsA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                           rdfs:label "10–20 mg/kg 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>10–20 mg/kg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """10–20 mg/kg 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                           rdfs:label "1–2 g twice daily, total daily dose may alternatively be given in 3–4 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>1–2 g twice daily, total daily dose may alternatively be given in 3–4 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """1–2 g twice daily, total daily dose may alternatively be given in 3–4 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "up to 4 g once daily, alternatively up to 4 g daily in 2–4 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Up to 4 g once daily, alternatively up to 4 g daily in 2–4 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Up to 4 g once daily, alternatively up to 4 g daily in 2–4 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-granules#PHP83389>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                                rdfs:label "child 5–17 years (body-weight 40 kg and above)"^^xsd:string;
                                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                            rdfs:label "child 5–17 years (body-weight up to 40 kg)"^^xsd:string;
                                                                            rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#inChildren> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                      rdfs:label "in children"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#21bX-V2JMkmEzieAHywy2w>,
                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#O0jAVuzevk26q__SOxOM3A>;
                                                                                        nicebnf:hasTitle """<title>Pentasa<tm tmtype=\"reg\" /> retention enema</title>"""^^<rdf:XMLLiteral>;
                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                        rdfs:label "pentasa retention enema"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#21bX-V2JMkmEzieAHywy2w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                  rdfs:label "1 g once daily, dose to be administered at bedtime."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>1 g once daily, dose to be administered at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """1 g once daily, dose to be administered at bedtime.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectosigmoidRegion>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#PHP83453>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#O0jAVuzevk26q__SOxOM3A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                  rdfs:label "1 g once daily, dose to be administered at bedtime."^^xsd:string ; 
                                                                                                                                  nicebnf:hasDitaContent "<p>1 g once daily, dose to be administered at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                  nicebnf:hasTextContent """1 g once daily, dose to be administered at bedtime.

"""^^xsd:string ; 
                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisOrMaintenanceOfRemission>;
                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#PHP83453>;
                                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-retention-enema#PHP83453> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectosigmoidRegion> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region

"""^^xsd:string;
                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisOrMaintenanceOfRemission> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#549uX2GBPEONETPID2ZqCg>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#Zt80ILuF-UuKbHI3e-x57w>;
                                                                                      nicebnf:hasTitle """<title>Pentasa<tm tmtype=\"reg\" /> suppositories</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "pentasa suppositories"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#549uX2GBPEONETPID2ZqCg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                                rdfs:label "1 g daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>1 g daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """1 g daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "1 g daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>1 g daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """1 g daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceUlcerativeProctitis>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#PHP83422>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#PHP83422> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#Zt80ILuF-UuKbHI3e-x57w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> ; 
                                                                                                                                rdfs:label "1 g daily for 2–4 weeks."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>1 g daily for 2–4 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """1 g daily for 2–4 weeks.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "1 g daily for 2–4 weeks."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>1 g daily for 2–4 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """1 g daily for 2–4 weeks.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackUlcerativeProctitis>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-suppositories#PHP83422>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceUlcerativeProctitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance, ulcerative proctitis</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Maintenance, ulcerative proctitis

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "maintenance, ulcerative proctitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackUlcerativeProctitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack, ulcerative proctitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Treatment of acute attack, ulcerative proctitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "treatment of acute attack, ulcerative proctitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 15–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#A0jjuZlptU2nkLx3rqquhw>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#F7SoNFywz0yFVA_myABHrw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#y1btGDdT7EK-PGYUh221cg>;
                                                                                nicebnf:hasTitle """<title>Pentasa<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "pentasa tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#A0jjuZlptU2nkLx3rqquhw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "up to 4 g once daily, alternatively up to 4 g daily in 2–3 divided doses."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Up to 4 g once daily, alternatively up to 4 g daily in 2–3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Up to 4 g once daily, alternatively up to 4 g daily in 2–3 divided doses.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#PHP83344>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#F7SoNFywz0yFVA_myABHrw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "2 g once daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>2 g once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """2 g once daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#PHP83344>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#PHP83344> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#PHP83367> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#y1btGDdT7EK-PGYUh221cg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablets may be halved, quartered, or dispersed in water, but should not be chewed.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pentasa-tablets#PHP83367>;
                                                                                                       nicebnf:hasTextContent """Tablets may be halved, quartered, or dispersed in water, but should not be chewed.

"""^^xsd:string;
                                                                                                       a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#C03AnStXYkSITZwrhRQGvQ>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#wqf25TOqv0qthzrS4Rk0Yg>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#zsvk66a1g0OKM4m5Y8G6_A>;
                                                                         nicebnf:hasTitle """<title>Percutol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "percutol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#C03AnStXYkSITZwrhRQGvQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "½ inch to be administered on first day then increased by ½ inch/day until headache occurs, then reduced by ½ inch, approx. 800 micrograms/hour absorbed from 1 inch of ointment."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>½ inch to be administered on first day then increased by ½ inch/day until headache occurs, then reduced by ½ inch, approx. 800 micrograms/hour absorbed from 1 inch of ointment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """½ inch to be administered on first day then increased by ½ inch/day until headache occurs, then reduced by ½ inch, approx. 800 micrograms/hour absorbed from 1 inch of ointment.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAnginaToDetermineDose>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#PHP60793>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#PHP60726> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#PHP60793> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#wqf25TOqv0qthzrS4Rk0Yg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1–2 inches every 3–4 hours as required, to be measured on to applirule and applied (usually to chest, arm, or thigh) without rubbing in and secured with surgical tape, approx. 800 micrograms/hour absorbed from 1 inch of ointment."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent """<p>1–2 inches every 3–4 hours as required, to be measured on to <i>Applirule</i><tm tmtype=\"reg\" /> and applied (usually to chest, arm, or thigh) without rubbing in and secured with surgical tape, approx. 800 micrograms/hour absorbed from 1 inch of ointment.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1–2 inches every 3–4 hours as required, to be measured on to Applirule and applied (usually to chest, arm, or thigh) without rubbing in and secured with surgical tape, approx. 800 micrograms/hour absorbed from 1 inch of ointment.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#PHP60793>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#zsvk66a1g0OKM4m5Y8G6_A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer glyceryl trinitrate ointment.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/percutol#PHP60726>;
                                                                                                nicebnf:hasTextContent """Patients or carers should be given advice on how to administer glyceryl trinitrate ointment.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralPatientAdvice,
                                                                                                  nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAnginaToDetermineDose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina (to determine dose)</p>"""^^<rdf:XMLLiteral>;
                                                                             nicebnf:hasTextContent """Prophylaxis of angina (to determine dose)

"""^^xsd:string;
                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                             rdfs:label "prophylaxis of angina (to determine dose)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/peroxyl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/peroxyl#tfjbLhmevkO_DHkeA4yAgQ>;
                                                                        nicebnf:hasTitle """<title>Peroxyl<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "peroxyl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peroxyl#PHP78671> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/peroxyl#tfjbLhmevkO_DHkeA4yAgQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                                  rdfs:label "rinse or gargle 10 ml 3 times a day for about 1 minute, for maximum 7 days, to be used after meals and at bedtime."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Rinse or gargle 10 mL 3 times a day for about 1 minute, for maximum 7 days, to be used after meals and at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Rinse or gargle 10 mL 3 times a day for about 1 minute, for maximum 7 days, to be used after meals and at bedtime.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "rinse or gargle 10 ml up to 4 times a day for about 1 minute, to be used after meals and at bedtime."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Rinse or gargle 10 mL up to 4 times a day for about 1 minute, to be used after meals and at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Rinse or gargle 10 mL up to 4 times a day for about 1 minute, to be used after meals and at bedtime.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#oralHygiene>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/peroxyl#PHP78671>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#oralHygiene> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Oral hygiene</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Oral hygiene

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "oral hygiene"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#vfIIP6UyR0i5Jhl3_gukBg>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#35OpLRi920qMKpSvo-RqDQ>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#Rud21GcMjUWBiuFa9DZFuA>;
                                                                               nicebnf:hasTitle """<title>Phosex<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "phosex tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#35OpLRi920qMKpSvo-RqDQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer <i>Phosex</i><tm tmtype=\"reg\" /> tablets.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106803>;
                                                                                                      nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Phosex tablets.

"""^^xsd:string;
                                                                                                      a nicebnf:GeneralPatientAdvice,
                                                                                                        nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106719> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106785> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106803> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#Rud21GcMjUWBiuFa9DZFuA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Phosex</i>
    <tm tmtype=\"reg\" /> tablets are taken with meals.</p>
  <p>Tablets can be broken to aid swallowing, but not chewed (bitter taste).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106785>;
                                                                                                      nicebnf:hasTextContent """Phosex tablets are taken with meals.

Tablets can be broken to aid swallowing, but not chewed (bitter taste).

"""^^xsd:string;
                                                                                                      a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#vfIIP6UyR0i5Jhl3_gukBg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 1 tablet 3 times a day, to be taken with meals, dose to be adjusted according to serum-phosphate concentration, usual dose 4–6 tablets daily in divided doses, (1 or 2 tablets with each meal); maximum 12 tablets per day."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 1 tablet 3 times a day, to be taken with meals, dose to be adjusted according to serum-phosphate concentration, usual dose 4–6 tablets daily in divided doses, (1 or 2 tablets with each meal); maximum 12 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 1 tablet 3 times a day, to be taken with meals, dose to be adjusted according to serum-phosphate concentration, usual dose 4–6 tablets daily in divided doses, (1 or 2 tablets with each meal); maximum 12 tablets per day.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemia>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phosex-tablets#PHP106719>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperphosphataemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hyperphosphataemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hyperphosphataemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#5SNYTVHL6kmRFYiyGQix8A>;
                                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#h3EmeqVuAkKK1JXLbXyt0Q>,
                                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#rprYDyQG5kqEA-Zbg66M9w>;
                                                                                            nicebnf:hasTitle """<title>Phyllocontin Continus<tm tmtype=\"reg\" /> Forte</title>"""^^<rdf:XMLLiteral>;
                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                            rdfs:label "phyllocontin continus forte"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#5SNYTVHL6kmRFYiyGQix8A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                      rdfs:label "initially 350 mg twice daily for 1 week, then increased if necessary to 700 mg twice daily, increase dose according to plasma-theophylline concentration."^^xsd:string ; 
                                                                                                                                      nicebnf:hasDitaContent "<p>Initially 350 mg twice daily for 1 week, then increased if necessary to 700 mg twice daily, increase dose according to plasma-theophylline concentration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                      nicebnf:hasTextContent """Initially 350 mg twice daily for 1 week, then increased if necessary to 700 mg twice daily, increase dose according to plasma-theophylline concentration.

"""^^xsd:string ; 
                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP82986>;
                                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP82986> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP82994> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP83006> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#h3EmeqVuAkKK1JXLbXyt0Q> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>
  <p>
    <i>Phyllocontin Continus</i>
    <tm tmtype=\"reg\" /> Forte tablets are for smokers and other patients where theophylline half-life is shorter.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withOralUse>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP83006>;
                                                                                                                   nicebnf:hasTextContent """With oral use

Phyllocontin Continus Forte tablets are for smokers and other patients where theophylline half-life is shorter.

"""^^xsd:string;
                                                                                                                   a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#rprYDyQG5kqEA-Zbg66M9w> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Phyllocontin Continus</i>
    <tm tmtype=\"reg\" />
    <i>Forte</i> tablets are not licensed for use in children.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/phyllocontin-continus-forte#PHP82994>;
                                                                                                                   nicebnf:hasTextContent """Phyllocontin ContinusForte tablets are not licensed for use in children.

"""^^xsd:string;
                                                                                                                   a nicebnf:UnlicencedUse.
<http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reversible airways obstruction</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Reversible airways obstruction

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "reversible airways obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Route#oral> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                          rdfs:label "oral"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by mouth using modified-release medicines"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withOralUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#oral>;
                                                       a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "with oral use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#0aDLL-e3REaKuCRHgl9N5Q>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#-ea0dWoGfUK8K2_58UVT8w>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#-gVHUh5TakGmzpDKsKmXiA>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#hradRsfMDUKVYrAOCaQbgw>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#iU1wj4DbOEG5Cguk2v68AA>;
                                                                                nicebnf:hasTitle """<title>Picolax<tm tmtype=\"reg\" /> sachets</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "picolax sachets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#-ea0dWoGfUK8K2_58UVT8w> nicebnf:hasDitaContent """<sectiondiv>
  <p>Low residue diet recommended on the day before procedure and copious intake of water or other clear fluids recommended during treatment.</p>
  <p>Patients and carers should be given advice on how to administer oral powder; they should be warned that heat is generated during reconstitution and that the solution should be allowed to cool before drinking.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104520>;
                                                                                                       nicebnf:hasTextContent """Low residue diet recommended on the day before procedure and copious intake of water or other clear fluids recommended during treatment.

Patients and carers should be given advice on how to administer oral powder; they should be warned that heat is generated during reconstitution and that the solution should be allowed to cool before drinking.

"""^^xsd:string;
                                                                                                       a nicebnf:GeneralPatientAdvice,
                                                                                                         nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#-gVHUh5TakGmzpDKsKmXiA> nicebnf:hasDitaContent """<sectiondiv>
  <p>One sachet should be reconstituted with 150 mL (approx. half a glass) of cold water.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104501>;
                                                                                                       nicebnf:hasTextContent """One sachet should be reconstituted with 150 mL (approx. half a glass) of cold water.

"""^^xsd:string;
                                                                                                       a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#0aDLL-e3REaKuCRHgl9N5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Year> ; 
                                                                                                                          rdfs:label "0.25 sachet taken before 8 a.m, then 0.25 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>0.25 sachet taken before 8 a.m, then 0.25 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """0.25 sachet taken before 8 a.m, then 0.25 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child23Years> ; 
                                                                                                                          rdfs:label "0.5 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>0.5 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """0.5 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child48Years> ; 
                                                                                                                          rdfs:label "1 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 sachet taken before 8 a.m, then 0.5 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child917Years> ; 
                                                                                                                          rdfs:label "1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 sachet taken before 8 a.m, then 1 sachet after 6–8 hours.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationOnDayBeforeRadiologicalProcedureEndoscopyOrSurgery>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104437>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104437> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104501> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104520> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104545> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#hradRsfMDUKVYrAOCaQbgw> nicebnf:hasDitaContent """<section outputclass=\"pharmacokinetics\">
  <title>Pharmacokinetics</title>
  <p>Acts within 3 hours of first dose.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104437>;
                                                                                                       nicebnf:hasTextContent """PharmacokineticsActs within 3 hours of first dose.

"""^^xsd:string;
                                                                                                       a nicebnf:IndicationsAndDoseSection,
                                                                                                         nicebnf:Pharmacokinetics.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#iU1wj4DbOEG5Cguk2v68AA> nicebnf:hasDitaContent """<sectiondiv>
  <p>One reconstituted sachet contains K<sup>+</sup> 5 mmol and Mg<sup>2+</sup> 87 mmol.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/picolax-sachets#PHP104545>;
                                                                                                       nicebnf:hasTextContent """One reconstituted sachet contains K+ 5 mmol and Mg2+ 87 mmol.

"""^^xsd:string;
                                                                                                       a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#bowelEvacuationOnDayBeforeRadiologicalProcedureEndoscopyOrSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bowel evacuation on day before radiological procedure, endoscopy, or surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Bowel evacuation on day before radiological procedure, endoscopy, or surgery

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "bowel evacuation on day before radiological procedure, endoscopy, or surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Year> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                       rdfs:label "child 1 year"^^xsd:string;
                                                       rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child23Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                         rdfs:label "child 2–3 years"^^xsd:string;
                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child48Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                         rdfs:label "child 4–8 years"^^xsd:string;
                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child917Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 9–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/polytar-emollient> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/polytar-emollient#_B4C1BrkO0GrNYmXjxF60Q>;
                                                                                  nicebnf:hasTitle """<title>Polytar Emollient<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "polytar emollient"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/polytar-emollient#PHP106028> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/polytar-emollient#_B4C1BrkO0GrNYmXjxF60Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "2–4 capfuls/bath, add 15–30 ml to an adult-size bath; soak for 20 minutes."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>2–4 capfuls/bath, add 15–30 mL to an adult-size bath; soak for 20 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """2–4 capfuls/bath, add 15–30 mL to an adult-size bath; soak for 20 minutes.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasisEczemaAtopicAndPruriticDermatoses>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/polytar-emollient#PHP106028>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasisEczemaAtopicAndPruriticDermatoses> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis, eczema, atopic and pruritic dermatoses</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Psoriasis, eczema, atopic and pruritic dermatoses

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "psoriasis, eczema, atopic and pruritic dermatoses"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/powergel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/powergel#I1WqUvvd70Kf6dV_of7ZIQ>;
                                                                         nicebnf:hasTitle """<title>Powergel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "powergel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/powergel#I1WqUvvd70Kf6dV_of7ZIQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 2–3 times a day for up to max. 10 days."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 2–3 times a day for up to max. 10 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 2–3 times a day for up to max. 10 days.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctiveTreatmentInKneeOrHandOsteoarthritis>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInMusculoskeletalConditions>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/powergel#PHP84267>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/powergel#PHP84267> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctiveTreatmentInKneeOrHandOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunctive treatment in knee or hand osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Adjunctive treatment in knee or hand osteoarthritis

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "adjunctive treatment in knee or hand osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInMusculoskeletalConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of pain in musculoskeletal conditions</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Relief of pain in musculoskeletal conditions

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "relief of pain in musculoskeletal conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#EwksEitOw0ip0fBJQ4qlWA>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#RcvfNtwDaUqTv5YHfmC9zQ>;
                                                                                 nicebnf:hasTitle """<title>Premarin<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "premarin tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#EwksEitOw0ip0fBJQ4qlWA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "0.3–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.3–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.3–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#PHP102081>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#PHP102081> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#RcvfNtwDaUqTv5YHfmC9zQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "0.625–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.625–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.625–1.25 mg daily continuously; with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/premarin-tablets#PHP102081>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique-low-dose-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/premique-low-dose-tablets#ifYhFMfLRUSZrq35BPZ_-g>;
                                                                                          nicebnf:hasTitle """<title>Premique<tm tmtype=\"reg\" /> Low Dose tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "premique low dose tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique-low-dose-tablets#PHP107135> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique-low-dose-tablets#ifYhFMfLRUSZrq35BPZ_-g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "1 tablet daily continuously."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>1 tablet daily continuously.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """1 tablet daily continuously.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/premique-low-dose-tablets#PHP107135>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/premique#XZiOuFpZCkGGmoY8DayBCw>;
                                                                         nicebnf:hasTitle """<title>Premique<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "premique"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique#PHP95275> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/premique#XZiOuFpZCkGGmoY8DayBCw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1 tablet daily continuously."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet daily continuously.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1 tablet daily continuously.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/premique#PHP95275>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-0625> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-0625#fQULUSmPrEWhD8tAYsfBaw>;
                                                                               nicebnf:hasTitle """<title>Prempak C<tm tmtype=\"reg\" /> 0.625</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "prempak c 0.625"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-0625#PHP96325> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-0625#fQULUSmPrEWhD8tAYsfBaw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "1 tablet daily continuously, maroon tablet to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, brown tablet to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>1 tablet daily continuously, maroon tablet to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, brown tablet to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """1 tablet daily continuously, maroon tablet to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, brown tablet to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-0625#PHP96325>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-125> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-125#zOqc2Env806Fid65k-ODfg>;
                                                                              nicebnf:hasTitle """<title>Prempak C<tm tmtype=\"reg\" /> 1.25</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "prempak c 1.25"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-125#PHP96412> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-125#zOqc2Env806Fid65k-ODfg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "1 tablet daily continuously, (yellow tablet) to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, (brown tablet) to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>1 tablet daily continuously, (yellow tablet) to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, (brown tablet) to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """1 tablet daily continuously, (yellow tablet) to taken and started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent) and 1 tablet daily, (brown tablet) to be taken and started on days 17–28 of each 28-day treatment cycle, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusIfSymptomsNotFullyControlledWithLowerStrengthPack>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusIfSymptomsNotFullyControlledWithLowerStrengthPack>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prempak-c-125#PHP96412>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterusIfSymptomsNotFullyControlledWithLowerStrengthPack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus (if symptoms not fully controlled with lower strength pack)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                nicebnf:hasTextContent """Menopausal symptoms in women with a uterus (if symptoms not fully controlled with lower strength pack)

"""^^xsd:string;
                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                rdfs:label "menopausal symptoms in women with a uterus (if symptoms not fully controlled with lower strength pack)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterusIfSymptomsNotFullyControlledWithLowerStrengthPack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus (if symptoms not fully controlled with lower strength pack)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                     nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus (if symptoms not fully controlled with lower strength pack)

"""^^xsd:string;
                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                     rdfs:label "osteoporosis prophylaxis in women with a uterus (if symptoms not fully controlled with lower strength pack)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#uSgQuh5ENkyw1A2Xa3Ng3g>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#9xT00dzvek2-MXHCsQhk-Q>;
                                                                               nicebnf:hasTitle """<title>Priadel<tm tmtype=\"reg\" /> liquid</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "priadel liquid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#9xT00dzvek2-MXHCsQhk-Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>Lithium citrate tetrahydrate 520 mg is equivalent to lithium carbonate 204 mg.</p>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#PHP79013>;
                                                                                                      nicebnf:hasTextContent """Dose equivalence and conversionLithium citrate tetrahydrate 520 mg is equivalent to lithium carbonate 204 mg.

Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                      a nicebnf:DoseEquivalence,
                                                                                                        nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#PHP79013> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#uSgQuh5ENkyw1A2Xa3Ng3g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> ; 
                                                                                                                         rdfs:label "initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> ; 
                                                                                                                         rdfs:label "initially 1.04–3.12 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 1.04–3.12 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 1.04–3.12 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                         rdfs:label "initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 520 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-liquid#PHP79013>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Treatment and prophylaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "treatment and prophylaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Treatment and prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "treatment and prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment and prophylaxis of mania

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment and prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Treatment and prophylaxis of recurrent depression

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "treatment and prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 50 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 49 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#KQaU7PKm106v02ZCV4brKw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#ZkqLhbR4s0WQLgLryyU55Q>;
                                                                                nicebnf:hasTitle """<title>Priadel<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "priadel tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#KQaU7PKm106v02ZCV4brKw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> ; 
                                                                                                                          rdfs:label "initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> ; 
                                                                                                                          rdfs:label "initially 0.4–1.2 g once daily, alternatively initially 0.4–1.2 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 0.4–1.2 g once daily, alternatively initially 0.4–1.2 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 0.4–1.2 g once daily, alternatively initially 0.4–1.2 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                          rdfs:label "initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Initially 200–400 mg daily, dose adjusted to achieve a serum-lithium concentration of 0.4–1 mmol/litre 12 hours after a dose on days 4–7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphlyaxisOfAggressiveOrSelfHarmingBehaviour>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#PHP79472>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#PHP79472> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#ZkqLhbR4s0WQLgLryyU55Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/priadel-tablets#PHP79472>;
                                                                                                       nicebnf:hasTextContent """Dose equivalence and conversionPreparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.

"""^^xsd:string;
                                                                                                       a nicebnf:DoseEquivalence,
                                                                                                         nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphlyaxisOfAggressiveOrSelfHarmingBehaviour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophlyaxis of aggressive or self-harming behaviour</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Treatment and prophlyaxis of aggressive or self-harming behaviour

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "treatment and prophlyaxis of aggressive or self-harming behaviour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Treatment and prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "treatment and prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfMania> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of mania</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Treatment and prophylaxis of mania

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "treatment and prophylaxis of mania"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentAndProphylaxisOfRecurrentDepression> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of recurrent depression</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Treatment and prophylaxis of recurrent depression

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "treatment and prophylaxis of recurrent depression"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight50KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 50 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 49 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#SaotnnTp2kexoqRGrThT7g>;
                                                                           nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#YChW39wM2UaPVbfOBdOBuw>;
                                                                           nicebnf:hasTitle """<title>Prilotekal<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "prilotekal"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#PHP83030> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#PHP83046> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#SaotnnTp2kexoqRGrThT7g> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">intrathecal</ph> use</p>
  <p>The <i>Scottish Medicines Consortium</i> has advised (December 2010) that prilocaine 2% hyperbaric solution for injection (<i>Prilotekal</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland for use in spinal anaesthesia in ambulatory surgery settings.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withIntrathecalUse>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#PHP83046>;
                                                                                                  nicebnf:hasTextContent """With intrathecal use

The Scottish Medicines Consortium has advised (December 2010) that prilocaine 2% hyperbaric solution for injection (Prilotekal) is accepted for restricted use within NHS Scotland for use in spinal anaesthesia in ambulatory surgery settings.

"""^^xsd:string;
                                                                                                  a nicebnf:FundingDecision,
                                                                                                    nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#YChW39wM2UaPVbfOBdOBuw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "usual dose 40–60 mg (max. per dose 80 mg), dose may need to be reduced in elderly or debilitated patients, or in late pregnancy."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Usual dose 40–60 mg (max. per dose 80 mg), dose may need to be reduced in elderly or debilitated patients, or in late pregnancy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Usual dose 40–60 mg (max. per dose 80 mg), dose may need to be reduced in elderly or debilitated patients, or in late pregnancy.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntrathecalInjection>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#spinalAnaesthesia>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prilotekal#PHP83030>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#spinalAnaesthesia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Spinal anaesthesia</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Spinal anaesthesia

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "spinal anaesthesia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Route#intrathecal> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                                 rdfs:label "intrathecal"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntrathecalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intrathecal injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withIntrathecalUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#intrathecal>;
                                                              a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                              rdfs:label "with intrathecal use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/privigen> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/privigen#tR9CFD9VNkKfzIeGOZY6EA>;
                                                                         nicebnf:hasTitle """<title>Privigen<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "privigen"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/privigen#PHP98054> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/privigen#tR9CFD9VNkKfzIeGOZY6EA> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#hyperprolinaemiaContainsProline>;
                                                                                                nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Hyperprolinaemia (contains <ph outputclass=\"sc\"></ph>-proline)</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/privigen#PHP98054>;
                                                                                                nicebnf:hasTextContent """Hyperprolinaemia (contains -proline)

"""^^xsd:string;
                                                                                                a nicebnf:ContraindicationsGroup,
                                                                                                  nicebnf:GeneralContraindications.
<http://ld.nice.org.uk/ns/bnf/Contraindication#hyperprolinaemiaContainsProline> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Hyperprolinaemia (contains <ph outputclass=\"sc\"></ph>-proline)</ph>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent "Hyperprolinaemia (contains -proline)"^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                rdfs:label "hyperprolinaemia (contains -proline)"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-ointment#UL_irVoK_0Ww4YNCvvqEjw>;
                                                                                     nicebnf:hasTitle """<title>Proctosedyl<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "proctosedyl ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-ointment#PHP96534> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-ointment#UL_irVoK_0Ww4YNCvvqEjw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                               rdfs:label "apply twice daily, to be administered morning and night and after a bowel movement. apply externally or by rectum. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>Apply twice daily, to be administered morning and night and after a bowel movement. Apply externally or by rectum. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """Apply twice daily, to be administered morning and night and after a bowel movement. Apply externally or by rectum. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "apply twice daily, to be administered morning and night and after a bowel movement. apply externally or by rectum. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>Apply twice daily, to be administered morning and night and after a bowel movement. Apply externally or by rectum. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """Apply twice daily, to be administered morning and night and after a bowel movement. Apply externally or by rectum. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids>,
                                                                                                                                  <http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-ointment#PHP96534>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Haemorrhoids</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Haemorrhoids

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "haemorrhoids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus ani</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Pruritus ani

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "pruritus ani"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                               rdfs:label "to the skin, or by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-suppositories> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-suppositories#gllSEoHxZ0ySB0pkIHffNQ>;
                                                                                          nicebnf:hasTitle """<title>Proctosedyl<tm tmtype=\"reg\" /> suppositories</title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "proctosedyl suppositories"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-suppositories#PHP95905> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-suppositories#gllSEoHxZ0ySB0pkIHffNQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                    rdfs:label "1 suppository, insert suppository night and morning and after a bowel movement. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>1 suppository, insert suppository night and morning and after a bowel movement. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """1 suppository, insert suppository night and morning and after a bowel movement. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "1 suppository, insert suppository night and morning and after a bowel movement. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>1 suppository, insert suppository night and morning and after a bowel movement. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """1 suppository, insert suppository night and morning and after a bowel movement. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids>,
                                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/proctosedyl-suppositories#PHP95905>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Haemorrhoids</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Haemorrhoids

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "haemorrhoids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus ani</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Pruritus ani

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "pruritus ani"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#ZGr7TPlPr0ewuk1xBr61nA>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#_qEnYQfTOU6F1ooYos1ZOQ>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#dJxkdXXchU6mvonxfOgBig>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#evtr3T6reUC1g7AQAYhnDA>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#rrjQjRTSwkWqQhZSttcMig>;
                                                                                 nicebnf:hasTitle """<title>Prograf<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "prograf capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#ZGr7TPlPr0ewuk1xBr61nA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#_qEnYQfTOU6F1ooYos1ZOQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#dJxkdXXchU6mvonxfOgBig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#evtr3T6reUC1g7AQAYhnDA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#rrjQjRTSwkWqQhZSttcMig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-capsules#PHP79834>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#0sBuc3D-SUSj12zWlg8b3w>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#1C40jolS-UmY9Rxy_0tmgA>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#FaWT6wHUVUObCy_47FFzbQ>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#FegRfNjDpkG_chww9aI8RQ>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#ZbryWWi1n0GD0S1jAMQXtg>;
                                                                                 nicebnf:hasTitle """<title>Prograf<tm tmtype=\"reg\" /> infusion</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "prograf infusion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#0sBuc3D-SUSj12zWlg8b3w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 10–50 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 10–50 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 10–50 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantationWhenOralRouteNotAppropriate>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#1C40jolS-UmY9Rxy_0tmgA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#FaWT6wHUVUObCy_47FFzbQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 50–100 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 50–100 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 50–100 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantationWhenOralRouteNotAppropriate>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#FegRfNjDpkG_chww9aI8RQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "seek specialist advice (consult local protocol)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Seek specialist advice (consult local protocol).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Seek specialist advice (consult local protocol).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byContinuousIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#ZbryWWi1n0GD0S1jAMQXtg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 10–20 micrograms/kg daily for up to 7 days (then transfer to oral therapy), dose to be administered over 24 hours.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prograf-infusion#PHP79931>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantationWhenOralRouteNotAppropriate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation when oral route not appropriate</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                     nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation when oral route not appropriate

"""^^xsd:string;
                                                                                                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                     rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation when oral route not appropriate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantationWhenOralRouteNotAppropriate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation when oral route not appropriate</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation when oral route not appropriate

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation when oral route not appropriate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byContinuousIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                           rdfs:label "by continuous intravenous infusion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova-ts> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova-ts#cuF9CIvguE2InV4HY-dVYg>;
                                                                             nicebnf:hasTitle """<title>Progynova<tm tmtype=\"reg\" /> TS</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "progynova ts"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova-ts#PHP97637> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova-ts#cuF9CIvguE2InV4HY-dVYg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "apply 1 patch once weekly continuously, alternatively apply 1 patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with progynova ts 50, subsequently adjust according to response, women receiving progynova ts 100 patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Apply 1 patch once weekly continuously, alternatively apply 1 patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with <i>Progynova TS 50</i>, subsequently adjust according to response, women receiving <i>Progynova TS 100</i> patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Apply 1 patch once weekly continuously, alternatively apply 1 patch once weekly for 3 weeks, followed by a 7-day patch-free interval (cyclical), to be used with cyclical progestogen for 12–14 days of each cycle in women with a uterus, initiate therapy with Progynova TS 50, subsequently adjust according to response, women receiving Progynova TS 100 patches for menopausal symptoms may continue with this strength for osteoporosis prophylaxis.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova-ts#PHP97637>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#acM3L34WjEukY-smYlCg4A>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#zAEvPaOBnEe6cH72hL-N4Q>;
                                                                          nicebnf:hasTitle """<title>Progynova<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "progynova"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#PHP97601> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#acM3L34WjEukY-smYlCg4A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "2 mg daily continuously, to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>2 mg daily continuously, to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """2 mg daily continuously, to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#PHP97601>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#zAEvPaOBnEe6cH72hL-N4Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1–2 mg daily continuously, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1–2 mg daily continuously, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1–2 mg daily continuously, to be started on day 1 of menstruation (or at any time if cycles have ceased or are infrequent), to be taken with cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/progynova#PHP97601>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#Slq530np20i_H3zBitXSSA>;
                                                                       nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#-T7BR2CXj02PDj8vv_cjdA>;
                                                                       nicebnf:hasTitle """<title>Prolia<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "prolia"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#-T7BR2CXj02PDj8vv_cjdA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "60 mg every 6 months, supplement with calcium and vitamin d."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>60 mg every 6 months, supplement with calcium and vitamin D.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """60 mg every 6 months, supplement with calcium and vitamin D.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBoneLossAssociatedWithHormoneAblationInMenWithProstateCancerAtIncreasedRiskOfFractures>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfOsteoporosisInPostmenopausalWomenAndInMenAtIncreasedRiskOfFractures>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#PHP82290>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#PHP82290> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#PHP82326> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#Slq530np20i_H3zBitXSSA> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (November 2010) that denosumab (<i>Prolia</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland for the treatment of osteoporosis in postmenopausal women at increased risk of fractures who have a bone mineral density T-score &lt;–2.5 and ≥–4.0 and for whom bisphosphonates are unsuitable.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prolia#PHP82326>;
                                                                                              nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (November 2010) that denosumab (Prolia) is accepted for restricted use within NHS Scotland for the treatment of osteoporosis in postmenopausal women at increased risk of fractures who have a bone mineral density T-score <–2.5 and ≥–4.0 and for whom bisphosphonates are unsuitable.

"""^^xsd:string;
                                                                                              a nicebnf:FundingDecision,
                                                                                                nicebnf:SmcDecisions.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfBoneLossAssociatedWithHormoneAblationInMenWithProstateCancerAtIncreasedRiskOfFractures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                            nicebnf:hasTextContent """Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures

"""^^xsd:string;
                                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                            rdfs:label "treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfOsteoporosisInPostmenopausalWomenAndInMenAtIncreasedRiskOfFractures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures</p>"""^^<rdf:XMLLiteral>;
                                                                                                                         nicebnf:hasTextContent """Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures

"""^^xsd:string;
                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                         rdfs:label "treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/promixin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/promixin#92MvNO1StUO-DWrOOYarOg>;
                                                                         nicebnf:hasTitle """<title>Promixin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "promixin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/promixin#92MvNO1StUO-DWrOOYarOg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> ; 
                                                                                                                   rdfs:label "1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSolution>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """1–2 million units 2–3 times a day, for specific advice on administration using nebulisers—consult product literature; maximum 6 million units per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSolution>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#managementOfChronicPulmonaryInfectionsDueToPseudomonasAeruginosainPatientsWithCysticFibrosis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/promixin#PHP108703>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/promixin#PHP108703> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#managementOfChronicPulmonaryInfectionsDueToPseudomonasAeruginosainPatientsWithCysticFibrosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Management of chronic pulmonary infections due to <ph outputclass=\"organism\"><i>Pseudomonas aeruginosa</i></ph>in patients with cystic fibrosis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                       nicebnf:hasTextContent """Management of chronic pulmonary infections due to Pseudomonas aeruginosain patients with cystic fibrosis

"""^^xsd:string;
                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                       rdfs:label "management of chronic pulmonary infections due to pseudomonas aeruginosain patients with cystic fibrosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSolution> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                           rdfs:label "by inhalation of nebulised solution"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/propess> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/propess#aTNXwWrKnkuZ-kKV6DHUdQ>;
                                                                        nicebnf:hasTitle """<title>Propess<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "propess"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/propess#PHP79016> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/propess#aTNXwWrKnkuZ-kKV6DHUdQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 pessary, insert pessary (in retrieval device) high into posterior fornix and remove when cervical ripening adequate; if oxytocin necessary, remove 30 minutes before oxytocin infusion; remove if cervical ripening inadequate after 24 hours (dose not to be repeated)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 pessary, insert pessary (in retrieval device) high into posterior fornix and remove when cervical ripening adequate; if oxytocin necessary, remove 30 minutes before oxytocin infusion; remove if cervical ripening inadequate after 24 hours (dose not to be repeated).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 pessary, insert pessary (in retrieval device) high into posterior fornix and remove when cervical ripening adequate; if oxytocin necessary, remove 30 minutes before oxytocin infusion; remove if cervical ripening inadequate after 24 hours (dose not to be repeated).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#cervicalRipeningAndInductionOfLabourAtTerm>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/propess#PHP79016>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#cervicalRipeningAndInductionOfLabourAtTerm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Cervical ripening and induction of labour at term</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Cervical ripening and induction of labour at term

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "cervical ripening and induction of labour at term"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#BQNgLWtV30mSo8FV4C03kA>,
                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#GFWJ-aspHEq8C2EnWpLMmw>;
                                                                              nicebnf:hasTitle """<title>Prostap 3 DCS<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "prostap 3 dcs"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#BQNgLWtV30mSo8FV4C03kA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "11.25 mg every 3 months."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>11.25 mg every 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """11.25 mg every 3 months.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                           <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#PHP79565>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#GFWJ-aspHEq8C2EnWpLMmw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 11.25 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 11.25 mg every 3 months for maximum 6 months (course not to be repeated)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 11.25 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 11.25 mg every 3 months for maximum 6 months (course not to be repeated).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 11.25 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 11.25 mg every 3 months for maximum 6 months (course not to be repeated).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#PHP79565>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-3-dcs#PHP79565> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                              nicebnf:hasTextContent """Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                              rdfs:label "adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Locally advanced prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "locally advanced prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#Qn9PF_4-wkWzgMuyCpGvdw>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#QreQ54gxY0epK4VLnji0kg>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#Z249VSdRuESZqHIAn50Pjg>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#qikPWyYSl0Gv7YbTvQ-vzQ>;
                                                                               nicebnf:hasTitle """<title>Prostap SR DCS<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "prostap sr dcs"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#PHP79471> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#Qn9PF_4-wkWzgMuyCpGvdw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 3.75 mg every 1 month usually for 3–4 months (maximum 6 months)."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 3.75 mg every 1 month usually for 3–4 months (maximum 6 months).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 3.75 mg every 1 month usually for 3–4 months (maximum 6 months).

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reductionOfSizeOfUterineFibroidsAndOfAssociatedBleedingBeforeSurgery>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#PHP79471>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#QreQ54gxY0epK4VLnji0kg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 3.75 mg for 1 dose, dose to be given as a single dose between day 3 and 5 of menstrual cycle, 5–6 weeks before surgery."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 3.75 mg for 1 dose, dose to be given as a single dose between day 3 and 5 of menstrual cycle, 5–6 weeks before surgery.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 3.75 mg for 1 dose, dose to be given as a single dose between day 3 and 5 of menstrual cycle, 5–6 weeks before surgery.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometrialThinningBeforeIntraUterineSurgery>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#PHP79471>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#Z249VSdRuESZqHIAn50Pjg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 3.75 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 3.75 mg every 1 month for maximum 6 months (course not to be repeated)."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 3.75 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 3.75 mg every 1 month for maximum 6 months (course not to be repeated).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 3.75 mg for 1 dose, dose to be given as a single dose in first 5 days of menstrual cycle, then 3.75 mg every 1 month for maximum 6 months (course not to be repeated).

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#PHP79471>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#qikPWyYSl0Gv7YbTvQ-vzQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "3.75 mg every 1 month."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>3.75 mg every 1 month.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """3.75 mg every 1 month.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                            <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostap-sr-dcs#PHP79471>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                              nicebnf:hasTextContent """Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                              rdfs:label "adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometrialThinningBeforeIntraUterineSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometrial thinning before intra-uterine surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Endometrial thinning before intra-uterine surgery

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "endometrial thinning before intra-uterine surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Locally advanced prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "locally advanced prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionOfSizeOfUterineFibroidsAndOfAssociatedBleedingBeforeSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction of size of uterine fibroids and of associated bleeding before surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Reduction of size of uterine fibroids and of associated bleeding before surgery

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "reduction of size of uterine fibroids and of associated bleeding before surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                             rdfs:label "by subcutaneous injection, or by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#NiOPZc17Ske_UPU8GTlJ7g>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#RmJqvu5cqkmP9-89AeKTFA>;
                                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#Gd3SNlinlEeI6mUbko5h2Q>;
                                                                                       nicebnf:hasTitle """<title>Prostin E2<tm tmtype=\"reg\" /> vaginal gel</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "prostin e2 vaginal gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#Gd3SNlinlEeI6mUbko5h2Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <i>Prostin E2 Vaginal Gel</i> and <i>Vaginal Tablets</i> are not bioequivalent.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#PHP79449>;
                                                                                                              nicebnf:hasTextContent """Dose equivalence and conversionProstin E2 Vaginal Gel and Vaginal Tablets are not bioequivalent.

"""^^xsd:string;
                                                                                                              a nicebnf:DoseEquivalence,
                                                                                                                nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#NiOPZc17Ske_UPU8GTlJ7g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1–2 mg after 6 hours (max. per dose 3 mg) if required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1–2 mg after 6 hours (max. per dose 3 mg) if required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 mg, inserted high into the posterior fornix (avoid administration into the cervical canal), followed by 1–2 mg after 6 hours (max. per dose 3 mg) if required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabour>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#PHP79449>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#PHP79449> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#RmJqvu5cqkmP9-89AeKTFA> nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabourUnfavourablePrimigravida>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-gel#PHP79449>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Induction of labour</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Induction of labour

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "induction of labour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabourUnfavourablePrimigravida> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Induction of labour (unfavourable primigravida)</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Induction of labour (unfavourable primigravida)

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "induction of labour (unfavourable primigravida)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#VSyEIISE-EOImOgEL7PM5Q>;
                                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#qqKw78Y-LEKKijT2cT896A>;
                                                                                           nicebnf:hasTitle """<title>Prostin E2<tm tmtype=\"reg\" /> vaginal tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "prostin e2 vaginal tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#PHP79408> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#VSyEIISE-EOImOgEL7PM5Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "3 mg, inserted high into the posterior fornix, followed by 3 mg after 6–8 hours (max. per dose 6 mg), to be given if labour not established."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>3 mg, inserted high into the posterior fornix, followed by 3 mg after 6–8 hours (max. per dose 6 mg), to be given if labour not established.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """3 mg, inserted high into the posterior fornix, followed by 3 mg after 6–8 hours (max. per dose 6 mg), to be given if labour not established.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabour>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#PHP79408>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#qqKw78Y-LEKKijT2cT896A> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>
    <i>Prostin E2 Vaginal tablets</i> and <i>Vaginal Gel</i> are not bioequivalent.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/prostin-e2-vaginal-tablets#PHP79408>;
                                                                                                                  nicebnf:hasTextContent """Dose equivalence and conversionProstin E2 Vaginal tablets and Vaginal Gel are not bioequivalent.

"""^^xsd:string;
                                                                                                                  a nicebnf:DoseEquivalence,
                                                                                                                    nicebnf:IndicationsAndDoseSection.
<http://ld.nice.org.uk/ns/bnf/Indication#inductionOfLabour> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Induction of labour</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Induction of labour

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "induction of labour"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-cream#9JLhICNYgE6-a3IRqedfwg>;
                                                                                nicebnf:hasTitle """<title>Psoriderm<tm tmtype=\"reg\" /> cream</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "psoriderm cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-cream#9JLhICNYgE6-a3IRqedfwg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                          rdfs:label "apply 1–2 times a day, cream to be applied to the skin or scalp."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 1–2 times a day, cream to be applied to the skin or scalp.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 1–2 times a day, cream to be applied to the skin or scalp.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply 1–2 times a day, cream to be applied to the skin or scalp."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply 1–2 times a day, cream to be applied to the skin or scalp.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply 1–2 times a day, cream to be applied to the skin or scalp.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-cream#PHP95115>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-cream#PHP95115> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-emulsion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-emulsion#Pv1MIIuXvEWHz8k__xOZ1g>;
                                                                                   nicebnf:hasTitle """<title>Psoriderm<tm tmtype=\"reg\" /> emulsion</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "psoriderm emulsion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-emulsion#PHP106075> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-emulsion#Pv1MIIuXvEWHz8k__xOZ1g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "up to 30 ml/bath, use 30ml in adult-size bath, soak for 5 minutes."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Up to 30 mL/bath, use 30mL in adult-size bath, soak for 5 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Up to 30 mL/bath, use 30mL in adult-size bath, soak for 5 minutes.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#psoriasis>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-emulsion#PHP106075>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#psoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Psoriasis

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-scalp-lotion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-scalp-lotion#afbOaxkMlEKWu6JpKO4-1g>;
                                                                                       nicebnf:hasTitle """<title>Psoriderm<tm tmtype=\"reg\" /> scalp lotion</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "psoriderm scalp lotion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-scalp-lotion#PHP95441> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-scalp-lotion#afbOaxkMlEKWu6JpKO4-1g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                 rdfs:label "apply as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>Apply as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """Apply as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "apply as required."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>Apply as required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """Apply as required.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#scalpPsoriasis>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/psoriderm-scalp-lotion#PHP95441>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#scalpPsoriasis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Scalp psoriasis</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Scalp psoriasis

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "scalp psoriasis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-respules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-respules#ldA2S-zC80WR9GrrXBp4Lw>;
                                                                                   nicebnf:hasTitle """<title>Pulmicort<tm tmtype=\"reg\" /> Respules</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "pulmicort respules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-respules#PHP107845> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-respules#ldA2S-zC80WR9GrrXBp4Lw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child3Months11Years> ; 
                                                                                                                             rdfs:label "initially 0.5–1 mg twice daily, reduced to 250–500 micrograms twice daily."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 0.5–1 mg twice daily, reduced to 250–500 micrograms twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 0.5–1 mg twice daily, reduced to 250–500 micrograms twice daily.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSuspension>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                             rdfs:label "initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSuspension>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 1–2 mg twice daily, reduced to 0.5–1 mg twice daily.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSuspension>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-respules#PHP107845>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child3Months11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                rdfs:label "child 3 months–11 years"^^xsd:string;
                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfNebulisedSuspension> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                             rdfs:label "by inhalation of nebulised suspension"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#KeanERixkUSboZz-ClGAEQ>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#ZX-yQQM5PkGLXcyKR91voA>;
                                                                                     nicebnf:hasTitle """<title>Pulmicort<tm tmtype=\"reg\" /> Turbohaler</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "pulmicort turbohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#KeanERixkUSboZz-ClGAEQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """200–400 micrograms once daily (max. per dose 800 micrograms), to be taken in the evening.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#alternativeInMildToModerateAsthmaForPatientsPreviouslyStabilisedOnATwiceDailyDose>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#PHP83146>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#PHP83146> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#ZX-yQQM5PkGLXcyKR91voA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "100–800 micrograms twice daily, dose to be adjusted as necessary."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>100–800 micrograms twice daily, dose to be adjusted as necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """100–800 micrograms twice daily, dose to be adjusted as necessary.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulmicort-turbohaler#PHP83146>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#alternativeInMildToModerateAsthmaForPatientsPreviouslyStabilisedOnATwiceDailyDose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose</p>"""^^<rdf:XMLLiteral>;
                                                                                                                            nicebnf:hasTextContent """Alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose

"""^^xsd:string;
                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                            rdfs:label "alternative in mild to moderate asthma, for patients previously stabilised on a twice daily dose"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#E6o7e3q88EGR3ikNU6Wfpg>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#jCXgjyfavU6Kssjb5D_cQw>;
                                                                                    nicebnf:hasTitle """<title>Pulvinal<tm tmtype=\"reg\" /> Salbutamol</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "pulvinal salbutamol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#E6o7e3q88EGR3ikNU6Wfpg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "200 micrograms."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>200 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """200 micrograms.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#PHP82619>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#PHP82619> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#jCXgjyfavU6Kssjb5D_cQw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "initially 200 micrograms, up to 800 micrograms for persistent symptoms."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Initially 200 micrograms, up to 800 micrograms for persistent symptoms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Initially 200 micrograms, up to 800 micrograms for persistent symptoms.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/pulvinal-salbutamol#PHP82619>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Acute bronchospasm

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "acute bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Prophylaxis of allergen- or exercise-induced bronchospasm

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "prophylaxis of allergen- or exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#1PEf2tapZkW9Kgt8C3dDoQ>;
                                                                        nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#RXQdIQ7bu0i3yvNf7zNHzg>;
                                                                        nicebnf:hasTitle """<title>Qutenza<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "qutenza"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#1PEf2tapZkW9Kgt8C3dDoQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (January 2011) that capsaicin 179 mg (8%) patch (<i>Qutenza</i><tm tmtype=\"reg\" />) is accepted for restricted use within NHS Scotland for the treatment of postherpetic neuralgia in patients who have not achieved adequate pain relief from, or who have not tolerated conventional first and second line treatments. Treatment should be under the supervision of a specialist in pain management.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#PHP84390>;
                                                                                               nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (January 2011) that capsaicin 179 mg (8%) patch (Qutenza) is accepted for restricted use within NHS Scotland for the treatment of postherpetic neuralgia in patients who have not achieved adequate pain relief from, or who have not tolerated conventional first and second line treatments. Treatment should be under the supervision of a specialist in pain management.

"""^^xsd:string;
                                                                                               a nicebnf:FundingDecision,
                                                                                                 nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#PHP84376> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#PHP84390> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#RXQdIQ7bu0i3yvNf7zNHzg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#peripheralNeuropathicPainInNonDiabeticPatientsUnderTheSupervisionOfAPhysician>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qutenza#PHP84376>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#peripheralNeuropathicPainInNonDiabeticPatientsUnderTheSupervisionOfAPhysician> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Peripheral neuropathic pain in non-diabetic patients (under the supervision of a physician)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent """Peripheral neuropathic pain in non-diabetic patients (under the supervision of a physician)

"""^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                        rdfs:label "peripheral neuropathic pain in non-diabetic patients (under the supervision of a physician)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-bath-oil> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-bath-oil#sbZXbWcmkEi9ePACZBr0Mg>;
                                                                            nicebnf:hasTitle """<title>QV<tm tmtype=\"reg\" /> bath oil</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "qv bath oil"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-bath-oil#PHP105993> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-bath-oil#sbZXbWcmkEi9ePACZBr0Mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child111Months> ; 
                                                                                                                      rdfs:label "5 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>5 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """5 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                      rdfs:label "10 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>10 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """10 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "10 ml/bath, alternatively, to be applied to wet skin and rinse."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>10 mL/bath, alternatively, to be applied to wet skin and rinse.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """10 mL/bath, alternatively, to be applied to wet skin and rinse.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisIchthyosisAndPruritus>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-bath-oil#PHP105993>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisIchthyosisAndPruritus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus</p>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasTextContent """Dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus

"""^^xsd:string;
                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                         rdfs:label "dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child111Months> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 1–11 months"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-gentle-wash> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-gentle-wash#vPcpbD8uI0uJKKS5zR3lqg>;
                                                                               nicebnf:hasTitle """<title>QV<tm tmtype=\"reg\" /> gentle wash</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "qv gentle wash"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-gentle-wash#PHP106049> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-gentle-wash#vPcpbD8uI0uJKKS5zR3lqg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                         rdfs:label "to be used as a soap substitute."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>To be used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """To be used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "to be used as a soap substitute."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>To be used as a soap substitute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """To be used as a soap substitute.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisIchthyosisAndPruritus>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qv-gentle-wash#PHP106049>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczemaPsoriasisIchthyosisAndPruritus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus</p>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasTextContent """Dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus

"""^^xsd:string;
                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                         rdfs:label "dry skin conditions including eczema, psoriasis, ichthyosis, and pruritus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#pevgbcuN-EWAWnKJ_YWMrg>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#0YiAHbVl0E-ulmSusOLujw>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#pnw5sJn1GkWasSRA5xW2Rg>;
                                                                                  nicebnf:hasTitle """<title>Qvar<tm tmtype=\"reg\" /> preparations</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "qvar preparations"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#0YiAHbVl0E-ulmSusOLujw> nicebnf:hasDitaContent """<section outputclass=\"potency\">
  <title>Potency</title>
  <p>
    <i>Qvar</i>
    <tm tmtype=\"reg\" /> has extra-fine particles, is more potent than traditional beclometasone dipropionate CFC-containing inhalers and is approximately twice as potent as <i>Clenil Modulite</i><tm tmtype=\"reg\" />.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#PHP83082>;
                                                                                                         nicebnf:hasTextContent """PotencyQvar has extra-fine particles, is more potent than traditional beclometasone dipropionate CFC-containing inhalers and is approximately twice as potent as Clenil Modulite.

"""^^xsd:string;
                                                                                                         a nicebnf:IndicationsAndDoseSection,
                                                                                                           nicebnf:Potency.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#PHP83082> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#PHP83101> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#pevgbcuN-EWAWnKJ_YWMrg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                            rdfs:label "50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """50–200 micrograms twice daily; increased if necessary up to 400 micrograms twice daily.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#PHP83082>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#pnw5sJn1GkWasSRA5xW2Rg> nicebnf:hasDitaContent """<sectiondiv>
  <p>When switching a patient with well-controlled asthma from another corticosteroid inhaler, initially a 100-microgram metered dose of <i>Qvar</i><tm tmtype=\"reg\" /> should be prescribed for 200–250 micrograms of beclometasone dipropionate or budesonide and for 100 micrograms of fluticasone propionate.</p>
  <p>When switching a patient with poorly controlled asthma from another corticosteroid inhaler, initially a 100-microgram metered dose of <i>Qvar</i><tm tmtype=\"reg\" /> should be prescribed for 100 micrograms of beclometasone dipropionate, budesonide, or fluticasone propionate; the dose of <i>Qvar</i><tm tmtype=\"reg\" /> should be adjusted according to response.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/qvar-preparations#PHP83101>;
                                                                                                         nicebnf:hasTextContent """When switching a patient with well-controlled asthma from another corticosteroid inhaler, initially a 100-microgram metered dose of Qvar should be prescribed for 200–250 micrograms of beclometasone dipropionate or budesonide and for 100 micrograms of fluticasone propionate.

When switching a patient with poorly controlled asthma from another corticosteroid inhaler, initially a 100-microgram metered dose of Qvar should be prescribed for 100 micrograms of beclometasone dipropionate, budesonide, or fluticasone propionate; the dose of Qvar should be adjusted according to response.

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-capsules#lzANgzvSAkatJj1Tbvn18Q>;
                                                                                 nicebnf:hasTitle """<title>Rebetol<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "rebetol capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-capsules#PHP83822> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-capsules#lzANgzvSAkatJj1Tbvn18Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> ; 
                                                                                                                           rdfs:label "400 mg twice daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>400 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """400 mg twice daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> ; 
                                                                                                                           rdfs:label "400 mg, dose to be given in the morning and 600 mg, dose to be given in the evening."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>400 mg, dose to be given in the morning and 600 mg, dose to be given in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """400 mg, dose to be given in the morning and 600 mg, dose to be given in the evening.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81104Kg> ; 
                                                                                                                           rdfs:label "600 mg twice daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>600 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """600 mg twice daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight105KgAndAbove> ; 
                                                                                                                           rdfs:label "600 mg, dose to be given in the morning and 800 mg, dose to be given in the evening."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>600 mg, dose to be given in the morning and 800 mg, dose to be given in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """600 mg, dose to be given in the morning and 800 mg, dose to be given in the evening.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithInterferonAlfa2bOrPeginterferonAlfa2bWithOrWithoutBoceprevir>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-capsules#PHP83822>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithInterferonAlfa2bOrPeginterferonAlfa2bWithOrWithoutBoceprevir> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C (in combination with interferon alfa 2b, or peginterferon alfa 2b with or without boceprevir)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasTextContent """Chronic hepatitis C (in combination with interferon alfa 2b, or peginterferon alfa 2b with or without boceprevir)

"""^^xsd:string;
                                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                         rdfs:label "chronic hepatitis c (in combination with interferon alfa 2b, or peginterferon alfa 2b with or without boceprevir)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight105KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                         rdfs:label "adult (body-weight 105 kg and above)"^^xsd:string;
                                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 65–80 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81104Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                   rdfs:label "adult (body-weight 81–104 kg)"^^xsd:string;
                                                                   rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 64 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-oral-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-oral-solution#m1ifEXYFmkqg5YSsv9Onfw>;
                                                                                      nicebnf:hasTitle """<title>Rebetol<tm tmtype=\"reg\" /> oral solution</title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "rebetol oral solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-oral-solution#PHP83863> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-oral-solution#m1ifEXYFmkqg5YSsv9Onfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> ; 
                                                                                                                                rdfs:label "400 mg twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>400 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """400 mg twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> ; 
                                                                                                                                rdfs:label "400 mg daily, dose to be given in the morning and 600 mg daily, dose to be given in the evening."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>400 mg daily, dose to be given in the morning and 600 mg daily, dose to be given in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """400 mg daily, dose to be given in the morning and 600 mg daily, dose to be given in the evening.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81104Kg> ; 
                                                                                                                                rdfs:label "600 mg twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>600 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """600 mg twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight105KgAndAbove> ; 
                                                                                                                                rdfs:label "600 mg daily, dose to be given in the morning and 800 mg daily, dose to be given in the evening."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>600 mg daily, dose to be given in the morning and 800 mg daily, dose to be given in the evening.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """600 mg daily, dose to be given in the morning and 800 mg daily, dose to be given in the evening.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithInterferonAlfaOrPeginterferonAlfa>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebetol-oral-solution#PHP83863>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisCInCombinationWithInterferonAlfaOrPeginterferonAlfa> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C (in combination with interferon alfa or peginterferon alfa)</p>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasTextContent """Chronic hepatitis C (in combination with interferon alfa or peginterferon alfa)

"""^^xsd:string;
                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                              rdfs:label "chronic hepatitis c (in combination with interferon alfa or peginterferon alfa)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight105KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                         rdfs:label "adult (body-weight 105 kg and above)"^^xsd:string;
                                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight6580Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 65–80 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight81104Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                   rdfs:label "adult (body-weight 81–104 kg)"^^xsd:string;
                                                                   rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo64Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 64 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#0DKBb2Xql0alX51n3Oaoxw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#1iDcoE6c306QRSoI4nuvpQ>;
                                                                                nicebnf:hasTitle """<title>Rebif<tm tmtype=\"reg\" /> cartridge</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "rebif cartridge"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#0DKBb2Xql0alX51n3Oaoxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#PHP79135>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#1iDcoE6c306QRSoI4nuvpQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Cartridges for use with <i>RebiSmart</i><tm tmtype=\"reg\" /> auto-injector device.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#PHP79209>;
                                                                                                       nicebnf:hasTextContent """Cartridges for use with RebiSmart auto-injector device.

"""^^xsd:string;
                                                                                                       a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#PHP79135> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-cartridge#PHP79209> a nicebnf:PrescribingAndDispensingInformations.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-pre-filled-pen-and-syringe> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-pre-filled-pen-and-syringe#hqziCOEiqEK5sJ_37H-Nxg>;
                                                                                                 nicebnf:hasTitle """<title>Rebif<tm tmtype=\"reg\" /> pre-filled pen and syringe</title>"""^^<rdf:XMLLiteral>;
                                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                 rdfs:label "rebif pre-filled pen and syringe"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-pre-filled-pen-and-syringe#PHP79273> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-pre-filled-pen-and-syringe#hqziCOEiqEK5sJ_37H-Nxg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis>,
                                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided>;
                                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rebif-pre-filled-pen-and-syringe#PHP79273>;
                                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forASingleDemyelinatingEventWithAnActiveInflammatoryProcessIfSevereEnoughToRequireIntravenousCorticosteroidAndPatientAtHighRiskOfDevelopingMultipleSclerosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """For a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "for a single demyelinating event with an active inflammatory process (if severe enough to require intravenous corticosteroid and patient at high risk of developing multiple sclerosis)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#forRelapsingRemittingMultipleSclerosisCharacterisedByAtLeastTwoAttacksOfNeurologicalDysfunctionOverThePrevious2Or3YearsFollowedByCompleteOrIncompleteRecoveryWhoAreAbleToWalkUnaided> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                               nicebnf:hasTextContent """For relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided

"""^^xsd:string;
                                                                                                                                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                               rdfs:label "for relapsing, remitting multiple sclerosis (characterised by at least two attacks of neurological dysfunction over the previous 2 or 3 years, followed by complete or incomplete recovery) who are able to walk unaided"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#WrGkKbddT0mShny-DhJbaw>;
                                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#stkwFoOIdE2FF_r3qkWmrQ>;
                                                                                           nicebnf:hasTitle """<title>Recivit<tm tmtype=\"reg\" /> sublingual tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "recivit sublingual tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#PHP107134> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#PHP107175> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#WrGkKbddT0mShny-DhJbaw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "initially 133 micrograms, then 133 micrograms after 15–30 minutes (max. per dose 800 micrograms), dose to be repeated only if necessary. consult product literature for dose adjustments, no more than 2 dose units, 15-30 minutes apart, for each pain episode, maximum of 800 micrograms per episode of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia; maximum 4 doses per day."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 133 micrograms, then 133 micrograms after 15–30 minutes (max. per dose 800 micrograms), dose to be repeated only if necessary. Consult product literature for dose adjustments, no more than 2 dose units, 15-30 minutes apart, for each pain episode, maximum of 800 micrograms per episode of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia; maximum 4 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 133 micrograms, then 133 micrograms after 15–30 minutes (max. per dose 800 micrograms), dose to be repeated only if necessary. Consult product literature for dose adjustments, no more than 2 dose units, 15-30 minutes apart, for each pain episode, maximum of 800 micrograms per episode of breakthrough pain, if more than 4 episodes of breakthrough pain each day, adjust background analgesia; maximum 4 doses per day.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#PHP107134>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#stkwFoOIdE2FF_r3qkWmrQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients should be advised not to eat or drink until the tablet is completely dissolved; after 30 minutes, if any remnants remain, they may be swallowed. In patients with a dry mouth, the buccal mucosa may be moistened with water before administration of tablet.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/recivit-sublingual-tablets#PHP107175>;
                                                                                                                  nicebnf:hasTextContent """Patients should be advised not to eat or drink until the tablet is completely dissolved; after 30 minutes, if any remnants remain, they may be swallowed. In patients with a dry mouth, the buccal mucosa may be moistened with water before administration of tablet.

"""^^xsd:string;
                                                                                                                  a nicebnf:GeneralPatientAdvice,
                                                                                                                    nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#breakthroughPainInPatientsReceivingOpioidTherapyForChronicCancerPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Breakthrough pain in patients receiving opioid therapy for chronic cancer pain</p>"""^^<rdf:XMLLiteral>;
                                                                                                               nicebnf:hasTextContent """Breakthrough pain in patients receiving opioid therapy for chronic cancer pain

"""^^xsd:string;
                                                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                               rdfs:label "breakthrough pain in patients receiving opioid therapy for chronic cancer pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-foam> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-foam#wkh3B5zoXEyndtsb049d7Q>;
                                                                                                    nicebnf:hasTitle """<title>Regaine<tm tmtype=\"reg\" /> for men extra strength foam</title>"""^^<rdf:XMLLiteral>;
                                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                    rdfs:label "regaine for men extra strength foam"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-foam#PHP82730> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-foam#wkh3B5zoXEyndtsb049d7Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                              rdfs:label "apply 0.5 capful twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 16 weeks."^^xsd:string ; 
                                                                                                                                              nicebnf:hasDitaContent "<p>Apply 0.5 capful twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 16 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                              nicebnf:hasTextContent """Apply 0.5 capful twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 16 weeks.

"""^^xsd:string ; 
                                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia>;
                                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-foam#PHP82730>;
                                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Androgenetic alopecia</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Androgenetic alopecia

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "androgenetic alopecia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-solution#bWcn-I8L-U-FTCsTFhkBng>;
                                                                                                        nicebnf:hasTitle """<title>Regaine<tm tmtype=\"reg\" /> for men extra strength solution</title>"""^^<rdf:XMLLiteral>;
                                                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                        rdfs:label "regaine for men extra strength solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-solution#PHP82666> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-solution#bWcn-I8L-U-FTCsTFhkBng> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                  rdfs:label "apply 1 ml twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year."^^xsd:string ; 
                                                                                                                                                  nicebnf:hasDitaContent "<p>Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                  nicebnf:hasTextContent """Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year.

"""^^xsd:string ; 
                                                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia>;
                                                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-men-extra-strength-solution#PHP82666>;
                                                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Androgenetic alopecia</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Androgenetic alopecia

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "androgenetic alopecia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-women-regular-strength> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-women-regular-strength#y5dYHt9gok2RcW8gkOaDfw>;
                                                                                                   nicebnf:hasTitle """<title>Regaine<tm tmtype=\"reg\" /> for women regular strength</title>"""^^<rdf:XMLLiteral>;
                                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                   rdfs:label "regaine for women regular strength"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-women-regular-strength#PHP85301> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-women-regular-strength#y5dYHt9gok2RcW8gkOaDfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                             rdfs:label "apply 1 ml twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year."^^xsd:string ; 
                                                                                                                                             nicebnf:hasDitaContent "<p>Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                             nicebnf:hasTextContent """Apply 1 mL twice daily, to be applied to the affected areas of scalp; discontinue if no improvement after 1 year.

"""^^xsd:string ; 
                                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia>;
                                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/regaine-for-women-regular-strength#PHP85301>;
                                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#androgeneticAlopecia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Androgenetic alopecia</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Androgenetic alopecia

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "androgenetic alopecia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#9QeKaU_h3kSCgMdeAO_K0w>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#um1kxRkXIkKnDRskbO2Ung>;
                                                                               nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#N5aJiGXSqEWpjwGoPe3AvQ>;
                                                                               nicebnf:hasTitle """<title>Relactagel<tm tmtype=\"reg\" /> gel</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "relactagel gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#9QeKaU_h3kSCgMdeAO_K0w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "5 ml daily for 2–3 nights after menstruation, insert the contents of one tube."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>5 mL daily for 2–3 nights after menstruation, insert the contents of one tube.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """5 mL daily for 2–3 nights after menstruation, insert the contents of one tube.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfBacterialVaginosis>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106724>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#N5aJiGXSqEWpjwGoPe3AvQ> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Mild irritation</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#notKnown>;
                                                                                                      nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#mildIrritation>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106767>;
                                                                                                      nicebnf:hasTextContent """Mild irritation

"""^^xsd:string;
                                                                                                      a nicebnf:GeneralSideEffects,
                                                                                                        nicebnf:SideEffectGroup,
                                                                                                        nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106724> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106745> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106767> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#um1kxRkXIkKnDRskbO2Ung> nicebnf:hasDitaContent """<sectiondiv>
  <p>Not recommended if trying to conceive.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relactagel-gel#PHP106745>;
                                                                                                      nicebnf:hasTextContent """Not recommended if trying to conceive.

"""^^xsd:string;
                                                                                                      a nicebnf:ConceptionAndContraception.
<http://ld.nice.org.uk/ns/bnf/Frequency#notKnown> a nicebnf:Frequency;
                                                  rdfs:label "frequency not known"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfBacterialVaginosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of bacterial vaginosis</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Prevention of bacterial vaginosis

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "prevention of bacterial vaginosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#mildIrritation> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Mild irritation</ph>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent "Mild irritation"^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                         rdfs:label "mild irritation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/relaxit> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/relaxit#kc9eOt0ch06zCm2Hrr38GA>;
                                                                        nicebnf:hasTitle """<title>Relaxit<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "relaxit"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relaxit#PHP101418> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relaxit#kc9eOt0ch06zCm2Hrr38GA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2Years> ; 
                                                                                                                  rdfs:label "5 ml for 1 dose, insert only half the nozzle length."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5 mL for 1 dose, insert only half the nozzle length.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5 mL for 1 dose, insert only half the nozzle length.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> ; 
                                                                                                                  rdfs:label "5 ml for 1 dose."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "5 ml for 1 dose."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>5 mL for 1 dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """5 mL for 1 dose.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#constipation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relaxit#PHP101418>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#constipation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Constipation</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Constipation

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "constipation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month2Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                              rdfs:label "child 1 month–2 years"^^xsd:string;
                                                              rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child317Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 3–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#bPOnb9VLtUOtYxAzHhxcwg>;
                                                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PypFXUjcfkOaPeJrM-5TGw>,
                                                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#qCq1kFvBhEiJ6sQSVVoRSg>;
                                                                                                           nicebnf:hasTitle """<title>Relvar Ellipta<tm tmtype=\"reg\" /> 184 micrograms/22 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                           rdfs:label "relvar ellipta 184 micrograms/22 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PHP95426> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PHP95428> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PypFXUjcfkOaPeJrM-5TGw> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 inhalation (delivered dose) of fluticasone <i>furoate</i> 184 micrograms once daily is approximately equivalent to fluticasone <i>propionate</i> 500 micrograms twice daily.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PHP95426>;
                                                                                                                                  nicebnf:hasTextContent """Dose equivalence and conversion1 inhalation (delivered dose) of fluticasone furoate 184 micrograms once daily is approximately equivalent to fluticasone propionate 500 micrograms twice daily.

"""^^xsd:string;
                                                                                                                                  a nicebnf:DoseEquivalence,
                                                                                                                                    nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#bPOnb9VLtUOtYxAzHhxcwg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                                     rdfs:label "1 inhalation once daily."^^xsd:string ; 
                                                                                                                                                     nicebnf:hasDitaContent "<p>1 inhalation once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                     nicebnf:hasTextContent """1 inhalation once daily.

"""^^xsd:string ; 
                                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                     rdfs:label "1 inhalation once daily."^^xsd:string ; 
                                                                                                                                                     nicebnf:hasDitaContent "<p>1 inhalation once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                     nicebnf:hasTextContent """1 inhalation once daily.

"""^^xsd:string ; 
                                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PHP95426>;
                                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#qCq1kFvBhEiJ6sQSVVoRSg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Avoid in moderate to severe impairment.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-184-micrograms22-micrograms#PHP95428>;
                                                                                                                                  nicebnf:hasTextContent """Avoid in moderate to severe impairment.

"""^^xsd:string;
                                                                                                                                  a nicebnf:DoseAdjustment.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#_wju2t3tVkmWVhNTmbVV6Q>,
                                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#gex8rfhMJUyj8LQyHBn4dw>;
                                                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#3WrR8_4nJ0W-k-Lg0xIecg>;
                                                                                                          nicebnf:hasTitle """<title>Relvar Ellipta<tm tmtype=\"reg\" /> 92 micrograms/22 micrograms</title>"""^^<rdf:XMLLiteral>;
                                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                          rdfs:label "relvar ellipta 92 micrograms/22 micrograms"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#3WrR8_4nJ0W-k-Lg0xIecg> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 inhalation (delivered dose) of fluticasone <i>furoate</i> 92 micrograms once daily is approximately equivalent to fluticasone <i>propionate</i> 250 micrograms twice daily.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#PHP95368>;
                                                                                                                                 nicebnf:hasTextContent """Dose equivalence and conversion1 inhalation (delivered dose) of fluticasone furoate 92 micrograms once daily is approximately equivalent to fluticasone propionate 250 micrograms twice daily.

"""^^xsd:string;
                                                                                                                                 a nicebnf:DoseEquivalence,
                                                                                                                                   nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#PHP95368> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#_wju2t3tVkmWVhNTmbVV6Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                                    rdfs:label "1 inhalation once daily."^^xsd:string ; 
                                                                                                                                                    nicebnf:hasDitaContent "<p>1 inhalation once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                    nicebnf:hasTextContent """1 inhalation once daily.

"""^^xsd:string ; 
                                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                    rdfs:label "1 inhalation once daily."^^xsd:string ; 
                                                                                                                                                    nicebnf:hasDitaContent "<p>1 inhalation once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                    nicebnf:hasTextContent """1 inhalation once daily.

"""^^xsd:string ; 
                                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#PHP95368>;
                                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#gex8rfhMJUyj8LQyHBn4dw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                                    rdfs:label "1 inhalation once daily."^^xsd:string ; 
                                                                                                                                                    nicebnf:hasDitaContent "<p>1 inhalation once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                                    nicebnf:hasTextContent """1 inhalation once daily.

"""^^xsd:string ; 
                                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second70OfPredicted>;
                                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/relvar-ellipta-92-micrograms22-micrograms#PHP95368>;
                                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second70OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt; 70% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 70% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second < 70% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#MQpXhg4DrkelZ8UCkOeoBw>;
                                                                                nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#45Y_uq4z9USLksonPoAOXQ>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#F0juuiyPxUenBC9bHwHKqA>;
                                                                                nicebnf:hasTitle """<title>Renacet<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "renacet tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#45Y_uq4z9USLksonPoAOXQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer <i>Renacet</i><tm tmtype=\"reg\" /> tablets.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106801>;
                                                                                                       nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Renacet tablets.

"""^^xsd:string;
                                                                                                       a nicebnf:GeneralPatientAdvice,
                                                                                                         nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#F0juuiyPxUenBC9bHwHKqA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises that other drugs should be taken 1 to 2 hours before or after <i>Renacet</i><tm tmtype=\"reg\" /> to reduce the possible interference with absorption of other drugs.</p>
  <p>
    <i>Renacet</i>
    <tm tmtype=\"reg\" /> tablets are taken with meals.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106788>;
                                                                                                       nicebnf:hasTextContent """Manufacturer advises that other drugs should be taken 1 to 2 hours before or after Renacet to reduce the possible interference with absorption of other drugs.

Renacet tablets are taken with meals.

"""^^xsd:string;
                                                                                                       a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#MQpXhg4DrkelZ8UCkOeoBw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "475–950 mg, to be taken with breakfast and with snacks, 0.95–2.85 g, to be taken with main meals and 0.95–1.9 g, to be taken with supper, dose to be adjusted according to serum-phosphate concentration; maximum 6.65 g per day."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>475–950 mg, to be taken with breakfast and with snacks, 0.95–2.85 g, to be taken with main meals and 0.95–1.9 g, to be taken with supper, dose to be adjusted according to serum-phosphate concentration; maximum 6.65 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """475–950 mg, to be taken with breakfast and with snacks, 0.95–2.85 g, to be taken with main meals and 0.95–1.9 g, to be taken with supper, dose to be adjusted according to serum-phosphate concentration; maximum 6.65 g per day.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemia>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106718>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106718> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106788> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renacet-tablets#PHP106801> a nicebnf:PatientAndCarerAdvice.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperphosphataemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hyperphosphataemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hyperphosphataemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#FcgcNi4B0kOEH8OCSeuXsA>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#7xn_9_jvmkq1JXztZUkxEA>;
                                                                        nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#SBj3iAKZgUOdqO5MM92keg>;
                                                                        nicebnf:hasTitle """<title>Renagel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "renagel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#7xn_9_jvmkq1JXztZUkxEA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises use only if potential benefit outweighs risk.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97470>;
                                                                                               nicebnf:hasTextContent """Manufacturer advises use only if potential benefit outweighs risk.

"""^^xsd:string;
                                                                                               a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#FcgcNi4B0kOEH8OCSeuXsA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 2.4–4.8 g daily in 3 divided doses, dose to be given with meals and adjusted according to serum-phosphate concentration; usual dose 2.4–12 g daily in 3 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 2.4–4.8 g daily in 3 divided doses, dose to be given with meals and adjusted according to serum-phosphate concentration; usual dose 2.4–12 g daily in 3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 2.4–4.8 g daily in 3 divided doses, dose to be given with meals and adjusted according to serum-phosphate concentration; usual dose 2.4–12 g daily in 3 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsOnHaemodialysisOrPeritonealDialysis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97429>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97429> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97470> a nicebnf:BreastFeeding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97480> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#SBj3iAKZgUOdqO5MM92keg> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Diverticulitis</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#notKnown>;
                                                                                               nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#diverticulitis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renagel#PHP97480>;
                                                                                               nicebnf:hasTextContent """Diverticulitis

"""^^xsd:string;
                                                                                               a nicebnf:GeneralSideEffects,
                                                                                                 nicebnf:SideEffectGroup,
                                                                                                 nicebnf:SideEffectsGroup.
<http://ld.nice.org.uk/ns/bnf/Frequency#notKnown> a nicebnf:Frequency;
                                                  rdfs:label "frequency not known"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsOnHaemodialysisOrPeritonealDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperphosphataemia in patients on haemodialysis or peritoneal dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasTextContent """Hyperphosphataemia in patients on haemodialysis or peritoneal dialysis

"""^^xsd:string;
                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                          rdfs:label "hyperphosphataemia in patients on haemodialysis or peritoneal dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#diverticulitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Diverticulitis</ph>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent "Diverticulitis"^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                         rdfs:label "diverticulitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-24g-oral-powder-sachets-sanofi> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-24g-oral-powder-sachets-sanofi#FI7GiEO8iU6sMfpUGSagOQ>;
                                                                                                       nicebnf:hasTitle """<title>Renvela<tm tmtype=\"reg\" /> 2.4g oral powder sachets (Sanofi)</title>"""^^<rdf:XMLLiteral>;
                                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                       rdfs:label "renvela 2.4g oral powder sachets (sanofi)"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-24g-oral-powder-sachets-sanofi#FI7GiEO8iU6sMfpUGSagOQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients and carers should be advised on how to administer <i>Renvela</i><tm tmtype=\"reg\" /> powder for oral suspension.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-24g-oral-powder-sachets-sanofi#PHP104843>;
                                                                                                                              nicebnf:hasTextContent """Patients and carers should be advised on how to administer Renvela powder for oral suspension.

"""^^xsd:string;
                                                                                                                              a nicebnf:GeneralPatientAdvice,
                                                                                                                                nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-24g-oral-powder-sachets-sanofi#PHP104843> a nicebnf:PatientAndCarerAdvice.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#zyQ_fUZPsEOSuPtUCI_HZQ>;
                                                                                             nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#5pHtArmX-UCOqujhzrOLnw>,
                                                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#L5NzwJtpFUO3hhUvVfdf6Q>;
                                                                                             nicebnf:hasTitle """<title>Renvela<tm tmtype=\"reg\" /> 800mg tablets (Sanofi)</title>"""^^<rdf:XMLLiteral>;
                                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                                             rdfs:label "renvela 800mg tablets (sanofi)"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#5pHtArmX-UCOqujhzrOLnw> nicebnf:hasDitaContent """<sectiondiv>
  <p>For powder for oral supension, each sachet to be dispersed in 60 mL water.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104831>;
                                                                                                                    nicebnf:hasTextContent """For powder for oral supension, each sachet to be dispersed in 60 mL water.

"""^^xsd:string;
                                                                                                                    a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#L5NzwJtpFUO3hhUvVfdf6Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Unlikely to be present in milk (however, manufacturer advises avoid).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104818>;
                                                                                                                    nicebnf:hasTextContent """Unlikely to be present in milk (however, manufacturer advises avoid).

"""^^xsd:string;
                                                                                                                    a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104783> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104818> a nicebnf:BreastFeeding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104831> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#zyQ_fUZPsEOSuPtUCI_HZQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                       rdfs:label "initially 2.4–4.8 g daily in 3 divided doses, dose to be taken with meals and adjusted according to serum-phosphate concentration every 2–4 weeks; usual dose 6 g daily in 3 divided doses."^^xsd:string ; 
                                                                                                                                       nicebnf:hasDitaContent "<p>Initially 2.4–4.8 g daily in 3 divided doses, dose to be taken with meals and adjusted according to serum-phosphate concentration every 2–4 weeks; usual dose 6 g daily in 3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                       nicebnf:hasTextContent """Initially 2.4–4.8 g daily in 3 divided doses, dose to be taken with meals and adjusted according to serum-phosphate concentration every 2–4 weeks; usual dose 6 g daily in 3 divided doses.

"""^^xsd:string ; 
                                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsOnHaemodialysisOrPeritonealDialysis>,
                                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsWithChronicKidneyDiseaseNotOnDialysisWhoHaveASerumPhosphateConcentrationOf178MmolLitreOrMore>;
                                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/renvela-800mg-tablets-sanofi#PHP104783>;
                                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsOnHaemodialysisOrPeritonealDialysis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperphosphataemia in patients on haemodialysis or peritoneal dialysis</p>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasTextContent """Hyperphosphataemia in patients on haemodialysis or peritoneal dialysis

"""^^xsd:string;
                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                          rdfs:label "hyperphosphataemia in patients on haemodialysis or peritoneal dialysis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperphosphataemiaInPatientsWithChronicKidneyDiseaseNotOnDialysisWhoHaveASerumPhosphateConcentrationOf178MmolLitreOrMore> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperphosphataemia in patients with chronic kidney disease not on dialysis who have a serum-phosphate concentration of 1.78 mmol/litre or more</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                   nicebnf:hasTextContent """Hyperphosphataemia in patients with chronic kidney disease not on dialysis who have a serum-phosphate concentration of 1.78 mmol/litre or more

"""^^xsd:string;
                                                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                   rdfs:label "hyperphosphataemia in patients with chronic kidney disease not on dialysis who have a serum-phosphate concentration of 1.78 mmol/litre or more"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#FWUdJnjpvk6Mut8FAzlDMg>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#brbcJ9BC7USYOfog-bfFow>;
                                                                               nicebnf:hasTitle """<title>Rhinocort Aqua<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "rhinocort aqua"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#FWUdJnjpvk6Mut8FAzlDMg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "64 micrograms twice daily for up to 3 months, dose to be administered into each nostril."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>64 micrograms twice daily for up to 3 months, dose to be administered into each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """64 micrograms twice daily for up to 3 months, dose to be administered into each nostril.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#nasalPolyps>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#PHP78902>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#PHP78902> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#brbcJ9BC7USYOfog-bfFow> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "128 micrograms once daily, dose to be administered into each nostril in the morning, alternatively 64 micrograms twice daily; reduced to 64 micrograms once daily when control achieved. use for maximum 3 months, doses to be administered into each nostril."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>128 micrograms once daily, dose to be administered into each nostril in the morning, alternatively 64 micrograms twice daily; reduced to 64 micrograms once daily when control achieved. Use for maximum 3 months, doses to be administered into each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """128 micrograms once daily, dose to be administered into each nostril in the morning, alternatively 64 micrograms twice daily; reduced to 64 micrograms once daily when control achieved. Use for maximum 3 months, doses to be administered into each nostril.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#rhinitis>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhinocort-aqua#PHP78902>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#nasalPolyps> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Nasal polyps</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Nasal polyps

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "nasal polyps"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#rhinitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Rhinitis</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Rhinitis

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "rhinitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#JmV-aKHHxEyqrABiyrdm6Q>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#Wn37e4sZtUqUAeHK8P2IRQ>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#oXAQa8hou0W9e3K8bkR-MQ>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#wBmTAl3mf02ia_3RVleGxw>;
                                                                          nicebnf:hasTitle """<title>Rhophylac<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "rhophylac"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#JmV-aKHHxEyqrABiyrdm6Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                    rdfs:label "50 units/ml, dose per ml of transfused rhesus-positive blood, alternatively 100 units/ml, dose per ml of erythrocyte concentrate, intravenous route recommended for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>50 units/mL, dose per mL of transfused rhesus-positive blood, alternatively 100 units/mL, dose per mL of erythrocyte concentrate, intravenous route recommended for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """50 units/mL, dose per mL of transfused rhesus-positive blood, alternatively 100 units/mL, dose per mL of erythrocyte concentrate, intravenous route recommended for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingRh0DIncompatibleBloodTransfusion>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#PHP82394>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#PHP82394> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#Wn37e4sZtUqUAeHK8P2IRQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                    rdfs:label "1000–1500 units, dose to administered immediately or within 72 hours; for large transplacental bleed, extra 100 units per ml fetal red cells (preferably by intravenous injection), intravenous route recommended for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1000–1500 units, dose to administered immediately or within 72 hours; for large transplacental bleed, extra 100 units per mL fetal red cells (preferably by intravenous injection), intravenous route recommended for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1000–1500 units, dose to administered immediately or within 72 hours; for large transplacental bleed, extra 100 units per mL fetal red cells (preferably by intravenous injection), intravenous route recommended for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjectionOrByIntravenousInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingBirthOfRhesusPositiveInfant>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#PHP82394>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#oXAQa8hou0W9e3K8bkR-MQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                    rdfs:label "1500 units, dose to be given between weeks 28–30 of pregnancy; if infant rhesus-positive, a further dose is still needed immediately or within 72 hours of delivery, intravenous route recommended for patients with bleeding disorders."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1500 units, dose to be given between weeks 28–30 of pregnancy; if infant rhesus-positive, a further dose is still needed immediately or within 72 hours of delivery, intravenous route recommended for patients with bleeding disorders.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1500 units, dose to be given between weeks 28–30 of pregnancy; if infant rhesus-positive, a further dose is still needed immediately or within 72 hours of delivery, intravenous route recommended for patients with bleeding disorders.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjectionOrByIntravenousInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationAntenatalProphylaxis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#PHP82394>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#wBmTAl3mf02ia_3RVleGxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> ; 
                                                                                                                    rdfs:label "1000 units per episode, dose to be administered immediately or within 72 hours, intravenous route recommended for patients with bleeding disorders, higher doses may be required after 12 weeks gestation."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1000 units per episode, dose to be administered immediately or within 72 hours, intravenous route recommended for patients with bleeding disorders, higher doses may be required after 12 weeks gestation.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1000 units per episode, dose to be administered immediately or within 72 hours, intravenous route recommended for patients with bleeding disorders, higher doses may be required after 12 weeks gestation.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjectionOrByIntravenousInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingAnyPotentiallySensitisingEpisodeEGAbortionAmniocentesisChorionicVillousSamplingUpTo12WeeksGestation>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rhophylac#PHP82394>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationAntenatalProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To rhesus-negative woman for prevention of Rh0(D) sensitisation, antenatal prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasTextContent """To rhesus-negative woman for prevention of Rh0(D) sensitisation, antenatal prophylaxis

"""^^xsd:string;
                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                    rdfs:label "to rhesus-negative woman for prevention of rh0(d) sensitisation, antenatal prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingAnyPotentiallySensitisingEpisodeEGAbortionAmniocentesisChorionicVillousSamplingUpTo12WeeksGestation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To rhesus-negative woman for prevention of Rh0(D) sensitisation, following any potentially sensitising episode (e.g. abortion, amniocentesis, chorionic villous sampling) up to 12 weeks' gestation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                            nicebnf:hasTextContent """To rhesus-negative woman for prevention of Rh0(D) sensitisation, following any potentially sensitising episode (e.g. abortion, amniocentesis, chorionic villous sampling) up to 12 weeks' gestation

"""^^xsd:string;
                                                                                                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                            rdfs:label "to rhesus-negative woman for prevention of rh0(d) sensitisation, following any potentially sensitising episode (e.g. abortion, amniocentesis, chorionic villous sampling) up to 12 weeks' gestation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingBirthOfRhesusPositiveInfant> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To rhesus-negative woman for prevention of Rh0(D) sensitisation, following birth of rhesus-positive infant</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasTextContent """To rhesus-negative woman for prevention of Rh0(D) sensitisation, following birth of rhesus-positive infant

"""^^xsd:string;
                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                    rdfs:label "to rhesus-negative woman for prevention of rh0(d) sensitisation, following birth of rhesus-positive infant"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#toRhesusNegativeWomanForPreventionOfRh0DSensitisationFollowingRh0DIncompatibleBloodTransfusion> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">To rhesus-negative woman for prevention of Rh0(D) sensitisation, following Rh0(D) incompatible blood transfusion</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasTextContent """To rhesus-negative woman for prevention of Rh0(D) sensitisation, following Rh0(D) incompatible blood transfusion

"""^^xsd:string;
                                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                         rdfs:label "to rhesus-negative woman for prevention of rh0(d) sensitisation, following rh0(d) incompatible blood transfusion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#femalesOfChildbearingPotential> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                           rdfs:label "females of childbearing potential"^^xsd:string;
                                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjectionOrByIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                            rdfs:label "by intramuscular injection, or by intravenous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#9T8ATTg-_UqHtS90DZMQsw>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#gdo741uyy0mNxokAawmpEg>;
                                                                          nicebnf:hasTitle """<title>Roferon-A<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "roferon-a"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#9T8ATTg-_UqHtS90DZMQsw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "(consult local protocol)."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>(consult local protocol).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """(consult local protocol).

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#advancedRenalCellCarcinoma>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#aidsRelatedKaposiSSarcoma>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemia>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#follicularNonHodgkinSLymphoma>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#progressiveCutaneousTCellLymphoma>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#PHP80854>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#PHP80854> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#PHP80871> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#gdo741uyy0mNxokAawmpEg> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Roferon-A</i>
    <tm tmtype=\"reg\" /> injection for subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/roferon-a#PHP80871>;
                                                                                                 nicebnf:hasTextContent """Roferon-A injection for subcutaneous injection.

"""^^xsd:string;
                                                                                                 a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctToSurgeryInMalignantMelanoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct to surgery in malignant melanoma</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Adjunct to surgery in malignant melanoma

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "adjunct to surgery in malignant melanoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#advancedRenalCellCarcinoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Advanced renal cell carcinoma</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Advanced renal cell carcinoma

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "advanced renal cell carcinoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#aidsRelatedKaposiSSarcoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">AIDS-related Kaposi's sarcoma</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """AIDS-related Kaposi's sarcoma

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "aids-related kaposi's sarcoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisB> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis B</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis B

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis b"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisC> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis C</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Chronic hepatitis C

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "chronic hepatitis c"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicMyelogenousLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic myelogenous leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent """Chronic myelogenous leukaemia

"""^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                      rdfs:label "chronic myelogenous leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#follicularNonHodgkinSLymphoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Follicular non-Hodgkin's lymphoma</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Follicular non-Hodgkin's lymphoma

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "follicular non-hodgkin's lymphoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hairyCellLeukaemia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hairy cell leukaemia</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Hairy cell leukaemia

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "hairy cell leukaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#progressiveCutaneousTCellLymphoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Progressive cutaneous T-cell lymphoma</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Progressive cutaneous T-cell lymphoma

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "progressive cutaneous t-cell lymphoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rosiced> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rosiced#4UzU7i9bhkOL7rjYFDAA4A>;
                                                                        nicebnf:hasTitle """<title>Rosiced<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "rosiced"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rosiced#4UzU7i9bhkOL7rjYFDAA4A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply twice daily for 6 weeks (longer if necessary)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply twice daily for 6 weeks (longer if necessary).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply twice daily for 6 weeks (longer if necessary).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesAndPustulesOfRosacea>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rosiced#PHP84187>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rosiced#PHP84187> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesAndPustulesOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Inflammatory papules and pustules of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Inflammatory papules and pustules of rosacea

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "inflammatory papules and pustules of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-cream#HNwbcdR8fkK9iUXMWRvVTw>;
                                                                            nicebnf:hasTitle """<title>Rozex<tm tmtype=\"reg\" /> cream</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "rozex cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-cream#HNwbcdR8fkK9iUXMWRvVTw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "apply twice daily for 3–4 months."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Apply twice daily for 3–4 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Apply twice daily for 3–4 months.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesPustulesAndErythemaOfRosacea>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-cream#PHP84219>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-cream#PHP84219> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesPustulesAndErythemaOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Inflammatory papules, pustules and erythema of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Inflammatory papules, pustules and erythema of rosacea

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "inflammatory papules, pustules and erythema of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-gel#GPee0t7QO0K9KTVvmSi3bA>;
                                                                          nicebnf:hasTitle """<title>Rozex<tm tmtype=\"reg\" /> gel</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "rozex gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-gel#GPee0t7QO0K9KTVvmSi3bA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply twice daily for 3–4 months."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily for 3–4 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily for 3–4 months.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesPustulesAndErythemaOfRosacea>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-gel#PHP84250>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/rozex-gel#PHP84250> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#inflammatoryPapulesPustulesAndErythemaOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Inflammatory papules, pustules and erythema of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Inflammatory papules, pustules and erythema of rosacea

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "inflammatory papules, pustules and erythema of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#R4kV7oz8MU6CXO1u5f01iA>,
                                                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#fq8NNHMU6UuoW8_CKi4H_g>;
                                                                                                                     nicebnf:hasTitle """<title>Saizen<tm tmtype=\"reg\" /> powder and solvent for solution for injection</title>"""^^<rdf:XMLLiteral>;
                                                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                     rdfs:label "saizen powder and solvent for solution for injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#PHP82061> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#PHP82071> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#R4kV7oz8MU6CXO1u5f01iA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#PHP82061>;
                                                                                                                                            nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                                                            a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#fq8NNHMU6UuoW8_CKi4H_g> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use with <i>one. click</i><tm tmtype=\"reg\" /> autoinjector device or <i>cool.click</i><tm tmtype=\"reg\" /> needle-free autoinjector device or <i>easypod</i><tm tmtype=\"reg\" /> autoinjector device (non-NHS but available free of charge from clinics).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-powder-and-solvent-for-solution-for-injection#PHP82071>;
                                                                                                                                            nicebnf:hasTextContent """For use with one. click autoinjector device or cool.click needle-free autoinjector device or easypod autoinjector device (non-NHS but available free of charge from clinics).

"""^^xsd:string;
                                                                                                                                            a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#IrtddROTakufa_tLKmxm8g>,
                                                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#a9ZfbywKnEO9L3CqeEO8bg>;
                                                                                              nicebnf:hasTitle """<title>Saizen<tm tmtype=\"reg\" /> solution for injection</title>"""^^<rdf:XMLLiteral>;
                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                              rdfs:label "saizen solution for injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#IrtddROTakufa_tLKmxm8g> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use with <i>cool.click</i><tm tmtype=\"reg\" /> needle-free autoinjector device or <i>easypod</i><tm tmtype=\"reg\" /> autoinjector device (non-NHS but available free of charge from clinics).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#PHP85353>;
                                                                                                                     nicebnf:hasTextContent """For use with cool.click needle-free autoinjector device or easypod autoinjector device (non-NHS but available free of charge from clinics).

"""^^xsd:string;
                                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#PHP85334> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#PHP85353> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#a9ZfbywKnEO9L3CqeEO8bg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/saizen-solution-for-injection#PHP85334>;
                                                                                                                     nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                                     a nicebnf:DirectionForAdministration.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salactol> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salactol#qI7jQ5lVOky88SX51LTCtg>;
                                                                         nicebnf:hasTitle """<title>Salactol<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "salactol"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salactol#PHP96114> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salactol#qI7jQ5lVOky88SX51LTCtg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#calluses>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#corns>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#verrucas>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#wartsParticularlyPlantarWarts>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salactol#PHP96114>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#calluses> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Calluses</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Calluses

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "calluses"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#corns> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Corns</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Corns

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "corns"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#verrucas> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Verrucas</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Verrucas

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "verrucas"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#wartsParticularlyPlantarWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Warts (particularly plantar warts)</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Warts (particularly plantar warts)

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "warts (particularly plantar warts)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salatac> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salatac#-pmNbxhrSU69LkE0dUI7tQ>;
                                                                        nicebnf:hasTitle """<title>Salatac<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "salatac"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salatac#-pmNbxhrSU69LkE0dUI7tQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#calluses>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#corns>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#verrucas>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#warts>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salatac#PHP96380>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salatac#PHP96380> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#calluses> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Calluses</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Calluses

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "calluses"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#corns> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Corns</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Corns

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "corns"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#verrucas> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Verrucas</p>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent """Verrucas

"""^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                   rdfs:label "verrucas"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#warts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Warts</p>"""^^<rdf:XMLLiteral>;
                                                nicebnf:hasTextContent """Warts

"""^^xsd:string;
                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                rdfs:label "warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#Gvg4cWN2GESjqLsE4a1cwg>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#iz4APpwjRkGKp30qzupIMw>;
                                                                                   nicebnf:hasTitle """<title>Salbulin Novolizer<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "salbulin novolizer"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#Gvg4cWN2GESjqLsE4a1cwg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 100–200 micrograms, up to 800 micrograms daily for persistent symptoms."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 100–200 micrograms, up to 800 micrograms daily for persistent symptoms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 100–200 micrograms, up to 800 micrograms daily for persistent symptoms.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#PHP82689>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#PHP82689> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#iz4APpwjRkGKp30qzupIMw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "200 micrograms."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>200 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """200 micrograms.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salbulin-novolizer#PHP82689>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Acute bronchospasm

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "acute bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Prophylaxis of allergen- or exercise-induced bronchospasm

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "prophylaxis of allergen- or exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-enema> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-enema#Gif109TbM0-sNTF3LkB5RQ>;
                                                                               nicebnf:hasTitle """<title>Salofalk<tm tmtype=\"reg\" /> enema</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "salofalk enema"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-enema#Gif109TbM0-sNTF3LkB5RQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "2 g once daily, dose to be administered at bedtime."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>2 g once daily, dose to be administered at bedtime.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """2 g once daily, dose to be administered at bedtime.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisOrMaintenanceOfRemission>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-enema#PHP83614>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-enema#PHP83614> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisOrMaintenanceOfRemission> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#lwgOm65_MUquUq5Zgaygew>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#q05ZCgCkVUSx2moNcCa3WA>;
                                                                                  nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#E2nMP1SMMEGPDVObeFLFcA>;
                                                                                  nicebnf:hasTitle """<title>Salofalk<tm tmtype=\"reg\" /> granules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "salofalk granules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#E2nMP1SMMEGPDVObeFLFcA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Granules should be placed on tongue and washed down with water without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#PHP83533>;
                                                                                                         nicebnf:hasTextContent """Granules should be placed on tongue and washed down with water without chewing.

"""^^xsd:string;
                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#PHP83517> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#PHP83533> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#lwgOm65_MUquUq5Zgaygew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                            rdfs:label "30–50 mg/kg once daily, dose preferably given in the morning, alternatively 10–20 mg/kg 3 times a day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>30–50 mg/kg once daily, dose preferably given in the morning, alternatively 10–20 mg/kg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """30–50 mg/kg once daily, dose preferably given in the morning, alternatively 10–20 mg/kg 3 times a day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                            rdfs:label "1.5–3 g once daily, dose preferably given in the morning, alternatively 0.5–1 g 3 times a day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1.5–3 g once daily, dose preferably given in the morning, alternatively 0.5–1 g 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1.5–3 g once daily, dose preferably given in the morning, alternatively 0.5–1 g 3 times a day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1.5–3 g once daily, dose preferably taken in the morning, alternatively 0.5–1 g 3 times a day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1.5–3 g once daily, dose preferably taken in the morning, alternatively 0.5–1 g 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1.5–3 g once daily, dose preferably taken in the morning, alternatively 0.5–1 g 3 times a day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#PHP83517>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#q05ZCgCkVUSx2moNcCa3WA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                            rdfs:label "7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                            rdfs:label "500 mg 3 times a day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>500 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """500 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                           [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "500 mg 3 times a day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>500 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """500 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-granules#PHP83517>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                                rdfs:label "child 5–17 years (body-weight 40 kg and above)"^^xsd:string;
                                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                            rdfs:label "child 5–17 years (body-weight up to 40 kg)"^^xsd:string;
                                                                            rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-rectal-foam> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-rectal-foam#H32Pn3fb9EqQ-M65Qejg8Q>;
                                                                                     nicebnf:hasTitle """<title>Salofalk<tm tmtype=\"reg\" /> rectal foam</title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "salofalk rectal foam"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-rectal-foam#H32Pn3fb9EqQ-M65Qejg8Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                               rdfs:label "2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildUlcerativeColitisAffectingSigmoidColonAndRectum>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-rectal-foam#PHP83663>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-rectal-foam#PHP83663> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildUlcerativeColitisAffectingSigmoidColonAndRectum> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild ulcerative colitis affecting sigmoid colon and rectum</p>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasTextContent """Treatment of mild ulcerative colitis affecting sigmoid colon and rectum

"""^^xsd:string;
                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                         rdfs:label "treatment of mild ulcerative colitis affecting sigmoid colon and rectum"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#F6CHjqFikUmCny0eSi8PLA>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#kqfAhW3gOUmjB7H1kDlGcQ>;
                                                                                       nicebnf:hasTitle """<title>Salofalk<tm tmtype=\"reg\" /> suppositories</title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "salofalk suppositories"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#F6CHjqFikUmCny0eSi8PLA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 g daily, preferably at bedtime, dose to be given using 1 g suppositories."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 g daily, preferably at bedtime, dose to be given using 1 g suppositories.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 g daily, preferably at bedtime, dose to be given using 1 g suppositories.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectum>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#PHP83550>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#PHP83550> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#kqfAhW3gOUmjB7H1kDlGcQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "0.5–1 g 2–3 times a day, adjusted according to response, dose to be given using 500 mg suppositories."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>0.5–1 g 2–3 times a day, adjusted according to response, dose to be given using 500 mg suppositories.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """0.5–1 g 2–3 times a day, adjusted according to response, dose to be given using 500 mg suppositories.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectumSigmoidColonAndDescendingColon>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-suppositories#PHP83550>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectum> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum</p>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum

"""^^xsd:string;
                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                    rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfAcuteAttackOfMildToModerateUlcerativeColitisAffectingTheRectumSigmoidColonAndDescendingColon> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum, sigmoid colon and descending colon</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                  nicebnf:hasTextContent """Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum, sigmoid colon and descending colon

"""^^xsd:string;
                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                  rdfs:label "treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum, sigmoid colon and descending colon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#dGGmi2P1GkWD9d94mLHVsQ>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#rEdfMt9KpUOjQVzFe7bQqQ>;
                                                                                 nicebnf:hasTitle """<title>Salofalk<tm tmtype=\"reg\" /> tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "salofalk tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#PHP83486> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#dGGmi2P1GkWD9d94mLHVsQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                           rdfs:label "7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                           rdfs:label "500 mg 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>500 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """500 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "500 mg 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>500 mg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """500 mg 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#PHP83486>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#rEdfMt9KpUOjQVzFe7bQqQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> ; 
                                                                                                                           rdfs:label "10–20 mg/kg 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>10–20 mg/kg 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """10–20 mg/kg 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> ; 
                                                                                                                           rdfs:label "0.5–1 g 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.5–1 g 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.5–1 g 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                          [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "0.5–1 g 3 times a day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>0.5–1 g 3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """0.5–1 g 3 times a day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salofalk-tablets#PHP83486>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceOfRemissionOfUlcerativeColitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance of remission of ulcerative colitis</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Maintenance of remission of ulcerative colitis

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "maintenance of remission of ulcerative colitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfMildToModerateUlcerativeColitisAcuteAttack> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate ulcerative colitis, acute attack</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasTextContent """Treatment of mild to moderate ulcerative colitis, acute attack

"""^^xsd:string;
                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                rdfs:label "treatment of mild to moderate ulcerative colitis, acute attack"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeight40KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                                rdfs:label "child 5–17 years (body-weight 40 kg and above)"^^xsd:string;
                                                                                rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517YearsBodyWeightUpTo40Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                            rdfs:label "child 5–17 years (body-weight up to 40 kg)"^^xsd:string;
                                                                            rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#QsYWKv6c2UGDOdRFZ7h1CQ>;
                                                                         nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#eN1_MwC4wUmEJ_YgxNoRVQ>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#RRWQhN51pkut7R11IlZt8g>;
                                                                         nicebnf:hasTitle """<title>Salvacyl<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "salvacyl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82541> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82545> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82548> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#QsYWKv6c2UGDOdRFZ7h1CQ> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#increasedRiskOfSensitivityToRestoredTestosteroneIfTreatmentInterruptedConsiderAdministrationOfAnAntiandrogenBeforeStoppingTreatment>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Caution#transientIncreaseInSerumTestosteroneOccursOnInitiationConsiderAdministrationOfAnAntiAndrogen>;
                                                                                                nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Increased risk of sensitivity to restored testosterone if treatment interrupted—consider administration of an antiandrogen before stopping treatment</ph>; <ph outputclass=\"caution\">transient increase in serum testosterone occurs on initiation—consider administration of an anti-androgen</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82541>;
                                                                                                nicebnf:hasTextContent """Increased risk of sensitivity to restored testosterone if treatment interrupted—consider administration of an antiandrogen before stopping treatment; transient increase in serum testosterone occurs on initiation—consider administration of an anti-androgen

"""^^xsd:string;
                                                                                                a nicebnf:CautionsGroup,
                                                                                                  nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#RRWQhN51pkut7R11IlZt8g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "11.25 mg every 12 weeks."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>11.25 mg every 12 weeks.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """11.25 mg every 12 weeks.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maleHypersexualityWithSevereSexualDeviation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82548>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#eN1_MwC4wUmEJ_YgxNoRVQ> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#severeOsteoporosis>;
                                                                                                nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Severe osteoporosis</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/salvacyl#PHP82545>;
                                                                                                nicebnf:hasTextContent """Severe osteoporosis

"""^^xsd:string;
                                                                                                a nicebnf:ContraindicationsGroup,
                                                                                                  nicebnf:GeneralContraindications.
<http://ld.nice.org.uk/ns/bnf/Caution#increasedRiskOfSensitivityToRestoredTestosteroneIfTreatmentInterruptedConsiderAdministrationOfAnAntiandrogenBeforeStoppingTreatment> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Increased risk of sensitivity to restored testosterone if treatment interrupted—consider administration of an antiandrogen before stopping treatment</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                           nicebnf:hasTextContent "Increased risk of sensitivity to restored testosterone if treatment interrupted—consider administration of an antiandrogen before stopping treatment"^^xsd:string;
                                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                                                           rdfs:label "increased risk of sensitivity to restored testosterone if treatment interrupted—consider administration of an antiandrogen before stopping treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#transientIncreaseInSerumTestosteroneOccursOnInitiationConsiderAdministrationOfAnAntiAndrogen> nicebnf:hasDitaContent """<ph outputclass=\"caution\">transient increase in serum testosterone occurs on initiation—consider administration of an anti-androgen</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasTextContent "transient increase in serum testosterone occurs on initiation—consider administration of an anti-androgen"^^xsd:string;
                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                    rdfs:label "transient increase in serum testosterone occurs on initiation—consider administration of an anti-androgen"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Contraindication#severeOsteoporosis> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Severe osteoporosis</ph>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent "Severe osteoporosis"^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                   rdfs:label "severe osteoporosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maleHypersexualityWithSevereSexualDeviation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Male hypersexuality with severe sexual deviation</p>"""^^<rdf:XMLLiteral>;
                                                                                      nicebnf:hasTextContent """Male hypersexuality with severe sexual deviation

"""^^xsd:string;
                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                      rdfs:label "male hypersexuality with severe sexual deviation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/samsca> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/samsca#t0BHUNSau0SrJFX6G-bWLw>;
                                                                       nicebnf:hasTitle """<title>Samsca<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "samsca"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/samsca#PHP108800> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/samsca#t0BHUNSau0SrJFX6G-bWLw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "15 mg once daily, increased if necessary up to 60 mg daily treatment duration is determined by the underlying disease and its treatment."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>15 mg once daily, increased if necessary up to 60 mg daily treatment duration is determined by the underlying disease and its treatment.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """15 mg once daily, increased if necessary up to 60 mg daily treatment duration is determined by the underlying disease and its treatment.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHyponatraemiaSecondaryToSyndromeOfInappropriateAntidiureticHormoneSecretion>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/samsca#PHP108800>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHyponatraemiaSecondaryToSyndromeOfInappropriateAntidiureticHormoneSecretion> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                 nicebnf:hasTextContent """Treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion

"""^^xsd:string;
                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                 rdfs:label "treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#nIbUiwYJwEOYCO2Wp7s_pw>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#mUCQtmnG0kqMiIZH0dsBYg>;
                                                                         nicebnf:hasTitle """<title>Sandrena<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "sandrena"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#PHP97737> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#PHP97747> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#mUCQtmnG0kqMiIZH0dsBYg> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use</p>
  <p>Apply gel to intact areas of skin such as lower trunk or thighs, using right and left sides on alternate days. Wash hands after application. Not to be applied on the breasts or face and avoid contact with eyes. Allow area of application to dry for 5 minutes and do not wash area for at least 1 hour.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withTopicalUse>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#PHP97747>;
                                                                                                nicebnf:hasTextContent """With topical use

Apply gel to intact areas of skin such as lower trunk or thighs, using right and left sides on alternate days. Wash hands after application. Not to be applied on the breasts or face and avoid contact with eyes. Allow area of application to dry for 5 minutes and do not wash area for at least 1 hour.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralPatientAdvice,
                                                                                                  nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#nIbUiwYJwEOYCO2Wp7s_pw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 1 mg once daily, to be applied over area 1–2 times size of hand; with cyclical progestogen for 12–14 days of each cycle in women with a uterus, dose may be adjusted after 2–3 cycles to lowest effective dose; usual dose 0.5–1.5 mg daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 1 mg once daily, to be applied over area 1–2 times size of hand; with cyclical progestogen for 12–14 days of each cycle in women with a uterus, dose may be adjusted after 2–3 cycles to lowest effective dose; usual dose 0.5–1.5 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 1 mg once daily, to be applied over area 1–2 times size of hand; with cyclical progestogen for 12–14 days of each cycle in women with a uterus, dose may be adjusted after 2–3 cycles to lowest effective dose; usual dose 0.5–1.5 mg daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sandrena#PHP97737>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Route#topical> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                             rdfs:label "topical"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withTopicalUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#topical>;
                                                          a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                          rdfs:label "with topical use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#mfoshIqS0UaPjV6ecrg0Vg>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#VneARSrBu0WVOiaMVjuIwA>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#gYzgrS-Pzk2EY5pwzcMttQ>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#jfVN0fJDiEatU9ZkPgdPEQ>;
                                                                       nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#oHqHqCfNlEG-h4l1W-NSNw>,
                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#udt_qvgB-E2TvhEL_IbjRA>;
                                                                       nicebnf:hasTitle """<title>Savene<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "savene"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80030> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80035> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80040> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80061> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80072> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#VneARSrBu0WVOiaMVjuIwA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises avoid—no information available.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80035>;
                                                                                              nicebnf:hasTextContent """Manufacturer advises avoid—no information available.

"""^^xsd:string;
                                                                                              a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#gYzgrS-Pzk2EY5pwzcMttQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For <i>intravenous infusion</i>, give intermittently <i>in </i>diluent; reconstitute each 500-mg vial with 25 mL of diluent; dilute requisite dose further in remaining diluent and give over 1–2 hours into a large vein in an area other than the one affected.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80072>;
                                                                                              nicebnf:hasTextContent """For intravenous infusion, give intermittently in diluent; reconstitute each 500-mg vial with 25 mL of diluent; dilute requisite dose further in remaining diluent and give over 1–2 hours into a large vein in an area other than the one affected.

"""^^xsd:string;
                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#jfVN0fJDiEatU9ZkPgdPEQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Manufacturer advises avoid—risk of accumulation.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80040>;
                                                                                              nicebnf:hasTextContent """Manufacturer advises avoid—risk of accumulation.

"""^^xsd:string;
                                                                                              a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#mfoshIqS0UaPjV6ecrg0Vg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 1 g/m2 daily (max. per dose 2 g) for 2 days, then 500 mg/m2 for 1 day, first dose to be given as soon as possible and within 6 hours after injury."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 1 g/m<sup>2</sup> daily (max. per dose 2 g) for 2 days, then 500 mg/m<sup>2</sup> for 1 day, first dose to be given as soon as possible and within 6 hours after injury.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 1 g/m2 daily (max. per dose 2 g) for 2 days, then 500 mg/m2 for 1 day, first dose to be given as soon as possible and within 6 hours after injury.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anthracyclineExtravasation>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80030>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#oHqHqCfNlEG-h4l1W-NSNw> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">anaemia</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">erythema</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">infection</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">malaise</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">oedema</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">phlebitis</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>; <ph outputclass=\"sideEffect\">stomatitis</ph>; <ph outputclass=\"sideEffect\">syncope</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">vaginal haemorrhage</ph>; <ph outputclass=\"sideEffect\">vomiting</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon>;
                                                                                              nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#alopecia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#anaemia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#anorexia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#bloodDisorders>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#diarrhoea>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#dizziness>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#drowsiness>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#dryMouth>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#dyspnoea>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#erythema>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#fatigue>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#infection>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#injectionSiteReactions>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#leucopenia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#malaise>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#nausea>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#oedema>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralOedema>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#phlebitis>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#pruritus>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#pyrexia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#stomatitis>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#syncope>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#thrombocytopenia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#tremor>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#vaginalHaemorrhage>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#vomiting>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80061>;
                                                                                              nicebnf:hasTextContent """Alopecia; anaemia; anorexia; blood disorders; diarrhoea; dizziness; drowsiness; dry mouth; dyspnoea; erythema; fatigue; infection; injection-site reactions; leucopenia; malaise; nausea; oedema; peripheral neuropathy; peripheral oedema; phlebitis; pruritus; pyrexia; stomatitis; syncope; thrombocytopenia; tremor; vaginal haemorrhage; vomiting

"""^^xsd:string;
                                                                                              a nicebnf:GeneralSideEffects,
                                                                                                nicebnf:SideEffectGroup,
                                                                                                nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#udt_qvgB-E2TvhEL_IbjRA> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Drowsiness</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">thromboembolism (when given with cytotoxic drugs)</ph>; <ph outputclass=\"sideEffect\">weight loss</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#uncommon>;
                                                                                              nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#drowsiness>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#myalgia>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#thromboembolismWhenGivenWithCytotoxicDrugs>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/SideEffect#weightLoss>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savene#PHP80061>;
                                                                                              nicebnf:hasTextContent """Drowsiness; myalgia; thromboembolism (when given with cytotoxic drugs); weight loss

"""^^xsd:string;
                                                                                              a nicebnf:GeneralSideEffects,
                                                                                                nicebnf:SideEffectGroup,
                                                                                                nicebnf:SideEffectsGroup.
<http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon> a nicebnf:Frequency;
                                                            rdfs:label "common or very common"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#uncommon> a nicebnf:Frequency;
                                                  rdfs:label "uncommon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#anthracyclineExtravasation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Anthracycline extravasation</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Anthracycline extravasation

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "anthracycline extravasation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#alopecia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Alopecia</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "Alopecia"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "alopecia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#anaemia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">anaemia</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "anaemia"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "anaemia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#anorexia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">anorexia</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "anorexia"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "anorexia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#bloodDisorders> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">blood disorders</ph>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent "blood disorders"^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                         rdfs:label "blood disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#diarrhoea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">diarrhoea</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "diarrhoea"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "diarrhoea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dizziness> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dizziness</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "dizziness"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "dizziness"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#drowsiness> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">drowsiness</ph>"""^^<rdf:XMLLiteral>,
                                                                            """<ph outputclass=\"sideEffect\">Drowsiness</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "drowsiness"^^xsd:string,
                                                                            "Drowsiness"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "drowsiness"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dryMouth> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dry mouth</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "dry mouth"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "dry mouth"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dyspnoea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dyspnoea</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "dyspnoea"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "dyspnoea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#erythema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">erythema</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "erythema"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "erythema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#fatigue> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">fatigue</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "fatigue"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "fatigue"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#infection> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">infection</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "infection"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#injectionSiteReactions> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">injection-site reactions</ph>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent "injection-site reactions"^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                 rdfs:label "injection-site reactions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#leucopenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">leucopenia</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "leucopenia"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "leucopenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#malaise> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">malaise</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "malaise"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "malaise"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#myalgia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">myalgia</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "myalgia"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "myalgia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#nausea> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">nausea</ph>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent "nausea"^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                 rdfs:label "nausea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#oedema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">oedema</ph>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent "oedema"^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                 rdfs:label "oedema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">peripheral neuropathy</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "peripheral neuropathy"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                               rdfs:label "peripheral neuropathy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralOedema> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">peripheral oedema</ph>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent "peripheral oedema"^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                           rdfs:label "peripheral oedema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#phlebitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">phlebitis</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "phlebitis"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "phlebitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#pruritus> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">pruritus</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "pruritus"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "pruritus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#pyrexia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">pyrexia</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "pyrexia"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "pyrexia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#stomatitis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">stomatitis</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "stomatitis"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "stomatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#syncope> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">syncope</ph>"""^^<rdf:XMLLiteral>;
                                                  nicebnf:hasTextContent "syncope"^^xsd:string;
                                                  a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                  rdfs:label "syncope"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#thrombocytopenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">thrombocytopenia</ph>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent "thrombocytopenia"^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                           rdfs:label "thrombocytopenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#thromboembolismWhenGivenWithCytotoxicDrugs> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">thromboembolism (when given with cytotoxic drugs)</ph>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent "thromboembolism (when given with cytotoxic drugs)"^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                                     rdfs:label "thromboembolism (when given with cytotoxic drugs)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#tremor> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">tremor</ph>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent "tremor"^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                 rdfs:label "tremor"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#vaginalHaemorrhage> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">vaginal haemorrhage</ph>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent "vaginal haemorrhage"^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                             rdfs:label "vaginal haemorrhage"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#vomiting> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">vomiting</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "vomiting"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "vomiting"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#weightLoss> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">weight loss</ph>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent "weight loss"^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                     rdfs:label "weight loss"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/savlon-dry> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/savlon-dry#w_1u6zWVYEmLgjk2asrNXA>;
                                                                           nicebnf:hasTitle """<title>Savlon<tm tmtype=\"reg\" /> Dry</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "savlon dry"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savlon-dry#PHP85194> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/savlon-dry#w_1u6zWVYEmLgjk2asrNXA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfectionOfMinorWounds>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/savlon-dry#PHP85194>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfectionOfMinorWounds> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Skin disinfection of minor wounds</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Skin disinfection of minor wounds

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "skin disinfection of minor wounds"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/sebco-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/sebco-ointment#Cplw7y2TdEO-1Kc7P8iTzA>;
                                                                               nicebnf:hasTitle """<title>Sebco<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "sebco ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sebco-ointment#Cplw7y2TdEO-1Kc7P8iTzA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                         rdfs:label "medical supervision required."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Medical supervision required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Medical supervision required.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply as required, alternatively (to the skin) apply daily for the first 3–7 days (if severe), shampoo off after 1 hour.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#scalyScalpDisordersIncludingPsoriasisEczemaSeborrhoeicDermatitisAndDandruff>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sebco-ointment#PHP107234>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sebco-ointment#PHP107234> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#scalyScalpDisordersIncludingPsoriasisEczemaSeborrhoeicDermatitisAndDandruff> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff</p>"""^^<rdf:XMLLiteral>;
                                                                                                                      nicebnf:hasTextContent """Scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff

"""^^xsd:string;
                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                      rdfs:label "scaly scalp disorders including psoriasis, eczema, seborrhoeic dermatitis and dandruff"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#initiallyToTheSkinUsingScalpOintment> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "initially to the skin using scalp ointment"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#1Hd2254fPkC_DFmqi4uV3w>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#FxfJ20VIZk-G7vAZ_r3Vig>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#QBAl0xsALES4fj_8Fn4FkA>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#V2OFpb1LREawqvuYB9VrqQ>;
                                                                           nicebnf:hasTitle """<title>Securon<tm tmtype=\"reg\" /> SR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "securon sr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#1Hd2254fPkC_DFmqi4uV3w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """240 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#PHP62317>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#FxfJ20VIZk-G7vAZ_r3Vig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "240 mg twice daily, may sometimes be reduced to once daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>240 mg twice daily, may sometimes be reduced to once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """240 mg twice daily, may sometimes be reduced to once daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#PHP62317>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#PHP62317> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#QBAl0xsALES4fj_8Fn4FkA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening or 120 mg 3 times daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening <i>or</i> 120 mg 3 times daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """360 mg daily in divided doses, started at least 1 week after infarction, given as either 240 mg in the morning and 120 mg in the evening or 120 mg 3 times daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAfterMyocardialInfarctionWhereBetaBlockersNotAppropriate>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#PHP62317>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#V2OFpb1LREawqvuYB9VrqQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 120 mg daily, increased if necessary up to 480 mg daily, doses above 240 mg daily as 2 divided doses.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/securon-sr#PHP62317>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension (in patients new to verapamil)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Hypertension (in patients new to verapamil)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "hypertension (in patients new to verapamil)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisAfterMyocardialInfarctionWhereBetaBlockersNotAppropriate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis after myocardial infarction where beta-blockers not appropriate</p>"""^^<rdf:XMLLiteral>;
                                                                                                              nicebnf:hasTextContent """Prophylaxis after myocardial infarction where beta-blockers not appropriate

"""^^xsd:string;
                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                              rdfs:label "prophylaxis after myocardial infarction where beta-blockers not appropriate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-100-accuhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-100-accuhaler#Mjdw-f4prU6rkHTdU_SMUw>;
                                                                                       nicebnf:hasTitle """<title>Seretide 100 Accuhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "seretide 100 accuhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-100-accuhaler#Mjdw-f4prU6rkHTdU_SMUw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517Years> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily, reduced to 1 inhalation daily, reduce dose if control maintained.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-100-accuhaler#PHP95532>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-100-accuhaler#PHP95532> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 5–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-125-evohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-125-evohaler#jHrBqzm4_EKL6N_N8Mskww>;
                                                                                      nicebnf:hasTitle """<title>Seretide 125 Evohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "seretide 125 evohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-125-evohaler#PHP95111> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-125-evohaler#jHrBqzm4_EKL6N_N8Mskww> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-125-evohaler#PHP95111>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-accuhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-accuhaler#uqqcwW3vAkSkY7X_BH9riA>;
                                                                                       nicebnf:hasTitle """<title>Seretide 250 Accuhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "seretide 250 accuhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-accuhaler#PHP95110> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-accuhaler#uqqcwW3vAkSkY7X_BH9riA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-accuhaler#PHP95110>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-evohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-evohaler#ZvtvelCeAESWbnJjG6Ih0Q>;
                                                                                      nicebnf:hasTitle """<title>Seretide 250 Evohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "seretide 250 evohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-evohaler#PHP95242> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-evohaler#ZvtvelCeAESWbnJjG6Ih0Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-250-evohaler#PHP95242>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                        rdfs:label "by inhalation"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-50-evohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-50-evohaler#wVQYbSFfI0KhlPXTMV_BDA>;
                                                                                     nicebnf:hasTitle """<title>Seretide 50 Evohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                     a nicebnf:ClinicalMedicinalProductInformation;
                                                                                     rdfs:label "seretide 50 evohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-50-evohaler#PHP95491> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-50-evohaler#wVQYbSFfI0KhlPXTMV_BDA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child517Years> ; 
                                                                                                                               rdfs:label "2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation>],
                                                                                                                              [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                               rdfs:label "2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained."^^xsd:string ; 
                                                                                                                               nicebnf:hasDitaContent "<p>2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                               nicebnf:hasTextContent """2 puffs twice daily, reduced to 2 puffs once daily, reduce dose if control maintained.

"""^^xsd:string ; 
                                                                                                                               nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation>];
                                                                                                            nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                            nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-50-evohaler#PHP95491>;
                                                                                                            a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child517Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 5–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalation> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                        rdfs:label "by inhalation"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#MZPgPBV3SEC2lDhSC_ofnA>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#zF6dnjbxv0eE1PulqcoVCw>;
                                                                                       nicebnf:hasTitle """<title>Seretide 500 Accuhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                       rdfs:label "seretide 500 accuhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#MZPgPBV3SEC2lDhSC_ofnA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#PHP95419>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#PHP95419> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#zF6dnjbxv0eE1PulqcoVCw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                 rdfs:label "1 inhalation twice daily."^^xsd:string ; 
                                                                                                                                 nicebnf:hasDitaContent "<p>1 inhalation twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                 nicebnf:hasTextContent """1 inhalation twice daily.

"""^^xsd:string ; 
                                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second60OfPredicted>;
                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/seretide-500-accuhaler#PHP95419>;
                                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second60OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt;60% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second <60% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second <60% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of asthma

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#Zi6HEFWo7Ue1CN6MskaPjg>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#xl-eVf1CVkS0-_CYxF3shw>;
                                                                           nicebnf:hasTitle """<title>Sinemet<tm tmtype=\"reg\" /> CR</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "sinemet cr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#PHP81134> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#Zi6HEFWo7Ue1CN6MskaPjg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 1 tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 1 tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 1 tablet twice daily, both dose and interval then adjusted according to response at intervals of not less than 3 days.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsNotReceivingLevodopaDopaDecarboxylaseInhibitorTherapy>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#PHP81134>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#xl-eVf1CVkS0-_CYxF3shw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "1 tablet twice daily, dose can be substituted for a daily dose of levodopa 300–400 mg in immediate-release sinemet tablets (substitute sinemetcr to provide approximately 10% more levodopa per day and extend dosing interval by 30–50%); dose and interval then adjusted according to response at intervals of not less than 3 days."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent """<p>1 tablet twice daily, dose can be substituted for a daily dose of levodopa 300–400 mg in immediate-release <i>Sinemet</i><tm tmtype=\"reg\" /> tablets (substitute <i>Sinemet</i><tm tmtype=\"reg\" /><i>CR</i> to provide approximately 10% more levodopa per day and extend dosing interval by 30–50%); dose and interval then adjusted according to response at intervals of not less than 3 days.</p>"""^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """1 tablet twice daily, dose can be substituted for a daily dose of levodopa 300–400 mg in immediate-release Sinemet tablets (substitute SinemetCR to provide approximately 10% more levodopa per day and extend dosing interval by 30–50%); dose and interval then adjusted according to response at intervals of not less than 3 days.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsTransferringFromImmediateReleaseLevodopaDopaDecarboxylaseInhibitorPreparations>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sinemet-cr#PHP81134>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsNotReceivingLevodopaDopaDecarboxylaseInhibitorTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                         nicebnf:hasTextContent """Parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)

"""^^xsd:string;
                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                         rdfs:label "parkinson's disease (patients not receiving levodopa/dopa-decarboxylase inhibitor therapy)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseasePatientsTransferringFromImmediateReleaseLevodopaDopaDecarboxylaseInhibitorPreparations> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)

"""^^xsd:string;
                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                  rdfs:label "parkinson's disease (patients transferring from immediate-release levodopa/dopa-decarboxylase inhibitor preparations)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-chewable-tablets> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-chewable-tablets#Sp898qWepEiAaXdE0QP4zQ>;
                                                                                           nicebnf:hasTitle """<title>Singulair<tm tmtype=\"reg\" /> chewable tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "singulair chewable tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-chewable-tablets#PHP83190> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-chewable-tablets#Sp898qWepEiAaXdE0QP4zQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (June 2007) that <i>Singulair</i><tm tmtype=\"reg\" /> chewable tablets are restricted for use as an alternative to low-dose inhaled corticosteroids for children 2–14 years with mild persistent asthma who have not recently had serious asthma attacks that required oral corticosteroid use and who are not capable of using inhaled corticosteroids; <i>Singulair</i><tm tmtype=\"reg\" /> chewable tablets should be initiated by a specialist in paediatric asthma.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-chewable-tablets#PHP83190>;
                                                                                                                  nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (June 2007) that Singulair chewable tablets are restricted for use as an alternative to low-dose inhaled corticosteroids for children 2–14 years with mild persistent asthma who have not recently had serious asthma attacks that required oral corticosteroid use and who are not capable of using inhaled corticosteroids; Singulair chewable tablets should be initiated by a specialist in paediatric asthma.

"""^^xsd:string;
                                                                                                                  a nicebnf:FundingDecision,
                                                                                                                    nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-granules> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-granules#klnSxlbMS0iqx0OYE5Doyw>;
                                                                                   nicebnf:hasTitle """<title>Singulair<tm tmtype=\"reg\" /> granules</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "singulair granules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-granules#PHP83226> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-granules#klnSxlbMS0iqx0OYE5Doyw> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (June 2007) that <i>Singulair</i><tm tmtype=\"reg\" /> granules are restricted for use as an alternative to low-dose inhaled corticosteroids for children 2–14 years with mild persistent asthma who have not recently had serious asthma attacks that required oral corticosteroid use and who are not capable of using inhaled corticosteroids; <i>Singulair</i><tm tmtype=\"reg\" /> granules should be initiated by a specialist in paediatric asthma.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/singulair-granules#PHP83226>;
                                                                                                          nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (June 2007) that Singulair granules are restricted for use as an alternative to low-dose inhaled corticosteroids for children 2–14 years with mild persistent asthma who have not recently had serious asthma attacks that required oral corticosteroid use and who are not capable of using inhaled corticosteroids; Singulair granules should be initiated by a specialist in paediatric asthma.

"""^^xsd:string;
                                                                                                          a nicebnf:FundingDecision,
                                                                                                            nicebnf:SmcDecisions.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#IpagQErBLk--0d-XHq02zA>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#YS0e5EhDE0qht-IsnTjA4Q>;
                                                                         nicebnf:hasTitle """<title>Skinoren<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "skinoren"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#IpagQErBLk--0d-XHq02zA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                   rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply twice daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#PHP82017>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#PHP82017> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#YS0e5EhDE0qht-IsnTjA4Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                   rdfs:label "apply once daily for 1 week, then apply twice daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply once daily for 1 week, then apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply once daily for 1 week, then apply twice daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply once daily for 1 week, then apply twice daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply once daily for 1 week, then apply twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply once daily for 1 week, then apply twice daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgarisInPatientsWithSensitiveSkin>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/skinoren#PHP82017>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Acne vulgaris

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgarisInPatientsWithSensitiveSkin> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris in patients with sensitive skin</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Acne vulgaris in patients with sensitive skin

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "acne vulgaris in patients with sensitive skin"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#7Z78ZKpDbkiQS95OUr5afQ>,
                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#v3OO9bZQIkGXC16OfccXhw>;
                                                                            nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#4aQe2C3KGkquEYYABfT2XQ>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#9B6kY_Yne0akfuYvXnzr6w>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#ZM1ds0xXyU2Sa_orYil07w>,
                                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#ZulDgb-dDkGb-AFdatEfgw>;
                                                                            nicebnf:hasTitle """<title>Slo-Phyllin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "slo-phyllin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#4aQe2C3KGkquEYYABfT2XQ> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">In adults</p>
  <p>Swallow whole with fluid or swallow enclosed granules with soft food (e.g. yoghurt).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#inAdults>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82902>;
                                                                                                   nicebnf:hasTextContent """In adults

Swallow whole with fluid or swallow enclosed granules with soft food (e.g. yoghurt).

"""^^xsd:string;
                                                                                                   a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#7Z78ZKpDbkiQS95OUr5afQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child25Years> ; 
                                                                                                                      rdfs:label "60–120 mg every 12 hours."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>60–120 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """60–120 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> ; 
                                                                                                                      rdfs:label "125–250 mg every 12 hours."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>125–250 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """125–250 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>],
                                                                                                                     [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                      rdfs:label "250–500 mg every 12 hours."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>250–500 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """250–500 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82890>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#9B6kY_Yne0akfuYvXnzr6w> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">In children</p>
  <p>
    <i>Slo-phyllin</i>
    <tm tmtype=\"reg\" /> capsules not licensed for use in children under 2 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#inChildren>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82900>;
                                                                                                   nicebnf:hasTextContent """In children

Slo-phyllin capsules not licensed for use in children under 2 years.

"""^^xsd:string;
                                                                                                   a nicebnf:UnlicencedUse.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82890> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82900> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82902> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82905> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#ZM1ds0xXyU2Sa_orYil07w> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">In children</p>
  <p>Contents of the capsule (enteric-coated granules) may be sprinkled on to a spoonful of soft food (e.g. yoghurt) and swallowed without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#inChildren>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82902>;
                                                                                                   nicebnf:hasTextContent """In children

Contents of the capsule (enteric-coated granules) may be sprinkled on to a spoonful of soft food (e.g. yoghurt) and swallowed without chewing.

"""^^xsd:string;
                                                                                                   a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#ZulDgb-dDkGb-AFdatEfgw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patient or carer should be given advice on how to administer theophylline modified release capsules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82905>;
                                                                                                   nicebnf:hasTextContent """Patient or carer should be given advice on how to administer theophylline modified release capsules.

"""^^xsd:string;
                                                                                                   a nicebnf:GeneralPatientAdvice,
                                                                                                     nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#v3OO9bZQIkGXC16OfccXhw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "250–500 mg every 12 hours."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>250–500 mg every 12 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """250–500 mg every 12 hours.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction>,
                                                                                                                         <http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slo-phyllin#PHP82890>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic asthma</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Chronic asthma

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "chronic asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reversible airways obstruction</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Reversible airways obstruction

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "reversible airways obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe acute asthma</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Severe acute asthma

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "severe acute asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child25Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                         rdfs:label "child 2–5 years"^^xsd:string;
                                                         rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child611Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by mouth using modified-release medicines"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#inAdults> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "in adults"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#inChildren> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                      rdfs:label "in children"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#ZeMsDFpBe0SpO9_wPDmAFA>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#ICBFkybqu0OIwJfnxqP7Wg>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#YBwefyK620ySXZRsHh508Q>;
                                                                       nicebnf:hasTitle """<title>Slozem<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "slozem"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#ICBFkybqu0OIwJfnxqP7Wg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP59980>;
                                                                                              nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                              a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP59980> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP59995> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP60014> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#YBwefyK620ySXZRsHh508Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP59995>;
                                                                                              nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                              a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#ZeMsDFpBe0SpO9_wPDmAFA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "initially 240 mg daily; increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 240 mg daily; increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 240 mg daily; increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                 rdfs:label "initially 120 mg daily; increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Initially 120 mg daily; increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Initially 120 mg daily; increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                    <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/slozem#PHP60014>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#DtZfBOw-VEKALrupLnIOkA>,
                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#x3_a64FJKkujXjTUcU8mTQ>;
                                                                           nicebnf:hasTitle """<title>Sodiofolin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "sodiofolin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#DtZfBOw-VEKALrupLnIOkA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrByIntravenousInfusion>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctToFluorouracilInColorectalCancer>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#PHP79721>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#PHP79721> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#x3_a64FJKkujXjTUcU8mTQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusionOrByIntravenousInjection>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asAnAntidoteToMethotrexate>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sodiofolin#PHP79721>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctToFluorouracilInColorectalCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct to fluorouracil in colorectal cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Adjunct to fluorouracil in colorectal cancer

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "adjunct to fluorouracil in colorectal cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#asAnAntidoteToMethotrexate> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">As an antidote to methotrexate</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """As an antidote to methotrexate

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "as an antidote to methotrexate"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusionOrByIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                         rdfs:label "by intravenous infusion, or by intravenous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjectionOrByIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                         rdfs:label "by intravenous injection, or by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/solaraze> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/solaraze#laptUkUG_EeEDwR8AZNbfA>;
                                                                         nicebnf:hasTitle """<title>Solaraze<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "solaraze"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solaraze#PHP82968> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solaraze#laptUkUG_EeEDwR8AZNbfA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply twice daily for 60–90 days, to be applied thinly; maximum 8 g per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply twice daily for 60–90 days, to be applied thinly; maximum 8 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply twice daily for 60–90 days, to be applied thinly; maximum 8 g per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solaraze#PHP82968>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Actinic keratosis</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Actinic keratosis

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "actinic keratosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#NfLMOlYRkk6JOhWmm8gDZg>,
                                                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#YZt_bcaQfkaLGWYyUQTydQ>;
                                                                                                                  nicebnf:hasTitle "<title>Solivito N powder for solution for infusion vials</title>"^^<rdf:XMLLiteral>;
                                                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                  rdfs:label "solivito n powder for solution for infusion vials"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#NfLMOlYRkk6JOhWmm8gDZg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dissolve in water for injections or glucose intravenous infusion for adding to glucose intravenous infusion or <i>Intralipid</i><tm tmtype=\"reg\" />; dissolve in <i>Vitlipid N</i><tm tmtype=\"reg\" /> or <i>Intralipid</i><tm tmtype=\"reg\" /> for adding to <i>Intralipid</i><tm tmtype=\"reg\" /> only.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#PHP107301>;
                                                                                                                                         nicebnf:hasTextContent """Dissolve in water for injections or glucose intravenous infusion for adding to glucose intravenous infusion or Intralipid; dissolve in Vitlipid N or Intralipid for adding to Intralipid only.

"""^^xsd:string;
                                                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#PHP107301> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#PHP107341> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#YZt_bcaQfkaLGWYyUQTydQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Solivito N</i>
    <tm tmtype=\"reg\" /> powder for reconstitution contains biotin 60 micrograms, cyanocobalamin 5 micrograms, folic acid 400 micrograms, glycine 300 mg, nicotinamide 40 mg, pyridoxine hydrochloride 4.9 mg, riboflavin sodium phosphate 4.9 mg, sodium ascorbate 113 mg, sodium pantothenate 16.5 mg, thiamine mononitrate 3.1 mg.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solivito-n-powder-for-solution-for-infusion-vials#PHP107341>;
                                                                                                                                         nicebnf:hasTextContent """Solivito N powder for reconstitution contains biotin 60 micrograms, cyanocobalamin 5 micrograms, folic acid 400 micrograms, glycine 300 mg, nicotinamide 40 mg, pyridoxine hydrochloride 4.9 mg, riboflavin sodium phosphate 4.9 mg, sodium ascorbate 113 mg, sodium pantothenate 16.5 mg, thiamine mononitrate 3.1 mg.

"""^^xsd:string;
                                                                                                                                         a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-caplets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-caplets#cy9irLJbwUariJz0CDGTMQ>;
                                                                                 nicebnf:hasTitle """<title>Solpadol<tm tmtype=\"reg\" /> caplets</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "solpadol caplets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-caplets#PHP80037> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-caplets#cy9irLJbwUariJz0CDGTMQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "2 tablets every 4–6 hours as required; maximum 8 tablets per day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>2 tablets every 4–6 hours as required; maximum 8 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """2 tablets every 4–6 hours as required; maximum 8 tablets per day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severePain>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-caplets#PHP80037>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#severePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Severe pain

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "severe pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-capsules#NDMDC4aMUkeM4c6Wrh0S1w>;
                                                                                  nicebnf:hasTitle """<title>Solpadol<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "solpadol capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-capsules#NDMDC4aMUkeM4c6Wrh0S1w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "2 capsules every 4–6 hours as required; maximum 8 capsules per day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>2 capsules every 4–6 hours as required; maximum 8 capsules per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """2 capsules every 4–6 hours as required; maximum 8 capsules per day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severePain>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-capsules#PHP80155>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-capsules#PHP80155> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#severePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Severe pain

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "severe pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-effervescent-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-effervescent-tablets#PNp5qMBux0WVIMM6mTD7tA>;
                                                                                              nicebnf:hasTitle """<title>Solpadol<tm tmtype=\"reg\" /> effervescent tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                              rdfs:label "solpadol effervescent tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-effervescent-tablets#PHP80236> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-effervescent-tablets#PNp5qMBux0WVIMM6mTD7tA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                        rdfs:label "2 tablets every 4–6 hours as required, tablets to be dispersed in water; maximum 8 tablets per day."^^xsd:string ; 
                                                                                                                                        nicebnf:hasDitaContent "<p>2 tablets every 4–6 hours as required, tablets to be dispersed in water; maximum 8 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                        nicebnf:hasTextContent """2 tablets every 4–6 hours as required, tablets to be dispersed in water; maximum 8 tablets per day.

"""^^xsd:string ; 
                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingEffervescentTablets>];
                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#severePain>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/solpadol-effervescent-tablets#PHP80236>;
                                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#severePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Severe pain

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "severe pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingEffervescentTablets> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                           rdfs:label "by mouth using effervescent tablets"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#B28F1MnWLEmT0TFD4LroRQ>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#BJXJAvinBkmMOgLllEGw2Q>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#YAA0PEoGTUWknxcWyFjVyA>;
                                                                                   nicebnf:hasTitle """<title>Somatuline Autogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "somatuline autogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#B28F1MnWLEmT0TFD4LroRQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "120 mg every 28 days."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>120 mg every 28 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """120 mg every 28 days.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepSubcutaneousInjection>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#unresectableLocallyAdvancedOrMetastaticGastroenteropancreaticNeuroendocrineTumoursOfMidgutPancreaticOrUnknownOriginWhereHindgutSitesOfOriginHaveBeenExcluded>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#PHP101421>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#BJXJAvinBkmMOgLllEGw2Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 60–120 mg every 28 days, adjusted according to response, dose to be given in the gluteal region."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 60–120 mg every 28 days, adjusted according to response, dose to be given in the gluteal region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 60–120 mg every 28 days, adjusted according to response, dose to be given in the gluteal region.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepSubcutaneousInjection>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#neuroendocrineParticularlyCarcinoidTumours>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#PHP101421>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#PHP101421> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#YAA0PEoGTUWknxcWyFjVyA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 60 mg every 28 days, adjusted according to response, (consult product literature), for patients treated previously with somatostatin analogue, consult product literature for initial dose, dose to be given in the gluteal region."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 60 mg every 28 days, adjusted according to response, (consult product literature), for patients treated previously with somatostatin analogue, consult product literature for initial dose, dose to be given in the gluteal region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 60 mg every 28 days, adjusted according to response, (consult product literature), for patients treated previously with somatostatin analogue, consult product literature for initial dose, dose to be given in the gluteal region.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepSubcutaneousInjection>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acromegalyIfSomatostatinAnalogueNotGivenPreviously>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-autogel#PHP101421>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acromegalyIfSomatostatinAnalogueNotGivenPreviously> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acromegaly (if somatostatin analogue not given previously)</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Acromegaly (if somatostatin analogue not given previously)

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "acromegaly (if somatostatin analogue not given previously)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neuroendocrineParticularlyCarcinoidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neuroendocrine (particularly carcinoid) tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Neuroendocrine (particularly carcinoid) tumours

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "neuroendocrine (particularly carcinoid) tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#unresectableLocallyAdvancedOrMetastaticGastroenteropancreaticNeuroendocrineTumoursOfMidgutPancreaticOrUnknownOriginWhereHindgutSitesOfOriginHaveBeenExcluded> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Unresectable locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                       nicebnf:hasTextContent """Unresectable locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded

"""^^xsd:string;
                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                       rdfs:label "unresectable locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byDeepSubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                       rdfs:label "by deep subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#Jo5yDxRwFU287JefAmmTiQ>,
                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#wd7okVGV70yOxhz2eXRofA>;
                                                                              nicebnf:hasTitle """<title>Somatuline LA<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "somatuline la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#Jo5yDxRwFU287JefAmmTiQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 30 mg every 14 days, increased to 30 mg every 7–10 days, adjusted according to response."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 30 mg every 14 days, increased to 30 mg every 7–10 days, adjusted according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 30 mg every 14 days, increased to 30 mg every 7–10 days, adjusted according to response.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acromegalyAndNeuroendocrineParticularlyCarcinoidTumours>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#PHP101763>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#PHP101763> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#wd7okVGV70yOxhz2eXRofA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 30 mg every 14 days, increased to 30 mg every 10 days, adjusted according to response."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 30 mg every 14 days, increased to 30 mg every 10 days, adjusted according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 30 mg every 14 days, increased to 30 mg every 10 days, adjusted according to response.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#thyroidTumours>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/somatuline-la#PHP101763>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acromegalyAndNeuroendocrineParticularlyCarcinoidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acromegaly and neuroendocrine (particularly carcinoid) tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasTextContent """Acromegaly and neuroendocrine (particularly carcinoid) tumours

"""^^xsd:string;
                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                  rdfs:label "acromegaly and neuroendocrine (particularly carcinoid) tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#thyroidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Thyroid tumours</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Thyroid tumours

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "thyroid tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#gCuXBLeVDEGKfPJ0pIjM9A>;
                                                                                   nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#gtwknRE6N0qWvp0glyE9lA>;
                                                                                   nicebnf:hasTitle """<title>Sorbisterit<tm tmtype=\"reg\" /> powder</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "sorbisterit powder"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#PHP107009> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#PHP107062> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#gCuXBLeVDEGKfPJ0pIjM9A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "20 g 1–3 times a day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>20 g 1–3 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """20 g 1–3 times a day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "40 g 1–3 times a day, retained for 6 hours followed by irrigation to remove resin from colon."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>40 g 1–3 times a day, retained for 6 hours followed by irrigation to remove resin from colon.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """40 g 1–3 times a day, retained for 6 hours followed by irrigation to remove resin from colon.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hyperkalaemiaAssociatedWithAnuriaOrSevereOliguriaAndInDialysisPatients>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#PHP107009>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#gtwknRE6N0qWvp0glyE9lA> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>By mouth</i>, administer in a small amount of water or soft drink—do not give with fruit juice or squash, which have a high potassium content.</p>
  <p>
    <i>By rectum</i>, mix each 40 g of resin with 150 mL of 5% glucose.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/sorbisterit-powder#PHP107062>;
                                                                                                          nicebnf:hasTextContent """By mouth, administer in a small amount of water or soft drink—do not give with fruit juice or squash, which have a high potassium content.

By rectum, mix each 40 g of resin with 150 mL of 5% glucose.

"""^^xsd:string;
                                                                                                          a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#hyperkalaemiaAssociatedWithAnuriaOrSevereOliguriaAndInDialysisPatients> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hyperkalaemia associated with anuria or severe oliguria, and in dialysis patients</p>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasTextContent """Hyperkalaemia associated with anuria or severe oliguria, and in dialysis patients

"""^^xsd:string;
                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                 rdfs:label "hyperkalaemia associated with anuria or severe oliguria, and in dialysis patients"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#QAA2dr959kecHMSOQ_2l2g>;
                                                                                 nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#al6jvWj2aEiMFnx67U89gA>;
                                                                                 nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#OSwPf5SHokiUcDw6Yaaung>;
                                                                                 nicebnf:hasTitle """<title>Spiriva Respimat<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "spiriva respimat"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#OSwPf5SHokiUcDw6Yaaung> nicebnf:hasDitaContent """<sectiondiv>
  <p>Use <i>Spiriva Respimat</i><tm tmtype=\"reg\" /> only when patient unable to use <i>Spiriva Handihaler</i><tm tmtype=\"reg\" /> device.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP99044>;
                                                                                                        nicebnf:hasTextContent """Use Spiriva Respimat only when patient unable to use Spiriva Handihaler device.

"""^^xsd:string;
                                                                                                        a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP98935> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP99031> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP99044> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#QAA2dr959kecHMSOQ_2l2g> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (November 2007) that <i>Spiriva Respimat</i><tm tmtype=\"reg\" /> is restricted for use in chronic obstructive pulmonary disease in patients who have poor manual dexterity and difficulty using the <i>Handihaler</i><tm tmtype=\"reg\" /> device.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP99031>;
                                                                                                        nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (November 2007) that Spiriva Respimat is restricted for use in chronic obstructive pulmonary disease in patients who have poor manual dexterity and difficulty using the Handihaler device.

"""^^xsd:string;
                                                                                                        a nicebnf:FundingDecision,
                                                                                                          nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#al6jvWj2aEiMFnx67U89gA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "5 micrograms once daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>5 micrograms once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """5 micrograms once daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctToInhaledCorticosteroidsAndLongActingBeta2AgonistsForTheMaintenanceTreatmentOfPatientsWithAsthmaWhoHaveSufferedOneOrMoreSevereExacerbationsInTheLastYear>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#maintenanceTreatmentOfChronicObstructivePulmonaryDisease>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/spiriva-respimat#PHP98935>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctToInhaledCorticosteroidsAndLongActingBeta2AgonistsForTheMaintenanceTreatmentOfPatientsWithAsthmaWhoHaveSufferedOneOrMoreSevereExacerbationsInTheLastYear> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunct to inhaled corticosteroids and long-acting beta<sub>2</sub> agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                          nicebnf:hasTextContent """Adjunct to inhaled corticosteroids and long-acting beta2 agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year

"""^^xsd:string;
                                                                                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                          rdfs:label "adjunct to inhaled corticosteroids and long-acting beta2 agonists for the maintenance treatment of patients with asthma who have suffered one or more severe exacerbations in the last year"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maintenanceTreatmentOfChronicObstructivePulmonaryDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maintenance treatment of chronic obstructive pulmonary disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Maintenance treatment of chronic obstructive pulmonary disease

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "maintenance treatment of chronic obstructive pulmonary disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfAerosol> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by inhalation of aerosol"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-10025200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-10025200#Kwmu4ttaAku1TM0RCP4A5A>;
                                                                                 nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 100/25/200</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "stalevo 100/25/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-10025200#Kwmu4ttaAku1TM0RCP4A5A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "1 tablet for each dose; maximum 10 tablets per day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 10 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """1 tablet for each dose; maximum 10 tablets per day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-10025200#PHP95112>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-10025200#PHP95112> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1253125200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1253125200#wQkoMsweX0SGWEzjrbNiHg>;
                                                                                   nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 125/31.25/200</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "stalevo 125/31.25/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1253125200#PHP95384> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1253125200#wQkoMsweX0SGWEzjrbNiHg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet for each dose; maximum 10 tablets per day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 10 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet for each dose; maximum 10 tablets per day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1253125200#PHP95384>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-150375200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-150375200#TCbs6sjz0UOnp3sy-L9r9w>;
                                                                                  nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 150/37.5/200</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "stalevo 150/37.5/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-150375200#PHP95402> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-150375200#TCbs6sjz0UOnp3sy-L9r9w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 tablet for each dose; maximum 10 tablets per day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 10 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 tablet for each dose; maximum 10 tablets per day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-150375200#PHP95402>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1754375200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1754375200#ztwEdBlRtUqSjzcqxSgIlQ>;
                                                                                   nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 175/43.75/200</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "stalevo 175/43.75/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1754375200#PHP95241> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1754375200#ztwEdBlRtUqSjzcqxSgIlQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "1 tablet for each dose; maximum 8 tablets per day."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 8 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """1 tablet for each dose; maximum 8 tablets per day.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-1754375200#PHP95241>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-20050200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-20050200#elcuUErUQ0GFekgDYm-WEQ>;
                                                                                 nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 200/50/200</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "stalevo 200/50/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-20050200#PHP95116> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-20050200#elcuUErUQ0GFekgDYm-WEQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "1 tablet for each dose; maximum 7 tablets per day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 7 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """1 tablet for each dose; maximum 7 tablets per day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-20050200#PHP95116>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-50125200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-50125200#xTuU4nfMYEetzsu7mpbcUQ>;
                                                                                 nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 50/12.5/200</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "stalevo 50/12.5/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-50125200#PHP95238> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-50125200#xTuU4nfMYEetzsu7mpbcUQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "1 tablet for each dose; maximum 10 tablets per day."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 10 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """1 tablet for each dose; maximum 10 tablets per day.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-50125200#PHP95238>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-751875200> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-751875200#9IjR--yxwk-VKrJYfTjlQw>;
                                                                                  nicebnf:hasTitle """<title>Stalevo<tm tmtype=\"reg\" /> 75/18.75/200</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "stalevo 75/18.75/200"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-751875200#9IjR--yxwk-VKrJYfTjlQw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "1 tablet for each dose; maximum 10 tablets per day."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>1 tablet for each dose; maximum 10 tablets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """1 tablet for each dose; maximum 10 tablets per day.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-751875200#PHP95318>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stalevo-751875200#PHP95318> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#parkinsonSDiseaseAndEndOfDoseMotorFluctuationsNotAdequatelyControlledWithLevodopaAndDopaDecarboxylaseInhibitorTreatment> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                  nicebnf:hasTextContent """Parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment

"""^^xsd:string;
                                                                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                  rdfs:label "parkinson's disease and end-of-dose motor fluctuations not adequately controlled with levodopa and dopa-decarboxylase inhibitor treatment"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#xHJM3kyHU0Gj7JnAgOli2Q>;
                                                                          nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#nl88a3sR8ECRt1X6F-yDag>;
                                                                          nicebnf:hasTitle """<title>Stiemycin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "stiemycin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#PHP82204> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#PHP82209> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#nl88a3sR8ECRt1X6F-yDag> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                    rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply twice daily, to be applied thinly."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply twice daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply twice daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#PHP82209>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#xHJM3kyHU0Gj7JnAgOli2Q> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#someManufacturersAdvisePreparationsContainingAlcoholAreNotSuitableForUseWithBenzoylPeroxide>;
                                                                                                 nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Some manufacturers advise preparations containing alcohol are not suitable for use with benzoyl peroxide</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/stiemycin#PHP82204>;
                                                                                                 nicebnf:hasTextContent """Some manufacturers advise preparations containing alcohol are not suitable for use with benzoyl peroxide

"""^^xsd:string;
                                                                                                 a nicebnf:CautionsGroup,
                                                                                                   nicebnf:GeneralCautions.
<http://ld.nice.org.uk/ns/bnf/Caution#someManufacturersAdvisePreparationsContainingAlcoholAreNotSuitableForUseWithBenzoylPeroxide> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Some manufacturers advise preparations containing alcohol are not suitable for use with benzoyl peroxide</ph>"""^^<rdf:XMLLiteral>;
                                                                                                                                   nicebnf:hasTextContent "Some manufacturers advise preparations containing alcohol are not suitable for use with benzoyl peroxide"^^xsd:string;
                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                                                                   rdfs:label "some manufacturers advise preparations containing alcohol are not suitable for use with benzoyl peroxide"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Acne vulgaris

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#baCDj8uQmke0hz6xC0pGrg>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#GASZp_Gi3Eed4T-uOu2_mw>;
                                                                       nicebnf:hasTitle """<title>Subgam<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "subgam"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#GASZp_Gi3Eed4T-uOu2_mw> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Subgam</i>
    <tm tmtype=\"reg\" /> is not licensed for prophylactic use, but due to difficulty in obtaining suitable immunoglobulin products, Public Health England recommends intramuscular use for prophylaxis against Hepatitis A or rubella.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#PHP82337>;
                                                                                              nicebnf:hasTextContent """Subgam is not licensed for prophylactic use, but due to difficulty in obtaining suitable immunoglobulin products, Public Health England recommends intramuscular use for prophylaxis against Hepatitis A or rubella.

"""^^xsd:string;
                                                                                              a nicebnf:UnlicencedUse.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#PHP82330> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#PHP82337> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#baCDj8uQmke0hz6xC0pGrg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "750 mg."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>750 mg.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """750 mg.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hepatitisAProphylaxisInOutbreaks>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/subgam#PHP82330>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#hepatitisAProphylaxisInOutbreaks> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hepatitis A prophylaxis in outbreaks</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Hepatitis A prophylaxis in outbreaks

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "hepatitis a prophylaxis in outbreaks"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#Zd4FJqLYEEiLcZSqXNHg8A>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#f1fPPMp6h0us-AvjoWosXg>;
                                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#xL153Q9dCE2dNRxp68vv-g>;
                                                                                          nicebnf:hasTitle """<title>Symbicort 100/6 Turbohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "symbicort 100/6 turbohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#PHP95239> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#PHP95264> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#Zd4FJqLYEEiLcZSqXNHg8A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> ; 
                                                                                                                                    rdfs:label "initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#PHP95239>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#f1fPPMp6h0us-AvjoWosXg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "maintenance 2 puffs daily in 1–2 divided doses; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Maintenance 2 puffs daily in 1–2 divided doses; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Maintenance 2 puffs daily in 1–2 divided doses; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#PHP95239>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#xL153Q9dCE2dNRxp68vv-g> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in children</p>
  <p>
    <i>Symbicort</i>
    <tm tmtype=\"reg\" /> not licensed for use in children for asthma maintenance and reliever therapy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#whenUsedByInhalationInChildren>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-1006-turbohaler#PHP95264>;
                                                                                                                 nicebnf:hasTextContent """When used by inhalation in children

Symbicort not licensed for use in children for asthma maintenance and reliever therapy.

"""^^xsd:string;
                                                                                                                 a nicebnf:UnlicencedUse.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma, maintenance and reliever therapy</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Asthma, maintenance and reliever therapy

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "asthma, maintenance and reliever therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma, maintenance therapy</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Asthma, maintenance therapy

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "asthma, maintenance therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 6–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Route#inhalation> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                                rdfs:label "inhalation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#whenUsedByInhalationInChildren> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#inhalation>;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                          rdfs:label "when used by inhalation in children"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#1cVmvNn_yUS0risaEHptMw>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#Sppcnk7LmUqkf6_-zg5uQA>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#t6HlWKVdmkiU4INqYFKZeQ>;
                                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#6SOLxz2hi0qXUxdYFv2F6g>;
                                                                                          nicebnf:hasTitle """<title>Symbicort 200/6 Turbohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                                          rdfs:label "symbicort 200/6 turbohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#1cVmvNn_yUS0risaEHptMw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                    rdfs:label "initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 1–2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Initially 1–2 puffs twice daily, increased if necessary up to 4 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95321>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#6SOLxz2hi0qXUxdYFv2F6g> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in children</p>
  <p>
    <i>Symbicort</i>
    <tm tmtype=\"reg\" /> not licensed for use in children for asthma maintenance and reliever therapy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#whenUsedByInhalationInChildren>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95336>;
                                                                                                                 nicebnf:hasTextContent """When used by inhalation in children

Symbicort not licensed for use in children for asthma maintenance and reliever therapy.

"""^^xsd:string;
                                                                                                                 a nicebnf:UnlicencedUse.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95321> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95336> a nicebnf:UnlicencedUsageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#Sppcnk7LmUqkf6_-zg5uQA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "2 puffs twice daily."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>2 puffs twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """2 puffs twice daily.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95321>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#t6HlWKVdmkiU4INqYFKZeQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                    rdfs:label "maintenance 2 puffs daily in 1–2 divided doses, increased if necessary to 2 puffs twice daily; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered."^^xsd:string ; 
                                                                                                                                    nicebnf:hasDitaContent "<p>Maintenance 2 puffs daily in 1–2 divided doses, increased if necessary to 2 puffs twice daily; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                    nicebnf:hasTextContent """Maintenance 2 puffs daily in 1–2 divided doses, increased if necessary to 2 puffs twice daily; 1 puff as required for relief of symptoms, increased if necessary up to 6 puffs as required, max. 8 puffs per day; up to 12 puffs daily can be used for a limited time but medical assessment should be considered.

"""^^xsd:string ; 
                                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy>;
                                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-2006-turbohaler#PHP95321>;
                                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceAndRelieverTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma, maintenance and reliever therapy</p>"""^^<rdf:XMLLiteral>;
                                                                              nicebnf:hasTextContent """Asthma, maintenance and reliever therapy

"""^^xsd:string;
                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                              rdfs:label "asthma, maintenance and reliever therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma maintenance therapy</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Asthma maintenance therapy

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "asthma maintenance therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt;50% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second <50% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second <50% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Route#inhalation> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                                rdfs:label "inhalation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#whenUsedByInhalationInChildren> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#inhalation>;
                                                                          a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                          rdfs:label "when used by inhalation in children"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#cohAyGBtpU6QXa9ilJD0kA>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#nux5JO7XR0WxhTi-2HgnMg>;
                                                                                           nicebnf:hasTitle """<title>Symbicort 400/12 Turbohaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "symbicort 400/12 turbohaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#PHP95113> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#cohAyGBtpU6QXa9ilJD0kA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "1 puff twice daily."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>1 puff twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """1 puff twice daily.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#PHP95113>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#nux5JO7XR0WxhTi-2HgnMg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                     rdfs:label "initially 1 puff twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 1 puff twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 1 puff twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>],
                                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "initially 1 puff twice daily, increased if necessary up to 2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 1 puff twice daily, increased if necessary up to 2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 1 puff twice daily, increased if necessary up to 2 puffs twice daily; reduced to 1 puff daily, dose reduced only if control is maintained.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/symbicort-40012-turbohaler#PHP95113>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#asthmaMaintenanceTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Asthma, maintenance therapy</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Asthma, maintenance therapy

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "asthma, maintenance therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicObstructivePulmonaryDiseaseWithForcedExpiratoryVolumeIn1Second50OfPredicted> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic obstructive pulmonary disease with forced expiratory volume in 1 second &lt;50% of predicted</p>"""^^<rdf:XMLLiteral>;
                                                                                                                             nicebnf:hasTextContent """Chronic obstructive pulmonary disease with forced expiratory volume in 1 second <50% of predicted

"""^^xsd:string;
                                                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                             rdfs:label "chronic obstructive pulmonary disease with forced expiratory volume in 1 second <50% of predicted"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#M7EkJrYoXk28w-b8WTZVxw>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#dsksVjGi2UOKWl7XLcFm6Q>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#eMgykNzPR06L8KF5kVsxUw>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#w_Ppluvc30aKOklA8-TPzQ>;
                                                                             nicebnf:hasTitle """<title>Syner-KINASE<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "syner-kinase"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#M7EkJrYoXk28w-b8WTZVxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by (by intravenous infusion) 4400 micrograms/kg/hour for 12 hours, alternatively (by intra-arterial injection) initially 15 000 units/kg, to be injected into pulmonary artery, subsequent doses adjusted according to response; maximum 3 doses per day."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by (by intravenous infusion) 4400 micrograms/kg/hour for 12 hours, alternatively (by intra-arterial injection) initially 15 000 units/kg, to be injected into pulmonary artery, subsequent doses adjusted according to response; maximum 3 doses per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by (by intravenous infusion) 4400 micrograms/kg/hour for 12 hours, alternatively (by intra-arterial injection) initially 15 000 units/kg, to be injected into pulmonary artery, subsequent doses adjusted according to response; maximum 3 doses per day.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByIntravenousInfusion>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pulmonaryEmbolismThromboembolicOcclusiveVascularDisease>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#PHP63881>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#PHP63881> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#dsksVjGi2UOKWl7XLcFm6Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by 4400 units/kg/hour for 12–24 hours."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by 4400 units/kg/hour for 12–24 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 4400 units/kg, to be given over 10 minutes, dose to be made up in 15 ml sodium chloride 0.9%, followed by 4400 units/kg/hour for 12–24 hours.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#deepVeinThrombosisThromboembolicOcclusiveVascularDisease>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#PHP63881>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#eMgykNzPR06L8KF5kVsxUw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArterialInfusion>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#occlusivePeripheralArterialDisease>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#PHP63881>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#w_Ppluvc30aKOklA8-TPzQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "5000–25 000 units, to be injected directly into catheter or cannula, dose dissolved in suitable volume of sodium chloride 0.9% to fill the catheter or cannula lumen; leave for 20–60 minutes then aspirate the lysate; repeat if necessary."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>5000–25 000 units, to be injected directly into catheter or cannula, dose dissolved in suitable volume of sodium chloride 0.9% to fill the catheter or cannula lumen; leave for 20–60 minutes then aspirate the lysate; repeat if necessary.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """5000–25 000 units, to be injected directly into catheter or cannula, dose dissolved in suitable volume of sodium chloride 0.9% to fill the catheter or cannula lumen; leave for 20–60 minutes then aspirate the lysate; repeat if necessary.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArterialInjectionOrByIntravenousInjection>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#occludedCathetersAndCannulas>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/syner-kinase#PHP63881>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#deepVeinThrombosisThromboembolicOcclusiveVascularDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Deep-vein thrombosis (thromboembolic occlusive vascular disease)</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Deep-vein thrombosis (thromboembolic occlusive vascular disease)

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "deep-vein thrombosis (thromboembolic occlusive vascular disease)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#occludedCathetersAndCannulas> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Occluded catheters and cannulas</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Occluded catheters and cannulas

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "occluded catheters and cannulas"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#occlusivePeripheralArterialDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Occlusive peripheral arterial disease</p>"""^^<rdf:XMLLiteral>;
                                                                             nicebnf:hasTextContent """Occlusive peripheral arterial disease

"""^^xsd:string;
                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                             rdfs:label "occlusive peripheral arterial disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pulmonaryEmbolismThromboembolicOcclusiveVascularDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pulmonary embolism (thromboembolic occlusive vascular disease)</p>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasTextContent """Pulmonary embolism (thromboembolic occlusive vascular disease)

"""^^xsd:string;
                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                  rdfs:label "pulmonary embolism (thromboembolic occlusive vascular disease)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArterialInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by intra-arterial infusion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntraArterialInjectionOrByIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                            rdfs:label "by intra-arterial injection, or by intravenous injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#initiallyByIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                          rdfs:label "initially by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/t-safe-380a-ql> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/t-safe-380a-ql#Q2_DN7lroEmyqSp-2Rk0aQ>;
                                                                               nicebnf:hasTitle """<title>T-Safe<tm tmtype=\"reg\" /> 380A QL</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "t-safe 380a ql"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/t-safe-380a-ql#PHP105541> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/t-safe-380a-ql#Q2_DN7lroEmyqSp-2Rk0aQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 10 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/t-safe-380a-ql#PHP105541>;
                                                                                                      nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 10 years.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#-_-CHWqN3kWmH28MGZJ-PQ>,
                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#beR5U8KzCkO9-Y2WmUWumg>,
                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#bnZnJdLca0-9UHz0rZor3w>,
                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#gVp_G--tQ0qOmgl0TxO_Dw>,
                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#mtmFTmNwd0aAOFL33gb5zA>;
                                                                      nicebnf:hasTitle """<title>Tacni<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "tacni"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#-_-CHWqN3kWmH28MGZJ-PQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#beR5U8KzCkO9-Y2WmUWumg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#bnZnJdLca0-9UHz0rZor3w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#gVp_G--tQ0qOmgl0TxO_Dw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#mtmFTmNwd0aAOFL33gb5zA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tacni#PHP80081>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#OJr2UrxeNEqXkI38LdTtVQ>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#d8qtwXrSBEKDiVerc7lXEg>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#iizqdOZJUkWJh6u3e9Js_Q>,
                                                                                                                         <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#kEhCwdNm80SZD-8VX3LJ4A>;
                                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#a-RkDOPqTEiOuiDix9IwOQ>;
                                                                                           nicebnf:hasTitle """<title>Tegretol<tm tmtype=\"reg\" /> prolonged release</title>"""^^<rdf:XMLLiteral>;
                                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                                           rdfs:label "tegretol prolonged release"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#OJr2UrxeNEqXkI38LdTtVQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "initially 100–400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 2 divided doses; increased if necessary up to 1.6–2 g daily in 2 divided doses."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 100–400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 2 divided doses; increased if necessary up to 1.6–2 g daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 100–400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks, usual dose 0.8–1.2 g daily in 2 divided doses; increased if necessary up to 1.6–2 g daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                                     rdfs:label "reduce initial dose."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Reduce initial dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Reduce initial dose.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#focalAndSecondaryGeneralisedTonicClonicSeizures>,
                                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#primaryGeneralisedTonicClonicSeizures>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81516>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81516> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81524> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#a-RkDOPqTEiOuiDix9IwOQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Tegretol</i>
    <tm tmtype=\"reg\" />
    <i>Prolonged Release</i> tablets can be halved but should not be chewed.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81524>;
                                                                                                                  nicebnf:hasTextContent """TegretolProlonged Release tablets can be halved but should not be chewed.

"""^^xsd:string;
                                                                                                                  a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#d8qtwXrSBEKDiVerc7lXEg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "initially 100–200 mg daily in 2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 2 divided doses; increased if necessary up to 1.6 g daily in 2 divided doses, dose should be increased slowly."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 100–200 mg daily in 2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 2 divided doses; increased if necessary up to 1.6 g daily in 2 divided doses, dose should be increased slowly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 100–200 mg daily in 2 divided doses, some patients may require higher initial dose, increased in steps of 100–200 mg every 2 weeks, adjusted according to response, usual dose 600–800 mg daily in 2 divided doses; increased if necessary up to 1.6 g daily in 2 divided doses, dose should be increased slowly.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#trigeminalNeuralgia>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81516>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#iizqdOZJUkWJh6u3e9Js_Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> ; 
                                                                                                                                     rdfs:label "initially 5 mg/kg daily in 2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 2 divided doses, increased if necessary up to 20 mg/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 5 mg/kg daily in 2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 2 divided doses, increased if necessary up to 20 mg/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 5 mg/kg daily in 2 divided doses, then increased in steps of 2.5–5 mg/kg every 3–7 days as required; maintenance 10–15 mg/kg daily in 2 divided doses, increased if necessary up to 20 mg/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                     rdfs:label "initially 100–400 mg daily in 2 divided doses, then increased to 400–1200 mg daily in 2 divided doses, increased if necessary up to 1.8 g daily in 2 divided doses, dose should be increased slowly."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 100–400 mg daily in 2 divided doses, then increased to 400–1200 mg daily in 2 divided doses, increased if necessary up to 1.8 g daily in 2 divided doses, dose should be increased slowly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 100–400 mg daily in 2 divided doses, then increased to 400–1200 mg daily in 2 divided doses, increased if necessary up to 1.8 g daily in 2 divided doses, dose should be increased slowly.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#focalAndGeneralisedTonicClonicSeizures>,
                                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81516>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#kEhCwdNm80SZD-8VX3LJ4A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                     rdfs:label "initially 400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 2 divided doses; maximum 1.6 g per day."^^xsd:string ; 
                                                                                                                                     nicebnf:hasDitaContent "<p>Initially 400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 2 divided doses; maximum 1.6 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                     nicebnf:hasTextContent """Initially 400 mg daily in 2 divided doses, increased in steps of 100–200 mg every 2 weeks until symptoms controlled; usual dose 400–600 mg daily in 2 divided doses; maximum 1.6 g per day.

"""^^xsd:string ; 
                                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorderUnresponsiveToLithium>;
                                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tegretol-prolonged-release#PHP81516>;
                                                                                                                  a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#focalAndGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Focal and generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Focal and generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "focal and generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#focalAndSecondaryGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Focal and secondary generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                          nicebnf:hasTextContent """Focal and secondary generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                          rdfs:label "focal and secondary generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#primaryGeneralisedTonicClonicSeizures> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Primary generalised tonic-clonic seizures</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Primary generalised tonic-clonic seizures

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "primary generalised tonic-clonic seizures"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorder> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Prophylaxis of bipolar disorder

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "prophylaxis of bipolar disorder"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfBipolarDisorderUnresponsiveToLithium> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of bipolar disorder unresponsive to lithium</p>"""^^<rdf:XMLLiteral>;
                                                                                            nicebnf:hasTextContent """Prophylaxis of bipolar disorder unresponsive to lithium

"""^^xsd:string;
                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                            rdfs:label "prophylaxis of bipolar disorder unresponsive to lithium"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#trigeminalNeuralgia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Trigeminal neuralgia</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Trigeminal neuralgia

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "trigeminal neuralgia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child511Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 5–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tensipine-mr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tensipine-mr#E-VEUzfQ9UiKIk1J0qMlrA>;
                                                                             nicebnf:hasTitle """<title>Tensipine<tm tmtype=\"reg\" /> MR</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "tensipine mr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tensipine-mr#E-VEUzfQ9UiKIk1J0qMlrA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "initially 10 mg twice daily, adjusted according to response to 40 mg twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>Initially 10 mg twice daily, adjusted according to response to 40 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """Initially 10 mg twice daily, adjusted according to response to 40 mg twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tensipine-mr#PHP60852>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tensipine-mr#PHP60852> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#anginaProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Angina prophylaxis

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "angina prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#amJ1k5kPjEe3UT2nIJQfkw>;
                                                                       nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#18349oeoa0elV3wv1lwmEg>,
                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#Z13zWT1d7U2lFyvH71u-MQ>;
                                                                       nicebnf:hasTitle """<title>Testim<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "testim"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#18349oeoa0elV3wv1lwmEg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Squeeze entire content of tube on to one palm and apply as a thin layer on clean, dry, healthy skin of shoulder or upper arm, preferably in the morning after washing or bathing (if 2 tubes required use 1 per shoulder or upper arm); rub in and allow to dry before putting on clothing to cover site; wash hands with soap after application; avoid washing application site for at least 6 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#PHP101746>;
                                                                                              nicebnf:hasTextContent """Squeeze entire content of tube on to one palm and apply as a thin layer on clean, dry, healthy skin of shoulder or upper arm, preferably in the morning after washing or bathing (if 2 tubes required use 1 per shoulder or upper arm); rub in and allow to dry before putting on clothing to cover site; wash hands with soap after application; avoid washing application site for at least 6 hours.

"""^^xsd:string;
                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#PHP101728> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#PHP101746> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#Z13zWT1d7U2lFyvH71u-MQ> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>One tube of 5 g contains 50 mg testosterone.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#PHP101728>;
                                                                                              nicebnf:hasTextContent """Dose equivalence and conversionOne tube of 5 g contains 50 mg testosterone.

"""^^xsd:string;
                                                                                              a nicebnf:DoseEquivalence,
                                                                                                nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#amJ1k5kPjEe3UT2nIJQfkw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply 50 mg once daily, subsequent application adjusted according to response; maximum 100 mg per day."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply 50 mg once daily, subsequent application adjusted according to response; maximum 100 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply 50 mg once daily, subsequent application adjusted according to response; maximum 100 mg per day.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToTestosteroneDeficiencyInMen>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testim#PHP101728>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToTestosteroneDeficiencyInMen> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypogonadism due to testosterone deficiency in men</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Hypogonadism due to testosterone deficiency in men

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "hypogonadism due to testosterone deficiency in men"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#-M6Zv9kllEmdYIL96vJBBw>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#YP-lj3Wb0kimPbb-EJJqXA>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#yZsXOKK8Z0alJLOSTJuSaQ>;
                                                                         nicebnf:hasTitle """<title>Testogel<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "testogel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#-M6Zv9kllEmdYIL96vJBBw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply 50 mg once daily; increased in steps of 25 mg, adjusted according to response; maximum 100 mg per day."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply 50 mg once daily; increased in steps of 25 mg, adjusted according to response; maximum 100 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply 50 mg once daily; increased in steps of 25 mg, adjusted according to response; maximum 100 mg per day.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToAndrogenDeficiencyInMen>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#PHP101724>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#PHP101724> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#PHP101741> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#YP-lj3Wb0kimPbb-EJJqXA> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>One sachet of 5 g contains 50 mg of testosterone.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#PHP101724>;
                                                                                                nicebnf:hasTextContent """Dose equivalence and conversionOne sachet of 5 g contains 50 mg of testosterone.

"""^^xsd:string;
                                                                                                a nicebnf:DoseEquivalence,
                                                                                                  nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#yZsXOKK8Z0alJLOSTJuSaQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Apply thin layer of gel on clean, dry, healthy skin such as shoulders, arms or abdomen, immediately after sachet is opened. Not to be applied on genital area as high alcohol content may cause local irritation. Allow to dry for 3–5 minutes before dressing. Wash hands with soap and water after applying gel, avoid shower or bath for at least 6 hours.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/testogel#PHP101741>;
                                                                                                nicebnf:hasTextContent """Apply thin layer of gel on clean, dry, healthy skin such as shoulders, arms or abdomen, immediately after sachet is opened. Not to be applied on genital area as high alcohol content may cause local irritation. Allow to dry for 3–5 minutes before dressing. Wash hands with soap and water after applying gel, avoid shower or bath for at least 6 hours.

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToAndrogenDeficiencyInMen> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypogonadism due to androgen deficiency in men</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Hypogonadism due to androgen deficiency in men

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "hypogonadism due to androgen deficiency in men"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#kXJjgy1fXkat2ofMY-EfXQ>;
                                                                           nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#4yk_JVTwY0acJQbHTRCjpQ>,
                                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#sqDW3A1Hik-RzzmRJ-xBhw>;
                                                                           nicebnf:hasTitle """<title>Tildiem<tm tmtype=\"reg\" /> LA</title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "tildiem la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#4yk_JVTwY0acJQbHTRCjpQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 200 mg daily; increased if necessary to 300 mg daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59480>;
                                                                                                  nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 200 mg daily; increased if necessary to 300 mg daily.

"""^^xsd:string;
                                                                                                  a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59480> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59485> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59489> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#kXJjgy1fXkat2ofMY-EfXQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "initially 200 mg daily, to be taken with or before food, increased if necessary to 300–400 mg daily; maximum 500 mg per day."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 200 mg daily, to be taken with or before food, increased if necessary to 300–400 mg daily; maximum 500 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 200 mg daily, to be taken with or before food, increased if necessary to 300–400 mg daily; maximum 500 mg per day.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                    [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                     rdfs:label "initially 200 mg daily, increased if necessary to 300 mg daily."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>Initially 200 mg daily, increased if necessary to 300 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """Initially 200 mg daily, increased if necessary to 300 mg daily.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59489>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#sqDW3A1Hik-RzzmRJ-xBhw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 200 mg daily; increased if necessary to 300 mg daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-la#PHP59485>;
                                                                                                  nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 200 mg daily; increased if necessary to 300 mg daily.

"""^^xsd:string;
                                                                                                  a nicebnf:DoseAdjustment.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#3jaSoVwRFUm2Oy5t4pBP2A>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#y_0VjH7XQUqTQ2nziV0p_g>;
                                                                               nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#9Xi-nNjRz0aAlks02ttR0g>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#bbIUv_iRUk-J5VEzdt-9ug>,
                                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#lcHpKaDpqkqfvT_THYFS8A>;
                                                                               nicebnf:hasTitle """<title>Tildiem Retard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "tildiem retard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#3jaSoVwRFUm2Oy5t4pBP2A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 90–120 mg twice daily; increased if necessary to 480 mg daily in divided doses."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 90–120 mg twice daily; increased if necessary to 480 mg daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 90–120 mg twice daily; increased if necessary to 480 mg daily in divided doses.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                         rdfs:label "up to 120 mg twice daily, dose form not appropriate for initial dose titration."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Up to 120 mg twice daily, dose form not appropriate for initial dose titration.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Up to 120 mg twice daily, dose form not appropriate for initial dose titration.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60112>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#9Xi-nNjRz0aAlks02ttR0g> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for mild to moderate hypertension—initially 120 mg once a day; increased if necessary to 120 mg twice a day.</p>
  <p>For treatment of angina, dose form not appropriate for initial titration; up to 120 mg twice a day may be required.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60104>;
                                                                                                      nicebnf:hasTextContent """Dose for mild to moderate hypertension—initially 120 mg once a day; increased if necessary to 120 mg twice a day.

For treatment of angina, dose form not appropriate for initial titration; up to 120 mg twice a day may be required.

"""^^xsd:string;
                                                                                                      a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60002> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60104> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60109> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60112> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#bbIUv_iRUk-J5VEzdt-9ug> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for mild to moderate hypertension—initially 120 mg once a day; increased if necessary to 120 mg twice a day.</p>
  <p>For treatment of angina, dose form not appropriate for initial titration; up to 120 mg twice a day may be required.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60109>;
                                                                                                      nicebnf:hasTextContent """Dose for mild to moderate hypertension—initially 120 mg once a day; increased if necessary to 120 mg twice a day.

For treatment of angina, dose form not appropriate for initial titration; up to 120 mg twice a day may be required.

"""^^xsd:string;
                                                                                                      a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#lcHpKaDpqkqfvT_THYFS8A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablet membrane may pass through gastro-intestinal tract unchanged, but being porous has no effect on efficacy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60002>;
                                                                                                      nicebnf:hasTextContent """Tablet membrane may pass through gastro-intestinal tract unchanged, but being porous has no effect on efficacy.

"""^^xsd:string;
                                                                                                      a nicebnf:GeneralPatientAdvice,
                                                                                                        nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#y_0VjH7XQUqTQ2nziV0p_g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "initially 90–120 mg twice daily; increased if necessary to 360 mg daily in divided doses."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 90–120 mg twice daily; increased if necessary to 360 mg daily in divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 90–120 mg twice daily; increased if necessary to 360 mg daily in divided doses.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                        [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                         rdfs:label "initially 120 mg daily; increased if necessary to 120 mg twice daily."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Initially 120 mg daily; increased if necessary to 120 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Initially 120 mg daily; increased if necessary to 120 mg twice daily.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tildiem-retard#PHP60112>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/timoptol-la> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/timoptol-la#0_zys_ycoU6yqAgNJCb7kg>;
                                                                            nicebnf:hasTitle """<title>Timoptol-LA<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "timoptol-la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/timoptol-la#0_zys_ycoU6yqAgNJCb7kg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "apply once daily."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Apply once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Apply once daily.

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheEye>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reductionOfIntraOcularPressureInPrimaryOpenAngleGlaucoma>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/timoptol-la#PHP78667>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/timoptol-la#PHP78667> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionOfIntraOcularPressureInPrimaryOpenAngleGlaucoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction of intra-ocular pressure in primary open-angle glaucoma</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Reduction of intra-ocular pressure in primary open-angle glaucoma

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "reduction of intra-ocular pressure in primary open-angle glaucoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheEye> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "to the eye"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#TTl-6pCthku6eA9iZ_cY3w>;
                                                                       nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#Va1o7k6DrkyM_QUUt6ypeg>;
                                                                       nicebnf:hasTitle """<title>Tiopex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "tiopex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#PHP79012> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#PHP79113> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#TTl-6pCthku6eA9iZ_cY3w> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (February 2014) that timolol gel eye drops (<i>Tiopex</i><tm tmtype=\"reg\" />) are accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure in patients with ocular hypertension or chronic open angle glaucoma who have proven sensitivity to preservatives.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#PHP79113>;
                                                                                              nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (February 2014) that timolol gel eye drops (Tiopex) are accepted for restricted use within NHS Scotland for the reduction of elevated intraocular pressure in patients with ocular hypertension or chronic open angle glaucoma who have proven sensitivity to preservatives.

"""^^xsd:string;
                                                                                              a nicebnf:FundingDecision,
                                                                                                nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#Va1o7k6DrkyM_QUUt6ypeg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply once daily, to be applied in the morning."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply once daily, to be applied in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply once daily, to be applied in the morning.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheEye>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reductionOfIntraOcularPressureInPrimaryOpenAngleGlaucoma>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tiopex#PHP79012>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionOfIntraOcularPressureInPrimaryOpenAngleGlaucoma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction of intra-ocular pressure in primary open-angle glaucoma</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Reduction of intra-ocular pressure in primary open-angle glaucoma

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "reduction of intra-ocular pressure in primary open-angle glaucoma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheEye> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "to the eye"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#S9DhLD02oUS8UFetDB8I2A>,
                                                                                                                          <http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#eT541WjHekWmHAHL9FL9wQ>;
                                                                                 nicebnf:hasTitle """<title>Topamax<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "topamax capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#PHP98339> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#PHP98341> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#S9DhLD02oUS8UFetDB8I2A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Swallow whole or sprinkle contents of capsule on soft food and swallow immediately without chewing.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#PHP98339>;
                                                                                                        nicebnf:hasTextContent """Swallow whole or sprinkle contents of capsule on soft food and swallow immediately without chewing.

"""^^xsd:string;
                                                                                                        a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#eT541WjHekWmHAHL9FL9wQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer <i>Topamax</i><tm tmtype=\"reg\" /> capsules.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/topamax-capsules#PHP98341>;
                                                                                                        nicebnf:hasTextContent """Patients or carers should be given advice on how to administer Topamax capsules.

"""^^xsd:string;
                                                                                                        a nicebnf:GeneralPatientAdvice,
                                                                                                          nicebnf:PatientAndCarerAdvice.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#NZssDs5vSkqi7mM5hE9KTQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#JLFpBPcRrEa4sYtg-1Oo9Q>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#LA1CSzeiX0eso0RFkBazVw>;
                                                                        nicebnf:hasTitle """<title>Tostran<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "tostran"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#JLFpBPcRrEa4sYtg-1Oo9Q> nicebnf:hasDitaContent """<section outputclass=\"doseEquivalence\">
  <title>Dose equivalence and conversion</title>
  <p>1 g of gel contains 20 mg testosterone.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#PHP101422>;
                                                                                               nicebnf:hasTextContent """Dose equivalence and conversion1 g of gel contains 20 mg testosterone.

"""^^xsd:string;
                                                                                               a nicebnf:DoseEquivalence,
                                                                                                 nicebnf:IndicationsAndDoseSection.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#LA1CSzeiX0eso0RFkBazVw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Apply gel on clean, dry, intact skin of abdomen or both inner thighs, preferably in the morning. Gently rub in with a finger until dry before dressing. Wash hands with soap and water after applying gel; avoid washing application site for at least 2 hours. Not to be applied on genital area.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#PHP101483>;
                                                                                               nicebnf:hasTextContent """Apply gel on clean, dry, intact skin of abdomen or both inner thighs, preferably in the morning. Gently rub in with a finger until dry before dressing. Wash hands with soap and water after applying gel; avoid washing application site for at least 2 hours. Not to be applied on genital area.

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#NZssDs5vSkqi7mM5hE9KTQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply 60 mg once daily, subsequent application adjusted according to response; maximum 80 mg per day."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply 60 mg once daily, subsequent application adjusted according to response; maximum 80 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply 60 mg once daily, subsequent application adjusted according to response; maximum 80 mg per day.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToTestosteroneDeficiencyInMen>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#PHP101422>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#PHP101422> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tostran#PHP101483> a nicebnf:DirectionsForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#hypogonadismDueToTestosteroneDeficiencyInMen> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypogonadism due to testosterone deficiency in men</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Hypogonadism due to testosterone deficiency in men

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "hypogonadism due to testosterone deficiency in men"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/toujeo> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/toujeo#HFTojqZY00SAf2M8PgzHGw>;
                                                                       nicebnf:hasTitle """<title>Toujeo <tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "toujeo"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/toujeo#HFTojqZY00SAf2M8PgzHGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "according to requirements."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>According to requirements.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """According to requirements.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#diabetesMellitus>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/toujeo#PHP108801>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/toujeo#PHP108801> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#diabetesMellitus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Diabetes mellitus</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Diabetes mellitus

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "diabetes mellitus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#IQeMoYtzHUy7h-JLVCiRhg>,
                                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#VuhtL5hqkUm31RjprtzaPQ>;
                                                                                  nicebnf:hasTitle """<title>Tracutil<tm tmtype=\"reg\" /> ampoules</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "tracutil ampoules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#IQeMoYtzHUy7h-JLVCiRhg> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>
  <p>For addition to infusion solutions.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#PHP107531>;
                                                                                                         nicebnf:hasTextContent """With intravenous use

For addition to infusion solutions.

"""^^xsd:string;
                                                                                                         a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#PHP107531> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#PHP107546> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#VuhtL5hqkUm31RjprtzaPQ> nicebnf:hasDitaContent """<sectiondiv>
  <p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>
  <p>
    <i>Tracutil</i>
    <tm tmtype=\"reg\" /> solution contains trace elements Fe<sup>2+</sup>, Zn<sup>2+</sup>, Mn<sup>2+</sup>, Cu<sup>2+</sup>, Cr<sup>3+</sup>, Se<sup>4+</sup>, Mo<sup>6+</sup>, I<sup>-</sup>, F<sup>-</sup>.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tracutil-ampoules#PHP107546>;
                                                                                                         nicebnf:hasTextContent """With intravenous use

Tracutil solution contains trace elements Fe2+, Zn2+, Mn2+, Cu2+, Cr3+, Se4+, Mo6+, I-, F-.

"""^^xsd:string;
                                                                                                         a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Route#intravenous> a <http://ld.nice.org.uk/ns/bnf/Route>;
                                                 rdfs:label "intravenous"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#withIntravenousUse> nicebnf:hasRoute <http://ld.nice.org.uk/ns/bnf/Route#intravenous>;
                                                              a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                              rdfs:label "with intravenous use"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#B_HxEqArqUKTdcf6eqS_Zg>,
                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#scdTKDjtKEKVS9JGlQb-wQ>;
                                                                                 nicebnf:hasTitle """<title>Transiderm-Nitro<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "transiderm-nitro"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#B_HxEqArqUKTdcf6eqS_Zg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "one ‘5’ or one ‘10’ patch to be applied to lateral chest wall and replaced every 24 hours, siting replacement patch on different area, max. two ‘10’ patches daily."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>One ‘5’ or one ‘10’ patch to be applied to lateral chest wall and replaced every 24 hours, siting replacement patch on different area, max. two ‘10’ patches daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """One ‘5’ or one ‘10’ patch to be applied to lateral chest wall and replaced every 24 hours, siting replacement patch on different area, max. two ‘10’ patches daily.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#PHP60637>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#PHP60637> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#scdTKDjtKEKVS9JGlQb-wQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfPhlebitisAndExtravasation5PatchOnly>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transiderm-nitro#PHP60637>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfPhlebitisAndExtravasation5PatchOnly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of phlebitis and extravasation (‘5’ patch only)</p>"""^^<rdf:XMLLiteral>;
                                                                                           nicebnf:hasTextContent """Prophylaxis of phlebitis and extravasation (‘5’ patch only)

"""^^xsd:string;
                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                           rdfs:label "prophylaxis of phlebitis and extravasation (‘5’ patch only)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplication> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by transdermal application"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#O7S2dzHuLU2dkHmMN3H5mg>,
                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#qmGgbFK3RUaIUQQ_A9GgZQ>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#6RV8Jx_WPkCr9BEk7MIkaw>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#8D3Q4SkwpEq2Yae-mYSgMQ>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#L3agkFcIqEOggaAEIokruw>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#z35hwBr2iEu1RKPGPLRRzQ>;
                                                                         nicebnf:hasTitle """<title>Transtec<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "transtec"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#6RV8Jx_WPkCr9BEk7MIkaw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Patients or carers should be given advice on how to administer buprenorphine transdermal patches.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80279>;
                                                                                                nicebnf:hasTextContent """Patients or carers should be given advice on how to administer buprenorphine transdermal patches.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralPatientAdvice,
                                                                                                  nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#8D3Q4SkwpEq2Yae-mYSgMQ> nicebnf:hasDitaContent """<section outputclass=\"pharmacokinetics\">
  <title>Pharmacokinetics</title>
  <p>It may take approximately 30 hours for the plasma-buprenorphine concentration to decrease by 50% after patch is removed.</p>
</section>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80257>;
                                                                                                nicebnf:hasTextContent """PharmacokineticsIt may take approximately 30 hours for the plasma-buprenorphine concentration to decrease by 50% after patch is removed.

"""^^xsd:string;
                                                                                                a nicebnf:IndicationsAndDoseSection,
                                                                                                  nicebnf:Pharmacokinetics.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#L3agkFcIqEOggaAEIokruw> nicebnf:hasDitaContent """<sectiondiv>
  <p>In view of the long duration of action, patients who have severe side-effects should be monitored for up to 30 hours after removing patch.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80271>;
                                                                                                nicebnf:hasTextContent """In view of the long duration of action, patients who have severe side-effects should be monitored for up to 30 hours after removing patch.

"""^^xsd:string;
                                                                                                a nicebnf:SideEffectAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#O7S2dzHuLU2dkHmMN3H5mg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 35 micrograms/hour up to every 96 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 35 micrograms/hour up to every 96 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at <i>same time</i> to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 35 micrograms/hour up to every 96 hours, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80257>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80257> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80271> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80275> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80279> a nicebnf:PatientAndCarerAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#qmGgbFK3RUaIUQQ_A9GgZQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "the initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>The initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at <i>same time</i> to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """The initial dose should be based on previous 24-hour opioid requirement, consult product literature, dose adjustment—when starting, analgesic effect should not be evaluated until the system has been worn for 24 hours (to allow for gradual increase in plasma-buprenorphine concentration)—if necessary, dose should be adjusted at intervals of no longer than 96 hours using a patch of the next strength or using 2 patches of the same strength (applied at same time to avoid confusion). Maximum 2 patches can be used at any one time, for breakthrough pain, consider 200–400 micrograms buprenorphine sublingually.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80257>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#z35hwBr2iEu1RKPGPLRRzQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after no longer than 96 hours and siting replacement patch on a different area (avoid same area for at least 6 days).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/transtec#PHP80275>;
                                                                                                nicebnf:hasTextContent """Apply patch to dry, non-irritated, non-hairy skin on upper torso, removing after no longer than 96 hours and siting replacement patch on a different area (avoid same area for at least 6 days).

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                       nicebnf:hasTextContent """Moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                       rdfs:label "moderate to severe chronic cancer pain in patients who have not previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSevereChronicCancerPainInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                    nicebnf:hasTextContent """Moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                    rdfs:label "moderate to severe chronic cancer pain in patients who have previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHaveNotPreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                 nicebnf:hasTextContent """Severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                 rdfs:label "severe pain unresponsive to non-opioid analgesics in patients who have not previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severePainUnresponsiveToNonOpioidAnalgesicsInPatientsWhoHavePreviouslyReceivedStrongOpioidAnalgesic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                              nicebnf:hasTextContent """Severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic

"""^^xsd:string;
                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                              rdfs:label "severe pain unresponsive to non-opioid analgesics in patients who have previously received strong opioid analgesic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byTransdermalApplicationUsingPatches> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by transdermal application using patches"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tridestra> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/tridestra#FQpTBR9HnUSYGbaws-IfQA>;
                                                                          nicebnf:hasTitle """<title>Tridestra<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "tridestra"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tridestra#FQpTBR9HnUSYGbaws-IfQA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1 tablet daily for 70 days, white tablet to be taken, then 1 tablet daily for 14 days, blue tablet to be taken, then 1 tablet daily for 7 days, yellow tablet to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1 tablet daily for 70 days, white tablet to be taken, then 1 tablet daily for 14 days, blue tablet to be taken, then 1 tablet daily for 7 days, yellow tablet to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1 tablet daily for 70 days, white tablet to be taken, then 1 tablet daily for 14 days, blue tablet to be taken, then 1 tablet daily for 7 days, yellow tablet to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tridestra#PHP96687>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tridestra#PHP96687> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/trisequens> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/trisequens#8SoeDDdk-kaZPgeUGm2pSw>;
                                                                           nicebnf:hasTitle """<title>Trisequens<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "trisequens"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/trisequens#8SoeDDdk-kaZPgeUGm2pSw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "1 tablet daily for 12 days, blue tablets to be taken, followed by 1 tablet daily for 10 days, white tablet to be taken, then 1 tablet daily for 6 days, red tablet to be taken, subsequent courses are repeated without interval."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>1 tablet daily for 12 days, blue tablets to be taken, followed by 1 tablet daily for 10 days, white tablet to be taken, then 1 tablet daily for 6 days, red tablet to be taken, subsequent courses are repeated without interval.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """1 tablet daily for 12 days, blue tablets to be taken, followed by 1 tablet daily for 10 days, white tablet to be taken, then 1 tablet daily for 6 days, red tablet to be taken, subsequent courses are repeated without interval.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/trisequens#PHP96032>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/trisequens#PHP96032> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptomsInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Menopausal symptoms in women with a uterus

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "menopausal symptoms in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxisInWomenWithAUterus> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis in women with a uterus</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Osteoporosis prophylaxis in women with a uterus

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "osteoporosis prophylaxis in women with a uterus"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/tt380-slimline> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/tt380-slimline#9ZyJ4z3nNUupcejExnnGDg>;
                                                                               nicebnf:hasTitle """<title>TT380<tm tmtype=\"reg\" /> Slimline</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "tt380 slimline"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tt380-slimline#9ZyJ4z3nNUupcejExnnGDg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 10 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/tt380-slimline#PHP105575>;
                                                                                                      nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 10 years.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/tt380-slimline#PHP105575> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#FMudQ-23LUqdvY0PuOXLTA>,
                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#ZdDilLUt6kabyXRVMolMfg>;
                                                                              nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#inB8eSXpVEmba0XejuP3fg>;
                                                                              nicebnf:hasTitle """<title>Twinrix<tm tmtype=\"reg\" /> Adult</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "twinrix adult"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#FMudQ-23LUqdvY0PuOXLTA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                        rdfs:label "initially 1 ml for 1 dose, then 1 ml after 7 days for 1 dose, then 1 ml after 14 days for 1 dose, then 1 ml for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 1 ml for 1 dose, then 1 ml after 7 days for 1 dose, then 1 ml after 14 days for 1 dose, then 1 ml for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 7 days for 1 dose, then 1 mL after 14 days for 1 dose, then 1 mL for 1 dose given 12 months after the first dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfectionAcceleratedScheduleForTravellersDepartingWithin1Month>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#PHP96247>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#PHP96247> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#PHP96296> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#ZdDilLUt6kabyXRVMolMfg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                        rdfs:label "initially 1 ml every 1 month for 2 doses, then 1 ml after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "initially 1 ml every 1 month for 2 doses, then 1 ml after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Initially 1 mL every 1 month for 2 doses, then 1 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in adults and older children; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#PHP96247>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#inB8eSXpVEmba0XejuP3fg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Primary course should be completed with <i>Twinrix</i><tm tmtype=\"reg\" /> (single component vaccines given at appropriate intervals may be used for booster dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-adult#PHP96296>;
                                                                                                     nicebnf:hasTextContent """Primary course should be completed with Twinrix (single component vaccines given at appropriate intervals may be used for booster dose).

"""^^xsd:string;
                                                                                                     a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent """Immunisation against hepatitis A and hepatitis B infection

"""^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                              rdfs:label "immunisation against hepatitis a and hepatitis b infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfectionAcceleratedScheduleForTravellersDepartingWithin1Month> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection (accelerated schedule for travellers departing within 1 month)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                   nicebnf:hasTextContent """Immunisation against hepatitis A and hepatitis B infection (accelerated schedule for travellers departing within 1 month)

"""^^xsd:string;
                                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                   rdfs:label "immunisation against hepatitis a and hepatitis b infection (accelerated schedule for travellers departing within 1 month)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#WwVhMo7wOkC3jf0WLMqtfw>;
                                                                                   nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#cQwKaSAj2kWOo89eHDcRqA>;
                                                                                   nicebnf:hasTitle """<title>Twinrix<tm tmtype=\"reg\" /> Paediatric</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "twinrix paediatric"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#PHP96313> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#PHP96339> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#WwVhMo7wOkC3jf0WLMqtfw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> ; 
                                                                                                                             rdfs:label "initially 0.5 ml every 1 month for 2 doses, then 0.5 ml after 5 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 0.5 mL every 1 month for 2 doses, then 0.5 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 0.5 mL every 1 month for 2 doses, then 0.5 mL after 5 months for 1 dose, the deltoid region is the preferred site of injection in older children; anterolateral thigh is the preferred site in infants; not to be injected into the buttock (vaccine efficacy reduced), subcutaneous route used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#PHP96313>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#cQwKaSAj2kWOo89eHDcRqA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Primary course should be completed with <i>Twinrix</i><tm tmtype=\"reg\" /> (single component vaccines given at appropriate intervals may be used for booster dose).</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/twinrix-paediatric#PHP96339>;
                                                                                                          nicebnf:hasTextContent """Primary course should be completed with Twinrix (single component vaccines given at appropriate intervals may be used for booster dose).

"""^^xsd:string;
                                                                                                          a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndHepatitisBInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and hepatitis B infection</p>"""^^<rdf:XMLLiteral>;
                                                                                              nicebnf:hasTextContent """Immunisation against hepatitis A and hepatitis B infection

"""^^xsd:string;
                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                              rdfs:label "immunisation against hepatitis a and hepatitis b infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child115Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–15 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#0WkUlQC1-0u2-vkoL0BFxg>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#5pn4YugVIUu79cNwIxgqFg>;
                                                                                    nicebnf:hasTitle """<title>Uniphyllin Continus<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "uniphyllin continus"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#0WkUlQC1-0u2-vkoL0BFxg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child211Years> ; 
                                                                                                                              rdfs:label "9 mg/kg every 12 hours (max. per dose 200 mg), dose may be increased in some children with chronic asthma; increased to 10–16 mg/kg every 12 hours (max. per dose 400 mg), may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>9 mg/kg every 12 hours (max. per dose 200 mg), dose may be increased in some children with chronic asthma; increased to 10–16 mg/kg every 12 hours (max. per dose 400 mg), may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """9 mg/kg every 12 hours (max. per dose 200 mg), dose may be increased in some children with chronic asthma; increased to 10–16 mg/kg every 12 hours (max. per dose 400 mg), may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                              rdfs:label "200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#PHP82938>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#5pn4YugVIUu79cNwIxgqFg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """200 mg every 12 hours, adjusted according to response to 400 mg every 12 hours, may be appropriate to give larger evening or morning dose to achieve optimum therapeutic effect when symptoms most severe; in patients whose night or daytime symptoms persist despite other therapy, who are not currently receiving theophylline, total daily requirement may be added as single evening or morning dose.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#PHP82938>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniphyllin-continus#PHP82938> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic asthma</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Chronic asthma

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "chronic asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reversibleAirwaysObstruction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reversible airways obstruction</p>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent """Reversible airways obstruction

"""^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                       rdfs:label "reversible airways obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeAcuteAsthma> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe acute asthma</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Severe acute asthma

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "severe acute asthma"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child211Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 2–11 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseMedicines> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                rdfs:label "by mouth using modified-release medicines"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-ointment> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-ointment#VSpXAGfTeESNZ7bzDQokGw>;
                                                                                    nicebnf:hasTitle """<title>Uniroid-HC<tm tmtype=\"reg\" /> ointment</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "uniroid-hc ointment"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-ointment#PHP96033> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-ointment#VSpXAGfTeESNZ7bzDQokGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                              rdfs:label "apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum>],
                                                                                                                             [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>Apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """Apply twice daily, and apply after a bowel movement, apply externally or by rectum, do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids>,
                                                                                                                                 <http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-ointment#PHP96033>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Haemorrhoids</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Haemorrhoids

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "haemorrhoids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus ani</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Pruritus ani

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "pruritus ani"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkinOrByRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                               rdfs:label "to the skin, or by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-suppositories> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-suppositories#s8zZnpymEUG7JwxpVtXovg>;
                                                                                         nicebnf:hasTitle """<title>Uniroid-HC<tm tmtype=\"reg\" /> suppositories</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "uniroid-hc suppositories"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-suppositories#PHP96122> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-suppositories#s8zZnpymEUG7JwxpVtXovg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                                   rdfs:label "1 suppository, insert twice daily and after a bowel movement. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>1 suppository, insert twice daily and after a bowel movement. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """1 suppository, insert twice daily and after a bowel movement. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>],
                                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "1 suppository, insert twice daily and after a bowel movement. do not use for longer than 7 days."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>1 suppository, insert twice daily and after a bowel movement. Do not use for longer than 7 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """1 suppository, insert twice daily and after a bowel movement. Do not use for longer than 7 days.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byRectum>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/uniroid-hc-suppositories#PHP96122>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#haemorrhoids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Haemorrhoids</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Haemorrhoids

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "haemorrhoids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusAni> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus ani</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Pruritus ani

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "pruritus ani"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byRectum> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by rectum"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/unisept> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/unisept#ihnu0BosuEGa-kCiaOvz8w>;
                                                                        nicebnf:hasTitle """<title>Unisept<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "unisept"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/unisept#PHP99937> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/unisept#ihnu0BosuEGa-kCiaOvz8w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forCleansingAndDisinfectingWoundsAndBurnsAndSwabbingInObstetrics>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/unisept#PHP99937>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forCleansingAndDisinfectingWoundsAndBurnsAndSwabbingInObstetrics> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For cleansing and disinfecting wounds and burns and swabbing in obstetrics</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """For cleansing and disinfecting wounds and burns and swabbing in obstetrics

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "for cleansing and disinfecting wounds and burns and swabbing in obstetrics"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/univer> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#UrYEZAmvUUiHifwgD9yYbQ>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#kYTlrJo3uUapse5geYeZRQ>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#nDFwLsfaxESyvHEe9z5DgQ>;
                                                                       nicebnf:hasTitle """<title>Univer<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "univer"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#PHP62030> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#UrYEZAmvUUiHifwgD9yYbQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "360 mg daily; maximum 480 mg per day."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>360 mg daily; maximum 480 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """360 mg daily; maximum 480 mg per day.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#PHP62030>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#kYTlrJo3uUapse5geYeZRQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "240 mg daily; maximum 480 mg per day."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>240 mg daily; maximum 480 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """240 mg daily; maximum 480 mg per day.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#PHP62030>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#nDFwLsfaxESyvHEe9z5DgQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "120 mg daily; maximum 480 mg per day."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>120 mg daily; maximum 480 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """120 mg daily; maximum 480 mg per day.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/univer#PHP62030>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertensionInPatientsNewToVerapamil> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension (in patients new to verapamil)</p>"""^^<rdf:XMLLiteral>;
                                                                               nicebnf:hasTextContent """Hypertension (in patients new to verapamil)

"""^^xsd:string;
                                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                               rdfs:label "hypertension (in patients new to verapamil)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-short> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-short#4S5uTrzae0CdhIYGYWRtaA>;
                                                                            nicebnf:hasTitle """<title>UT380 Short<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "ut380 short"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-short#4S5uTrzae0CdhIYGYWRtaA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 5–7 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-short#PHP105620>;
                                                                                                   nicebnf:hasTextContent """For uterine length 5–7 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                   a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-short#PHP105620> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-standard> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-standard#bnb1bIt6qkqTmK28oOOlmQ>;
                                                                               nicebnf:hasTitle """<title>UT380 Standard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "ut380 standard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-standard#PHP105657> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-standard#bnb1bIt6qkqTmK28oOOlmQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>For uterine length 6.5–9 cm; replacement every 5 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ut380-standard#PHP105657>;
                                                                                                      nicebnf:hasTextContent """For uterine length 6.5–9 cm; replacement every 5 years.

"""^^xsd:string;
                                                                                                      a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-capsules#JB-z2CadsEahizf-jcgw6w>;
                                                                                    nicebnf:hasTitle """<title>Utrogestan<tm tmtype=\"reg\" /> capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                    a nicebnf:ClinicalMedicinalProductInformation;
                                                                                    rdfs:label "utrogestan capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-capsules#JB-z2CadsEahizf-jcgw6w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                              rdfs:label "200 mg once daily on days 15–26 of each 28-day oestrogen hrt cycle, alternatively 100 mg once daily on days 1–25 of each 28-day oestrogen hrt cycle."^^xsd:string ; 
                                                                                                                              nicebnf:hasDitaContent "<p>200 mg once daily on days 15–26 of each 28-day oestrogen HRT cycle, alternatively 100 mg once daily on days 1–25 of each 28-day oestrogen HRT cycle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                              nicebnf:hasTextContent """200 mg once daily on days 15–26 of each 28-day oestrogen HRT cycle, alternatively 100 mg once daily on days 1–25 of each 28-day oestrogen HRT cycle.

"""^^xsd:string ; 
                                                                                                                              nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                           nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#progestogenicOppositionOfOestrogenHrt>;
                                                                                                           nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-capsules#PHP104440>;
                                                                                                           a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-capsules#PHP104440> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#progestogenicOppositionOfOestrogenHrt> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Progestogenic opposition of oestrogen HRT</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Progestogenic opposition of oestrogen HRT

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "progestogenic opposition of oestrogen hrt"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-vaginal-capsules> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-vaginal-capsules#fxytupANVE2mfIH63J7GBg>;
                                                                                            nicebnf:hasTitle """<title>Utrogestan<tm tmtype=\"reg\" /> vaginal capsules</title>"""^^<rdf:XMLLiteral>;
                                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                                            rdfs:label "utrogestan vaginal capsules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-vaginal-capsules#PHP104683> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-vaginal-capsules#fxytupANVE2mfIH63J7GBg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                      rdfs:label "1 capsule 3 times a day from day of embryo transfer until at least week 7 of pregnancy up to week 12 of pregnancy."^^xsd:string ; 
                                                                                                                                      nicebnf:hasDitaContent "<p>1 capsule 3 times a day from day of embryo transfer until at least week 7 of pregnancy up to week 12 of pregnancy.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                      nicebnf:hasTextContent """1 capsule 3 times a day from day of embryo transfer until at least week 7 of pregnancy up to week 12 of pregnancy.

"""^^xsd:string ; 
                                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#supplementationOfLutealPhaseDuringAssistedReproductiveTechnologyArtCycles>;
                                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/utrogestan-vaginal-capsules#PHP104683>;
                                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#supplementationOfLutealPhaseDuringAssistedReproductiveTechnologyArtCycles> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Supplementation of luteal phase during assisted reproductive technology (ART) cycles</p>"""^^<rdf:XMLLiteral>;
                                                                                                                    nicebnf:hasTextContent """Supplementation of luteal phase during assisted reproductive technology (ART) cycles

"""^^xsd:string;
                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                    rdfs:label "supplementation of luteal phase during assisted reproductive technology (art) cycles"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#yeAygzCmEkWh6tOdcGx9cA>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#swflI-6O90GuJpc5vK0wvw>;
                                                                        nicebnf:hasTitle """<title>Vagifem<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "vagifem"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#PHP101938> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#PHP101966> a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#swflI-6O90GuJpc5vK0wvw> nicebnf:hasDitaContent """<sectiondiv>
  <p>No evidence of damage to latex condoms and diaphragms.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#PHP101966>;
                                                                                               nicebnf:hasTextContent """No evidence of damage to latex condoms and diaphragms.

"""^^xsd:string;
                                                                                               a nicebnf:ConceptionAndContraception.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#yeAygzCmEkWh6tOdcGx9cA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "1 tablet daily for 2 weeks, then reduced to 1 tablet twice weekly."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>1 tablet daily for 2 weeks, then reduced to 1 tablet twice weekly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """1 tablet daily for 2 weeks, then reduced to 1 tablet twice weekly.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byVagina>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vagifem#PHP101938>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#improveTheVaginalEpitheliumInMenopausalAtrophicVaginitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Improve the vaginal epithelium in menopausal atrophic vaginitis</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Improve the vaginal epithelium in menopausal atrophic vaginitis

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "improve the vaginal epithelium in menopausal atrophic vaginitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byVagina> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "by vagina"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#lzjZkWW53U-SbklIFTkzpw>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#nPN5N0T5oUadrR4FiUXC3A>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#HuKscTnYq0edkCMYRxyvHA>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#STqlYV49SEut34GdDcOVGQ>;
                                                                         nicebnf:hasTitle """<title>Valni<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "valni xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#HuKscTnYq0edkCMYRxyvHA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate for use where there is a history of oesophageal or gastro-intestinal obstruction, decreased lumen diameter of the gastro-intestinal tract, inflammatory bowel disease, or ileostomy after proctocolectomy. </p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63939>;
                                                                                                nicebnf:hasTextContent """Dose form not appropriate for use where there is a history of oesophageal or gastro-intestinal obstruction, decreased lumen diameter of the gastro-intestinal tract, inflammatory bowel disease, or ileostomy after proctocolectomy. 

"""^^xsd:string;
                                                                                                a nicebnf:ImportantAdvice.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63813> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63847> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63939> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#STqlYV49SEut34GdDcOVGQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose form not appropriate.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63813>;
                                                                                                nicebnf:hasTextContent """Dose form not appropriate.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#lzjZkWW53U-SbklIFTkzpw> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#decreasedLumenDiameterOfGastroIntestinalTract>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Caution#historyOfGastroIntestinalObstruction>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Caution#historyOfOesophagealObstruction>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Caution#ileostomyAfterProctocolectomy>,
                                                                                                                   <http://ld.nice.org.uk/ns/bnf/Caution#inflammatoryBowelDisease>;
                                                                                                nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Decreased lumen diameter of gastro-intestinal tract</ph>; <ph outputclass=\"caution\">history of gastro-intestinal obstruction</ph>; <ph outputclass=\"caution\">history of oesophageal obstruction</ph>; <ph outputclass=\"caution\">ileostomy after proctocolectomy</ph>; <ph outputclass=\"caution\">inflammatory bowel disease</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63939>;
                                                                                                nicebnf:hasTextContent """Decreased lumen diameter of gastro-intestinal tract; history of gastro-intestinal obstruction; history of oesophageal obstruction; ileostomy after proctocolectomy; inflammatory bowel disease

"""^^xsd:string;
                                                                                                a nicebnf:CautionsGroup,
                                                                                                  nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#nPN5N0T5oUadrR4FiUXC3A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "30 mg once daily, increased if necessary up to 90 mg once daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>30 mg once daily, increased if necessary up to 90 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """30 mg once daily, increased if necessary up to 90 mg once daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#severeHypertension>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/valni-xl#PHP63847>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Caution#decreasedLumenDiameterOfGastroIntestinalTract> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Decreased lumen diameter of gastro-intestinal tract</ph>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent "Decreased lumen diameter of gastro-intestinal tract"^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                     rdfs:label "decreased lumen diameter of gastro-intestinal tract"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#historyOfGastroIntestinalObstruction> nicebnf:hasDitaContent """<ph outputclass=\"caution\">history of gastro-intestinal obstruction</ph>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent "history of gastro-intestinal obstruction"^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                            rdfs:label "history of gastro-intestinal obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#historyOfOesophagealObstruction> nicebnf:hasDitaContent """<ph outputclass=\"caution\">history of oesophageal obstruction</ph>"""^^<rdf:XMLLiteral>;
                                                                       nicebnf:hasTextContent "history of oesophageal obstruction"^^xsd:string;
                                                                       a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                       rdfs:label "history of oesophageal obstruction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#ileostomyAfterProctocolectomy> nicebnf:hasDitaContent """<ph outputclass=\"caution\">ileostomy after proctocolectomy</ph>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent "ileostomy after proctocolectomy"^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                     rdfs:label "ileostomy after proctocolectomy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Caution#inflammatoryBowelDisease> nicebnf:hasDitaContent """<ph outputclass=\"caution\">inflammatory bowel disease</ph>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent "inflammatory bowel disease"^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                rdfs:label "inflammatory bowel disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#severeHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Severe hypertension</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Severe hypertension

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "severe hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-adult> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-adult#z4-28mMo80iBE9b0z3Kv-w>;
                                                                            nicebnf:hasTitle """<title>Vaqta<tm tmtype=\"reg\" /> Adult</title>"""^^<rdf:XMLLiteral>;
                                                                            a nicebnf:ClinicalMedicinalProductInformation;
                                                                            rdfs:label "vaqta adult"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-adult#PHP97817> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-adult#z4-28mMo80iBE9b0z3Kv-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                      rdfs:label "initially 1 ml for 1 dose, then 1 ml after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders (but immune response may be delayed)."^^xsd:string ; 
                                                                                                                      nicebnf:hasDitaContent "<p>Initially 1 mL for 1 dose, then 1 mL after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders (but immune response may be delayed).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                      nicebnf:hasTextContent """Initially 1 mL for 1 dose, then 1 mL after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders (but immune response may be delayed).

"""^^xsd:string ; 
                                                                                                                      nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                   nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection>;
                                                                                                   nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-adult#PHP97817>;
                                                                                                   a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis A infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis a infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-paediatric> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-paediatric#-SNUdt3SEU6JE0PaPLVbXQ>;
                                                                                 nicebnf:hasTitle """<title>Vaqta<tm tmtype=\"reg\" /> paediatric</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "vaqta paediatric"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-paediatric#-SNUdt3SEU6JE0PaPLVbXQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                           rdfs:label "initially 0.5 ml for 1 dose, then 0.5 ml after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. the subcutaneous route may be used for patients with bleeding disorders (but immune response may be reduced)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 0.5 mL for 1 dose, then 0.5 mL after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders (but immune response may be reduced).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 0.5 mL for 1 dose, then 0.5 mL after 6–18 months, dose given as booster, the deltoid region is the preferred site of injection. The subcutaneous route may be used for patients with bleeding disorders (but immune response may be reduced).

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-paediatric#PHP81396>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vaqta-paediatric#PHP81396> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A infection</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Immunisation against hepatitis A infection

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "immunisation against hepatitis a infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#MgTCQXDXMUKCRvSrBx_4rQ>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#EE9nrxDdE0C5nuTYnmSkEA>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#lCRpu9WlFUKTOsZMvUXilw>;
                                                                         nicebnf:hasSideEffectsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#UUdpHRN5B0asHJ4bGKWvng>,
                                                                                                     <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#euDAySC3AESaIp1ythQO_Q>;
                                                                         nicebnf:hasTitle """<title>Vargatef <tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "vargatef"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#EE9nrxDdE0C5nuTYnmSkEA> nicebnf:hasDitaContent """<sectiondiv>
  <p> See also <i>Pregnancy and reproductive function</i> in <xref format=\"dita\" href=\"treatment-summary/cytotoxic-drugs.xml\" type=\"bookmark\" rel=\"treatmentsummary\" bnfid=\"PHP78537\">Cytotoxic drugs</xref>.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108722>;
                                                                                                nicebnf:hasTextContent """ See also Pregnancy and reproductive function in Cytotoxic drugs.

"""^^xsd:string;
                                                                                                a nicebnf:GeneralInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#MgTCQXDXMUKCRvSrBx_4rQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "200 mg twice daily on days 2–21 of a standard 21 day docetaxel cycle, for treatment following discontinuation of docetaxel and for dose adjustments due to side-effects, consult product literature."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>200 mg twice daily on days 2–21 of a standard 21 day docetaxel cycle, for treatment following discontinuation of docetaxel and for dose adjustments due to side-effects, consult product literature.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """200 mg twice daily on days 2–21 of a standard 21 day docetaxel cycle, for treatment following discontinuation of docetaxel and for dose adjustments due to side-effects, consult product literature.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfLocallyAdvancedMetastaticOrLocallyRecurrentNonSmallCellLungCancerOfAdenocarcinomaHistologyAfterFirstLineChemotherapyInCombinationWithDocetaxelInitiatedUnderSpecialistSupervision>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108701>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108701> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108722> a nicebnf:Pregnancy.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108730> a nicebnf:SideEffects.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108767> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#UUdpHRN5B0asHJ4bGKWvng> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Gastrointestinal perforation</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#uncommon>;
                                                                                                nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#gastrointestinalPerforation>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108730>;
                                                                                                nicebnf:hasTextContent """Gastrointestinal perforation

"""^^xsd:string;
                                                                                                a nicebnf:GeneralSideEffects,
                                                                                                  nicebnf:SideEffectGroup,
                                                                                                  nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#euDAySC3AESaIp1ythQO_Q> nicebnf:hasDitaContent """<p outputclass=\"sideEffects\">
  <ph outputclass=\"sideEffect\">Abscesses</ph>; <ph outputclass=\"sideEffect\">bleeding</ph>; <ph outputclass=\"sideEffect\">dehydration</ph>; <ph outputclass=\"sideEffect\">electrolyte imbalance</ph>; <ph outputclass=\"sideEffect\">mucositis</ph>; <ph outputclass=\"sideEffect\">neutropenia</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">venous thromboembolism</ph></p>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasFrequency <http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon>;
                                                                                                nicebnf:hasSideEffect <http://ld.nice.org.uk/ns/bnf/SideEffect#abscesses>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#bleeding>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#dehydration>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#electrolyteImbalance>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#mucositis>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#neutropenia>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy>,
                                                                                                                      <http://ld.nice.org.uk/ns/bnf/SideEffect#venousThromboembolism>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108730>;
                                                                                                nicebnf:hasTextContent """Abscesses; bleeding; dehydration; electrolyte imbalance; mucositis; neutropenia; peripheral neuropathy; venous thromboembolism

"""^^xsd:string;
                                                                                                a nicebnf:GeneralSideEffects,
                                                                                                  nicebnf:SideEffectGroup,
                                                                                                  nicebnf:SideEffectsGroup.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#lCRpu9WlFUKTOsZMvUXilw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Not to be taken on the same day as docetaxel therapy.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vargatef#PHP108767>;
                                                                                                nicebnf:hasTextContent """Not to be taken on the same day as docetaxel therapy.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://ld.nice.org.uk/ns/bnf/Frequency#commonOrVeryCommon> a nicebnf:Frequency;
                                                            rdfs:label "common or very common"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Frequency#uncommon> a nicebnf:Frequency;
                                                  rdfs:label "uncommon"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfLocallyAdvancedMetastaticOrLocallyRecurrentNonSmallCellLungCancerOfAdenocarcinomaHistologyAfterFirstLineChemotherapyInCombinationWithDocetaxelInitiatedUnderSpecialistSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer of adenocarcinoma histology after first-line chemotherapy (in combination with docetaxel) (initiated under specialist supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                       nicebnf:hasTextContent """Treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer of adenocarcinoma histology after first-line chemotherapy (in combination with docetaxel) (initiated under specialist supervision)

"""^^xsd:string;
                                                                                                                                                                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                       rdfs:label "treatment of locally advanced, metastatic or locally recurrent non-small cell lung cancer of adenocarcinoma histology after first-line chemotherapy (in combination with docetaxel) (initiated under specialist supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/SideEffect#abscesses> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Abscesses</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "Abscesses"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "abscesses"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#bleeding> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">bleeding</ph>"""^^<rdf:XMLLiteral>;
                                                   nicebnf:hasTextContent "bleeding"^^xsd:string;
                                                   a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                   rdfs:label "bleeding"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#dehydration> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">dehydration</ph>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent "dehydration"^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                      rdfs:label "dehydration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#electrolyteImbalance> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">electrolyte imbalance</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "electrolyte imbalance"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                               rdfs:label "electrolyte imbalance"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#gastrointestinalPerforation> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">Gastrointestinal perforation</ph>"""^^<rdf:XMLLiteral>;
                                                                      nicebnf:hasTextContent "Gastrointestinal perforation"^^xsd:string;
                                                                      a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                      rdfs:label "gastrointestinal perforation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#mucositis> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">mucositis</ph>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent "mucositis"^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                    rdfs:label "mucositis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#neutropenia> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">neutropenia</ph>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent "neutropenia"^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                      rdfs:label "neutropenia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#peripheralNeuropathy> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">peripheral neuropathy</ph>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent "peripheral neuropathy"^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                               rdfs:label "peripheral neuropathy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/SideEffect#venousThromboembolism> nicebnf:hasDitaContent """<ph outputclass=\"sideEffect\">venous thromboembolism</ph>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent "venous thromboembolism"^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/SideEffect>;
                                                                rdfs:label "venous thromboembolism"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/varilrix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/varilrix#04PdHQqAn02Arx1FU3ehMg>;
                                                                         nicebnf:hasTitle """<title>Varilrix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "varilrix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/varilrix#04PdHQqAn02Arx1FU3ehMg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> ; 
                                                                                                                   rdfs:label "0.5 ml every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>0.5 mL every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """0.5 mL every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "0.5 ml every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>0.5 mL every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """0.5 mL every 4–6 weeks for 2 doses, to be administered preferably into the deltoid region.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpox>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/varilrix#PHP82139>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/varilrix#PHP82139> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpox> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of varicella infection (chickenpox)</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Prevention of varicella infection (chickenpox)

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "prevention of varicella infection (chickenpox)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child117Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–17 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/variquel-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/variquel-injection#DSU7_2uSEEOV5nuszbqe3Q>;
                                                                                   nicebnf:hasTitle """<title>Variquel<tm tmtype=\"reg\" /> injection</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "variquel injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/variquel-injection#DSU7_2uSEEOV5nuszbqe3Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> ; 
                                                                                                                             rdfs:label "initially 1 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 1 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 1 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5069Kg> ; 
                                                                                                                             rdfs:label "initially 1.5 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 1.5 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 1.5 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>],
                                                                                                                            [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight70KgAndAbove> ; 
                                                                                                                             rdfs:label "initially 2 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 2 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 2 mg, then 1 mg every 4–6 hours for up to 72 hours, to be administered over 1 minute.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bleedingFromOesophagealVarices>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/variquel-injection#PHP85494>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/variquel-injection#PHP85494> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#bleedingFromOesophagealVarices> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bleeding from oesophageal varices</p>"""^^<rdf:XMLLiteral>;
                                                                         nicebnf:hasTextContent """Bleeding from oesophageal varices

"""^^xsd:string;
                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                         rdfs:label "bleeding from oesophageal varices"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight5069Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                  rdfs:label "adult (body-weight 50–69 kg)"^^xsd:string;
                                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeight70KgAndAbove> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                        rdfs:label "adult (body-weight 70 kg and above)"^^xsd:string;
                                                                        rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adultBodyWeightUpTo49Kg> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                                    rdfs:label "adult (body-weight up to 49 kg)"^^xsd:string;
                                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                  rdfs:label "by intravenous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#DB4kOIOE50KlWZwDCZ8mZw>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#V3kcVlvozUiN4yRfoNM0Ig>;
                                                                        nicebnf:hasTitle """<title>Varivax<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "varivax"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#DB4kOIOE50KlWZwDCZ8mZw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child112Years> ; 
                                                                                                                  rdfs:label "0.5 ml for 2 doses, interval of at least 4 weeks between each dose, to be administered into the deltoid region (or higher anterolateral thigh)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5 mL for 2 doses, interval of at least 4 weeks between each dose, to be administered into the deltoid region (or higher anterolateral thigh).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5 mL for 2 doses, interval of at least 4 weeks between each dose, to be administered into the deltoid region (or higher anterolateral thigh).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1317Years> ; 
                                                                                                                  rdfs:label "0.5 ml every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region (or higher anterolateral thigh in children)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5 mL every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region (or higher anterolateral thigh in children).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5 mL every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region (or higher anterolateral thigh in children).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "0.5 ml every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5 mL every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5 mL every 4–8 weeks for 2 doses, to be administered preferably into the deltoid region.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpox>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#PHP82202>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#PHP82202> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#V3kcVlvozUiN4yRfoNM0Ig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child112Years> ; 
                                                                                                                  rdfs:label "0.5 ml every 12 weeks for 2 doses, to be administered into the deltoid region (or higher anterolateral thigh)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>0.5 mL every 12 weeks for 2 doses, to be administered into the deltoid region (or higher anterolateral thigh).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """0.5 mL every 12 weeks for 2 doses, to be administered into the deltoid region (or higher anterolateral thigh).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpoxInChildrenWithAsymptomaticHivInfection>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/varivax#PHP82202>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpox> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of varicella infection (chickenpox)</p>"""^^<rdf:XMLLiteral>;
                                                                                   nicebnf:hasTextContent """Prevention of varicella infection (chickenpox)

"""^^xsd:string;
                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                   rdfs:label "prevention of varicella infection (chickenpox)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfVaricellaInfectionChickenpoxInChildrenWithAsymptomaticHivInfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of varicella infection (chickenpox) in children with asymptomatic HIV infection</p>"""^^<rdf:XMLLiteral>;
                                                                                                                         nicebnf:hasTextContent """Prevention of varicella infection (chickenpox) in children with asymptomatic HIV infection

"""^^xsd:string;
                                                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                         rdfs:label "prevention of varicella infection (chickenpox) in children with asymptomatic hiv infection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child112Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                          rdfs:label "child 1–12 years"^^xsd:string;
                                                          rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1317Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 13–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjectionOrByIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                                             rdfs:label "by subcutaneous injection, or by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#PRiEa_QWOU-urCo9qVC_1w>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#cr28mCPK_k6-J9_anUSRzg>;
                                                                                   nicebnf:hasTitle """<title>Ventolin Accuhaler<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "ventolin accuhaler"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#PHP82758> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#PRiEa_QWOU-urCo9qVC_1w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "200 micrograms."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>200 micrograms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """200 micrograms.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#PHP82758>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#cr28mCPK_k6-J9_anUSRzg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "initially 200 micrograms, up to 4 times daily for persistent symptoms."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Initially 200 micrograms, up to 4 times daily for persistent symptoms.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Initially 200 micrograms, up to 4 times daily for persistent symptoms.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/ventolin-accuhaler#PHP82758>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Acute bronchospasm

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "acute bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAllergenOrExerciseInducedBronchospasm> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasTextContent """Prophylaxis of allergen- or exercise-induced bronchospasm

"""^^xsd:string;
                                                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                             rdfs:label "prophylaxis of allergen- or exercise-induced bronchospasm"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byInhalationOfPowder> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                rdfs:label "by inhalation of powder"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#Bj2it2hJUEyNUChghpyVZQ>,
                                                                                                           <http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#pdwNR8-g1EaWaL-1wqSMUQ>;
                                                                             nicebnf:hasTitle """<title>Verapress<tm tmtype=\"reg\" /> MR</title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "verapress mr"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#Bj2it2hJUEyNUChghpyVZQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "240 mg daily, increased if necessary to 240 mg twice daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>240 mg daily, increased if necessary to 240 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """240 mg daily, increased if necessary to 240 mg twice daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypertension>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#PHP61607>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#PHP61607> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#pdwNR8-g1EaWaL-1wqSMUQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "240 mg twice daily, may sometimes be reduced to once daily."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>240 mg twice daily, may sometimes be reduced to once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """240 mg twice daily, may sometimes be reduced to once daily.

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/verapress-mr#PHP61607>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#hypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypertension</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Hypertension

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/verrugon> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/verrugon#wRvE216VRU6fJXLaguYVEg>;
                                                                         nicebnf:hasTitle """<title>Verrugon<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "verrugon"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/verrugon#PHP82348> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/verrugon#wRvE216VRU6fJXLaguYVEg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                   rdfs:label "apply daily, treatment may need to be continued for up to 3 months."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply daily, treatment may need to be continued for up to 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply daily, treatment may need to be continued for up to 3 months.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply daily, treatment may need to be continued for up to 3 months."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply daily, treatment may need to be continued for up to 3 months.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply daily, treatment may need to be continued for up to 3 months.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#forPlantarWarts>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/verrugon#PHP82348>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#forPlantarWarts> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">For plantar warts</p>"""^^<rdf:XMLLiteral>;
                                                          nicebnf:hasTextContent """For plantar warts

"""^^xsd:string;
                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                          rdfs:label "for plantar warts"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#ALYeF9FgI0mDEhFJ_bczkg>;
                                                                         nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#CtIGJfMiiUK4IPS8f3VBEA>;
                                                                         nicebnf:hasTitle """<title>Versatis<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "versatis"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#ALYeF9FgI0mDEhFJ_bczkg> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (July 2008) that <i>Versatis</i><tm tmtype=\"reg\" /> is accepted for restricted use within NHS Scotland for the treatment of postherpetic neuralgia in patients who are intolerant of first-line systemic therapies or when they have been ineffective.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#PHP82918>;
                                                                                                nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (July 2008) that Versatis is accepted for restricted use within NHS Scotland for the treatment of postherpetic neuralgia in patients who are intolerant of first-line systemic therapies or when they have been ineffective.

"""^^xsd:string;
                                                                                                a nicebnf:FundingDecision,
                                                                                                  nicebnf:SmcDecisions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#CtIGJfMiiUK4IPS8f3VBEA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "apply once daily for up to 12 hours, followed by a 12-hour plaster-free period; discontinue if no response after 4 weeks, to be applied to intact, dry, non-hairy, non-irritated skin, up to 3 plasters may be used to cover large areas; plasters may be cut."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Apply once daily for up to 12 hours, followed by a 12-hour plaster-free period; discontinue if no response after 4 weeks, to be applied to intact, dry, non-hairy, non-irritated skin, up to 3 plasters may be used to cover large areas; plasters may be cut.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Apply once daily for up to 12 hours, followed by a 12-hour plaster-free period; discontinue if no response after 4 weeks, to be applied to intact, dry, non-hairy, non-irritated skin, up to 3 plasters may be used to cover large areas; plasters may be cut.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#postherpeticNeuralgia>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#PHP82899>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#PHP82899> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/versatis#PHP82918> a nicebnf:NationalFunding.
<http://ld.nice.org.uk/ns/bnf/Indication#postherpeticNeuralgia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postherpetic neuralgia</p>"""^^<rdf:XMLLiteral>;
                                                                nicebnf:hasTextContent """Postherpetic neuralgia

"""^^xsd:string;
                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                rdfs:label "postherpetic neuralgia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#MrR3u5BVpUyIBQicbr8iFA>,
                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#SkOCBvoSX0WNnJzH6VyAWQ>;
                                                                              nicebnf:hasTitle """<title>Vertab<tm tmtype=\"reg\" /> SR 240</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "vertab sr 240"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#MrR3u5BVpUyIBQicbr8iFA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "240 mg twice daily, dose frequency may sometimes be reduced to once daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>240 mg twice daily, dose frequency may sometimes be reduced to once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """240 mg twice daily, dose frequency may sometimes be reduced to once daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#PHP61218>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#PHP61218> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#SkOCBvoSX0WNnJzH6VyAWQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "240 mg daily, increased if necessary to 240 mg twice daily."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>240 mg daily, increased if necessary to 240 mg twice daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """240 mg daily, increased if necessary to 240 mg twice daily.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vertab-sr-240#PHP61218>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/viatim> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/viatim#WRd5NSuk0UuM9FIhK_Ykcw>;
                                                                       nicebnf:hasTitle """<title>ViATIM<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "viatim"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viatim#PHP96551> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viatim#WRd5NSuk0UuM9FIhK_Ykcw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> ; 
                                                                                                                 rdfs:label "1 ml for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). the subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>],
                                                                                                                [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "1 ml for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). the subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """1 mL for 1 dose, the deltoid region is the preferred site of injection; not to be injected into the buttock (vaccine efficacy reduced). The subcutaneous route may be used for patients with bleeding disorders, booster dose given using single component vaccines.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndTyphoidInfectionPrimaryCourse>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viatim#PHP96551>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#immunisationAgainstHepatitisAAndTyphoidInfectionPrimaryCourse> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Immunisation against hepatitis A and typhoid infection (primary course)</p>"""^^<rdf:XMLLiteral>;
                                                                                                        nicebnf:hasTextContent """Immunisation against hepatitis A and typhoid infection (primary course)

"""^^xsd:string;
                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                        rdfs:label "immunisation against hepatitis a and typhoid infection (primary course)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1617Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 16–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                    rdfs:label "by intramuscular injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#ImHYuA5MTUeNiUdm44oSnA>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#6EmhpgHD0UiOmdDa46pc_A>,
                                                                                                                   <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#71Rou-FK60S4lno6c7C1Mg>;
                                                                          nicebnf:hasTitle """<title>Viazem<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "viazem xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#6EmhpgHD0UiOmdDa46pc_A> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily, adjusted according to response.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59574>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily, adjusted according to response.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#71Rou-FK60S4lno6c7C1Mg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily, adjusted according to response.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59589>;
                                                                                                 nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily, adjusted according to response.

"""^^xsd:string;
                                                                                                 a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#ImHYuA5MTUeNiUdm44oSnA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "initially 180 mg once daily, adjusted according to response to 240 mg once daily; maximum 360 mg per day."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 180 mg once daily, adjusted according to response to 240 mg once daily; maximum 360 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 180 mg once daily, adjusted according to response to 240 mg once daily; maximum 360 mg per day.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "initially 120 mg once daily, adjusted according to response."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Initially 120 mg once daily, adjusted according to response.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Initially 120 mg once daily, adjusted according to response.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59601>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59574> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59589> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viazem-xl#PHP59601> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-solution> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-solution#GeGTZY2X0EKbApQJYkezBQ>;
                                                                                nicebnf:hasTitle """<title>Videne<tm tmtype=\"reg\" /> solution</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "videne solution"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-solution#GeGTZY2X0EKbApQJYkezBQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                          rdfs:label "apply undiluted in pre-operative skin disinfection and general antisepsis."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply undiluted in pre-operative skin disinfection and general antisepsis.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply undiluted in pre-operative skin disinfection and general antisepsis.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                         [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply undiluted in pre-operative skin disinfection and general antisepsis."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply undiluted in pre-operative skin disinfection and general antisepsis.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply undiluted in pre-operative skin disinfection and general antisepsis.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-solution#PHP85226>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-solution#PHP85226> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Skin disinfection

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-surgical-scrub> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-surgical-scrub#spUzqkhXwEGeVVuKWVIVig>;
                                                                                      nicebnf:hasTitle """<title>Videne<tm tmtype=\"reg\" /> surgical scrub<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                      rdfs:label "videne surgical scrub"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-surgical-scrub#PHP85242> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-surgical-scrub#spUzqkhXwEGeVVuKWVIVig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child> ; 
                                                                                                                                rdfs:label "use as a pre-operative scrub for hand and skin disinfection."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>Use as a pre-operative scrub for hand and skin disinfection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """Use as a pre-operative scrub for hand and skin disinfection.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                               [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                rdfs:label "use as a pre-operative scrub for hand and skin disinfection."^^xsd:string ; 
                                                                                                                                nicebnf:hasDitaContent "<p>Use as a pre-operative scrub for hand and skin disinfection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                nicebnf:hasTextContent """Use as a pre-operative scrub for hand and skin disinfection.

"""^^xsd:string ; 
                                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection>;
                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-surgical-scrub#PHP85242>;
                                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Skin disinfection

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "child"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture> nicebnf:hasCautionsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#LeQbLrT-kkanFF5GBtlVZQ>;
                                                                                nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#4F_qLLeZtka8CFghCA1kcQ>;
                                                                                nicebnf:hasTitle """<title>Videne<tm tmtype=\"reg\" /> tincture</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "videne tincture"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#4F_qLLeZtka8CFghCA1kcQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply undiluted in pre-operative skin disinfection."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply undiluted in pre-operative skin disinfection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply undiluted in pre-operative skin disinfection.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#PHP85210>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#LeQbLrT-kkanFF5GBtlVZQ> nicebnf:hasCaution <http://ld.nice.org.uk/ns/bnf/Caution#proceduresInvolvingHotWireCauteryAndDiathermy>;
                                                                                                       nicebnf:hasDitaContent """<p>
  <ph outputclass=\"caution\">Procedures involving hot wire cautery and diathermy</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#PHP85208>;
                                                                                                       nicebnf:hasTextContent """Procedures involving hot wire cautery and diathermy

"""^^xsd:string;
                                                                                                       a nicebnf:CautionsGroup,
                                                                                                         nicebnf:GeneralCautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#PHP85208> a nicebnf:Cautions.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/videne-tincture#PHP85210> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Caution#proceduresInvolvingHotWireCauteryAndDiathermy> nicebnf:hasDitaContent """<ph outputclass=\"caution\">Procedures involving hot wire cautery and diathermy</ph>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent "Procedures involving hot wire cautery and diathermy"^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Caution>;
                                                                                     rdfs:label "procedures involving hot wire cautery and diathermy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#skinDisinfection> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Skin disinfection</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Skin disinfection

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "skin disinfection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/viraferonpeg> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/viraferonpeg#0D42OmmApU6yu3Sn3WHf-A>;
                                                                             nicebnf:hasTitle """<title>ViraferonPeg<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                             a nicebnf:ClinicalMedicinalProductInformation;
                                                                             rdfs:label "viraferonpeg"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viraferonpeg#0D42OmmApU6yu3Sn3WHf-A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                       rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                       nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                       nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                       nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                    nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavarinAndBoceprevirForChronicHepatitisCInfectionOfGenotype1InPatientsWithCompensatedLiverDisease>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavirinForChronicHepatitisC>,
                                                                                                                          <http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisCIfRibavarinNotToleratedOrContraIndicated>;
                                                                                                    nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viraferonpeg#PHP80884>;
                                                                                                    a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viraferonpeg#PHP80884> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavarinAndBoceprevirForChronicHepatitisCInfectionOfGenotype1InPatientsWithCompensatedLiverDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Combined with ribavarin and boceprevir for chronic hepatitis C infection of genotype 1 in patients with compensated liver disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                          nicebnf:hasTextContent """Combined with ribavarin and boceprevir for chronic hepatitis C infection of genotype 1 in patients with compensated liver disease

"""^^xsd:string;
                                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                          rdfs:label "combined with ribavarin and boceprevir for chronic hepatitis c infection of genotype 1 in patients with compensated liver disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#combinedWithRibavirinForChronicHepatitisC> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Combined with ribavirin for chronic hepatitis C</p>"""^^<rdf:XMLLiteral>;
                                                                                    nicebnf:hasTextContent """Combined with ribavirin for chronic hepatitis C

"""^^xsd:string;
                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                    rdfs:label "combined with ribavirin for chronic hepatitis c"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#monotherapyForChronicHepatitisCIfRibavarinNotToleratedOrContraIndicated> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Monotherapy for chronic hepatitis C if ribavarin not tolerated or contra-indicated</p>"""^^<rdf:XMLLiteral>;
                                                                                                                  nicebnf:hasTextContent """Monotherapy for chronic hepatitis C if ribavarin not tolerated or contra-indicated

"""^^xsd:string;
                                                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                  rdfs:label "monotherapy for chronic hepatitis c if ribavarin not tolerated or contra-indicated"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#GFJlSpglRkavSE4IVzNIyQ>,
                                                                                                                            <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#XKOg8NaRvUqZOky_mM6Iqw>;
                                                                                              nicebnf:hasTitle """<title>Viridal<tm tmtype=\"reg\" /> Duo Continuation Pack</title>"""^^<rdf:XMLLiteral>;
                                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                                              rdfs:label "viridal duo continuation pack"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#GFJlSpglRkavSE4IVzNIyQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                        rdfs:label "initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours."^^xsd:string ; 
                                                                                                                                        nicebnf:hasDitaContent "<p>Initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                        nicebnf:hasTextContent """Initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.

"""^^xsd:string ; 
                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#PHP79498>;
                                                                                                                     a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#PHP79498> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#XKOg8NaRvUqZOky_mM6Iqw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                        rdfs:label "initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours."^^xsd:string ; 
                                                                                                                                        nicebnf:hasDitaContent "<p>Initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                        nicebnf:hasTextContent """Initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.

"""^^xsd:string ; 
                                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#neurogenicErectileDysfunction>;
                                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-continuation-pack#PHP79498>;
                                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Erectile dysfunction

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neurogenicErectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neurogenic erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Neurogenic erectile dysfunction

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "neurogenic erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intracavernosal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#FFuuGQC04EKXf4xsJbroMA>,
                                                                                                                       <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#tDk0ZANepUWrzZw9ff7XFg>;
                                                                                         nicebnf:hasTitle """<title>Viridal<tm tmtype=\"reg\" /> Duo Starter Pack</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "viridal duo starter pack"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#FFuuGQC04EKXf4xsJbroMA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>Initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """Initially 2.5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#neurogenicErectileDysfunction>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#PHP79407>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#PHP79407> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#tDk0ZANepUWrzZw9ff7XFg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>Initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """Initially 5 micrograms, increased in steps of 2.5–5 micrograms, to obtain dose suitable for producing erection not lasting more than 1 hour; usual dose 10–20 micrograms (max. per dose 40 micrograms), maximum frequency of injection not more than 2–3 times per week with at least 24 hour interval between injections; reduce dose if erection lasts longer than 2 hours.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/viridal-duo-starter-pack#PHP79407>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#erectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Erectile dysfunction

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neurogenicErectileDysfunction> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neurogenic erectile dysfunction</p>"""^^<rdf:XMLLiteral>;
                                                                        nicebnf:hasTextContent """Neurogenic erectile dysfunction

"""^^xsd:string;
                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                        rdfs:label "neurogenic erectile dysfunction"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntracavernosalInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intracavernosal injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#4sjK1rDdjk-4eXhIJnupQQ>,
                                                                                                             <http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#uzwtNKCsokCmH9tUyME_iA>;
                                                                               nicebnf:hasTitle """<title>Vistamethasone<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "vistamethasone"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#4sjK1rDdjk-4eXhIJnupQQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply 2–3 drops twice daily, dose to be applied into each nostril."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply 2–3 drops twice daily, dose to be applied into each nostril.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply 2–3 drops twice daily, dose to be applied into each nostril.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#nonInfectedInflammatoryConditionsOfNose>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#PHP80389>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#PHP80389> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#uzwtNKCsokCmH9tUyME_iA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply 2–3 drops every 3–4 hours, reduce frequency when relief obtained."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply 2–3 drops every 3–4 hours, reduce frequency when relief obtained.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply 2–3 drops every 3–4 hours, reduce frequency when relief obtained.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheEar>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#eczematousInflammationInOtitisExterna>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vistamethasone#PHP80389>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#eczematousInflammationInOtitisExterna> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Eczematous inflammation in otitis externa</p>"""^^<rdf:XMLLiteral>;
                                                                                nicebnf:hasTextContent """Eczematous inflammation in otitis externa

"""^^xsd:string;
                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                rdfs:label "eczematous inflammation in otitis externa"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#nonInfectedInflammatoryConditionsOfNose> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Non-infected inflammatory conditions of nose</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Non-infected inflammatory conditions of nose

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "non-infected inflammatory conditions of nose"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntranasalAdministration> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                      rdfs:label "by intranasal administration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheEar> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                    rdfs:label "to the ear"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#I40ynCvU5kS_GZdpKJ8kTg>,
                                                                                                                                                               <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#lgA-EFWDhEay1rqaM4oU0w>;
                                                                                                                      nicebnf:hasTitle "<title>Vitlipid N Adult emulsion for injection 10ml ampoules</title>"^^<rdf:XMLLiteral>;
                                                                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                      rdfs:label "vitlipid n adult emulsion for injection 10ml ampoules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#I40ynCvU5kS_GZdpKJ8kTg> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to <i>Intralipid</i><tm tmtype=\"reg\" />.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#PHP107297>;
                                                                                                                                             nicebnf:hasTextContent """For addition to Intralipid.

"""^^xsd:string;
                                                                                                                                             a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#PHP107297> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#PHP107339> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#lgA-EFWDhEay1rqaM4oU0w> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Vitlipid N </i>
    <tm tmtype=\"reg\" /> adult emulsion contains vitamin A 330 units, ergocalciferol 20 units, <i>dl</i>-alpha tocopherol 1 unit, phytomenadione 15 micrograms/mL.</p>
  <p>For adults and children over 11 years.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-adult-emulsion-for-injection-10ml-ampoules#PHP107339>;
                                                                                                                                             nicebnf:hasTextContent """Vitlipid N  adult emulsion contains vitamin A 330 units, ergocalciferol 20 units, dl-alpha tocopherol 1 unit, phytomenadione 15 micrograms/mL.

For adults and children over 11 years.

"""^^xsd:string;
                                                                                                                                             a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#CidZd7V-CkmnAL_F_exWWQ>,
                                                                                                                                                                <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#Jkbf_hY5tkOIXtpf1bKw6Q>;
                                                                                                                       nicebnf:hasTitle "<title>Vitlipid N Infant emulsion for injection 10ml ampoules</title>"^^<rdf:XMLLiteral>;
                                                                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                                       rdfs:label "vitlipid n infant emulsion for injection 10ml ampoules"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#CidZd7V-CkmnAL_F_exWWQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>
    <i>Vitlipid N </i>
    <tm tmtype=\"reg\" /> infant emulsion contains vitamin A 230 units, ergocalciferol 40 units, <i>dl</i>-alpha tocopherol 0.7 unit, phytomenadione 20 micrograms/mL.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#PHP107343>;
                                                                                                                                              nicebnf:hasTextContent """Vitlipid N  infant emulsion contains vitamin A 230 units, ergocalciferol 40 units, dl-alpha tocopherol 0.7 unit, phytomenadione 20 micrograms/mL.

"""^^xsd:string;
                                                                                                                                              a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#Jkbf_hY5tkOIXtpf1bKw6Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>For addition to <i>Intralipid</i><tm tmtype=\"reg\" />.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#PHP107298>;
                                                                                                                                              nicebnf:hasTextContent """For addition to Intralipid.

"""^^xsd:string;
                                                                                                                                              a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#PHP107298> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vitlipid-n-infant-emulsion-for-injection-10ml-ampoules#PHP107343> a nicebnf:PrescribingAndDispensingInformations.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#OkJPDpdGcUuLkK6sBuV8Ig>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#OyQmy4yy-0mhvsE1dRjdew>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#Q_ogpNlwcECylnAKaRPZmQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#T5ljUieND0aKkmQK52BqmQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#zg6dPoFNWEeCmqf2Wi2lhQ>;
                                                                        nicebnf:hasTitle """<title>Vivadex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "vivadex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#OkJPDpdGcUuLkK6sBuV8Ig> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#OyQmy4yy-0mhvsE1dRjdew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 200–300 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 200–300 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 200–300 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#Q_ogpNlwcECylnAKaRPZmQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "seek specialist advice."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Seek specialist advice.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Seek specialist advice.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#T5ljUieND0aKkmQK52BqmQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 100–200 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 100–200 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 100–200 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#zg6dPoFNWEeCmqf2Wi2lhQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 75 micrograms/kg daily in 2 divided doses."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 75 micrograms/kg daily in 2 divided doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 75 micrograms/kg daily in 2 divided doses.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/vivadex#PHP80125>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#allograftRejectionResistantToConventionalImmunosuppressiveTherapy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Allograft rejection resistant to conventional immunosuppressive therapy</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Allograft rejection resistant to conventional immunosuppressive therapy

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "allograft rejection resistant to conventional immunosuppressive therapy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationFollowingAntibodyInductionStartingWithin5DaysOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation following antibody induction, starting within 5 days of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingHeartTransplantationWithoutAntibodyInductionStartingWithin12HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                 nicebnf:hasTextContent """Prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation

"""^^xsd:string;
                                                                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                 rdfs:label "prophylaxis of graft rejection following heart transplantation without antibody induction, starting within 12 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingKidneyTransplantationStartingWithin24HoursOfTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                          nicebnf:hasTextContent """Prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation

"""^^xsd:string;
                                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                          rdfs:label "prophylaxis of graft rejection following kidney transplantation, starting within 24 hours of transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfGraftRejectionFollowingLiverTransplantationStarting12HoursAfterTransplantation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                      nicebnf:hasTextContent """Prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation

"""^^xsd:string;
                                                                                                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                      rdfs:label "prophylaxis of graft rejection following liver transplantation, starting 12 hours after transplantation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-75mg-sr-tablets> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-75mg-sr-tablets#hnENaJT7jE2EX9QX12mfPw>;
                                                                                         nicebnf:hasTitle """<title>Voltarol<tm tmtype=\"reg\" /> 75mg SR tablets</title>"""^^<rdf:XMLLiteral>;
                                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                                         rdfs:label "voltarol 75mg sr tablets"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-75mg-sr-tablets#PHP99750> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-75mg-sr-tablets#hnENaJT7jE2EX9QX12mfPw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                   rdfs:label "1 tablet 1–2 times a day."^^xsd:string ; 
                                                                                                                                   nicebnf:hasDitaContent "<p>1 tablet 1–2 times a day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                   nicebnf:hasTextContent """1 tablet 1–2 times a day.

"""^^xsd:string ; 
                                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteGout>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders>,
                                                                                                                                      <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-75mg-sr-tablets#PHP99750>;
                                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteGout> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute gout</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Acute gout

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "acute gout"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                    nicebnf:hasTextContent """Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders

"""^^xsd:string;
                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                    rdfs:label "pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-emulgel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-emulgel#3GR8AXPj7k-KZrjRBTeQew>;
                                                                                 nicebnf:hasTitle """<title>Voltarol<tm tmtype=\"reg\" /> Emulgel</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "voltarol emulgel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-emulgel#3GR8AXPj7k-KZrjRBTeQew> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "apply 3–4 times a day, therapy should be reviewed after 14 days (or after 28 days for osteoarthritis)."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Apply 3–4 times a day, therapy should be reviewed after 14 days (or after 28 days for osteoarthritis).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Apply 3–4 times a day, therapy should be reviewed after 14 days (or after 28 days for osteoarthritis).

"""^^xsd:string];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjunctiveTreatmentInKneeOrHandOsteoarthritis>,
                                                                                                                              <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInMusculoskeletalConditions>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-emulgel#PHP82874>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-emulgel#PHP82874> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#adjunctiveTreatmentInKneeOrHandOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjunctive treatment in knee or hand osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                                        nicebnf:hasTextContent """Adjunctive treatment in knee or hand osteoarthritis

"""^^xsd:string;
                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                        rdfs:label "adjunctive treatment in knee or hand osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInMusculoskeletalConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of pain in musculoskeletal conditions</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Relief of pain in musculoskeletal conditions

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "relief of pain in musculoskeletal conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#MsT_RKwECE2ZC0ABQcEPrg>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#wkHWfeE1QUuR0ILyWu7-jw>;
                                                                                   nicebnf:hasTitle """<title>Voltarol<tm tmtype=\"reg\" /> gel patch</title>"""^^<rdf:XMLLiteral>;
                                                                                   a nicebnf:ClinicalMedicinalProductInformation;
                                                                                   rdfs:label "voltarol gel patch"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#MsT_RKwECE2ZC0ABQcEPrg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "apply 1 patch twice daily for up to 14 days."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply 1 patch twice daily for up to 14 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply 1 patch twice daily for up to 14 days.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#epicondylitis>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#PHP82922>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#PHP82922> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#wkHWfeE1QUuR0ILyWu7-jw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                             rdfs:label "apply 1 patch daily for up to 3 days."^^xsd:string ; 
                                                                                                                             nicebnf:hasDitaContent "<p>Apply 1 patch daily for up to 3 days.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                             nicebnf:hasTextContent """Apply 1 patch daily for up to 3 days.

"""^^xsd:string ; 
                                                                                                                             nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                          nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#ankleSprain>;
                                                                                                          nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-gel-patch#PHP82922>;
                                                                                                          a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#ankleSprain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ankle sprain</p>"""^^<rdf:XMLLiteral>;
                                                      nicebnf:hasTextContent """Ankle sprain

"""^^xsd:string;
                                                      a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                      rdfs:label "ankle sprain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#epicondylitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Epicondylitis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Epicondylitis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "epicondylitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-retard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-retard#_ZGht4NQpEKBX6SUjY4EUg>;
                                                                                nicebnf:hasTitle """<title>Voltarol<tm tmtype=\"reg\" /> Retard</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "voltarol retard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-retard#PHP82810> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-retard#_ZGht4NQpEKBX6SUjY4EUg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "1 tablet once daily."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>1 tablet once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """1 tablet once daily.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteGout>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders>,
                                                                                                                             <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-retard#PHP82810>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteGout> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute gout</p>"""^^<rdf:XMLLiteral>;
                                                    nicebnf:hasTextContent """Acute gout

"""^^xsd:string;
                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                    rdfs:label "acute gout"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#painAndInflammationInRheumaticDiseaseIncludingJuvenileIdiopathicArthritisAndOtherMusculoskeletalDisorders> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                    nicebnf:hasTextContent """Pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders

"""^^xsd:string;
                                                                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                    rdfs:label "pain and inflammation in rheumatic disease (including juvenile idiopathic arthritis) and other musculoskeletal disorders"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#4PeWP3ATA0SW0KjZLcwXxw>,
                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#Bx_EPnQoSEW--KMKUzBf0Q>,
                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#GrJj63m160iSBOjjtIsArg>,
                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#k-aGz97ctky4sDhewKZp6w>,
                                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#wMyZohCNlEWzOSCv4Fo0nQ>;
                                                                                                nicebnf:hasTitle """<title>Voltarol<tm tmtype=\"reg\" /> solution for injection</title>"""^^<rdf:XMLLiteral>;
                                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                                rdfs:label "voltarol solution for injection"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#4PeWP3ATA0SW0KjZLcwXxw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#Bx_EPnQoSEW--KMKUzBf0Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "75 mg, then 75 mg after 30 minutes if required."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>75 mg, then 75 mg after 30 minutes if required.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """75 mg, then 75 mg after 30 minutes if required.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#uretericColic>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#GrJj63m160iSBOjjtIsArg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """75 mg 1–2 times a day for maximum 2 days, twice daily administration in severe cases, to be injected into the gluteal muscle.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPain>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#k-aGz97ctky4sDhewKZp6w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "75 mg, then 75 mg after 4–6 hours if required for maximum 2 days; maximum 150 mg per day."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>75 mg, then 75 mg after 4–6 hours if required for maximum 2 days; maximum 150 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """75 mg, then 75 mg after 4–6 hours if required for maximum 2 days; maximum 150 mg per day.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acutePostoperativePainInHospitalSetting>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#wMyZohCNlEWzOSCv4Fo0nQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                                          rdfs:label "initially 25–50 mg, to be given after surgery over 15–60 minutes, then 5 mg/hour for maximum 2 days; maximum 150 mg per day."^^xsd:string ; 
                                                                                                                                          nicebnf:hasDitaContent "<p>Initially 25–50 mg, to be given after surgery over 15–60 minutes, then 5 mg/hour for maximum 2 days; maximum 150 mg per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                                          nicebnf:hasTextContent """Initially 25–50 mg, to be given after surgery over 15–60 minutes, then 5 mg/hour for maximum 2 days; maximum 150 mg per day.

"""^^xsd:string ; 
                                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPostoperativePainInHospitalSetting>;
                                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voltarol-solution-for-injection#PHP106720>;
                                                                                                                       a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteExacerbationsOfPain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute exacerbations of pain</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Acute exacerbations of pain

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "acute exacerbations of pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#acutePostoperativePainInHospitalSetting> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute postoperative pain (in hospital setting)</p>"""^^<rdf:XMLLiteral>;
                                                                                  nicebnf:hasTextContent """Acute postoperative pain (in hospital setting)

"""^^xsd:string;
                                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                  rdfs:label "acute postoperative pain (in hospital setting)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#postoperativePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Postoperative pain</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Postoperative pain

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "postoperative pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfPostoperativePainInHospitalSetting> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of postoperative pain (in hospital setting)</p>"""^^<rdf:XMLLiteral>;
                                                                                         nicebnf:hasTextContent """Prevention of postoperative pain (in hospital setting)

"""^^xsd:string;
                                                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                         rdfs:label "prevention of postoperative pain (in hospital setting)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#uretericColic> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ureteric colic</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Ureteric colic

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "ureteric colic"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byDeepIntramuscularInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                        rdfs:label "by deep intramuscular injection"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/volulyte-infusion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/volulyte-infusion#2tN6H6xJ80yf4d0CCh3NpQ>;
                                                                                  nicebnf:hasTitle """<title>Volulyte<tm tmtype=\"reg\" /> Infusion</title>"""^^<rdf:XMLLiteral>;
                                                                                  a nicebnf:ClinicalMedicinalProductInformation;
                                                                                  rdfs:label "volulyte infusion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/volulyte-infusion#2tN6H6xJ80yf4d0CCh3NpQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                            rdfs:label "initially 10–20 ml, then increased to up to 30 ml/kilogram daily for a maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible."^^xsd:string ; 
                                                                                                                            nicebnf:hasDitaContent "<p>Initially 10–20 mL, then increased to up to 30 mL/kilogram daily for a maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                            nicebnf:hasTextContent """Initially 10–20 mL, then increased to up to 30 mL/kilogram daily for a maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible.

"""^^xsd:string ; 
                                                                                                                            nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                         nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHypovolaemiaDueToAcuteBloodLossWhenCrystalloidsAloneAreNotSufficient>;
                                                                                                         nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/volulyte-infusion#PHP107945>;
                                                                                                         a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/volulyte-infusion#PHP107945> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHypovolaemiaDueToAcuteBloodLossWhenCrystalloidsAloneAreNotSufficient> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/voluven-infusion> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/voluven-infusion#an4CVX442UypQNpxHLVwAA>;
                                                                                 nicebnf:hasTitle """<title>Voluven<tm tmtype=\"reg\" /> Infusion</title>"""^^<rdf:XMLLiteral>;
                                                                                 a nicebnf:ClinicalMedicinalProductInformation;
                                                                                 rdfs:label "voluven infusion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voluven-infusion#PHP107946> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/voluven-infusion#an4CVX442UypQNpxHLVwAA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                           rdfs:label "initially 10–20 ml, then increased to up to 30 ml/kilogram daily for maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible."^^xsd:string ; 
                                                                                                                           nicebnf:hasDitaContent "<p>Initially 10–20 mL, then increased to up to 30 mL/kilogram daily for maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                           nicebnf:hasTextContent """Initially 10–20 mL, then increased to up to 30 mL/kilogram daily for maximum duration of treatment of 24 hours, the initial dose must be given slowly and with careful monitoring of the patient to allow any anaphylactic reaction to be detected as early as possible.

"""^^xsd:string ; 
                                                                                                                           nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                        nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHypovolaemiaDueToAcuteBloodLossWhenCrystalloidsAloneAreNotSufficient>;
                                                                                                        nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/voluven-infusion#PHP107946>;
                                                                                                        a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfHypovolaemiaDueToAcuteBloodLossWhenCrystalloidsAloneAreNotSufficient> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient</p>"""^^<rdf:XMLLiteral>;
                                                                                                                          nicebnf:hasTextContent """Treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient

"""^^xsd:string;
                                                                                                                          a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                          rdfs:label "treatment of hypovolaemia due to acute blood loss when crystalloids alone are not sufficient"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#rOEFOi8Vk02Ph72EJPGLEw>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#u9gVxiwFukqN_QgdiVL2zQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PvTxuotnDk6tsS2gwrt8-Q>;
                                                                        nicebnf:hasTitle """<title>Votubia<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "votubia"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PHP79978> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PHP80013> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PvTxuotnDk6tsS2gwrt8-Q> nicebnf:hasDitaContent """<sectiondiv>
  <p>Tablets may be dispersed in approximately 30 mL of water by gently stirring, immediately before drinking. After solution has been swallowed, any residue must be re-dispersed in the same volume of water and swallowed.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PHP80013>;
                                                                                               nicebnf:hasTextContent """Tablets may be dispersed in approximately 30 mL of water by gently stirring, immediately before drinking. After solution has been swallowed, any residue must be re-dispersed in the same volume of water and swallowed.

"""^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#rOEFOi8Vk02Ph72EJPGLEw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#subependymalGiantCellAstrocytomaAssociatedWithTuberousSclerosisComplex>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PHP79978>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#u9gVxiwFukqN_QgdiVL2zQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "(consult product literature)."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>(consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """(consult product literature).

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#renalAngiomyolipomaAssociatedWithTuberousSclerosisComplex>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/votubia#PHP79978>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#renalAngiomyolipomaAssociatedWithTuberousSclerosisComplex> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Renal angiomyolipoma associated with tuberous sclerosis complex</p>"""^^<rdf:XMLLiteral>;
                                                                                                    nicebnf:hasTextContent """Renal angiomyolipoma associated with tuberous sclerosis complex

"""^^xsd:string;
                                                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                    rdfs:label "renal angiomyolipoma associated with tuberous sclerosis complex"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#subependymalGiantCellAstrocytomaAssociatedWithTuberousSclerosisComplex> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Subependymal giant cell astrocytoma associated with tuberous sclerosis complex</p>"""^^<rdf:XMLLiteral>;
                                                                                                                 nicebnf:hasTextContent """Subependymal giant cell astrocytoma associated with tuberous sclerosis complex

"""^^xsd:string;
                                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                 rdfs:label "subependymal giant cell astrocytoma associated with tuberous sclerosis complex"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-cream> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-cream#yJBcNPQLuUS7BSuuHmqZJA>;
                                                                               nicebnf:hasTitle """<title>Warticon<tm tmtype=\"reg\" /> cream</title>"""^^<rdf:XMLLiteral>;
                                                                               a nicebnf:ClinicalMedicinalProductInformation;
                                                                               rdfs:label "warticon cream"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-cream#PHP85431> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-cream#yJBcNPQLuUS7BSuuHmqZJA> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                         rdfs:label "apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm2."^^xsd:string ; 
                                                                                                                         nicebnf:hasDitaContent "<p>Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm<sup>2</sup>.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                         nicebnf:hasTextContent """Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm2.

"""^^xsd:string ; 
                                                                                                                         nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                      nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia>;
                                                                                                      nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-cream#PHP85431>;
                                                                                                      a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Condylomata acuminata affecting the penis or the female external genitalia</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Condylomata acuminata affecting the penis or the female external genitalia

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "condylomata acuminata affecting the penis or the female external genitalia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-liquid> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-liquid#Mw_yyFGYmUuUv_6DHfqIYw>;
                                                                                nicebnf:hasTitle """<title>Warticon<tm tmtype=\"reg\" /> liquid</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "warticon liquid"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-liquid#Mw_yyFGYmUuUv_6DHfqIYw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm2, maximum 50 single applications (‘loops’) per session (consult product literature)."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm<sup>2</sup>, maximum 50 single applications (‘loops’) per session (consult product literature).</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """Apply twice daily for 3 consecutive days, treatment may be repeated at weekly intervals if necessary for a total of four 3-day treatment courses, direct medical supervision for lesions greater than 4 cm2, maximum 50 single applications (‘loops’) per session (consult product literature).

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-liquid#PHP85497>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/warticon-liquid#PHP85497> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#condylomataAcuminataAffectingThePenisOrTheFemaleExternalGenitalia> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Condylomata acuminata affecting the penis or the female external genitalia</p>"""^^<rdf:XMLLiteral>;
                                                                                                            nicebnf:hasTextContent """Condylomata acuminata affecting the penis or the female external genitalia

"""^^xsd:string;
                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                            rdfs:label "condylomata acuminata affecting the penis or the female external genitalia"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/welldorm-elixir> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/welldorm-elixir#7u7Dx1jP0kKdkyS1ACVGBw>;
                                                                                nicebnf:hasTitle """<title>Welldorm<tm tmtype=\"reg\" /> elixir</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "welldorm elixir"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/welldorm-elixir#7u7Dx1jP0kKdkyS1ACVGBw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "15–45 ml, alternatively 0.4–1.3 g, dose to be taken with water or milk at bedtime; maximum 70 ml per day; maximum 2 g per day."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>15–45 mL, alternatively 0.4–1.3 g, dose to be taken with water or milk at bedtime; maximum 70 mL per day; maximum 2 g per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """15–45 mL, alternatively 0.4–1.3 g, dose to be taken with water or milk at bedtime; maximum 70 mL per day; maximum 2 g per day.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#insomniaShortTermUse>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/welldorm-elixir#PHP79017>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/welldorm-elixir#PHP79017> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#insomniaShortTermUse> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Insomnia (short-term use)</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Insomnia (short-term use)

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "insomnia (short-term use)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva> nicebnf:hasContraindicationsGroup <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#z3HY0S_NCU-wHiw0s5t7fg>;
                                                                      nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#V_KbI8j6lUyVO4iNKfSm4g>,
                                                                                                    <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#zUIncOsyIEinpEd9D8RaDw>;
                                                                      nicebnf:hasTitle """<title>XGEVA<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "xgeva"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#PHP82351> a nicebnf:ContraIndications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#PHP82354> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#V_KbI8j6lUyVO4iNKfSm4g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "120 mg every 4 weeks, supplementation of at least calcium 500 mg and vitamin d 400 units daily should also be taken unless hypercalcaemia is present."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>120 mg every 4 weeks, supplementation of at least Calcium 500 mg and vitamin D 400 units daily should also be taken unless hypercalcaemia is present.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """120 mg every 4 weeks, supplementation of at least Calcium 500 mg and vitamin D 400 units daily should also be taken unless hypercalcaemia is present.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfSkeletalRelatedEventsInPatientsWithBoneMetastasesFromSolidTumours>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#PHP82354>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#z3HY0S_NCU-wHiw0s5t7fg> nicebnf:hasContraindication <http://ld.nice.org.uk/ns/bnf/Contraindication#unhealedLesionsFromDentalOrOralSurgery>;
                                                                                             nicebnf:hasDitaContent """<p>
  <ph outputclass=\"contraindication\">Unhealed lesions from dental or oral surgery</ph>
</p>"""^^<rdf:XMLLiteral>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#PHP82351>;
                                                                                             nicebnf:hasTextContent """Unhealed lesions from dental or oral surgery

"""^^xsd:string;
                                                                                             a nicebnf:ContraindicationsGroup,
                                                                                               nicebnf:GeneralContraindications.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#zUIncOsyIEinpEd9D8RaDw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "120 mg every 4 weeks, give additional dose on days 8 and 15 of the first month of treatment only, supplementation of at least calcium 500 mg and vitamin d 400 units daily should also be taken unless hypercalcaemia is present."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>120 mg every 4 weeks, give additional dose on days 8 and 15 of the first month of treatment only, supplementation of at least Calcium 500 mg and vitamin D 400 units daily should also be taken unless hypercalcaemia is present.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """120 mg every 4 weeks, give additional dose on days 8 and 15 of the first month of treatment only, supplementation of at least Calcium 500 mg and vitamin D 400 units daily should also be taken unless hypercalcaemia is present.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfGiantCellTumourOfBoneThatIsUnresectableOrWhereSurgicalResectionIsLikelyToResultInSevereMorbidityInAdultsAndSkeletallyMatureAdolescent>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xgeva#PHP82354>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Contraindication#unhealedLesionsFromDentalOrOralSurgery> nicebnf:hasDitaContent """<ph outputclass=\"contraindication\">Unhealed lesions from dental or oral surgery</ph>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent "Unhealed lesions from dental or oral surgery"^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Contraindication>;
                                                                                       rdfs:label "unhealed lesions from dental or oral surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfSkeletalRelatedEventsInPatientsWithBoneMetastasesFromSolidTumours> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of skeletal related events in patients with bone metastases from solid tumours</p>"""^^<rdf:XMLLiteral>;
                                                                                                                        nicebnf:hasTextContent """Prevention of skeletal related events in patients with bone metastases from solid tumours

"""^^xsd:string;
                                                                                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                        rdfs:label "prevention of skeletal related events in patients with bone metastases from solid tumours"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#treatmentOfGiantCellTumourOfBoneThatIsUnresectableOrWhereSurgicalResectionIsLikelyToResultInSevereMorbidityInAdultsAndSkeletallyMatureAdolescent> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Treatment of giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity in adults and skeletally mature adolescent</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                           nicebnf:hasTextContent """Treatment of giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity in adults and skeletally mature adolescent

"""^^xsd:string;
                                                                                                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                           rdfs:label "treatment of giant cell tumour of bone that is unresectable or where surgical resection is likely to result in severe morbidity in adults and skeletally mature adolescent"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#-OGRqGmITkyOOU-t99Yujw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#V3CIFNGYFECwNzhya-GkMw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#VfH0GZYrjkidGOwva_b8Yw>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#qm94rJAvcEG_oqcvqnKBPg>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#yv7FJH01dEmRWh2YqidsQw>;
                                                                          nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#qdZ4ZRV7FEOE6At2sz70HQ>;
                                                                          nicebnf:hasTitle """<title>Xylocaine<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "xylocaine"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#-OGRqGmITkyOOU-t99Yujw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "up to 20 doses."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Up to 20 doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Up to 20 doses.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#duringDeliveryInObstetrics>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP94579> a nicebnf:ProfessionSpecificInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#V3CIFNGYFECwNzhya-GkMw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "up to 20 doses."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Up to 20 doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Up to 20 doses.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#bronchoscopy>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#endotrachealIntubation>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#laryngoscopy>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#oesophagoscopy>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#VfH0GZYrjkidGOwva_b8Yw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "apply thinly to the ulcer using a cotton bud."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>Apply thinly to the ulcer using a cotton bud.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """Apply thinly to the ulcer using a cotton bud.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInOralLesions>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#qdZ4ZRV7FEOE6At2sz70HQ> nicebnf:hasDitaContent """<sectiondiv>
  <p>May be prescribed as lidocaine spray 10%.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP94579>;
                                                                                                 nicebnf:hasTextContent """May be prescribed as lidocaine spray 10%.

"""^^xsd:string;
                                                                                                 a nicebnf:DentalPractitionersFormularyInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#qm94rJAvcEG_oqcvqnKBPg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "1–5 doses."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>1–5 doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """1–5 doses.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dentalPractice>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#yv7FJH01dEmRWh2YqidsQw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "3 doses."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>3 doses.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """3 doses.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#maxillarySinusPuncture>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/xylocaine#PHP82949>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#bronchoscopy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Bronchoscopy</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Bronchoscopy

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "bronchoscopy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#dentalPractice> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dental practice</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Dental practice

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "dental practice"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#duringDeliveryInObstetrics> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">During delivery in obstetrics</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """During delivery in obstetrics

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "during delivery in obstetrics"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endotrachealIntubation> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endotracheal intubation</p>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent """Endotracheal intubation

"""^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                 rdfs:label "endotracheal intubation"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#laryngoscopy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Laryngoscopy</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Laryngoscopy

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "laryngoscopy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#maxillarySinusPuncture> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Maxillary sinus puncture</p>"""^^<rdf:XMLLiteral>;
                                                                 nicebnf:hasTextContent """Maxillary sinus puncture

"""^^xsd:string;
                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                 rdfs:label "maxillary sinus puncture"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#oesophagoscopy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Oesophagoscopy</p>"""^^<rdf:XMLLiteral>;
                                                         nicebnf:hasTextContent """Oesophagoscopy

"""^^xsd:string;
                                                         a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                         rdfs:label "oesophagoscopy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reliefOfPainInOralLesions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Relief of pain in oral lesions</p>"""^^<rdf:XMLLiteral>;
                                                                    nicebnf:hasTextContent """Relief of pain in oral lesions

"""^^xsd:string;
                                                                    a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                    rdfs:label "relief of pain in oral lesions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toMucousMembranes> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                             rdfs:label "to mucous membranes"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheLesion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                       rdfs:label "to the lesion"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zacin> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zacin#wVBrNwiveUuLy4lTF7VNFw>;
                                                                      nicebnf:hasTitle """<title>Zacin<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "zacin"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zacin#PHP84331> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zacin#wVBrNwiveUuLy4lTF7VNFw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "apply 4 times a day, dose to be applied sparingly, not more often than every 4 hours."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Apply 4 times a day, dose to be applied sparingly, not more often than every 4 hours.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Apply 4 times a day, dose to be applied sparingly, not more often than every 4 hours.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefInOsteoarthritis>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zacin#PHP84331>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#symptomaticReliefInOsteoarthritis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Symptomatic relief in osteoarthritis</p>"""^^<rdf:XMLLiteral>;
                                                                            nicebnf:hasTextContent """Symptomatic relief in osteoarthritis

"""^^xsd:string;
                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                            rdfs:label "symptomatic relief in osteoarthritis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeffix> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zeffix#g6GcOR_zR0euCwx7kbxFBg>;
                                                                       nicebnf:hasTitle """<title>Zeffix<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "zeffix"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeffix#PHP83728> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeffix#g6GcOR_zR0euCwx7kbxFBg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "100 mg once daily, patients receiving lamivudine for concomitant hiv infection should continue to receive lamivudine in a dose appropriate for hiv infection."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>100 mg once daily, patients receiving lamivudine for concomitant HIV infection should continue to receive lamivudine in a dose appropriate for HIV infection.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """100 mg once daily, patients receiving lamivudine for concomitant HIV infection should continue to receive lamivudine in a dose appropriate for HIV infection.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisBInfectionEitherWithCompensatedLiverDiseaseWithEvidenceOfViralReplicationAndHistologyOfActiveLiverInflammationOrFibrosisWhenFirstLineTreatmentsCannotBeUsedOrInCombinationWithAnotherAntiviralDrugWithoutCrossResistanceToLamivudineWithDecompensatedLiverDisease>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zeffix#PHP83728>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#chronicHepatitisBInfectionEitherWithCompensatedLiverDiseaseWithEvidenceOfViralReplicationAndHistologyOfActiveLiverInflammationOrFibrosisWhenFirstLineTreatmentsCannotBeUsedOrInCombinationWithAnotherAntiviralDrugWithoutCrossResistanceToLamivudineWithDecompensatedLiverDisease> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Chronic hepatitis B infection either with compensated liver disease (with evidence of viral replication and histology of active liver inflammation or fibrosis) when first-line treatments cannot be used, or (in combination with another antiviral drug without cross-resistance to lamivudine) with decompensated liver disease</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                                                                                                                                                            nicebnf:hasTextContent """Chronic hepatitis B infection either with compensated liver disease (with evidence of viral replication and histology of active liver inflammation or fibrosis) when first-line treatments cannot be used, or (in combination with another antiviral drug without cross-resistance to lamivudine) with decompensated liver disease

"""^^xsd:string;
                                                                                                                                                                                                                                                                                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                                                                                                                                                            rdfs:label "chronic hepatitis b infection either with compensated liver disease (with evidence of viral replication and histology of active liver inflammation or fibrosis) when first-line treatments cannot be used, or (in combination with another antiviral drug without cross-resistance to lamivudine) with decompensated liver disease"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemon> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemon#JX6Zvhh38EeB2q519qvN9g>;
                                                                      nicebnf:hasTitle """<title>Zemon<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                      a nicebnf:ClinicalMedicinalProductInformation;
                                                                      rdfs:label "zemon"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemon#JX6Zvhh38EeB2q519qvN9g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                rdfs:label "initially 30 mg daily for 2–4 days, to minimise possibility of headache, then 40–60 mg daily, increased if necessary to 80–120 mg once daily, to be taken in the morning."^^xsd:string ; 
                                                                                                                nicebnf:hasDitaContent "<p>Initially 30 mg daily for 2–4 days, to minimise possibility of headache, then 40–60 mg daily, increased if necessary to 80–120 mg once daily, to be taken in the morning.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                nicebnf:hasTextContent """Initially 30 mg daily for 2–4 days, to minimise possibility of headache, then 40–60 mg daily, increased if necessary to 80–120 mg once daily, to be taken in the morning.

"""^^xsd:string ; 
                                                                                                                nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                             nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina>;
                                                                                             nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemon#PHP63096>;
                                                                                             a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemon#PHP63096> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#prophylaxisOfAngina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>"""^^<rdf:XMLLiteral>;
                                                              nicebnf:hasTextContent """Prophylaxis of angina

"""^^xsd:string;
                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                              rdfs:label "prophylaxis of angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#RL8kWZ96iEWOLXp_o86YDQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#tcTL8e9mSUi8YYRF146Nfg>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#HSuYC4cFbkOuxaZSE3hhaw>,
                                                                                                                 <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#aCrV40FZGkm9FZJlfon5oA>;
                                                                        nicebnf:hasTitle """<title>Zemtard<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "zemtard"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#HSuYC4cFbkOuxaZSE3hhaw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60067>;
                                                                                               nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                               a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60051> a nicebnf:RenalImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60067> a nicebnf:HepaticImpairment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60076> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#RL8kWZ96iEWOLXp_o86YDQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "180–300 mg daily, increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>180–300 mg daily, increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """180–300 mg daily, increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                  rdfs:label "initially 120 mg daily, increased if necessary to 360 mg daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 120 mg daily, increased if necessary to 360 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 120 mg daily, increased if necessary to 360 mg daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60076>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#aCrV40FZGkm9FZJlfon5oA> nicebnf:hasDitaContent """<sectiondiv>
  <p>Dose for angina and mild to moderate hypertension—initially 120 mg once daily.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60051>;
                                                                                               nicebnf:hasTextContent """Dose for angina and mild to moderate hypertension—initially 120 mg once daily.

"""^^xsd:string;
                                                                                               a nicebnf:DoseAdjustment.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#tcTL8e9mSUi8YYRF146Nfg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "180–300 mg daily, increased if necessary to 480 mg daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>180–300 mg daily, increased if necessary to 480 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """180–300 mg daily, increased if necessary to 480 mg daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>],
                                                                                                                 [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                  rdfs:label "initially 120 mg daily, increased if necessary to 480 mg daily."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 120 mg daily, increased if necessary to 480 mg daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 120 mg daily, increased if necessary to 480 mg daily.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#angina>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zemtard#PHP60076>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#angina> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Angina</p>"""^^<rdf:XMLLiteral>;
                                                 nicebnf:hasTextContent """Angina

"""^^xsd:string;
                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                 rdfs:label "angina"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#mildToModerateHypertension> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Mild to moderate hypertension

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "mild to moderate hypertension"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#-WQof-E2tEaw3R1DSo9HxQ>,
                                                                                                        <http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#IVM6Wzp8IU6YLPsZY3ujqQ>;
                                                                          nicebnf:hasTitle """<title>Zerolatum<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                          a nicebnf:ClinicalMedicinalProductInformation;
                                                                          rdfs:label "zerolatum"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#-WQof-E2tEaw3R1DSo9HxQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                    rdfs:label "5–10 ml/bath."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>5–10 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """5–10 mL/bath.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                    rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                   [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                    rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#dermatitis>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions>,
                                                                                                                       <http://ld.nice.org.uk/ns/bnf/Indication#ichthyosis>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#PHP106106>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#IVM6Wzp8IU6YLPsZY3ujqQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> ; 
                                                                                                                    rdfs:label "15–20 ml/bath."^^xsd:string ; 
                                                                                                                    nicebnf:hasDitaContent "<p>15–20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                    nicebnf:hasTextContent """15–20 mL/bath.

"""^^xsd:string ; 
                                                                                                                    nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                 nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly>;
                                                                                                 nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#PHP106106>;
                                                                                                 a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zerolatum#PHP106106> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#dermatitis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dermatitis</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Dermatitis

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "dermatitis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditions> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions</p>"""^^<rdf:XMLLiteral>;
                                                            nicebnf:hasTextContent """Dry skin conditions

"""^^xsd:string;
                                                            a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                            rdfs:label "dry skin conditions"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#ichthyosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Ichthyosis</p>"""^^<rdf:XMLLiteral>;
                                                     nicebnf:hasTextContent """Ichthyosis

"""^^xsd:string;
                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                     rdfs:label "ichthyosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pruritusOfTheElderly> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pruritus of the elderly</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Pruritus of the elderly

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "pruritus of the elderly"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#elderly> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                    rdfs:label "elderly"^^xsd:string;
                                                    rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeroneum> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zeroneum#gKPKI0JKbUOhQVwMGn-AGw>;
                                                                         nicebnf:hasTitle """<title>Zeroneum<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "zeroneum"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeroneum#PHP106427> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zeroneum#gKPKI0JKbUOhQVwMGn-AGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> ; 
                                                                                                                   rdfs:label "5 ml/bath."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>5 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """5 mL/bath.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                   rdfs:label "20 ml/bath."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """20 mL/bath.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "20 ml/bath."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>20 mL/bath.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """20 mL/bath.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zeroneum#PHP106427>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#drySkinConditionsIncludingEczema> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Dry skin conditions including eczema</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Dry skin conditions including eczema

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "dry skin conditions including eczema"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1Month11Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                               rdfs:label "child 1 month–11 years"^^xsd:string;
                                                               rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zindaclin-gel> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zindaclin-gel#_UKiyMH8PEW-LJeOx_0shQ>;
                                                                              nicebnf:hasTitle """<title>Zindaclin<tm tmtype=\"reg\" /> gel</title>"""^^<rdf:XMLLiteral>;
                                                                              a nicebnf:ClinicalMedicinalProductInformation;
                                                                              rdfs:label "zindaclin gel"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zindaclin-gel#PHP85300> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zindaclin-gel#_UKiyMH8PEW-LJeOx_0shQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                        rdfs:label "apply once daily, to be applied thinly."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Apply once daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Apply once daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>],
                                                                                                                       [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                        rdfs:label "apply once daily, to be applied thinly."^^xsd:string ; 
                                                                                                                        nicebnf:hasDitaContent "<p>Apply once daily, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                        nicebnf:hasTextContent """Apply once daily, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                        nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                                     nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris>;
                                                                                                     nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zindaclin-gel#PHP85300>;
                                                                                                     a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acneVulgaris> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acne vulgaris</p>"""^^<rdf:XMLLiteral>;
                                                       nicebnf:hasTextContent """Acne vulgaris

"""^^xsd:string;
                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                       rdfs:label "acne vulgaris"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex-la> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex-la#GJ4VfudRt0KRtCZ_tmDn0A>;
                                                                           nicebnf:hasTitle """<title>Zoladex LA<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                           a nicebnf:ClinicalMedicinalProductInformation;
                                                                           rdfs:label "zoladex la"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex-la#GJ4VfudRt0KRtCZ_tmDn0A> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                     rdfs:label "10.8 mg every 12 weeks, to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                     nicebnf:hasDitaContent "<p>10.8 mg every 12 weeks, to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                     nicebnf:hasTextContent """10.8 mg every 12 weeks, to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                     nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                  nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>,
                                                                                                                        <http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>;
                                                                                                  nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex-la#PHP79597>;
                                                                                                  a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex-la#PHP79597> a nicebnf:IndicationAndDosageInformation.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                              nicebnf:hasTextContent """Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                              rdfs:label "adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Locally advanced prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "locally advanced prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasTextContent """Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                rdfs:label "neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#3X-4wNCcEkOUD9ZXAjHO-Q>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#6-cBqav8nEeYs3yMd2lm-w>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#7jHCUC02jUaqsrr030AsFQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#eos2orq-n0iVOMrYTqsrSQ>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#ruvYfz9l_0ao57BqzU_sGw>;
                                                                        nicebnf:hasTitle """<title>Zoladex<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "zoladex"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#3X-4wNCcEkOUD9ZXAjHO-Q> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "3.6 mg every 28 days maximum duration of treatment 6 months (do not repeat), to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>3.6 mg every 28 days maximum duration of treatment 6 months (do not repeat), to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """3.6 mg every 28 days maximum duration of treatment 6 months (do not repeat), to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometriosis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#6-cBqav8nEeYs3yMd2lm-w> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "3.6 mg every 28 days maximum duration of treatment 3 months, to be given with supplementary iron, to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>3.6 mg every 28 days maximum duration of treatment 3 months, to be given with supplementary iron, to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """3.6 mg every 28 days maximum duration of treatment 3 months, to be given with supplementary iron, to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#beforeSurgeryInWomenWhoHaveAnaemiaDueToUterineFibroids>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#7jHCUC02jUaqsrr030AsFQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "3.6 mg, dose given to achieve pituitary down-regulation (usually 1–3 weeks) then gonadotrophin is administered (stopping gonadotrophin on administration of chorionic gonadotrophin at appropriate stage of follicular development), to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>3.6 mg, dose given to achieve pituitary down-regulation (usually 1–3 weeks) then gonadotrophin is administered (stopping gonadotrophin on administration of chorionic gonadotrophin at appropriate stage of follicular development), to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """3.6 mg, dose given to achieve pituitary down-regulation (usually 1–3 weeks) then gonadotrophin is administered (stopping gonadotrophin on administration of chorionic gonadotrophin at appropriate stage of follicular development), to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#pituitaryDesensitisationBeforeInductionOfOvulationByGonadotrophinsForInVitroFertilisationAfterExclusionOfPregnancyUnderExpertSupervision>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#eos2orq-n0iVOMrYTqsrSQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "3.6 mg, dose may be repeated after 28 days if uterus is large or to allow flexible surgical timing, to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>3.6 mg, dose may be repeated after 28 days if uterus is large or to allow flexible surgical timing, to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """3.6 mg, dose may be repeated after 28 days if uterus is large or to allow flexible surgical timing, to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#endometrialThinningBeforeIntraUterineSurgery>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#ruvYfz9l_0ao57BqzU_sGw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "3.6 mg every 28 days, to be administered into the anterior abdominal wall."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>3.6 mg every 28 days, to be administered into the anterior abdominal wall.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """3.6 mg every 28 days, to be administered into the anterior abdominal wall.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#advancedBreastCancer>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer>,
                                                                                                                     <http://ld.nice.org.uk/ns/bnf/Indication#oestrogenReceptorPositiveEarlyBreastCancer>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zoladex#PHP79573>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#adjuvantTreatmentToRadiotherapyOrRadicalProstatectomyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                              nicebnf:hasTextContent """Adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                              a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                              rdfs:label "adjuvant treatment to radiotherapy or radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#advancedBreastCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Advanced breast cancer</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Advanced breast cancer

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "advanced breast cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#beforeSurgeryInWomenWhoHaveAnaemiaDueToUterineFibroids> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Before surgery in women who have anaemia due to uterine fibroids</p>"""^^<rdf:XMLLiteral>;
                                                                                                 nicebnf:hasTextContent """Before surgery in women who have anaemia due to uterine fibroids

"""^^xsd:string;
                                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                 rdfs:label "before surgery in women who have anaemia due to uterine fibroids"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometrialThinningBeforeIntraUterineSurgery> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometrial thinning before intra-uterine surgery</p>"""^^<rdf:XMLLiteral>;
                                                                                       nicebnf:hasTextContent """Endometrial thinning before intra-uterine surgery

"""^^xsd:string;
                                                                                       a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                       rdfs:label "endometrial thinning before intra-uterine surgery"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#endometriosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Endometriosis</p>"""^^<rdf:XMLLiteral>;
                                                        nicebnf:hasTextContent """Endometriosis

"""^^xsd:string;
                                                        a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                        rdfs:label "endometriosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#locallyAdvancedProstateCancerAsAnAlternativeToSurgicalCastration> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Locally advanced prostate cancer as an alternative to surgical castration</p>"""^^<rdf:XMLLiteral>;
                                                                                                           nicebnf:hasTextContent """Locally advanced prostate cancer as an alternative to surgical castration

"""^^xsd:string;
                                                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                           rdfs:label "locally advanced prostate cancer as an alternative to surgical castration"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#metastaticProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Metastatic prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                   nicebnf:hasTextContent """Metastatic prostate cancer

"""^^xsd:string;
                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                   rdfs:label "metastatic prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#neoadjuvantTreatmentPriorToRadiotherapyInPatientsWithHighRiskLocalisedOrLocallyAdvancedProstateCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                nicebnf:hasTextContent """Neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer

"""^^xsd:string;
                                                                                                                                                a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                rdfs:label "neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#oestrogenReceptorPositiveEarlyBreastCancer> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Oestrogen-receptor-positive early breast cancer</p>"""^^<rdf:XMLLiteral>;
                                                                                     nicebnf:hasTextContent """Oestrogen-receptor-positive early breast cancer

"""^^xsd:string;
                                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                     rdfs:label "oestrogen-receptor-positive early breast cancer"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#pituitaryDesensitisationBeforeInductionOfOvulationByGonadotrophinsForInVitroFertilisationAfterExclusionOfPregnancyUnderExpertSupervision> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (after exclusion of pregnancy) (under expert supervision)</p>"""^^<rdf:XMLLiteral>;
                                                                                                                                                                                   nicebnf:hasTextContent """Pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (after exclusion of pregnancy) (under expert supervision)

"""^^xsd:string;
                                                                                                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                                                                                                   rdfs:label "pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (after exclusion of pregnancy) (under expert supervision)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton> nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#JD7KrRohh06USpXe-OEjQA>,
                                                                                                                  <http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#_ibT1mD0R0-TCkbRw9ddag>;
                                                                         nicebnf:hasTitle """<title>Zomacton<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "zomacton"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#JD7KrRohh06USpXe-OEjQA> nicebnf:hasDitaContent """<sectiondiv>
  <p>For use by subcutaneous injection.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#PHP82125>;
                                                                                                nicebnf:hasTextContent """For use by subcutaneous injection.

"""^^xsd:string;
                                                                                                a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#PHP82125> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#PHP82135> a nicebnf:PrescribingAndDispensingInformations.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#_ibT1mD0R0-TCkbRw9ddag> nicebnf:hasDitaContent """<sectiondiv>
  <p>4 mg vial for use with <i>ZomaJet 2</i><tm tmtype=\"reg\" /><i>Vision</i> needle-free device (non-NHS but available free of charge from clinics) or with needles and syringes.</p>
  <p>10 mg vial for use with <i>ZomaJet Vision X</i><tm tmtype=\"reg\" /> needle-free device (non-NHS but available free of charge from clinics) or with needles and syringes.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zomacton#PHP82135>;
                                                                                                nicebnf:hasTextContent """4 mg vial for use with ZomaJet 2Vision needle-free device (non-NHS but available free of charge from clinics) or with needles and syringes.

10 mg vial for use with ZomaJet Vision X needle-free device (non-NHS but available free of charge from clinics) or with needles and syringes.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion> nicebnf:hasFundingDecision <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#dfomQHwIXEutWoqSO_gZYw>;
                                                                                nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#3m96iHM7Sky5twWdamWidQ>,
                                                                                                              <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#R3Iy4qd_Nkqq_K3RMGoQFQ>;
                                                                                nicebnf:hasTitle """<title>Zometa<tm tmtype=\"reg\" /> infusion</title>"""^^<rdf:XMLLiteral>;
                                                                                a nicebnf:ClinicalMedicinalProductInformation;
                                                                                rdfs:label "zometa infusion"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#3m96iHM7Sky5twWdamWidQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "4 mg every 3–4 weeks, to be administered over at least 15 minutes, calcium 500 mg daily and vitamin d 400 units daily should also be taken."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>4 mg every 3–4 weeks, to be administered over at least 15 minutes, calcium 500 mg daily and vitamin D 400 units daily should also be taken.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """4 mg every 3–4 weeks, to be administered over at least 15 minutes, calcium 500 mg daily and vitamin D 400 units daily should also be taken.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#reductionOfBoneDamageInAdvancedMalignanciesInvolvingBone>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#PHP85426>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#PHP85426> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#PHP85474> a nicebnf:NationalFunding.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#R3Iy4qd_Nkqq_K3RMGoQFQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                          rdfs:label "4 mg for 1 dose, to be administered over at least 15 minutes."^^xsd:string ; 
                                                                                                                          nicebnf:hasDitaContent "<p>4 mg for 1 dose, to be administered over at least 15 minutes.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                          nicebnf:hasTextContent """4 mg for 1 dose, to be administered over at least 15 minutes.

"""^^xsd:string ; 
                                                                                                                          nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion>];
                                                                                                       nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#hypercalcaemiaOfMalignancy>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#PHP85426>;
                                                                                                       a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#dfomQHwIXEutWoqSO_gZYw> nicebnf:hasDitaContent """<sectiondiv>
  <p>The <i>Scottish Medicines Consortium</i> has advised (May 2003) that for the prevention of skeletal related events <i>Zometa</i><tm tmtype=\"reg\" /> is accepted for restricted use within NHS Scotland for the treatment of patients with breast cancer and multiple myeloma if prescribed by an oncologist.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                       nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zometa-infusion#PHP85474>;
                                                                                                       nicebnf:hasTextContent """The Scottish Medicines Consortium has advised (May 2003) that for the prevention of skeletal related events Zometa is accepted for restricted use within NHS Scotland for the treatment of patients with breast cancer and multiple myeloma if prescribed by an oncologist.

"""^^xsd:string;
                                                                                                       a nicebnf:FundingDecision,
                                                                                                         nicebnf:SmcDecisions.
<http://ld.nice.org.uk/ns/bnf/Indication#hypercalcaemiaOfMalignancy> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Hypercalcaemia of malignancy</p>"""^^<rdf:XMLLiteral>;
                                                                     nicebnf:hasTextContent """Hypercalcaemia of malignancy

"""^^xsd:string;
                                                                     a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                     rdfs:label "hypercalcaemia of malignancy"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#reductionOfBoneDamageInAdvancedMalignanciesInvolvingBone> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Reduction of bone damage in advanced malignancies involving bone</p>"""^^<rdf:XMLLiteral>;
                                                                                                   nicebnf:hasTextContent """Reduction of bone damage in advanced malignancies involving bone

"""^^xsd:string;
                                                                                                   a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                                   rdfs:label "reduction of bone damage in advanced malignancies involving bone"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byIntravenousInfusion> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                 rdfs:label "by intravenous infusion"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#ApJ7hIguy0yGdJIsHZr9zQ>;
                                                                         nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#6mzkmhVmNEOH3cDOeqmgHw>;
                                                                         nicebnf:hasTitle """<title>Zostavax<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "zostavax"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#6mzkmhVmNEOH3cDOeqmgHw> nicebnf:hasDitaContent """<sectiondiv>
  <p>Advice in the BNF may differ from that in product literature.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#PHP82301>;
                                                                                                nicebnf:hasTextContent """Advice in the BNF may differ from that in product literature.

"""^^xsd:string;
                                                                                                a nicebnf:PrescribingAndDispensingInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#ApJ7hIguy0yGdJIsHZr9zQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult7079Years> ; 
                                                                                                                   rdfs:label "0.65 ml for 1 dose, to be administered preferably into the deltoid region."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>0.65 mL for 1 dose, to be administered preferably into the deltoid region.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """0.65 mL for 1 dose, to be administered preferably into the deltoid region.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#preventionOfHerpesZosterShingles>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#PHP82266>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#PHP82266> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zostavax#PHP82301> a nicebnf:PrescribingAndDispensingInformations.
<http://ld.nice.org.uk/ns/bnf/Indication#preventionOfHerpesZosterShingles> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Prevention of herpes zoster (shingles)</p>"""^^<rdf:XMLLiteral>;
                                                                           nicebnf:hasTextContent """Prevention of herpes zoster (shingles)

"""^^xsd:string;
                                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                           rdfs:label "prevention of herpes zoster (shingles)"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult7079Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "adult 70–79 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#bySubcutaneousInjection> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                   rdfs:label "by subcutaneous injection"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#UKqYqFL-x0Sbp9EimIiJeg>,
                                                                                                      <http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#dFQaYqM98UOV0xHLw4u8Cw>;
                                                                        nicebnf:hasTitle """<title>Zumenon<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "zumenon"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#PHP97754> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#UKqYqFL-x0Sbp9EimIiJeg> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "initially 1 mg daily, to be started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), increased if necessary to 2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Initially 1 mg daily, to be started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), increased if necessary to 2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Initially 1 mg daily, to be started within 5 days of onset of menstruation (or any time if cycles have ceased or are infrequent), increased if necessary to 2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#PHP97754>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#dFQaYqM98UOV0xHLw4u8Cw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """2 mg daily, to be taken with a cyclical progestogen for 12–14 days of each cycle in women with a uterus.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouth>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zumenon#PHP97754>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#menopausalSymptoms> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>"""^^<rdf:XMLLiteral>;
                                                             nicebnf:hasTextContent """Menopausal symptoms

"""^^xsd:string;
                                                             a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                             rdfs:label "menopausal symptoms"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/Indication#osteoporosisProphylaxis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>"""^^<rdf:XMLLiteral>;
                                                                  nicebnf:hasTextContent """Osteoporosis prophylaxis

"""^^xsd:string;
                                                                  a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                  rdfs:label "osteoporosis prophylaxis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouth> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                   rdfs:label "by mouth"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#zRvfNaUCvUqovTrWqmCOSQ>;
                                                                        nicebnf:hasPrescribingInformationSection <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#2UyOOzsplUq8vxSBJnZ4tg>;
                                                                        nicebnf:hasTitle """<title>Zyclara<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                        a nicebnf:ClinicalMedicinalProductInformation;
                                                                        rdfs:label "zyclara"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#2UyOOzsplUq8vxSBJnZ4tg> nicebnf:hasDitaContent """<sectiondiv>
  <p>Should be rubbed in and allowed to stay on the treated area for 8 hours, then washed off with mild soap and water.</p>
</sectiondiv>"""^^<rdf:XMLLiteral>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#PHP82560>;
                                                                                               nicebnf:hasTextContent """Should be rubbed in and allowed to stay on the treated area for 8 hours, then washed off with mild soap and water.

"""^^xsd:string;
                                                                                               nicebnf:hasTitle "Important"^^xsd:string;
                                                                                               a nicebnf:DirectionForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#PHP82539> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#PHP82560> a nicebnf:DirectionsForAdministration.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#zRvfNaUCvUqovTrWqmCOSQ> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                  rdfs:label "apply once daily for 2 weeks, to be applied at bedtime to lesion on face or balding scalp, repeat course after a 2-week treatment-free interval, assess response 8 weeks after second course; maximum 2 sachets per day."^^xsd:string ; 
                                                                                                                  nicebnf:hasDitaContent "<p>Apply once daily for 2 weeks, to be applied at bedtime to lesion on face or balding scalp, repeat course after a 2-week treatment-free interval, assess response 8 weeks after second course; maximum 2 sachets per day.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                  nicebnf:hasTextContent """Apply once daily for 2 weeks, to be applied at bedtime to lesion on face or balding scalp, repeat course after a 2-week treatment-free interval, assess response 8 weeks after second course; maximum 2 sachets per day.

"""^^xsd:string ; 
                                                                                                                  nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                               nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis>;
                                                                                               nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyclara#PHP82539>;
                                                                                               a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#actinicKeratosis> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Actinic keratosis</p>"""^^<rdf:XMLLiteral>;
                                                           nicebnf:hasTextContent """Actinic keratosis

"""^^xsd:string;
                                                           a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                           rdfs:label "actinic keratosis"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zydol-xl> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zydol-xl#Sm6DpMubdkaOMY_rRx0d9g>;
                                                                         nicebnf:hasTitle """<title>Zydol<tm tmtype=\"reg\" /> XL</title>"""^^<rdf:XMLLiteral>;
                                                                         a nicebnf:ClinicalMedicinalProductInformation;
                                                                         rdfs:label "zydol xl"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zydol-xl#PHP80357> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zydol-xl#Sm6DpMubdkaOMY_rRx0d9g> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> ; 
                                                                                                                   rdfs:label "initially 150 mg once daily, increased if necessary up to 400 mg once daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 150 mg once daily, increased if necessary up to 400 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 150 mg once daily, increased if necessary up to 400 mg once daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets>],
                                                                                                                  [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                   rdfs:label "initially 150 mg once daily, increased if necessary up to 400 mg once daily."^^xsd:string ; 
                                                                                                                   nicebnf:hasDitaContent "<p>Initially 150 mg once daily, increased if necessary up to 400 mg once daily.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                   nicebnf:hasTextContent """Initially 150 mg once daily, increased if necessary up to 400 mg once daily.

"""^^xsd:string ; 
                                                                                                                   nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets>];
                                                                                                nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePain>;
                                                                                                nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zydol-xl#PHP80357>;
                                                                                                a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#moderateToSeverePain> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Moderate to severe pain</p>"""^^<rdf:XMLLiteral>;
                                                               nicebnf:hasTextContent """Moderate to severe pain

"""^^xsd:string;
                                                               a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                               rdfs:label "moderate to severe pain"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#child1217Years> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                           rdfs:label "child 12–17 years"^^xsd:string;
                                                           rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#child>.
<http://ld.nice.org.uk/ns/bnf/Specificity#byMouthUsingModifiedReleaseTablets> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                                              rdfs:label "by mouth using modified-release tablets"^^xsd:string.

@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>.
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#>.
@prefix xsd: <http://www.w3.org/2001/XMLSchema#>.
@prefix nicebnf: <http://ld.nice.org.uk/ns/bnf#>.
@prefix bnfsite: <http://bnf.nice.org.uk/>.

<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyomet> nicebnf:hasIndicationsAndDose <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyomet#p_NGENehpEqXrs8NDjByAw>;
                                                                       nicebnf:hasTitle """<title>Zyomet<tm tmtype=\"reg\" /></title>"""^^<rdf:XMLLiteral>;
                                                                       a nicebnf:ClinicalMedicinalProductInformation;
                                                                       rdfs:label "zyomet"^^xsd:string.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyomet#PHP84282> a nicebnf:IndicationAndDosageInformation.
<http://bnf.nice.org.uk/clinical-medicinal-product-information/zyomet#p_NGENehpEqXrs8NDjByAw> nicebnf:hasDosage [nicebnf:hasPatientGroup <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> ; 
                                                                                                                 rdfs:label "apply twice daily for 8–9 weeks, to be applied thinly."^^xsd:string ; 
                                                                                                                 nicebnf:hasDitaContent "<p>Apply twice daily for 8–9 weeks, to be applied thinly.</p>"^^<rdf:XMLLiteral> ; 
                                                                                                                 nicebnf:hasTextContent """Apply twice daily for 8–9 weeks, to be applied thinly.

"""^^xsd:string ; 
                                                                                                                 nicebnf:hasSpecificity <http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin>];
                                                                                              nicebnf:hasIndication <http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea>;
                                                                                              nicebnf:hasSubject <http://bnf.nice.org.uk/clinical-medicinal-product-information/zyomet#PHP84282>;
                                                                                              a nicebnf:IndicationsAndDose.
<http://ld.nice.org.uk/ns/bnf/Indication#acuteInflammatoryExacerbationOfRosacea> nicebnf:hasDitaContent """<p outputclass=\"therapeuticIndication\">Acute inflammatory exacerbation of rosacea</p>"""^^<rdf:XMLLiteral>;
                                                                                 nicebnf:hasTextContent """Acute inflammatory exacerbation of rosacea

"""^^xsd:string;
                                                                                 a <http://ld.nice.org.uk/ns/bnf/Indication>;
                                                                                 rdfs:label "acute inflammatory exacerbation of rosacea"^^xsd:string.
<http://ld.nice.org.uk/ns/bnf/PatientGroup#adult> a <http://ld.nice.org.uk/ns/bnf/PatientGroup>;
                                                  rdfs:label "adult"^^xsd:string;
                                                  rdfs:subClassOf <http://ld.nice.org.uk/ns/bnf/PatientGroup#adult>.
<http://ld.nice.org.uk/ns/bnf/Specificity#toTheSkin> a <http://ld.nice.org.uk/ns/bnf/Specificity>;
                                                     rdfs:label "to the skin"^^xsd:string.

